data_1ckv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ckv _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.455 ' HA ' HG12 ' A' ' 12' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.224 0.535 . . . . 0.0 111.49 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.5 -15.89 60.36 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.848 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.03 -9.25 2.2 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.333 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.455 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.1 pp -60.4 -19.2 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-N 117.538 0.669 . . . . 0.0 112.069 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.91 9.64 11.69 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.041 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.04 -43.8 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.732 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.58 -80.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 110.989 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.43 -14.49 26.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.438 0.637 . . . . 0.0 111.512 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.8 -18.03 62.35 Favored Glycine 0 C--N 1.312 -0.805 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.895 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.22 81.11 1.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 110.878 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 9.2 t0 -138.67 8.36 2.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.515 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.46 ' CG ' ' O ' ' A' ' 19' ' ' ASP . 13.3 p90 46.91 73.93 0.17 Allowed 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.8 0.81 . . . . 0.0 111.087 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.56 -8.44 38.19 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.602 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -90.13 11.85 19.64 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.032 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.239 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.88 0.371 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.0 m -74.37 145.23 43.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.884 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -86.26 106.32 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.884 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 40' ' ' LEU . 13.5 t -118.3 154.09 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.328 0.585 . . . . 0.0 111.832 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.679 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -177.93 125.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.265 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.03 135.22 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.668 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.505 ' HB3' HG12 ' A' ' 48' ' ' ILE . 3.5 tp -125.73 139.52 53.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.639 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -50.76 139.61 16.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.129 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.466 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -87.52 87.65 7.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.396 0.617 . . . . 0.0 110.462 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -125.78 170.64 11.39 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.543 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.67 -12.13 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.993 0.425 . . . . 0.0 110.34 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.504 ' HG3' ' CD2' ' A' ' 96' ' ' LEU . 1.4 tt0 -80.82 -58.11 3.24 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.342 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.573 ' HA ' ' CD2' ' A' ' 51' ' ' PHE . 1.4 mp -63.86 -44.89 98.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.963 0.411 . . . . 0.0 110.241 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -40.49 -59.85 1.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.058 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.404 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 58.5 m -69.96 -68.47 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.007 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.604 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -42.66 -47.01 5.23 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.565 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.5 tp -55.87 -47.97 79.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.165 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.485 ' O ' ' CD2' ' A' ' 57' ' ' LEU . 1.6 pt-20 -53.29 -48.78 68.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 109.755 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.455 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.3 OUTLIER -70.64 -81.6 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.67 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.595 HG21 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -22.02 -57.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.689 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.4 mp -74.22 -66.0 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -63.41 -33.12 74.85 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -177.251 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.516 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 70.0 p -62.93 -66.2 0.58 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.338 0.59 . . . . 0.0 110.757 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.61 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -83.24 -46.35 12.78 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.689 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 49.6 m-85 -69.04 -24.71 64.21 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.99 -51.48 5.32 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.657 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 58' ' ' THR . 13.6 ttpt -60.68 -43.16 98.05 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.271 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 62' ' ' LYS . 2.0 p30 179.76 103.8 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.103 0.477 . . . . 0.0 111.753 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 59' ' ' ASP . 0.9 OUTLIER 178.51 -52.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.027 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.413 ' N ' HG13 ' A' ' 64' ' ' VAL . 5.1 m-20 178.86 141.56 0.28 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.738 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.55 -10.41 10.87 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.698 2.265 . . . . 0.0 111.956 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -78.3 -106.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.61 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.522 ' CG1' ' CD2' ' A' ' 60' ' ' TYR . 9.7 p 26.56 49.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.359 0.599 . . . . 0.0 111.629 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -82.32 136.52 35.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.199 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.75 153.76 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.041 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 7.9 mm-40 -142.44 116.28 9.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.188 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -86.38 114.52 23.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.571 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.423 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 21.4 mmt180 -103.17 -120.67 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.973 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.78 -54.04 50.92 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.862 0.363 . . . . 0.0 111.133 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.83 -39.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.644 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -79.93 162.5 24.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.673 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.552 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 22.8 m95 -90.92 142.71 27.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.154 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.518 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.4 m0 -106.52 102.4 11.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.266 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -97.01 107.41 19.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.174 0.511 . . . . 0.0 110.411 -179.184 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.9 143.71 49.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.455 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.499 ' HA ' ' OG1' ' A' ' 67' ' ' THR . . . -143.4 158.51 43.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.296 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -102.94 132.84 48.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.865 0.364 . . . . 0.0 111.438 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.52 -68.21 3.47 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.001 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.449 ' HA ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -176.46 152.89 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 110.691 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -133.69 157.92 42.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 12.5 pt-20 -147.75 122.27 9.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.467 . . . . 0.0 111.825 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.601 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 29.2 t -94.74 137.16 23.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.59 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 18.0 p30 -84.31 151.93 24.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.893 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.465 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 21.4 t -109.83 100.55 9.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.131 0.491 . . . . 0.0 109.849 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 0.8 OUTLIER 161.5 -35.87 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.079 -179.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.02 -70.35 0.36 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.826 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.604 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.5 tt -57.8 -58.93 4.23 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.191 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 t -44.75 -34.76 2.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.798 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.6 mm-40 -60.9 -48.22 82.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.542 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -90.23 -16.98 28.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.725 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.504 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.33 10.19 41.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 98' ' ' ARG . . . 125.46 70.72 0.19 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.117 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -30.72 147.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.149 0.5 . . . . 0.0 111.834 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.45 17.91 11.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.038 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -165.19 0.05 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.933 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.21 -167.88 1.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.513 HG21 ' CD1' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -113.14 -43.89 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.719 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -2.57 16.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.36 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.83 -40.79 22.25 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.878 0.37 . . . . 0.0 110.264 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.431 ' CE1' HG12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -83.4 146.36 28.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.788 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.414 ' O ' ' CG ' ' A' ' 106' ' ' LEU . 3.5 tt 64.51 14.76 9.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 111.179 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.2 p -74.17 -44.88 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.813 0.34 . . . . 0.0 111.07 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.6 p30 178.54 54.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.67 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.0 -166.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -43.61 -40.15 3.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.154 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 170.52 149.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.846 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 37.1 p -157.75 84.9 0.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.4 mm -77.16 114.5 17.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.434 0.635 . . . . 0.0 111.395 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 143.89 142.01 3.87 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.029 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 126' ' ' THR . 23.4 ttt180 -77.1 120.1 21.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.614 0.245 . . . . 0.0 110.44 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.76 125.39 50.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.077 0.465 . . . . 0.0 112.202 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.464 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 3.5 p90 -131.63 127.42 36.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.101 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.448 ' HB ' HG23 ' A' ' 102' ' ' VAL . 11.7 t -100.26 149.35 23.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.344 0.592 . . . . 0.0 112.097 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.408 ' CD1' ' O ' ' A' ' 119' ' ' LEU . 3.3 pp -146.62 118.11 7.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.663 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.14 -104.29 0.51 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.981 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -133.06 83.68 2.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.028 0.442 . . . . 0.0 109.932 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.3 OUTLIER 152.95 115.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.471 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.601 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -104.21 138.46 40.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.988 0.423 . . . . 0.0 110.789 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 17.8 p -114.13 133.33 55.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.315 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.431 HG12 ' CE1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -113.82 117.56 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.819 0.818 . . . . 0.0 110.565 179.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 115' ' ' ARG . 8.8 t -100.54 156.37 17.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.748 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.44 ' CB ' HG11 ' A' ' 38' ' ' VAL . 8.9 t -142.36 17.27 2.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.348 0.594 . . . . 0.0 109.555 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 N--CA 1.446 -0.655 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.14 -178.714 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.466 ' HA ' HG12 ' A' ' 12' ' ' ILE . 4.1 m-20 . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.114 0.483 . . . . 0.0 111.408 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.73 -16.74 56.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.389 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.6 -8.91 2.7 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.261 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.466 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.1 pp -61.09 -19.84 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 117.626 0.713 . . . . 0.0 111.852 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.435 ' HB2' ' HE1' ' A' ' 13' ' ' MET . 0.0 OUTLIER -84.72 8.5 16.85 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.789 178.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.11 -43.5 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.33 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.19 -80.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.68 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.74 11.19 32.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.064 0.459 . . . . 0.0 111.17 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -112.62 -17.17 8.2 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.145 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -128.54 80.83 1.99 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.027 0.442 . . . . 0.0 110.42 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -142.51 13.71 1.96 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.36 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -86.51 6.23 31.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 0.0 111.095 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.34 -177.15 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.344 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 t0 65.29 13.35 8.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.197 0.522 . . . . 0.0 110.017 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.815 179.939 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 CA--C 1.53 0.195 0 CA-C-O 120.613 0.244 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.3 m -67.59 153.52 43.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.957 0.408 . . . . 0.0 111.124 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.441 HG23 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -102.23 112.61 36.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.676 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.7 t -129.11 152.05 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.436 0.636 . . . . 0.0 112.436 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.779 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -159.84 129.96 5.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.778 178.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.84 134.42 54.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.281 0.562 . . . . 0.0 111.998 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.53 ' HB3' HG12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -126.29 140.32 52.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.434 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -52.53 129.0 27.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.46 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -75.29 90.0 2.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.498 0.666 . . . . 0.0 110.617 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 47' ' ' GLU . 3.3 m -126.01 171.09 11.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.442 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.54 -16.25 0.21 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.048 0.451 . . . . 0.0 110.047 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.483 ' HG3' ' CG ' ' A' ' 96' ' ' LEU . 6.8 tt0 -72.6 -63.47 1.15 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.175 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.575 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 1.6 mp -61.31 -44.16 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.294 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -40.82 -59.05 1.51 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.807 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.4 m -75.56 -62.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.941 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.641 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -44.34 -48.42 9.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.398 -179.075 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -57.62 -47.77 84.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.879 0.371 . . . . 0.0 110.432 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -53.21 -49.47 66.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.253 0.549 . . . . 0.0 109.601 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.3 OUTLIER -69.86 -82.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.54 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.574 HG21 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -21.66 -58.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.646 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.4 mp -73.51 -66.3 0.71 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -63.32 -30.54 71.66 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 72.0 p -62.89 -66.8 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.283 0.563 . . . . 0.0 110.611 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.625 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 65.6 m-20 -83.66 -44.86 14.07 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.646 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 66.9 m-85 -70.07 -21.63 63.14 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -93.84 -47.97 6.5 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.864 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.5 OUTLIER -58.01 -48.57 79.63 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.752 0.31 . . . . 0.0 110.814 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.439 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER 179.31 99.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.289 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.625 ' HB ' ' O ' ' A' ' 59' ' ' ASP . 0.9 OUTLIER -172.23 -50.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.764 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 177.41 143.97 0.27 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 0.0 111.935 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -85.29 -3.31 9.45 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.824 2.349 . . . . 0.0 111.71 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.526 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 1.1 t -82.84 -109.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.44 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.531 ' CG1' ' CD2' ' A' ' 60' ' ' TYR . 10.0 p 26.8 49.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 121.379 0.609 . . . . 0.0 111.606 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -82.05 139.0 34.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.133 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 78' ' ' TRP . 0.5 OUTLIER -97.67 153.45 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.031 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -142.38 116.12 9.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.249 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -86.17 114.51 23.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.735 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 5.7 mmt180 -95.64 -111.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.968 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.9 -38.23 64.43 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.867 0.365 . . . . 0.0 111.128 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.46 -37.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.417 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.95 162.55 23.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.752 0.311 . . . . 0.0 110.551 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.575 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 10.3 m95 -94.11 142.84 26.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.521 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.488 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 9.0 m0 -107.56 108.73 20.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.133 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.779 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.04 113.58 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.173 0.511 . . . . 0.0 110.338 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -122.39 140.23 52.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.526 ' HA ' ' OG1' ' A' ' 67' ' ' THR . . . -142.86 138.65 30.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.765 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.55 108.2 10.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.046 0.45 . . . . 0.0 111.455 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 104.03 -62.31 0.4 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.082 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.441 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 178.04 162.13 0.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.066 0.46 . . . . 0.0 111.353 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.421 HG21 ' HB2' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -136.67 159.61 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.13 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 0.1 OUTLIER -142.75 118.2 10.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.146 0.498 . . . . 0.0 111.468 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.612 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 17.4 t -94.4 128.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.826 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 2.6 m-20 -77.3 151.97 34.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.153 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 22.5 t -106.26 100.62 10.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.136 0.493 . . . . 0.0 109.906 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 9.3 t0 160.3 -35.69 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.823 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -70.83 -72.87 0.19 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.943 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.641 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.3 tt -56.56 -57.85 7.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.0 p -45.43 -36.61 4.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.755 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -58.34 -46.79 85.56 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.122 0.486 . . . . 0.0 110.239 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -90.26 -17.2 27.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.474 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.483 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -99.77 13.17 34.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.81 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' A' ' 100' ' ' PHE . . . 118.99 67.94 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.18 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -33.56 150.41 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.208 0.528 . . . . 0.0 111.99 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.52 19.02 10.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.373 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.412 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -77.24 -166.52 0.74 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.049 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -93.5 -169.47 2.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.882 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.569 HG21 ' CD1' ' A' ' 123' ' ' PHE . 1.4 p -111.64 -34.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.118 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -79.91 3.91 18.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.477 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.6 -38.22 80.66 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.705 0.288 . . . . 0.0 110.947 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -64.05 -43.04 96.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.765 0.316 . . . . 0.0 110.76 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.463 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 1.3 tp -106.73 26.03 10.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.218 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.0 p -73.69 -24.39 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.9 0.381 . . . . 0.0 110.947 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -171.57 -86.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.458 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 110' ' ' SER . 43.0 t 55.9 160.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.056 0.455 . . . . 0.0 111.601 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.417 ' N ' HG13 ' A' ' 109' ' ' VAL . 30.3 t -55.14 -47.89 74.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.053 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.56 150.93 9.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -156.73 74.31 0.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.049 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' A' ' 113' ' ' ILE . 5.1 mm -62.34 106.2 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.349 0.595 . . . . 0.0 111.23 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 148.39 140.28 3.3 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.046 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 126' ' ' THR . 61.3 ttp85 -76.7 126.01 30.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.614 0.245 . . . . 0.0 110.643 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.456 ' CB ' HG22 ' A' ' 125' ' ' ILE . . . -104.43 125.36 50.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.031 0.443 . . . . 0.0 112.007 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 1.7 p90 -128.32 120.79 27.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.8 t -98.37 161.25 13.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.343 0.592 . . . . 0.0 112.008 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -169.94 133.6 1.21 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.32 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.92 -110.78 1.21 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.681 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -134.33 84.02 2.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 7.6 mttt 153.73 117.39 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.489 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.612 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -104.72 137.75 42.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.063 0.458 . . . . 0.0 110.84 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 55.2 m -112.72 126.05 54.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.028 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.456 HG22 ' CB ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -110.94 117.42 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.859 0.838 . . . . 0.0 111.131 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 115' ' ' ARG . 5.2 t -115.23 154.27 29.36 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.995 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.5 t -147.55 25.85 1.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.343 0.592 . . . . 0.0 109.679 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.653 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.044 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.494 ' HA ' HG12 ' A' ' 12' ' ' ILE . 0.6 OUTLIER . . . . . 0 CA--C 1.52 -0.207 0 CA-C-O 121.256 0.55 . . . . 0.0 111.461 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.86 -21.72 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.529 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.51 -10.72 4.85 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.233 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.0 pp -61.16 -21.35 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-N 117.595 0.697 . . . . 0.0 111.842 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.57 8.99 22.62 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.775 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.412 ' HA2' ' CB ' ' A' ' 18' ' ' LYS . . . -136.09 -49.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.502 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mp -61.67 -81.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 110.866 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 10.04 26.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.007 0.432 . . . . 0.0 111.431 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.93 -26.45 3.83 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.961 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -128.9 81.49 2.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.142 0.496 . . . . 0.0 110.332 179.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -116.97 -27.27 6.6 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.367 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -92.76 15.47 14.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.363 . . . . 0.0 111.402 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.63 -6.37 58.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.221 0.534 . . . . 0.0 111.768 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -88.97 12.06 16.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.444 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.204 179.69 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.876 0.37 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.8 m -70.07 139.92 52.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -86.27 99.32 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.879 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.9 t -107.52 146.07 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.255 0.55 . . . . 0.0 112.321 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 6.3 mp -150.34 109.8 4.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.058 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.51 128.09 64.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.327 0.584 . . . . 0.0 112.193 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.507 ' HB3' HD13 ' A' ' 48' ' ' ILE . 24.8 mt -127.07 140.26 52.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.6 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.29 125.72 14.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.744 0.307 . . . . 0.0 111.765 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.487 ' HD2' ' CE2' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -57.36 87.71 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.267 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.635 ' C ' ' H ' ' A' ' 47' ' ' GLU . 33.2 m -125.02 170.16 11.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.381 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.37 11.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.635 ' H ' ' C ' ' A' ' 45' ' ' SER . 1.9 tt0 -98.84 -57.68 2.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.976 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.595 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 0.8 OUTLIER -61.23 -44.49 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.302 0.573 . . . . 0.0 109.613 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -39.43 -62.0 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.126 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 56.7 m -65.41 -74.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.62 ' CD2' ' HB ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -40.97 -58.78 1.62 Allowed 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.574 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.6 tp -41.72 -46.67 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.02 0.438 . . . . 0.0 109.963 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.459 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -57.36 -53.49 57.49 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.476 ' HA ' HG21 ' A' ' 58' ' ' THR . 35.5 mt-10 -66.55 -94.61 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.949 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.613 HG21 ' H ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -18.55 -58.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.747 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -62.96 -77.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.459 ' CD2' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -63.68 -16.08 60.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.476 HG21 ' HA ' ' A' ' 54' ' ' GLU . 6.3 p -65.01 -74.38 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.297 0.57 . . . . 0.0 110.137 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.572 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 8.7 m-20 -82.56 -32.71 28.39 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.858 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.747 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 78.1 m-85 -71.81 -32.04 67.18 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.78 -46.08 11.74 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.026 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 58' ' ' THR . 10.1 ttpt -57.85 -48.85 78.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.84 0.352 . . . . 0.0 110.821 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.448 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER 179.55 101.63 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 59' ' ' ASP . 0.9 OUTLIER -177.55 -52.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.063 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -177.1 138.99 0.43 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.772 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.48 3.07 8.09 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.673 2.249 . . . . 0.0 112.275 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 1.3 t -91.81 -114.1 0.09 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.108 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.565 HG13 ' CD2' ' A' ' 60' ' ' TYR . 8.4 p 28.46 43.47 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.115 0.484 . . . . 0.0 112.246 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.42 138.86 31.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.054 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.22 151.04 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-O 121.243 0.544 . . . . 0.0 111.659 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.764 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -143.42 116.89 9.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.02 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -80.19 124.29 28.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.461 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.441 ' HG3' ' CD2' ' A' ' 78' ' ' TRP . 5.2 mmt-85 -111.45 -117.4 0.3 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.64 -82.98 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -133.12 17.53 4.56 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.187 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.7 155.99 44.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.786 0.326 . . . . 0.0 110.688 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.595 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 73.7 m95 -76.4 125.89 30.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.29 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.764 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.1 m0 -96.62 106.59 18.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.663 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.58 122.12 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.194 -178.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -128.58 136.22 50.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.692 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.484 ' HA ' ' OG1' ' A' ' 67' ' ' THR . . . -142.75 153.48 43.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.835 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.0 129.52 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.644 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.96 -67.62 2.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.256 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.495 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 179.31 157.14 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.636 -179.272 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.411 HG12 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.97 154.76 15.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 11.7 pt-20 -141.03 124.57 16.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.05 0.452 . . . . 0.0 111.304 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.55 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 39.1 t -94.35 129.37 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.922 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 6.8 m-20 -76.41 151.78 36.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.911 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.452 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 27.8 t -108.9 100.79 9.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.138 0.495 . . . . 0.0 109.908 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.5 m-20 160.17 -36.13 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.17 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -71.28 -69.19 0.39 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.0 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.62 ' HB ' ' CD2' ' A' ' 51' ' ' PHE . 1.1 tt -59.21 -51.49 71.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.713 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.9 p -52.74 -33.59 48.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.454 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -62.22 -46.58 88.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.973 0.416 . . . . 0.0 111.078 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -90.18 -20.07 23.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.056 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.447 HD22 ' HG3' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -98.19 10.03 41.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.961 0.41 . . . . 0.0 111.018 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.42 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 129.67 69.11 0.11 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.231 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.5 158.82 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.072 0.463 . . . . 0.0 111.24 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 63.32 17.62 10.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.902 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER -75.66 -168.57 0.87 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.706 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -130.39 150.9 51.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.999 0.428 . . . . 0.0 111.236 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.539 HG21 ' CD1' ' A' ' 123' ' ' PHE . 7.7 p -64.66 166.79 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.779 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' A' ' 102' ' ' VAL . 1.2 m-85 71.62 7.16 5.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.049 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -79.7 -30.06 40.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 110.329 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.51 ' CE1' ' CD2' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -80.85 -0.58 39.58 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.278 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.71 29.5 1.12 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.832 0.349 . . . . 0.0 110.792 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.2 -32.88 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.246 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -174.73 36.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.736 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.9 m -69.5 167.91 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.563 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.1 m -47.52 -47.25 27.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.22 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.34 166.27 2.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 1.2 t 177.31 103.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.295 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.5 mm -81.93 117.49 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.389 0.614 . . . . 0.0 111.155 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.31 141.82 3.95 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.994 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.94 119.76 21.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.68 0.276 . . . . 0.0 110.492 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -107.28 125.39 51.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.978 0.418 . . . . 0.0 111.86 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 20.2 p90 -132.28 125.68 31.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.712 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.421 HG21 ' CE2' ' A' ' 103' ' ' TYR . 14.0 t -91.17 150.26 21.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.306 0.574 . . . . 0.0 111.985 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 pp -155.31 115.7 3.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.568 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.34 -106.75 1.11 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.535 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.47 83.52 2.02 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.1 OUTLIER 153.94 99.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.034 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.55 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 3.2 p90 -90.96 133.5 35.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.082 0.468 . . . . 0.0 110.721 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 2.4 p -108.0 141.02 40.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.436 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -118.38 117.4 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.913 0.863 . . . . 0.0 110.825 178.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 115' ' ' ARG . 4.5 t -97.95 155.99 16.83 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.52 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.439 ' CB ' HG11 ' A' ' 38' ' ' VAL . 13.2 t -147.28 20.52 1.21 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.257 0.551 . . . . 0.0 109.857 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.651 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.117 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.438 ' HA ' ' CD1' ' A' ' 12' ' ' ILE . 1.1 m-20 . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 121.638 0.733 . . . . 0.0 112.566 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.463 ' O ' ' CE ' ' A' ' 13' ' ' MET . . . -59.64 -7.97 1.78 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.598 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.37 -19.63 6.58 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.792 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.486 ' C ' ' HG3' ' A' ' 13' ' ' MET . 2.0 pp -108.18 66.88 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.486 ' HG3' ' C ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -139.47 14.96 2.56 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.884 178.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.431 ' HA2' ' CB ' ' A' ' 18' ' ' LYS . . . -127.7 -41.8 0.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.24 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 mp -60.85 -75.41 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.782 0.325 . . . . 0.0 110.749 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 9.39 43.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.84 -24.48 5.51 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.859 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.431 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -128.0 81.3 2.01 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.106 0.479 . . . . 0.0 110.074 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -121.12 -36.87 3.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.374 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.47 14.93 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.541 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.28 -173.68 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.901 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.56 13.9 5.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.03 0.443 . . . . 0.0 110.657 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.035 179.766 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.696 0.284 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.7 m -72.24 145.42 47.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.024 0.44 . . . . 0.0 111.125 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.514 HG23 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -89.32 102.31 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.154 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 t -116.23 153.33 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.331 0.586 . . . . 0.0 111.669 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.869 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -173.1 128.26 0.46 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.285 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.464 ' CG1' ' CD1' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -112.44 134.71 54.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.177 0.513 . . . . 0.0 111.662 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB3' HG12 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -126.52 139.96 52.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.465 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.45 129.17 21.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.51 ' HD3' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -75.72 90.17 2.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.796 0.808 . . . . 0.0 110.433 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 47' ' ' GLU . 1.1 t -126.27 171.01 11.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.449 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.11 -14.47 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.529 ' HG2' ' N ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -71.79 -61.56 1.74 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.221 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.6 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 1.5 mp -64.64 -43.22 96.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.092 0.472 . . . . 0.0 109.844 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -40.05 -58.18 1.49 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.727 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.411 ' HB ' HD13 ' A' ' 95' ' ' LEU . 1.2 m -78.11 -61.98 1.82 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.106 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.636 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -45.01 -44.44 9.96 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.517 -178.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.556 ' HA ' ' CG2' ' A' ' 55' ' ' ILE . 1.6 tp -62.2 -47.45 93.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.041 0.448 . . . . 0.0 109.868 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.629 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -53.91 -37.31 63.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.102 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.422 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.9 OUTLIER -83.8 -75.57 0.33 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.53 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.632 HG21 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -31.22 -54.07 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.62 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -76.92 -41.21 44.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -177.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.629 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.44 -47.18 12.56 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.498 -178.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.674 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 51.4 p -52.72 -68.91 0.13 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.485 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.445 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 0.5 OUTLIER -91.87 -33.8 14.78 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.62 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 7.5 m-85 -82.99 -3.12 56.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.455 -0.898 . . . . 0.0 113.091 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 2.3 tptt -115.99 -42.52 3.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.104 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.674 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -58.87 -51.27 70.76 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.573 0.225 . . . . 0.0 111.311 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.439 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -179.42 89.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.235 0.54 . . . . 0.0 111.862 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.454 ' CG1' ' CE1' ' A' ' 60' ' ' TYR . 24.4 t -160.12 -52.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.19 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 4.8 m-20 171.54 132.22 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.267 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 65' ' ' ASN . 4.7 Cg_exo -78.57 -18.36 12.14 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.658 2.239 . . . . 0.0 111.929 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -51.94 -50.84 60.38 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.4 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.567 ' CG1' ' HG ' ' A' ' 56' ' ' LEU . 78.2 t -43.83 87.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.651 0.262 . . . . 0.0 111.43 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 67' ' ' THR . 18.1 p30 -116.56 138.9 51.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.803 0.335 . . . . 0.0 111.613 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 78' ' ' TRP . 1.3 p -102.71 153.69 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.102 0.477 . . . . 0.0 111.662 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -142.82 129.72 20.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.432 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.51 114.89 20.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.935 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -89.92 -146.76 0.18 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.734 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.15 -22.42 60.88 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 111.398 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.14 -35.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.627 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.5 159.7 17.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 110.795 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.6 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 45.8 m95 -83.46 142.67 30.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.447 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.557 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 7.6 m0 -112.58 110.34 20.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.483 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.869 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -100.41 118.48 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.209 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -126.6 136.76 52.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.487 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.444 ' CB ' HG22 ' A' ' 85' ' ' ILE . . . -143.63 158.85 43.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.827 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.42 135.96 49.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.229 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.69 -69.43 2.92 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.143 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.514 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 178.76 160.9 0.66 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.965 0.412 . . . . 0.0 111.245 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.56 HG12 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -152.04 157.04 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.582 179.226 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 7.3 pt-20 -141.38 125.6 17.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.039 0.447 . . . . 0.0 111.708 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.517 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 6.2 t -94.76 127.21 46.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.546 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.408 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 5.3 m-20 -76.44 152.42 36.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.102 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.543 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -107.47 100.06 9.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.392 0.615 . . . . 0.0 109.671 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.439 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER 164.6 -36.3 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.115 -179.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -73.09 -72.25 0.26 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.666 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.636 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -55.86 -59.66 2.49 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.908 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.453 ' CB ' ' CZ ' ' A' ' 100' ' ' PHE . 16.3 p -44.03 -37.08 2.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -57.47 -48.68 78.55 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.141 0.496 . . . . 0.0 110.401 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.411 HD13 ' HB ' ' A' ' 50' ' ' THR . 2.7 tm? -90.75 -19.13 23.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.555 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.479 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -91.07 9.65 30.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . 110.47 74.24 0.76 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.593 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -38.63 162.94 0.0 OUTLIER 'General case' 0 CA--C 1.526 0.037 0 CA-C-O 121.14 0.495 . . . . 0.0 111.377 -179.348 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.439 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 19.1 pt20 47.84 98.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.66 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.453 ' CZ ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -160.04 -152.69 0.3 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.603 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -124.2 124.36 42.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.887 0.375 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.435 HG21 ' CD1' ' A' ' 123' ' ' PHE . 12.5 p -53.79 166.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.242 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 80.48 -2.21 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -60.47 -30.45 69.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.467 ' CD1' ' CE2' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -76.94 -30.02 55.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.34 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.442 HD22 ' CE1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -108.97 21.44 17.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.207 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.2 p -87.32 -37.08 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 0.0 111.277 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 168.82 88.48 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.802 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.55 83.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.11 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.8 t 66.74 -63.99 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.195 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.68 163.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.995 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 20.5 p -160.16 83.39 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' A' ' 113' ' ' ILE . 8.4 mm -66.58 110.27 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.56 0.695 . . . . 0.0 111.192 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 146.61 148.09 4.7 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.597 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 126' ' ' THR . 1.8 mmm180 -76.6 120.05 21.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.452 ' CB ' HG22 ' A' ' 125' ' ' ILE . . . -108.14 125.22 51.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.063 0.459 . . . . 0.0 112.144 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 11.4 p90 -136.33 118.52 15.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.412 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.7 t -91.21 134.92 34.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.189 0.519 . . . . 0.0 111.731 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.6 pp -134.01 115.92 14.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.797 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.05 -106.16 0.84 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.992 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 89' ' ' CYS . 0.5 OUTLIER -133.16 83.97 2.1 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.073 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.499 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.2 OUTLIER 152.25 95.14 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.455 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.517 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 24.0 p90 -88.12 126.62 35.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.015 0.436 . . . . 0.0 111.151 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 12.2 p -102.87 136.14 43.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.149 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.56 ' CD1' HG12 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -116.09 118.4 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.778 0.799 . . . . 0.0 111.232 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 115' ' ' ARG . 11.3 t -98.2 156.1 16.85 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.16 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' A' ' 127' ' ' SER . 0.5 OUTLIER -140.13 13.61 2.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.448 0.642 . . . . 0.0 109.54 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.445 -0.701 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.104 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.418 ' HA ' HG12 ' A' ' 12' ' ' ILE . 3.6 m-20 . . . . . 0 N--CA 1.461 0.109 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.14 -16.93 41.78 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.638 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.18 -13.11 2.44 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.959 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 9' ' ' ASP . 1.9 pp -56.73 -23.61 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 117.732 0.766 . . . . 0.0 111.854 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.73 8.21 17.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.866 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 18' ' ' LYS . . . -135.55 -38.07 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.469 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.66 -74.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.672 0.272 . . . . 0.0 111.127 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.5 9.13 41.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.582 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.88 -24.85 4.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.135 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.459 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 4.5 tmtt? -130.93 85.63 2.29 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.698 0.761 . . . . 0.0 110.321 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -128.04 2.51 5.89 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.471 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.2 18.0 7.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.877 0.37 . . . . 0.0 111.536 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.88 -178.16 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.042 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.96 11.08 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.904 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.041 179.763 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.85 0.357 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 m -67.69 140.85 56.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.449 ' CG1' ' CG2' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -97.18 131.22 44.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.987 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 113' ' ' ILE . 8.9 t -129.88 140.06 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 5.6 tp -128.5 104.33 7.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.481 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.417 ' CG2' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -111.74 126.85 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.24 0.543 . . . . 0.0 111.259 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 1.5 mt -126.69 140.9 52.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.684 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.7 OUTLIER -51.81 119.07 3.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.666 0.27 . . . . 0.0 111.054 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HD2' ' NE1' ' A' ' 77' ' ' TRP . 0.1 OUTLIER -46.79 91.97 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.529 ' C ' ' H ' ' A' ' 47' ' ' GLU . 13.6 m -125.38 169.36 12.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.914 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -67.03 3.69 1.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.561 ' HG2' ' CD1' ' A' ' 48' ' ' ILE . 1.4 tt0 -90.02 -59.32 2.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.801 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.604 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 0.5 OUTLIER -55.33 -43.72 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 121.171 0.51 . . . . 0.0 109.878 179.287 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -42.45 -61.59 1.17 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.342 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 83.8 m -68.43 -75.43 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.578 ' CD1' ' CG2' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -39.12 -62.02 0.69 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 119.687 -0.197 . . . . 0.0 111.5 -178.317 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -42.16 -46.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.983 0.421 . . . . 0.0 110.049 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.452 ' O ' ' CD2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -56.66 -53.64 55.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.459 ' HA ' HG21 ' A' ' 58' ' ' THR . 8.3 mt-10 -66.91 -94.42 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.016 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.631 HG21 ' H ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -18.74 -61.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.757 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -61.46 -76.22 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.486 ' HA ' HD11 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -64.12 -15.49 59.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 3.3 p -63.37 -75.39 0.08 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.204 0.525 . . . . 0.0 110.013 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.581 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 2.1 p30 -85.77 -31.47 22.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.768 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.757 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 86.1 m-85 -73.64 -29.46 62.35 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.23 -0.588 . . . . 0.0 112.048 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -86.43 -45.05 11.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.641 179.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.5 ttmt -55.58 -51.65 66.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.432 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.443 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER 179.62 100.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.939 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.581 ' HB ' ' O ' ' A' ' 59' ' ' ASP . 0.9 OUTLIER -177.52 -55.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.348 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.472 ' N ' HG13 ' A' ' 64' ' ' VAL . 4.4 m-20 178.69 129.92 0.22 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.846 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -86.63 -16.9 3.56 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.86 2.373 . . . . 0.0 112.111 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 82' ' ' ASN . 1.8 t -55.26 -39.49 69.86 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.551 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.629 HG13 ' CD1' ' A' ' 60' ' ' TYR . 11.6 p -66.02 65.81 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.406 0.622 . . . . 0.0 110.893 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -101.04 143.32 31.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.887 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.414 HG22 ' CD1' ' A' ' 79' ' ' ILE . 0.5 OUTLIER -95.65 149.67 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.483 0.658 . . . . 0.0 111.693 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.56 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 1.6 tp10 -143.66 125.97 15.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.529 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -84.66 115.45 22.67 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.225 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.427 ' HB2' ' CG ' ' A' ' 78' ' ' TRP . 0.1 OUTLIER -96.38 -114.39 0.13 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.417 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.77 -80.54 0.05 OUTLIER 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.783 0.325 . . . . 0.0 111.581 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.82 -24.84 2.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.037 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -102.52 162.6 12.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.752 0.31 . . . . 0.0 110.842 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.604 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 83.4 m95 -76.05 122.72 24.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.269 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.56 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.6 m0 -96.56 107.63 20.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.683 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.676 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -96.94 137.48 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.435 -178.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -128.81 136.0 49.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.316 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.403 ' O ' HG22 ' A' ' 38' ' ' VAL . . . -143.31 157.89 44.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.712 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -104.82 135.41 46.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.4 . . . . 0.0 110.701 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.63 -67.08 0.28 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.786 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 126' ' ' THR . 0.0 OUTLIER 178.14 173.57 0.62 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.116 0.484 . . . . 0.0 111.311 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.469 ' O ' ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -152.36 162.37 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.419 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 0.4 OUTLIER -129.23 121.94 28.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.183 0.516 . . . . 0.0 111.551 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.606 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 55.0 t -94.36 125.29 47.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.564 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -76.81 151.82 35.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.028 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.465 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 17.1 t -108.5 100.68 9.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 3.1 m-20 161.01 -32.95 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.09 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -74.34 -70.81 0.37 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.009 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.554 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -58.46 -51.61 69.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.589 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.2 p -52.68 -35.29 55.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.523 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -60.15 -44.65 94.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.928 0.394 . . . . 0.0 110.806 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -90.27 -21.6 22.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.761 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.466 HD22 ' HG3' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.46 12.26 35.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.901 0.382 . . . . 0.0 111.218 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.16 66.44 0.13 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.591 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.34 152.56 0.02 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 65.48 18.12 11.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.46 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -166.15 0.25 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.994 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -121.88 140.7 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' A' ' 123' ' ' PHE . 11.9 p -56.82 163.59 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.004 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.448 ' CE2' ' CG2' ' A' ' 118' ' ' THR . 0.9 OUTLIER 70.07 9.67 7.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.278 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.43 -32.48 24.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.365 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.43 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -66.66 -33.03 74.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.511 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.62 33.3 5.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.707 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.9 p -63.24 -40.55 89.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.414 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -174.65 81.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.856 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 t -127.73 165.67 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.036 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 t -43.3 -46.16 6.22 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.477 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.417 ' CB ' ' CG2' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -172.49 151.08 2.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.825 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 35.5 p -156.27 99.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.242 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.453 HD12 HG12 ' A' ' 125' ' ' ILE . 1.1 mp 59.75 -77.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.542 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 112' ' ' THR . . . 170.98 -100.07 0.15 Allowed Glycine 0 C--N 1.309 -0.925 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.173 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -93.25 129.76 39.2 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.469 ' CA ' HG21 ' A' ' 125' ' ' ILE . . . -122.47 136.37 54.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 36.5 p90 -136.44 116.74 13.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.253 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.448 ' CG2' ' CE2' ' A' ' 103' ' ' TYR . 14.1 t -86.38 151.19 23.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.818 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 pp -159.96 116.21 2.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.822 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.63 -110.47 2.8 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.713 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -132.85 83.85 2.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 1.9 mtpp 152.52 95.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.795 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.606 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 6.5 p90 -88.31 124.07 33.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.177 0.513 . . . . 0.0 110.785 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.443 ' HB ' ' CZ ' ' A' ' 117' ' ' TYR . 17.2 m -98.37 125.85 43.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.463 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.469 HG21 ' CA ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -102.05 117.23 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.009 0.909 . . . . 0.0 111.02 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' ARG . 9.7 t -97.43 155.38 16.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.967 -1.469 . . . . 0.0 110.513 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.429 ' OG ' HG11 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -136.83 14.85 3.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 109.668 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.446 -0.675 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.298 -178.352 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.465 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.5 p30 . . . . . 0 CA--C 1.519 -0.212 0 CA-C-O 121.169 0.509 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.24 -16.91 60.43 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.779 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.12 -9.92 2.33 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.377 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.465 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.1 pp -60.48 -19.73 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 117.466 0.633 . . . . 0.0 112.087 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.41 ' HB2' ' HE1' ' A' ' 13' ' ' MET . 0.0 OUTLIER -84.14 8.81 14.39 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.015 178.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -136.68 -52.77 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.401 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.51 -80.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.308 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 10.76 30.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 111.18 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.33 -21.18 5.95 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.05 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -128.05 80.69 1.98 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 110.373 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.468 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 17.7 t0 -128.04 -25.42 3.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.346 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 19' ' ' ASP . 9.2 p90 47.93 74.82 0.15 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.722 0.772 . . . . 0.0 111.11 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.29 -9.65 59.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.505 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.82 11.49 22.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.81 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.117 179.791 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.814 0.34 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.8 m -88.61 148.4 24.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.789 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.46 HG23 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -93.0 103.13 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.402 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 t -111.72 149.78 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.092 0.472 . . . . 0.0 111.423 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 5.7 mp -155.06 105.19 2.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.397 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -113.22 127.56 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.141 0.496 . . . . 0.0 112.269 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.509 ' HB2' ' CD1' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -128.53 147.19 50.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.181 178.137 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -48.86 132.28 18.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.13 89.95 0.46 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.499 0.666 . . . . 0.0 110.683 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -126.15 170.86 11.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.515 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -51.65 -14.24 0.32 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.534 ' HG2' ' CD1' ' A' ' 48' ' ' ILE . 11.6 tt0 -66.72 -70.98 0.21 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.252 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.614 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 0.8 OUTLIER -59.15 -43.65 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 121.183 0.516 . . . . 0.0 109.727 178.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -39.6 -59.06 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.407 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.6 m -78.85 -62.02 1.83 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.064 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.626 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -43.96 -47.26 8.5 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.324 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.62 ' HA ' ' CG2' ' A' ' 55' ' ' ILE . 1.7 tp -61.55 -47.11 94.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.025 0.44 . . . . 0.0 110.34 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.63 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 pt-20 -53.85 -41.72 67.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.567 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.434 ' O ' ' CG2' ' A' ' 58' ' ' THR . 1.0 OUTLIER -81.32 -66.86 0.83 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.0 0.429 . . . . 0.0 111.0 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.62 ' CG2' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -37.25 -58.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.63 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -75.13 -35.9 61.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -177.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -81.87 -46.82 13.58 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.65 -178.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.694 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 68.7 p -52.17 -70.17 0.09 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.381 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.445 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 2.5 m-20 -92.79 -32.52 14.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.63 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 2.4 m-85 -80.53 -6.01 57.58 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.839 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -113.96 -41.24 3.58 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.933 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.694 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.2 ttmt -57.61 -51.17 70.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.66 0.267 . . . . 0.0 111.43 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.453 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER 179.4 88.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 111.395 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 59' ' ' ASP . 20.9 t -156.44 -54.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.399 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.424 ' HB3' HG21 ' A' ' 67' ' ' THR . 4.6 m-20 169.86 149.36 0.14 Allowed Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.912 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -89.76 -20.72 1.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.192 2.595 . . . . 0.0 112.88 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -46.89 -65.52 0.55 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.211 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.579 HG12 ' CG ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -42.1 87.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.117 179.324 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.1 p30 -116.07 142.28 47.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.474 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.441 HG22 HD11 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.74 149.72 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.083 0.468 . . . . 0.0 111.029 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.713 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 17.1 mt-10 -143.35 116.05 8.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.35 114.34 26.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.905 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -101.06 -80.88 0.49 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.67 -73.36 0.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.87 0.366 . . . . 0.0 111.422 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.08 -42.15 0.19 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.518 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -83.27 164.26 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.394 . . . . 0.0 110.737 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.614 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 30.5 m95 -88.38 136.31 33.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.325 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.713 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 12.5 m0 -103.94 107.1 17.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.485 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.713 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -96.47 121.7 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -126.73 136.29 52.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.027 0.442 . . . . 0.0 111.654 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.427 ' CB ' HG22 ' A' ' 85' ' ' ILE . . . -143.53 158.67 43.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.783 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.55 139.17 47.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.866 0.365 . . . . 0.0 111.243 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.79 -69.56 3.03 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.025 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.46 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -179.05 158.4 0.91 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.948 0.404 . . . . 0.0 111.128 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.467 HG12 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -146.03 152.23 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 0.7 OUTLIER -135.41 123.01 22.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 111.428 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.543 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 24.3 t -94.61 136.68 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.826 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 8.6 t70 -76.72 152.03 35.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.957 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 10.6 t -109.59 101.08 10.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.155 0.502 . . . . 0.0 109.888 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.3 m-20 160.21 -36.38 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.3 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -71.76 -71.96 0.25 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.198 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.626 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.1 tt -57.71 -56.65 14.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.1 t -45.6 -35.94 4.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.655 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.436 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.2 mm-40 -60.93 -46.82 89.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.095 0.474 . . . . 0.0 110.508 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.88 -14.66 33.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.528 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.457 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -103.32 10.55 37.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.439 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 140.13 67.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.673 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -32.48 135.0 0.09 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.019 0.438 . . . . 0.0 111.618 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.23 17.3 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.602 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.5 OUTLIER -70.13 -171.62 0.47 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.591 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -132.99 151.68 52.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.061 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 123' ' ' PHE . 11.5 p -57.82 160.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.016 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 79.7 9.7 1.48 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.138 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -92.94 -23.33 18.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.958 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.504 ' CE1' ' CE2' ' A' ' 123' ' ' PHE . 1.0 OUTLIER -79.62 -37.89 35.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.134 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.79 29.67 6.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p -81.63 -44.49 20.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.995 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -179.98 88.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.77 81.41 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.065 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 t 68.95 -63.59 0.36 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.978 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m 174.05 160.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 2.0 p -163.91 94.8 0.77 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.0 mm -71.35 120.03 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.231 0.538 . . . . 0.0 111.13 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.94 137.2 3.45 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.032 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.1 OUTLIER -77.42 119.59 21.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.644 0.259 . . . . 0.0 110.321 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.56 125.46 49.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 0.0 112.014 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 13.1 p90 -128.91 121.18 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.364 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.4 t -95.96 153.56 17.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.363 0.602 . . . . 0.0 112.128 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.473 ' O ' ' CD2' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -163.59 123.7 2.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.436 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.04 -109.88 2.85 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.121 -1.037 . . . . 0.0 111.487 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -138.37 83.95 2.0 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 2.0 mtpm? 154.29 100.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.674 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.543 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 1.7 p90 -88.76 137.29 32.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.972 0.415 . . . . 0.0 111.006 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 23.9 m -110.6 129.38 55.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.246 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -110.22 117.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.859 0.838 . . . . 0.0 110.814 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.9 t -96.52 156.46 16.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.552 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.408 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.46 16.92 2.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.495 0.664 . . . . 0.0 109.555 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 N--CA 1.445 -0.692 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.296 -178.827 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.547 ' HA ' ' CD1' ' A' ' 12' ' ' ILE . 1.6 p-10 . . . . . 0 CA--C 1.513 -0.48 0 CA-C-O 121.209 0.528 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.55 -32.21 42.13 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.833 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.44 -40.52 47.71 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.286 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.593 ' O ' ' N ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -108.27 9.85 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 120.234 -0.587 . . . . 0.0 111.764 178.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.519 ' CE ' ' HA ' ' A' ' 13' ' ' MET . 0.0 OUTLIER 59.2 -62.99 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.647 0.737 . . . . 0.0 112.344 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -166.78 25.04 0.14 Allowed Glycine 0 C--N 1.3 -1.451 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.934 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.2 mt -82.64 -81.89 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.665 0.269 . . . . 0.0 110.958 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.03 8.57 37.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.033 0.444 . . . . 0.0 111.159 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.83 -20.89 5.56 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.049 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -128.49 81.01 2.0 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.339 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.01 8.95 3.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.534 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.506 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -84.08 2.15 40.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.163 0.506 . . . . 0.0 111.04 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.65 -170.76 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.063 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 t70 62.32 14.28 6.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.163 0.506 . . . . 0.0 110.339 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.955 179.748 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.985 0.421 . . . . 0.0 110.472 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.412 HG21 ' N ' ' A' ' 38' ' ' VAL . 88.4 m -93.46 148.24 22.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.266 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -85.69 97.9 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.477 179.379 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.31 150.85 13.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.337 0.589 . . . . 0.0 112.163 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.802 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.12 119.79 3.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.764 178.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.46 126.51 70.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.173 0.511 . . . . 0.0 111.85 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.468 ' HB3' HD13 ' A' ' 48' ' ' ILE . 7.6 mp -126.76 140.43 52.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.606 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -48.45 133.06 16.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.497 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -78.32 87.62 4.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.502 0.668 . . . . 0.0 110.99 -179.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 47' ' ' GLU . 21.8 m -126.4 170.99 11.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.887 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -14.12 0.17 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.289 0.566 . . . . 0.0 109.583 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HG3' ' CD2' ' A' ' 96' ' ' LEU . 12.2 tt0 -70.12 -71.6 0.23 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.327 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.585 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -59.18 -45.0 93.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.136 0.493 . . . . 0.0 110.073 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -38.78 -53.4 1.68 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.059 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 73.8 m -72.48 -74.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.643 ' CD1' HG23 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -41.23 -44.47 2.63 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.585 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -56.04 -48.08 79.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.223 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 3.0 pt-20 -52.14 -50.31 61.99 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HA ' HG21 ' A' ' 58' ' ' THR . 6.9 mt-10 -68.76 -87.89 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.536 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.643 HG23 ' CD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.13 -62.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -65.6 -70.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -64.4 -23.85 67.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.554 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 15.5 p -60.42 -70.95 0.15 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.337 0.589 . . . . 0.0 110.784 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.481 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -86.88 -36.72 18.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.345 -178.054 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.735 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 97.7 m-85 -76.66 -13.57 60.04 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -103.94 -41.02 6.0 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.198 178.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 58' ' ' THR . 3.8 ttpt -68.32 -50.07 56.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.071 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.461 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -177.4 87.0 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 121.379 0.609 . . . . 0.0 112.524 179.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.735 ' HB ' ' HA ' ' A' ' 60' ' ' TYR . 25.4 t -161.92 -54.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.495 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.428 ' HB3' HG21 ' A' ' 67' ' ' THR . 4.6 m-20 169.48 144.38 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.4 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -86.26 -20.87 2.62 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.897 2.398 . . . . 0.0 112.485 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 69' ' ' ASN . 4.6 t -51.77 -48.74 63.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.234 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.587 ' CG1' ' HG ' ' A' ' 56' ' ' LEU . 54.3 t -53.56 82.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.872 0.367 . . . . 0.0 110.635 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 67' ' ' THR . 19.5 p30 -116.06 142.73 46.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.495 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -96.82 153.89 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.267 0.556 . . . . 0.0 111.575 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -142.05 124.48 15.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.501 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.24 114.22 18.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.959 0.409 . . . . 0.0 110.771 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.457 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -90.49 -150.83 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.644 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.94 -49.74 76.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.673 0.273 . . . . 0.0 111.065 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.08 15.82 1.02 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.203 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.57 161.17 38.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.953 0.376 . . . . 0.0 111.081 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.566 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 63.4 m95 -85.44 143.37 28.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.499 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.3 m0 -116.72 105.7 12.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.634 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.802 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.52 112.22 30.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 0.0 110.155 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -112.34 135.41 53.06 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.218 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.45 ' CB ' HG22 ' A' ' 85' ' ' ILE . . . -144.65 158.65 43.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.015 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 67' ' ' THR . 0.0 OUTLIER -104.6 148.64 26.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.98 0.419 . . . . 0.0 111.298 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.94 -70.11 0.3 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.171 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.48 ' HA ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 178.97 159.68 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.371 . . . . 0.0 110.935 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.456 HG12 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.6 160.3 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 9.1 pt-20 -138.91 127.63 23.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.166 0.507 . . . . 0.0 111.636 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.627 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 27.5 t -94.52 146.2 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.533 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -88.98 152.04 21.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.043 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.454 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 42.7 t -109.49 101.03 10.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.234 0.54 . . . . 0.0 109.908 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 0.9 OUTLIER 161.11 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.226 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.34 -69.52 0.53 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.958 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.584 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.3 tt -62.2 -56.02 20.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.314 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.0 t -45.24 -32.43 1.93 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.389 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -63.5 -61.28 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.002 0.43 . . . . 0.0 110.493 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -17.24 60.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.909 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.531 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -101.89 8.32 41.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.293 -179.237 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.45 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 143.04 65.93 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.562 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -33.57 133.61 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.968 0.413 . . . . 0.0 111.736 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 70.14 17.34 7.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.638 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.45 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -66.33 -175.5 0.36 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.61 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -85.5 -95.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.769 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.408 HG21 ' CD1' ' A' ' 123' ' ' PHE . 10.1 p 179.4 -35.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.682 0.277 . . . . 0.0 111.284 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.448 ' CE2' ' CG2' ' A' ' 118' ' ' THR . 5.0 m-85 -72.81 -2.67 21.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.079 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -46.18 -39.44 9.69 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.874 0.369 . . . . 0.0 110.584 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.447 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -75.47 143.51 42.55 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.915 179.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 tt 62.06 18.57 10.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.187 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.8 -42.27 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.794 0.33 . . . . 0.0 111.038 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -179.95 51.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.703 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -113.08 85.87 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.487 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.8 -65.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.151 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 109' ' ' VAL . 6.6 t 168.65 172.37 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.765 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER 179.27 120.87 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.882 0.372 . . . . 0.0 111.505 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.1 mm -87.52 122.83 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.331 0.586 . . . . 0.0 111.059 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.87 141.6 3.88 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.984 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 126' ' ' THR . 41.7 mtt-85 -77.24 120.11 21.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.36 123.84 48.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.162 0.506 . . . . 0.0 112.156 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.473 ' CZ ' ' OG1' ' A' ' 124' ' ' THR . 13.5 p90 -137.73 119.49 15.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.369 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.448 ' CG2' ' CE2' ' A' ' 103' ' ' TYR . 14.7 t -93.99 136.24 34.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.118 0.485 . . . . 0.0 111.85 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.1 pp -135.07 118.75 17.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.76 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.73 -106.63 1.02 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.88 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.37 83.4 2.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.881 0.372 . . . . 0.0 110.118 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 3.7 mttt 152.3 97.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.592 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.627 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 15.1 p90 -88.26 126.31 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.423 . . . . 0.0 111.124 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 19.6 p -102.13 137.38 40.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.867 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.456 ' CD1' HG12 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -119.36 118.24 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.78 0.8 . . . . 0.0 111.268 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 115' ' ' ARG . 10.3 t -98.04 156.06 16.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.472 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.429 ' CB ' HG11 ' A' ' 38' ' ' VAL . 13.2 t -143.4 19.83 1.88 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.41 0.624 . . . . 0.0 109.489 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 N--CA 1.446 -0.644 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.019 -178.633 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.41 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.9 p30 . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 121.259 0.552 . . . . 0.0 111.511 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.42 -16.16 60.89 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.763 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.99 -10.98 1.89 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.308 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.41 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.0 pp -58.66 -20.84 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 117.482 0.641 . . . . 0.0 112.019 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.41 ' HB2' ' HE1' ' A' ' 13' ' ' MET . 0.0 OUTLIER -82.05 7.53 13.08 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.972 178.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.3 24.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.718 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 mp -133.62 -83.09 0.46 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.66 0.266 . . . . 0.0 110.673 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.71 7.57 38.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.142 0.496 . . . . 0.0 111.017 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -119.29 -25.17 2.76 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.536 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.89 85.48 2.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.7 0.762 . . . . 0.0 110.008 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -138.65 12.77 2.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.466 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.01 13.96 5.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.856 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.99 -174.29 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.783 0.325 . . . . 0.0 110.776 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.0 t0 62.09 13.84 6.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.997 0.427 . . . . 0.0 110.84 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.23 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.705 0.288 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.0 m -90.66 142.86 27.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 0.0 111.178 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.459 HG11 ' CB ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -93.97 92.75 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.858 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.43 145.26 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.363 0.602 . . . . 0.0 111.99 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.778 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.22 129.48 7.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.008 179.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.94 129.36 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.213 0.53 . . . . 0.0 111.731 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.499 ' HB3' HG12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -127.24 140.3 52.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.874 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -49.27 127.54 15.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HD3' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -73.14 92.2 1.7 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.73 0.776 . . . . 0.0 110.74 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.444 ' C ' ' N ' ' A' ' 47' ' ' GLU . 6.9 m -126.2 171.12 11.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.207 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -49.95 -16.8 0.31 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.608 ' HG2' ' N ' ' A' ' 48' ' ' ILE . 12.5 tt0 -65.46 -74.26 0.11 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.509 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.608 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 2.2 mp -54.7 -31.92 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.2 0.524 . . . . 0.0 109.912 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -47.5 -61.68 1.81 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.51 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.9 m -82.09 -44.78 16.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.056 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -52.52 -48.85 65.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.737 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.573 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.6 tp -62.53 -48.52 87.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.061 0.458 . . . . 0.0 109.964 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.676 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -50.54 -47.47 57.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.402 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' O ' ' OG1' ' A' ' 58' ' ' THR . 28.7 mt-10 -77.77 -71.05 0.44 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.343 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.573 HG23 ' CE1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -30.64 -59.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.667 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -78.91 -50.16 11.65 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.676 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 3.1 mm? -65.03 -48.25 74.56 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 119.312 0.96 . . . . 0.0 111.376 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 46.0 p -53.0 -71.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.018 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.435 ' N ' ' OG1' ' A' ' 58' ' ' THR . 9.1 m-20 -62.35 -18.17 60.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.964 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.667 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -51.24 -78.1 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.694 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -19.7 64.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.086 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 58' ' ' THR . 4.8 ttpp -59.73 -70.38 0.17 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.021 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.91 21.73 0.17 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.522 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 65' ' ' ASN . 43.1 t -98.38 -78.36 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.625 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.526 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 4.8 m-20 154.51 170.82 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.048 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 80.8 Cg_endo -88.62 -7.39 5.62 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.972 2.448 . . . . 0.0 111.955 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -64.62 -85.33 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.878 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -28.97 86.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.635 0.731 . . . . 0.0 111.815 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.2 p30 -115.91 143.28 45.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.563 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.413 ' CG2' ' HB3' ' A' ' 77' ' ' TRP . 1.5 p -96.27 151.0 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.321 0.581 . . . . 0.0 111.559 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 16.4 pt-20 -144.92 135.38 24.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.551 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -79.85 114.56 18.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.783 0.325 . . . . 0.0 110.434 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -85.09 -78.47 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.996 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.31 -66.73 0.68 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.0 3.85 8.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.676 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.6 158.1 44.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.808 0.337 . . . . 0.0 110.823 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.605 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 78.2 m95 -77.29 142.99 39.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.546 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.584 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.5 m0 -114.8 109.85 18.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.356 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.778 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -100.02 116.17 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.191 0.52 . . . . 0.0 111.382 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -111.72 134.63 53.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.122 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.425 ' HB2' HG21 ' A' ' 85' ' ' ILE . . . -144.43 158.76 43.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.898 0.38 . . . . 0.0 111.556 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -109.18 143.34 38.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.921 179.198 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.93 -69.05 0.62 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.483 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.449 ' HA ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -177.07 152.31 0.89 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.213 0.53 . . . . 0.0 111.728 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.477 HG12 ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -125.79 160.47 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 17.2 pt-20 -147.24 125.86 12.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.499 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 38.2 t -95.48 146.9 6.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.673 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 8.9 p30 -101.54 151.82 21.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.639 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.628 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 1.2 t -105.34 99.85 9.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.296 0.57 . . . . 0.0 110.186 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.1 m-20 159.75 -37.58 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.954 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -69.93 -75.82 0.11 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.635 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.547 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.6 tt -52.88 -56.42 7.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.505 ' CB ' ' CE1' ' A' ' 100' ' ' PHE . 56.0 p -46.14 -43.3 14.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.0 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -51.14 -45.81 61.75 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 109.959 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.2 -18.77 23.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.591 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.474 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.32 19.31 13.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.193 0.521 . . . . 0.0 110.746 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 98' ' ' ARG . . . 99.79 68.56 0.88 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.494 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -30.05 148.07 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.084 0.468 . . . . 0.0 111.895 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 55.3 105.59 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.412 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -175.46 -158.85 0.07 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.632 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.09 132.39 35.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.165 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.475 HG21 ' CD1' ' A' ' 123' ' ' PHE . 5.9 p -81.51 -28.59 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.806 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.462 ' CE2' ' CG2' ' A' ' 118' ' ' THR . 4.0 m-85 -77.44 -2.82 37.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.749 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.02 -35.87 5.17 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-O 120.876 0.369 . . . . 0.0 110.62 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.454 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -80.66 134.35 35.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.152 179.31 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 3.9 tt 75.46 7.68 3.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.862 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.4 p -86.02 -36.84 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.828 0.347 . . . . 0.0 111.255 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -178.43 48.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.616 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -113.41 86.17 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.261 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.97 -65.78 0.21 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.942 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 109' ' ' VAL . 5.9 t 165.44 169.81 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.524 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -179.18 133.84 0.12 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.976 0.417 . . . . 0.0 111.513 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.0 mm -104.85 113.71 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.54 0.686 . . . . 0.0 110.94 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 152.45 146.85 4.45 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.132 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.29 127.25 32.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.64 0.257 . . . . 0.0 110.594 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.408 ' CB ' HG22 ' A' ' 125' ' ' ILE . . . -115.72 124.66 51.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.088 0.47 . . . . 0.0 111.766 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 23.6 p90 -136.92 118.95 15.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.854 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.462 ' CG2' ' CE2' ' A' ' 103' ' ' TYR . 11.0 t -95.35 152.66 18.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.217 0.532 . . . . 0.0 111.498 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.7 pp -148.41 116.46 6.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.893 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.06 -104.17 0.37 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.188 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.628 ' ND2' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -129.61 83.97 2.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.24 0.543 . . . . 0.0 109.653 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 8.6 mttt 148.73 112.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.998 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.564 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 9.5 p90 -109.18 124.38 50.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.069 0.461 . . . . 0.0 110.817 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 7.3 p -100.49 141.72 32.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.643 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.454 HG12 ' CZ ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -120.82 117.61 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.87 0.843 . . . . 0.0 111.296 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 115' ' ' ARG . 12.8 t -103.61 155.47 18.52 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.105 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.459 ' CB ' HG11 ' A' ' 38' ' ' VAL . 30.1 t -144.41 18.96 1.71 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.301 0.572 . . . . 0.0 109.855 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 N--CA 1.447 -0.606 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.459 -178.647 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 121.126 0.489 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.58 -26.5 62.63 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.527 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.28 -26.22 14.52 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.731 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.436 HG13 ' N ' ' A' ' 13' ' ' MET . 0.7 OUTLIER -92.29 -26.33 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.79 0.805 . . . . 0.0 110.664 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.436 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER 28.7 46.07 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.79 -1.55 . . . . 0.0 113.34 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.2 -89.41 0.08 OUTLIER Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.184 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -44.01 -69.61 0.13 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.738 0.304 . . . . 0.0 111.415 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.61 -6.42 27.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.192 0.52 . . . . 0.0 111.642 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.16 -13.35 42.75 Favored Glycine 0 C--N 1.313 -0.723 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.704 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.45 81.55 2.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.133 0.492 . . . . 0.0 110.632 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -137.6 12.01 2.96 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.354 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.05 15.16 6.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.71 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.98 -171.69 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.849 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.71 14.22 4.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.06 0.457 . . . . 0.0 110.568 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.978 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.837 0.351 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.9 m -69.11 143.56 54.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.071 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.502 HG23 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -87.64 98.89 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.69 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 113' ' ' ILE . 7.2 t -117.17 152.82 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.314 0.578 . . . . 0.0 111.881 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.767 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -164.53 128.09 2.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.085 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.42 130.7 65.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.251 0.548 . . . . 0.0 111.927 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.537 ' HB3' HG12 ' A' ' 48' ' ' ILE . 9.0 tp -128.04 140.49 51.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.816 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -47.17 124.53 6.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.569 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.466 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -71.68 90.36 1.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.501 0.667 . . . . 0.0 110.655 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.475 ' C ' ' N ' ' A' ' 47' ' ' GLU . 3.7 m -125.72 171.79 10.34 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.198 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -48.11 -17.77 0.15 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.269 0.557 . . . . 0.0 109.526 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.556 ' HG2' ' N ' ' A' ' 48' ' ' ILE . 25.7 tt0 -63.23 -77.42 0.05 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.468 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.59 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 2.3 mp -54.62 -31.74 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -47.03 -60.23 2.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.276 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.9 m -84.17 -45.59 12.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.054 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.617 ' CE1' HG23 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -51.44 -47.64 62.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.513 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.5 tp -63.66 -49.04 83.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.062 0.458 . . . . 0.0 109.818 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -50.78 -45.04 58.9 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.802 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.455 ' O ' ' OG1' ' A' ' 58' ' ' THR . 3.2 mt-10 -77.25 -77.19 0.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.695 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.617 HG23 ' CE1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -30.98 -55.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.641 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 7.0 tt -71.28 -60.52 2.19 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 2.6 mm? -66.85 -48.23 69.5 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 51.8 p -51.98 -71.82 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.062 0.458 . . . . 0.0 110.279 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.438 ' N ' ' OG1' ' A' ' 58' ' ' THR . 6.3 m-20 -60.59 -23.21 64.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.891 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.641 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -47.32 -78.0 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -67.91 -26.17 65.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.297 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.0 ttpp -52.02 -66.54 0.37 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.872 0.367 . . . . 0.0 111.281 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -169.76 30.39 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.255 0.55 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 65' ' ' ASN . 24.1 t -101.68 -78.63 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.348 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 64' ' ' VAL . 5.1 m-20 154.49 165.92 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 O-C-N 123.523 0.514 . . . . 0.0 110.946 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 94.7 Cg_endo -86.19 -3.54 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.79 2.327 . . . . 0.0 111.922 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.461 ' O ' ' C ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -68.82 -86.75 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.44 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.555 HG23 ' HG ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -24.29 89.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.559 0.695 . . . . 0.0 111.895 -179.405 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -116.04 143.1 45.92 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.04 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 77' ' ' TRP . 1.5 p -96.73 153.06 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.146 0.498 . . . . 0.0 111.547 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 27.6 tt0 -143.83 133.09 23.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.991 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.65 114.37 21.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.295 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -94.3 -81.67 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.318 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.42 -69.21 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.835 0.35 . . . . 0.0 111.354 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.55 5.45 7.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.034 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.66 153.91 43.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 110.889 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.59 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 82.7 m95 -76.83 143.07 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.62 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.51 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.3 m0 -111.3 105.03 13.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.339 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.767 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.81 110.56 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.028 0.442 . . . . 0.0 110.824 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -112.13 135.71 52.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.066 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -144.09 156.9 44.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.417 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.423 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 0.5 OUTLIER -109.07 128.93 55.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.449 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.04 -67.67 3.12 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.327 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.502 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -178.61 152.38 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.252 0.548 . . . . 0.0 111.619 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.473 HG12 ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -127.08 160.21 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 2.3 pt-20 -149.39 125.69 10.81 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.547 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.595 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 62.1 t -95.3 146.48 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.476 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 6.7 t70 -95.72 151.41 19.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.408 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.491 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 7.6 t -104.01 100.02 9.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.111 0.482 . . . . 0.0 110.082 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.2 m-20 157.7 -36.43 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.337 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -76.41 0.1 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.543 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.528 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 2.8 tt -54.05 -56.5 9.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.357 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.9 p -47.58 -36.05 10.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.876 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.45 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -57.83 -46.21 85.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.109 0.481 . . . . 0.0 110.053 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.5 -18.46 25.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.626 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 47' ' ' GLU . 1.1 mm? -98.67 14.03 30.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.054 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.6 68.09 0.37 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.063 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -33.07 149.86 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.088 0.47 . . . . 0.0 111.97 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.63 17.99 9.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.324 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -165.36 0.4 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.939 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -96.0 -162.76 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.574 HG21 ' CD1' ' A' ' 123' ' ' PHE . 1.5 p -117.44 -32.07 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.084 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -81.58 5.77 17.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.579 0.228 . . . . 0.0 111.474 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.6 -39.32 87.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.651 0.262 . . . . 0.0 110.811 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.414 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -66.87 -14.03 62.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.13 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.01 35.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.786 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.8 p -87.18 -32.94 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.112 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -176.85 38.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.407 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.6 m -69.56 165.81 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.644 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.9 m -54.51 -46.79 73.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.004 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.3 140.85 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 1.4 p -149.75 75.35 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 39' ' ' VAL . 4.9 mm -58.99 106.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.48 0.657 . . . . 0.0 111.007 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.56 144.98 4.26 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.878 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 126' ' ' THR . 19.6 mtm180 -76.55 125.8 29.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.801 0.334 . . . . 0.0 110.736 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.418 ' CB ' HG22 ' A' ' 125' ' ' ILE . . . -104.04 125.28 50.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.965 0.412 . . . . 0.0 111.658 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 13.9 p90 -133.91 120.58 20.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.772 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.5 t -97.11 158.45 15.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.237 0.541 . . . . 0.0 111.929 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.0 pp -157.42 118.06 3.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.793 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.8 -106.35 0.86 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.817 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -132.55 83.85 2.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.5 OUTLIER 152.37 110.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.191 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.595 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 2.1 p90 -101.6 132.33 47.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.236 0.541 . . . . 0.0 111.132 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 30.4 m -106.98 134.43 50.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.747 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.418 HG22 ' CB ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -117.32 117.45 55.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.711 0.767 . . . . 0.0 111.011 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.9 t -109.57 155.16 21.76 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.943 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.433 ' CB ' HG12 ' A' ' 38' ' ' VAL . 28.8 t -142.63 21.97 1.99 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.354 0.597 . . . . 0.0 109.705 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.446 -0.674 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.106 -178.806 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.496 ' HA ' HG12 ' A' ' 12' ' ' ILE . 28.8 m-20 . . . . . 0 CA--C 1.519 -0.222 0 CA-C-O 121.135 0.493 . . . . 0.0 111.666 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.37 -22.52 54.73 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.625 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.29 -7.63 5.78 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.266 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.496 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.2 pp -61.33 -18.64 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 117.567 0.683 . . . . 0.0 111.793 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.19 9.33 13.07 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.91 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.99 -46.92 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.319 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -74.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.68 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -101.83 11.42 38.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.095 0.474 . . . . 0.0 111.161 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -112.55 -16.08 9.05 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.081 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.03 80.71 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.026 0.441 . . . . 0.0 110.531 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -142.67 7.61 1.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.669 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.84 18.19 7.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.812 0.339 . . . . 0.0 111.426 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.46 -174.26 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.908 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.2 t0 62.42 12.95 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.101 0.477 . . . . 0.0 110.912 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.961 179.728 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.664 0.268 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.5 m -120.47 144.56 47.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.859 0.362 . . . . 0.0 111.007 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.439 HG11 ' CB ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -101.45 106.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.498 179.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 113' ' ' ILE . 12.4 t -121.47 150.32 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 121.42 0.629 . . . . 0.0 112.252 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.765 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -164.78 130.96 2.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.865 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.403 HG21 ' HB3' ' A' ' 111' ' ' SER . 0.0 OUTLIER -112.65 128.92 69.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.262 0.553 . . . . 0.0 111.863 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.674 ' HB3' ' CG1' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -128.18 148.4 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.356 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.61 153.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.852 0.358 . . . . 0.0 111.381 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.438 ' HA ' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -90.7 22.35 3.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.599 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -71.52 171.64 11.0 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.068 -178.544 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -49.39 -14.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.57 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 1.4 tt0 -63.82 -76.82 0.06 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.674 ' CG1' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -55.96 -44.31 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.365 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -39.65 -58.61 1.28 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.907 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.5 m -84.16 -56.47 3.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.892 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.667 ' CE2' ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -47.15 -50.42 20.47 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.615 ' HB ' HG21 ' A' ' 48' ' ' ILE . 1.8 tp -59.43 -48.2 88.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.818 0.342 . . . . 0.0 110.179 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.492 ' O ' ' CD2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -50.51 -52.38 39.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.339 0.59 . . . . 0.0 109.604 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.485 ' HA ' HG21 ' A' ' 58' ' ' THR . 13.2 mm-40 -69.05 -81.18 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.649 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.604 HG21 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -23.27 -58.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.725 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.5 mp -73.25 -66.2 0.71 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -62.94 -33.33 75.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 70.0 p -60.89 -67.7 0.38 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.267 0.556 . . . . 0.0 110.905 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.604 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 0.1 OUTLIER -85.69 -42.81 13.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.725 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 52.0 m-85 -69.94 -24.28 63.33 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -92.59 -50.99 5.33 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.722 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.0 ttmt -60.81 -41.37 95.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.422 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 p30 179.72 104.0 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.888 0.375 . . . . 0.0 111.698 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.604 ' HB ' ' O ' ' A' ' 59' ' ' ASP . 0.9 OUTLIER 177.85 -53.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.138 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.406 ' N ' HG13 ' A' ' 64' ' ' VAL . 4.3 m-20 -179.53 143.07 0.38 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 111.876 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.04 -4.0 10.4 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.742 2.295 . . . . 0.0 111.858 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -83.52 -108.17 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.533 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.524 ' CG1' ' CD2' ' A' ' 60' ' ' TYR . 9.5 p 27.01 49.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.296 0.57 . . . . 0.0 111.657 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -82.25 137.72 34.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.124 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -98.06 154.0 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.228 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 2.4 mm-40 -142.23 120.12 11.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.059 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -78.85 114.0 17.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.418 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.432 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 2.2 tpt180 -98.08 -145.28 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.914 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.73 -19.9 44.33 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 120.605 0.24 . . . . 0.0 111.436 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.26 -50.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.593 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.49 156.14 29.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.381 . . . . 0.0 110.738 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.63 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 38.3 m95 -81.84 143.69 31.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.391 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.471 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 9.4 m0 -108.84 107.16 17.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.383 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.765 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.2 109.55 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.1 0.476 . . . . 0.0 110.051 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -118.35 141.7 48.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.184 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.529 ' HA ' ' OG1' ' A' ' 67' ' ' THR . . . -143.38 157.95 44.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.52 120.85 40.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.953 0.406 . . . . 0.0 111.595 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.07 -65.46 1.93 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.085 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.411 ' CA ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -178.53 155.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 0.0 110.769 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.431 HG12 ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -133.3 156.81 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 3.3 pt-20 -144.79 123.69 12.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.212 0.53 . . . . 0.0 111.664 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.62 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 28.8 t -94.3 146.28 6.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.553 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 0.8 OUTLIER -89.93 152.03 21.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.329 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 41.4 t -114.48 101.12 8.83 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.459 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 7.7 t0 161.55 -28.69 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.436 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -86.58 -69.11 0.7 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.649 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.605 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 0.9 OUTLIER -52.8 -80.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.494 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.585 ' N ' HG12 ' A' ' 92' ' ' ILE . 6.5 p -19.94 -55.68 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 76.5 mm-40 -54.79 -47.15 74.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 0.0 111.799 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER -89.96 -28.81 18.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.895 -178.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.489 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -56.9 -19.93 20.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 98' ' ' ARG . . . -177.99 -44.98 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.01 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER 171.11 -171.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -58.81 100.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.055 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.413 ' CB ' ' HB2' ' A' ' 93' ' ' SER . 0.1 OUTLIER -114.77 -165.7 1.04 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.98 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.65 -173.87 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 0.0 111.045 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.547 HG21 ' CD1' ' A' ' 123' ' ' PHE . 4.3 p -83.89 173.37 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.944 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 102' ' ' VAL . 0.5 OUTLIER 69.91 9.77 7.23 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.697 -179.044 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -80.14 -35.0 37.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.291 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.459 ' HB3' ' CE2' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -63.57 -52.97 58.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.703 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -97.93 31.78 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.986 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.91 -44.76 57.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.069 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.76 96.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.818 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.4 ' CG1' ' HG ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -134.38 -171.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.96 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.84 -40.28 20.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.403 ' HB3' HG21 ' A' ' 41' ' ' VAL . 2.2 t 171.83 157.54 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.817 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 63.0 p -156.51 75.95 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.119 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 39' ' ' VAL . 6.2 mm -59.95 108.17 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.386 0.612 . . . . 0.0 111.084 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.43 141.91 3.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.011 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 126' ' ' THR . 34.9 mtm105 -77.05 120.21 21.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.657 0.265 . . . . 0.0 110.409 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.54 126.41 51.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.096 0.475 . . . . 0.0 112.263 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.442 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 5.7 p90 -136.14 125.39 24.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.603 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.5 t -91.21 159.11 16.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.185 0.517 . . . . 0.0 111.961 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 pp -161.25 116.82 2.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.916 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.78 -109.13 1.85 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.689 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -129.1 83.1 2.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 11.5 mttt 151.34 120.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.525 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.62 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 1.3 p90 -108.45 135.5 49.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.845 0.355 . . . . 0.0 110.528 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 19.3 p -109.81 134.65 51.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.685 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.95 117.48 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.839 0.828 . . . . 0.0 110.6 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 115' ' ' ARG . 10.7 t -99.51 156.74 16.88 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.651 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.439 ' CB ' HG11 ' A' ' 38' ' ' VAL . 2.7 m -142.71 20.88 2.0 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.335 0.588 . . . . 0.0 109.653 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 N--CA 1.446 -0.666 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.986 -178.573 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.403 ' HA ' HG12 ' A' ' 12' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.32 -16.27 61.37 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.404 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.76 -1.56 3.34 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.322 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.408 HD13 ' HG3' ' A' ' 13' ' ' MET . 2.0 pp -67.97 -15.94 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-O 121.424 0.631 . . . . 0.0 111.912 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.408 ' HG3' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -84.49 9.12 14.28 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.916 178.203 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.23 -48.69 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.678 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -79.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 110.902 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -93.06 11.3 28.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.032 0.444 . . . . 0.0 111.242 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.96 -20.94 5.5 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.233 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -129.52 80.63 1.97 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.023 0.44 . . . . 0.0 110.623 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -145.52 9.76 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.738 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.28 17.28 10.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.893 0.377 . . . . 0.0 111.224 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.0 -9.49 58.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.673 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.3 11.3 24.04 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.865 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.965 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.832 0.349 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.9 m -85.75 155.8 20.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.115 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.46 ' CG2' ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -110.9 107.18 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.59 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 113' ' ' ILE . 11.6 t -119.48 152.45 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.401 0.62 . . . . 0.0 112.108 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.762 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -165.55 128.69 2.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.968 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.07 132.43 60.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.337 0.589 . . . . 0.0 111.739 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.564 ' HB3' ' CG1' ' A' ' 48' ' ' ILE . 1.1 tp -127.96 140.17 52.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.513 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -48.88 128.44 15.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.426 0.155 . . . . 0.0 110.761 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.487 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -78.72 86.94 4.64 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.545 0.688 . . . . 0.0 110.441 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -126.03 171.41 10.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.403 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.35 -14.35 0.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.201 0.524 . . . . 0.0 109.739 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' HG2' ' N ' ' A' ' 48' ' ' ILE . 2.6 tt0 -72.53 -63.83 1.08 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.088 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.583 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 1.0 OUTLIER -61.66 -44.92 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.169 0.509 . . . . 0.0 110.139 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -42.44 -55.89 3.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.588 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.442 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 75.8 m -67.0 -77.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.598 ' CD2' ' CG2' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -39.7 -55.15 1.96 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.102 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.543 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.5 tp -45.81 -45.7 5.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.076 0.465 . . . . 0.0 109.839 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.62 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.4 pt-20 -57.12 -40.54 77.28 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.467 ' O ' ' C ' ' A' ' 55' ' ' ILE . 2.9 mp0 -81.75 -91.8 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.547 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.598 ' CG2' ' CD2' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.78 -54.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.852 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -72.71 -42.53 64.09 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -83.14 -45.93 13.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.279 0.561 . . . . 0.0 110.696 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.615 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 69.5 p -53.61 -70.47 0.09 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.993 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.588 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 5.4 m-20 -89.66 -30.43 18.11 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.852 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 32.0 m-85 -80.15 -24.67 40.26 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.524 1.056 . . . . 0.0 111.566 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -90.39 -47.66 7.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.052 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -56.08 -47.46 77.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.752 0.31 . . . . 0.0 111.226 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -179.52 102.2 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.983 0.42 . . . . 0.0 111.282 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 59' ' ' ASP . 0.9 OUTLIER -179.92 -57.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.718 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.456 ' N ' HG13 ' A' ' 64' ' ' VAL . 1.1 m120 178.65 127.8 0.21 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.608 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -85.21 -17.33 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.658 2.239 . . . . 0.0 111.908 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ASN . 1.8 t -57.41 -49.91 74.69 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.561 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.473 ' CG1' ' CD1' ' A' ' 60' ' ' TYR . 2.9 p -42.73 87.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.09 0.472 . . . . 0.0 111.194 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.2 p30 -115.25 142.57 46.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.303 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.422 ' CG2' ' HB3' ' A' ' 77' ' ' TRP . 0.7 OUTLIER -96.97 153.2 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 121.187 0.518 . . . . 0.0 111.622 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -142.9 123.34 13.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.121 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -79.86 114.35 18.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.295 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -93.73 -71.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.368 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.09 -69.94 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.128 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.24 4.55 9.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.814 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.48 149.78 39.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.834 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.583 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 74.9 m95 -77.45 142.72 39.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.571 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.563 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.7 m0 -107.67 106.63 17.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.27 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.762 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.19 110.87 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 0.0 110.142 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -116.51 135.52 53.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.046 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.433 ' HB2' HG21 ' A' ' 85' ' ' ILE . . . -144.46 159.26 43.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.793 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -96.8 148.32 23.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.959 0.409 . . . . 0.0 111.352 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.87 -69.73 0.42 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.343 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.46 ' HA ' ' CG2' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -179.58 161.46 1.03 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.913 0.387 . . . . 0.0 110.883 -179.377 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.481 HG12 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -141.08 155.77 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.801 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 13.2 pt-20 -140.31 124.01 17.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.018 0.437 . . . . 0.0 111.481 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.61 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 24.8 t -93.67 143.86 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.581 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 6.3 t70 -88.25 151.73 22.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.012 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 54.0 t -111.78 100.51 8.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.047 0.451 . . . . 0.0 109.86 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 3.1 t70 162.41 -36.14 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.932 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.24 -68.05 0.56 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.984 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.555 ' HB ' ' CD2' ' A' ' 51' ' ' PHE . 1.6 tt -59.32 -55.67 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.591 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.9 p -48.81 -32.92 9.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.599 0.238 . . . . 0.0 111.628 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.2 mm-40 -62.55 -47.64 82.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.754 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -90.05 -17.21 28.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.703 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.484 ' CD1' ' HG3' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.26 8.35 44.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.832 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 131.23 70.08 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.177 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -31.23 147.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.059 0.457 . . . . 0.0 111.836 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 64.21 18.22 11.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.082 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -71.87 -167.14 0.26 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.086 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -100.79 -164.08 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.664 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.602 HG21 ' CD1' ' A' ' 123' ' ' PHE . 1.5 p -113.15 -33.56 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.041 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -80.1 5.59 13.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.327 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -59.4 -41.74 90.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.647 0.26 . . . . 0.0 110.968 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -60.73 -28.11 68.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.774 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.441 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 3.1 tp -131.5 40.6 3.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.028 0.442 . . . . 0.0 110.938 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.9 p -87.19 -36.29 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 178.65 69.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.486 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.26 179.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.062 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -46.54 -43.84 17.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.067 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 170.68 165.25 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.982 0.42 . . . . 0.0 111.301 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 42.4 p -159.08 80.67 0.77 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.85 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 39' ' ' VAL . 5.1 mm -58.95 105.09 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.49 0.662 . . . . 0.0 111.286 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' A' ' 126' ' ' THR . . . 144.34 144.72 4.23 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.965 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.75 120.04 21.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.58 0.229 . . . . 0.0 110.493 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.81 125.31 45.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.97 0.414 . . . . 0.0 112.037 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 1.7 p90 -131.45 122.36 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.361 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.2 t -103.33 158.9 16.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 111.882 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -167.78 134.32 2.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.356 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.45 -109.89 1.58 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.674 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.43 83.73 2.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 7.3 mttt 153.39 122.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.503 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.61 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -107.93 139.55 42.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.933 0.396 . . . . 0.0 110.444 179.214 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 37.6 m -114.24 130.04 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.44 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.481 ' CD1' HG12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -112.31 117.78 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.794 0.806 . . . . 0.0 110.74 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.4 t -98.31 156.34 16.77 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.504 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.414 ' OG ' HG23 ' A' ' 38' ' ' VAL . 71.7 p -150.0 30.96 0.7 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.562 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.899 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.424 ' HA ' HG12 ' A' ' 12' ' ' ILE . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.125 0 CA-C-O 121.064 0.459 . . . . 0.0 111.484 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.52 -17.23 54.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.413 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.66 -8.55 3.1 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.169 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.2 pp -60.52 -20.07 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 117.527 0.663 . . . . 0.0 111.871 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.41 ' HB2' ' HE1' ' A' ' 13' ' ' MET . 0.0 OUTLIER -84.76 8.64 16.49 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.742 177.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 18' ' ' LYS . . . -131.91 -34.37 0.39 Allowed Glycine 0 CA--C 1.518 0.268 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.477 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mp -77.15 -80.24 0.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.745 0.307 . . . . 0.0 111.002 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.48 9.94 29.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.967 0.413 . . . . 0.0 111.535 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.95 -27.14 2.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.948 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 1.4 tmtt? -130.14 85.29 2.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.719 0.771 . . . . 0.0 110.242 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -134.83 8.14 3.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.683 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 62.59 18.24 10.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.842 0.354 . . . . 0.0 111.384 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.29 -177.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.4 t0 63.87 12.0 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.79 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.943 179.845 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.882 0.373 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.4 m -75.23 146.36 41.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.478 ' CG1' ' HB2' ' A' ' 127' ' ' SER . 0.2 OUTLIER -90.58 102.36 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.103 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.9 139.42 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.115 0.483 . . . . 0.0 111.543 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 8.9 mp -136.42 104.27 5.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.036 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -109.62 127.03 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.363 0.602 . . . . 0.0 111.961 -179.462 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.495 ' HB3' HD13 ' A' ' 48' ' ' ILE . 4.5 mt -127.67 145.41 50.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.746 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.0 119.99 4.9 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.488 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.77 91.08 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.427 0.632 . . . . 0.0 110.888 -178.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 47' ' ' GLU . 50.0 m -125.93 170.3 11.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.451 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -53.65 -11.79 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.142 0.496 . . . . 0.0 109.793 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.581 ' HG2' ' N ' ' A' ' 48' ' ' ILE . 1.9 tt0 -75.11 -65.47 0.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.492 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.596 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 0.4 OUTLIER -58.27 -44.47 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.3 0.571 . . . . 0.0 109.67 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -43.87 -53.72 5.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.345 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.9 m -79.93 -64.96 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.196 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.645 ' O ' HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -45.07 -46.9 11.83 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.372 -178.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.4 tp -61.44 -48.48 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.163 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.627 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -50.76 -38.99 51.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.048 0.451 . . . . 0.0 109.822 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' A' ' 55' ' ' ILE . 2.8 mt-10 -82.89 -87.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.781 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.645 HG21 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.9 -56.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 179.472 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.657 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -72.98 -42.53 63.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.74 -46.35 13.27 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.623 -179.103 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.64 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 51.4 p -49.24 -72.61 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.57 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.442 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 0.9 OUTLIER -94.05 -25.92 16.99 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -177.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.657 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 7.7 m-85 -87.41 -1.37 57.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 119.306 -0.957 . . . . 0.0 112.737 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 2.5 tptt -118.06 -41.59 2.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.683 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.9 OUTLIER -58.91 -51.66 69.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.263 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.494 ' N ' HD21 ' A' ' 63' ' ' ASN . 0.1 OUTLIER -178.93 90.21 0.02 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.39 0.614 . . . . 0.0 112.012 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 59' ' ' ASP . 24.6 t -161.77 -53.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.505 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 177.62 141.67 0.25 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.396 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.48 -23.34 2.82 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.77 2.314 . . . . 0.0 112.152 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 69' ' ' ASN . 9.6 t -55.19 -38.44 68.38 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.302 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.615 ' CG1' ' HG ' ' A' ' 56' ' ' LEU . 82.2 t -61.9 74.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.64 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 67' ' ' THR . 16.0 p30 -116.0 142.29 46.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.973 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.41 HG22 HD11 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.54 149.38 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.389 0.614 . . . . 0.0 111.682 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.65 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.2 OUTLIER -143.75 123.53 13.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.573 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -88.44 114.84 25.47 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.107 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.407 ' NH1' ' CZ3' ' A' ' 78' ' ' TRP . 11.6 tpt180 -99.86 -100.04 0.24 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.618 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.31 -78.66 0.1 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.844 0.354 . . . . 0.0 111.27 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.68 -40.04 0.34 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.3 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.85 158.85 19.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.787 0.327 . . . . 0.0 110.545 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.596 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 75.4 m95 -77.43 126.32 30.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.527 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.65 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.7 m0 -96.69 109.97 22.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.289 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.702 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -96.52 136.68 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -129.11 135.72 49.26 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.021 0.438 . . . . 0.0 112.153 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.463 ' CB ' HG23 ' A' ' 85' ' ' ILE . . . -144.5 158.48 43.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.756 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.406 ' N ' ' OG1' ' A' ' 67' ' ' THR . 0.4 OUTLIER -115.06 127.39 55.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.95 0.405 . . . . 0.0 111.251 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 84.25 -68.31 3.54 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.902 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.453 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 178.42 160.71 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.014 0.435 . . . . 0.0 111.347 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.48 HG12 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -151.53 160.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.436 179.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.515 ' CB ' ' HA ' ' A' ' 124' ' ' THR . 0.3 OUTLIER -136.09 125.22 24.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.165 0.507 . . . . 0.0 111.693 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 99.6 t -92.31 144.65 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.524 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.418 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 5.7 m-20 -87.95 152.64 21.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.441 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.461 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 51.9 t -112.16 100.55 8.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.157 0.503 . . . . 0.0 109.743 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.464 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 10.0 t70 165.21 -36.51 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.773 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -74.96 -69.31 0.48 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.59 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.531 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 0.7 OUTLIER -63.99 -54.51 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.3 p -44.12 -30.69 0.8 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.133 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 3.2 mm-40 -68.51 -71.54 0.21 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.125 0.488 . . . . 0.0 110.235 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -19.94 63.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.134 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.526 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -98.06 -1.76 41.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.58 0.229 . . . . 0.0 111.395 -179.461 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.466 ' HA3' ' CD2' ' A' ' 100' ' ' PHE . . . 152.56 66.03 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.87 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -28.02 137.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.782 0.433 . . . . 0.0 112.123 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 64.17 19.66 11.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.541 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.466 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -58.55 -162.9 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.107 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -105.58 -85.74 0.48 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.998 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.526 HG21 ' CD1' ' A' ' 123' ' ' PHE . 2.0 p 179.54 -54.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.667 0.27 . . . . 0.0 111.554 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.434 ' CE2' HG23 ' A' ' 118' ' ' THR . 6.8 m-85 -64.98 -13.24 57.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.652 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -47.36 -29.98 2.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.598 0.237 . . . . 0.0 111.469 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.518 ' CD1' ' CE2' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -71.19 -30.09 65.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.034 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.438 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 0.9 OUTLIER -134.71 42.28 2.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.969 0.414 . . . . 0.0 110.92 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.1 p -83.19 -45.67 18.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.119 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -160.05 31.0 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.7 m -59.49 165.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.578 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.55 -46.27 66.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.023 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.59 163.37 3.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -177.18 85.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.138 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.4 mm -60.45 113.45 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.359 0.599 . . . . 0.0 110.779 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.73 140.93 3.79 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.702 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 26.3 ttp180 -79.65 119.62 22.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.622 0.249 . . . . 0.0 110.715 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.417 ' CB ' HG21 ' A' ' 125' ' ' ILE . . . -101.28 125.29 47.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.015 0.436 . . . . 0.0 111.776 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.48 ' CZ ' ' HB ' ' A' ' 124' ' ' THR . 30.9 p90 -132.71 116.55 16.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.521 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.434 HG23 ' CE2' ' A' ' 103' ' ' TYR . 14.8 t -83.03 163.17 21.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.313 0.577 . . . . 0.0 111.992 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 pp -170.16 115.57 0.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.578 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.64 -107.1 1.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.571 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.26 83.66 2.04 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER 152.04 109.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.598 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.573 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 1.1 p90 -95.16 139.74 31.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.873 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.515 ' HA ' ' CB ' ' A' ' 86' ' ' GLU . 45.1 m -111.31 127.18 55.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.359 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.48 ' CD1' HG12 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -108.6 118.14 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.857 0.837 . . . . 0.0 110.737 178.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 115' ' ' ARG . 2.6 t -96.82 155.8 16.62 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.728 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.478 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -149.07 23.74 0.94 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.267 0.556 . . . . 0.0 109.615 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.447 -0.578 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.316 -178.374 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.442 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.3 m-20 . . . . . 0 CA--C 1.52 -0.188 0 CA-C-O 121.149 0.5 . . . . 0.0 111.566 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.17 -18.65 52.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.443 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.31 -9.42 2.98 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.232 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.2 pp -59.06 -20.78 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 117.637 0.719 . . . . 0.0 111.883 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.41 ' HB2' ' HE1' ' A' ' 13' ' ' MET . 0.0 OUTLIER -85.76 9.33 16.78 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.915 178.118 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.81 -50.52 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.623 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.55 -77.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.752 0.311 . . . . 0.0 111.056 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.22 10.73 28.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.021 0.439 . . . . 0.0 111.397 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.68 -22.47 4.33 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.134 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.85 80.74 1.99 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.12 0.486 . . . . 0.0 110.408 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -138.02 9.06 2.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.61 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 63.3 18.51 11.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.359 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.34 -178.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t70 63.58 13.03 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.12 0.485 . . . . 0.0 110.617 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.214 179.992 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.885 0.374 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.0 m -115.79 141.76 47.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -88.88 93.75 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.992 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.67 147.54 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.225 0.536 . . . . 0.0 111.854 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.822 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.64 120.59 3.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.884 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.54 130.29 67.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.339 0.59 . . . . 0.0 112.116 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.47 ' HB3' HG12 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -127.05 139.86 52.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.429 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -54.29 132.03 42.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.484 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -61.88 89.22 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.505 0.669 . . . . 0.0 109.975 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.474 ' C ' ' H ' ' A' ' 47' ' ' GLU . 14.8 m -125.86 170.62 11.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.905 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -52.77 -11.75 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 109.931 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.519 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 3.6 tt0 -69.33 -75.5 0.11 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.245 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.63 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 3.8 mm -53.81 -39.87 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 24.4 m120 -43.48 -57.74 2.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.376 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.5 m -85.73 -57.63 2.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.605 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.61 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -47.23 -45.53 23.58 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.766 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.63 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.3 tp -65.56 -49.23 79.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.863 0.363 . . . . 0.0 110.272 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.681 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.3 pt-20 -53.41 -40.55 65.2 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.098 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' O ' ' CG2' ' A' ' 58' ' ' THR . 23.7 mm-40 -80.37 -70.08 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.942 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.601 HG23 ' CE1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -37.86 -59.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.668 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -72.52 -36.61 68.38 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.681 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -84.0 -46.81 11.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.517 -0.739 . . . . 0.0 110.916 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.69 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 71.6 p -50.0 -70.86 0.08 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.223 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 7.3 m-20 -94.35 -29.3 15.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.668 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 2.3 m-85 -83.83 -1.61 54.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.534 -0.867 . . . . 0.0 112.711 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.574 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -118.87 -40.41 2.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.785 178.518 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.69 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -58.23 -50.2 74.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.707 0.289 . . . . 0.0 111.289 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.452 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER 179.57 89.29 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.212 0.53 . . . . 0.0 111.276 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.471 ' CG1' ' CE1' ' A' ' 60' ' ' TYR . 9.7 t -158.94 -58.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.54 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.46 ' HB3' HG21 ' A' ' 67' ' ' THR . 3.8 m-20 174.25 145.92 0.21 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.894 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -89.14 -19.36 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.046 2.497 . . . . 0.0 112.462 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -47.15 -64.26 0.83 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.321 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.592 HG13 ' CD1' ' A' ' 60' ' ' TYR . 1.7 p -41.73 87.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 121.048 0.451 . . . . 0.0 110.96 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.8 p30 -116.22 142.57 46.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.479 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.0 153.23 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.105 0.479 . . . . 0.0 111.531 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.6 OUTLIER -142.65 118.74 10.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.241 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.27 114.64 24.05 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.445 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.422 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 3.8 mmp_? -101.58 -117.42 0.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.239 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.35 76.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.79 0.329 . . . . 0.0 111.272 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.88 -37.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.641 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -82.79 162.0 21.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.961 0.41 . . . . 0.0 110.618 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.547 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 50.0 m95 -86.01 140.56 30.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.742 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.574 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.4 m0 -110.97 108.7 18.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.39 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.822 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.47 116.21 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.629 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -119.46 136.39 54.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.08 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.432 ' HB2' ' CG2' ' A' ' 85' ' ' ILE . . . -143.41 158.71 43.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.69 137.6 44.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 111.358 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.07 -69.83 3.19 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.926 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.438 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 179.86 158.62 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 0.0 111.041 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.459 HG12 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.85 160.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 0.1 OUTLIER -140.71 125.2 17.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 111.643 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.628 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 18.0 t -94.66 138.55 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.641 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.51 152.24 28.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.207 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 46.9 t -113.11 100.85 8.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 109.958 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.5 m-20 161.88 -37.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.27 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -72.5 -68.59 0.46 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.697 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.61 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -58.55 -58.26 7.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.273 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.7 p -45.28 -34.14 2.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.553 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -47.34 86.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 110.359 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.11 -17.0 28.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.785 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.519 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -98.01 9.47 42.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.933 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 129.28 69.69 0.12 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.309 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -34.8 149.09 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.059 0.457 . . . . 0.0 111.439 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.88 17.66 10.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.149 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.432 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -69.57 -167.84 0.15 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.679 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -131.2 135.16 47.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.84 0.353 . . . . 0.0 110.966 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.497 HG21 ' CD1' ' A' ' 123' ' ' PHE . 8.1 p -51.14 166.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.934 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 79.38 1.87 2.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.895 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -73.77 -31.71 63.44 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.984 0.421 . . . . 0.0 110.232 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -64.82 -26.03 68.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.772 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 0.5 OUTLIER -127.69 30.65 5.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.624 179.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.2 p -83.05 -34.71 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.166 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -178.12 39.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.797 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.0 m -70.86 172.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.374 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.52 -44.43 56.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.166 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.2 m 172.95 157.7 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -178.95 122.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.926 0.393 . . . . 0.0 111.639 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.4 mm -92.56 121.12 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.3 0.571 . . . . 0.0 111.005 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.46 143.07 3.78 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.954 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -77.78 120.23 22.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.783 0.325 . . . . 0.0 110.39 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.09 125.22 47.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.065 0.46 . . . . 0.0 111.929 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 4.8 p90 -136.08 121.36 19.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.462 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.3 t -105.0 142.45 34.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.339 0.59 . . . . 0.0 111.995 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -148.24 125.69 11.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.652 179.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.99 -110.84 3.68 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.671 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.49 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.09 83.84 2.05 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.1 OUTLIER 153.22 101.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.747 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.628 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 8.4 p90 -88.67 128.88 35.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.102 0.477 . . . . 0.0 110.98 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 29.9 m -103.07 132.48 49.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.117 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.459 ' CD1' HG12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -114.88 118.67 59.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.924 0.869 . . . . 0.0 110.979 179.146 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 115' ' ' ARG . 5.4 t -96.3 156.28 16.41 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.456 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.437 ' HB3' HG11 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -138.05 14.84 2.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.383 0.611 . . . . 0.0 109.542 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.642 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.62 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.411 ' HA ' HG12 ' A' ' 12' ' ' ILE . 11.0 m-20 . . . . . 0 CA--C 1.521 -0.166 0 CA-C-O 121.114 0.483 . . . . 0.0 111.538 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.31 -16.09 58.08 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.485 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.73 -9.02 2.33 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.241 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.411 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.1 pp -60.39 -20.39 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 CA-C-N 117.574 0.687 . . . . 0.0 111.811 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.92 7.55 15.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.877 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.96 21.07 0.44 Allowed Glycine 0 CA--C 1.519 0.332 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.57 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.6 -83.49 0.63 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.661 0.267 . . . . 0.0 110.608 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.0 9.26 40.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.084 0.468 . . . . 0.0 110.938 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.11 -15.76 8.25 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.985 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.01 81.26 2.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.017 0.437 . . . . 0.0 110.216 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -140.53 10.8 2.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.635 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.67 14.44 7.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.3 -169.86 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.844 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.12 14.97 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.041 0.448 . . . . 0.0 110.541 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.066 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.937 0.399 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.2 m -72.93 145.38 46.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.206 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -99.41 99.18 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.606 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.9 t -112.0 152.44 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.33 0.586 . . . . 0.0 112.389 -178.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.59 107.88 3.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.527 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.489 HG11 ' HA ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -113.4 125.93 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.031 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.468 ' HB2' HD13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -128.63 148.66 50.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.133 178.127 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.32 127.53 17.51 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HA ' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -66.3 90.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.535 0.684 . . . . 0.0 111.043 -179.023 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.464 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -125.94 171.36 10.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.956 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.89 -17.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.548 ' HG2' ' CD1' ' A' ' 48' ' ' ILE . 8.2 tt0 -62.02 -72.31 0.13 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.239 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.595 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 0.3 OUTLIER -59.75 -40.66 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -40.83 -59.48 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.409 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.405 ' CG2' ' HG ' ' A' ' 95' ' ' LEU . 2.4 m -79.47 -61.87 1.87 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.877 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.62 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -43.82 -45.52 7.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.237 -179.184 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.595 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -62.63 -47.23 93.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.862 0.363 . . . . 0.0 110.284 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -54.23 -41.18 68.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.516 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' O ' ' OG1' ' A' ' 58' ' ' THR . 7.4 mt-10 -81.07 -68.64 0.67 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.043 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.617 HG23 ' CE1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -37.17 -57.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.611 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -74.85 -38.41 61.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.635 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.49 -46.88 12.86 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.884 -178.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.666 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 50.6 p -53.54 -69.81 0.11 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.489 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.452 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 20.5 m-20 -91.72 -29.66 16.7 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.611 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 8.4 m-85 -87.15 -2.07 58.36 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.427 -0.909 . . . . 0.0 113.236 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -117.75 -40.71 2.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 178.348 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -62.08 -49.98 73.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.478 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -177.71 90.49 0.03 OUTLIER 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.507 0.67 . . . . 0.0 112.297 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 63' ' ' ASN . 20.2 t -162.05 -54.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.076 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 170.49 143.45 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.482 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.64 -16.43 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.981 2.454 . . . . 0.0 112.237 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.43 ' O ' ' ND2' ' A' ' 69' ' ' ASN . 14.7 t -53.16 -39.47 63.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.286 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.597 ' CG1' ' HG ' ' A' ' 56' ' ' LEU . 63.5 t -61.81 86.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.826 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 67' ' ' THR . 8.9 m-80 -115.43 142.44 46.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.859 0.361 . . . . 0.0 111.056 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.84 153.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 121.235 0.541 . . . . 0.0 111.548 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.6 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -142.08 117.98 10.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.787 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.3 114.52 18.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.645 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.5 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -95.23 -146.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.083 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.2 -73.57 0.08 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.629 0.252 . . . . 0.0 111.637 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . -126.42 12.48 7.07 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.479 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.83 158.66 43.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.086 0.443 . . . . 0.0 111.091 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.595 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 58.7 m95 -80.73 142.75 33.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.229 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.6 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.0 m0 -115.79 108.5 16.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.635 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.736 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -96.89 127.21 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 135.83 49.66 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.947 0.403 . . . . 0.0 111.241 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.563 ' CB ' HG23 ' A' ' 85' ' ' ILE . . . -143.86 159.05 43.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.849 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -106.97 148.3 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.076 0.465 . . . . 0.0 111.328 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 68.08 -69.85 0.32 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.331 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.557 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 177.92 160.71 0.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.922 0.391 . . . . 0.0 111.02 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.563 HG23 ' CB ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -149.55 160.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.956 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 1.0 OUTLIER -138.14 126.1 22.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.128 0.49 . . . . 0.0 111.414 -179.501 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.63 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 23.0 t -94.49 146.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.603 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.417 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 8.8 t70 -90.11 152.15 21.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.103 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.472 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 49.8 t -109.46 100.74 9.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.295 0.569 . . . . 0.0 109.745 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 0.7 OUTLIER 162.45 -35.98 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.979 -179.257 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -74.26 -71.85 0.31 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.748 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.62 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.0 OUTLIER -57.11 -56.35 15.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.1 p -46.62 -35.62 6.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.734 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.9 OUTLIER -60.19 -46.21 90.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.098 0.475 . . . . 0.0 110.367 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.405 ' HG ' ' CG2' ' A' ' 50' ' ' THR . 1.1 tm? -90.17 -17.62 27.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.601 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.462 ' CD1' ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -99.7 12.33 36.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.974 0.416 . . . . 0.0 110.999 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.418 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 126.29 69.52 0.18 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.279 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -35.11 148.61 0.02 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.08 0.467 . . . . 0.0 111.66 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 64.8 17.48 11.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.342 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -69.65 -177.58 1.26 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.607 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -81.81 -91.87 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 123' ' ' PHE . 2.7 p 179.42 -42.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.688 0.28 . . . . 0.0 111.1 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.445 ' CE2' ' CG2' ' A' ' 118' ' ' THR . 4.9 m-85 -71.71 -6.69 43.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.367 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.71 -34.24 18.26 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.782 0.325 . . . . 0.0 111.026 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.533 ' CD1' ' CE2' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -60.54 -34.95 74.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.631 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 5.6 tp -133.21 41.89 3.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.473 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.9 p -81.59 -39.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.298 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -166.14 31.47 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.002 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.5 m -65.07 174.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.295 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -55.96 -42.47 76.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.401 ' O ' ' CG2' ' A' ' 112' ' ' THR . 0.9 OUTLIER 171.65 151.72 0.06 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 111' ' ' SER . 65.8 p -159.88 98.51 1.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.906 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.1 mm -65.89 127.31 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 0.0 110.966 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.81 144.48 5.37 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.041 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.84 120.55 22.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.7 0.286 . . . . 0.0 110.414 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.428 ' CB ' HG22 ' A' ' 125' ' ' ILE . . . -106.9 124.59 49.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.129 0.49 . . . . 0.0 112.263 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.499 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 2.0 p90 -137.04 119.29 15.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.296 178.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.445 ' CG2' ' CE2' ' A' ' 103' ' ' TYR . 10.9 t -99.81 142.71 30.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.251 0.548 . . . . 0.0 111.969 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.38 133.11 19.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.507 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 56.9 -112.02 3.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.611 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.503 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.9 84.06 2.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.4 OUTLIER 152.11 100.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.526 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.63 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 14.2 p90 -88.28 133.08 34.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.17 0.509 . . . . 0.0 110.949 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -107.93 130.67 55.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.858 -179.458 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.546 ' CD1' HG12 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -112.82 118.58 58.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.891 0.853 . . . . 0.0 111.368 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 115' ' ' ARG . 9.1 t -97.24 155.59 16.79 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.087 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.485 ' HB2' HG12 ' A' ' 38' ' ' VAL . 2.2 m -146.02 19.28 1.43 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.256 0.551 . . . . 0.0 109.842 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 N--CA 1.445 -0.698 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.246 -178.755 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mtp . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.841 0.353 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.0 t -92.54 79.56 4.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.49 97.9 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -78.27 145.44 35.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.3 t -144.29 123.21 12.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.026 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -130.98 95.14 3.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 62.43 -174.73 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.998 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.07 21.49 1.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.447 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.455 ' HA ' HG12 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -53.4 -20.78 4.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.224 0.535 . . . . 0.0 111.49 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.5 -15.89 60.36 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.848 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.03 -9.25 2.2 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.333 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.455 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.1 pp -60.4 -19.2 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-N 117.538 0.669 . . . . 0.0 112.069 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.91 9.64 11.69 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.041 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.04 -43.8 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.732 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.58 -80.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 110.989 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.43 -14.49 26.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.438 0.637 . . . . 0.0 111.512 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.8 -18.03 62.35 Favored Glycine 0 C--N 1.312 -0.805 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.895 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.22 81.11 1.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 110.878 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 9.2 t0 -138.67 8.36 2.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.515 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.46 ' CG ' ' O ' ' A' ' 19' ' ' ASP . 13.3 p90 46.91 73.93 0.17 Allowed 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.8 0.81 . . . . 0.0 111.087 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.56 -8.44 38.19 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.602 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -90.13 11.85 19.64 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.032 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -138.32 12.79 2.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.239 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -95.53 -54.38 3.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.525 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -120.98 111.13 17.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.519 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.36 -115.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.112 0.482 . . . . 0.0 111.028 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 t70 71.25 15.57 6.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.377 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -56.4 -26.74 54.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.918 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -177.49 105.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.106 0.479 . . . . 0.0 110.435 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -99.29 162.15 13.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.004 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -93.38 141.65 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.003 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 p -110.04 134.69 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.817 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -110.18 115.3 29.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.859 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 33.35 85.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.147 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.33 144.06 48.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.892 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -103.44 28.23 6.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.027 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.0 m -74.37 145.23 43.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.884 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -86.26 106.32 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.884 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 40' ' ' LEU . 13.5 t -118.3 154.09 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.328 0.585 . . . . 0.0 111.832 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.679 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -177.93 125.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.265 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.03 135.22 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.668 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.505 ' HB3' HG12 ' A' ' 48' ' ' ILE . 3.5 tp -125.73 139.52 53.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.639 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -50.76 139.61 16.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.129 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.466 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -87.52 87.65 7.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.396 0.617 . . . . 0.0 110.462 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -125.78 170.64 11.39 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.543 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.67 -12.13 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.993 0.425 . . . . 0.0 110.34 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' HG3' ' CD2' ' A' ' 96' ' ' LEU . 1.4 tt0 -80.82 -58.11 3.24 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.342 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.573 ' HA ' ' CD2' ' A' ' 51' ' ' PHE . 1.4 mp -63.86 -44.89 98.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.963 0.411 . . . . 0.0 110.241 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -40.49 -59.85 1.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.058 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.404 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 58.5 m -69.96 -68.47 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.007 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.604 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -42.66 -47.01 5.23 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.565 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.5 tp -55.87 -47.97 79.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.165 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.485 ' O ' ' CD2' ' A' ' 57' ' ' LEU . 1.6 pt-20 -53.29 -48.78 68.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 109.755 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.455 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.3 OUTLIER -70.64 -81.6 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.67 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.595 HG21 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -22.02 -57.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.689 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.4 mp -74.22 -66.0 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -63.41 -33.12 74.85 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -177.251 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.516 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 70.0 p -62.93 -66.2 0.58 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.338 0.59 . . . . 0.0 110.757 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.61 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -83.24 -46.35 12.78 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.689 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 49.6 m-85 -69.04 -24.71 64.21 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.99 -51.48 5.32 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.657 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 58' ' ' THR . 13.6 ttpt -60.68 -43.16 98.05 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.271 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 62' ' ' LYS . 2.0 p30 179.76 103.8 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.103 0.477 . . . . 0.0 111.753 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 59' ' ' ASP . 0.9 OUTLIER 178.51 -52.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.027 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.413 ' N ' HG13 ' A' ' 64' ' ' VAL . 5.1 m-20 178.86 141.56 0.28 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.738 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.55 -10.41 10.87 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.698 2.265 . . . . 0.0 111.956 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -78.3 -106.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.61 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.522 ' CG1' ' CD2' ' A' ' 60' ' ' TYR . 9.7 p 26.56 49.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.359 0.599 . . . . 0.0 111.629 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -82.32 136.52 35.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.199 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.75 153.76 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.041 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 7.9 mm-40 -142.44 116.28 9.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.188 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -86.38 114.52 23.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.571 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.423 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 21.4 mmt180 -103.17 -120.67 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.973 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.78 -54.04 50.92 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.862 0.363 . . . . 0.0 111.133 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.83 -39.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.644 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -79.93 162.5 24.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.673 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.552 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 22.8 m95 -90.92 142.71 27.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.154 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.518 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.4 m0 -106.52 102.4 11.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.266 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -97.01 107.41 19.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.174 0.511 . . . . 0.0 110.411 -179.184 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.9 143.71 49.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.455 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.499 ' HA ' ' OG1' ' A' ' 67' ' ' THR . . . -143.4 158.51 43.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.296 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -102.94 132.84 48.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.865 0.364 . . . . 0.0 111.438 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.52 -68.21 3.47 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.001 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.449 ' HA ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -176.46 152.89 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 110.691 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -133.69 157.92 42.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 12.5 pt-20 -147.75 122.27 9.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.467 . . . . 0.0 111.825 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.601 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 29.2 t -94.74 137.16 23.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.59 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 18.0 p30 -84.31 151.93 24.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.893 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.465 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 21.4 t -109.83 100.55 9.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.131 0.491 . . . . 0.0 109.849 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 0.8 OUTLIER 161.5 -35.87 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.079 -179.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.02 -70.35 0.36 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.826 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.604 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.5 tt -57.8 -58.93 4.23 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.191 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 t -44.75 -34.76 2.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.798 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.6 mm-40 -60.9 -48.22 82.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.542 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -90.23 -16.98 28.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.725 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.504 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.33 10.19 41.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 98' ' ' ARG . . . 125.46 70.72 0.19 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.117 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -30.72 147.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.149 0.5 . . . . 0.0 111.834 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.45 17.91 11.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.038 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -165.19 0.05 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.933 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.21 -167.88 1.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.513 HG21 ' CD1' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -113.14 -43.89 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.719 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -2.57 16.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.36 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.83 -40.79 22.25 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.878 0.37 . . . . 0.0 110.264 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.431 ' CE1' HG12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -83.4 146.36 28.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.788 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.414 ' O ' ' CG ' ' A' ' 106' ' ' LEU . 3.5 tt 64.51 14.76 9.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 111.179 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.2 p -74.17 -44.88 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.813 0.34 . . . . 0.0 111.07 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.6 p30 178.54 54.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.67 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.0 -166.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -43.61 -40.15 3.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.154 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 170.52 149.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.846 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 37.1 p -157.75 84.9 0.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.4 mm -77.16 114.5 17.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.434 0.635 . . . . 0.0 111.395 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 143.89 142.01 3.87 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.029 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 126' ' ' THR . 23.4 ttt180 -77.1 120.1 21.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.614 0.245 . . . . 0.0 110.44 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.76 125.39 50.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.077 0.465 . . . . 0.0 112.202 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.464 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 3.5 p90 -131.63 127.42 36.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.101 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.448 ' HB ' HG23 ' A' ' 102' ' ' VAL . 11.7 t -100.26 149.35 23.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.344 0.592 . . . . 0.0 112.097 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.408 ' CD1' ' O ' ' A' ' 119' ' ' LEU . 3.3 pp -146.62 118.11 7.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.663 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.14 -104.29 0.51 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.981 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -133.06 83.68 2.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.028 0.442 . . . . 0.0 109.932 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.3 OUTLIER 152.95 115.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.471 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.601 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -104.21 138.46 40.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.988 0.423 . . . . 0.0 110.789 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 17.8 p -114.13 133.33 55.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.315 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.431 HG12 ' CE1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -113.82 117.56 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.819 0.818 . . . . 0.0 110.565 179.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 115' ' ' ARG . 8.8 t -100.54 156.37 17.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.748 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.44 ' CB ' HG11 ' A' ' 38' ' ' VAL . 8.9 t -142.36 17.27 2.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.348 0.594 . . . . 0.0 109.555 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -124.75 -49.4 1.75 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.14 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.8 tp 63.86 18.08 10.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.301 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 12.4 ttp 69.34 15.7 8.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.246 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 78.3 102.82 0.2 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.493 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -29.97 65.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 110.93 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -113.64 69.72 0.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -33.51 23.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.809 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -109.64 -17.55 13.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.138 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 136' ' ' LEU . 0.2 OUTLIER -105.58 15.12 27.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.968 0.413 . . . . 0.0 111.177 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.35 -31.88 1.81 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.294 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -139.91 133.01 29.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -160.77 109.18 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.966 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -139.8 177.39 7.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.077 179.965 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.813 0.339 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 t -174.71 91.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 t -74.84 151.22 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.946 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.4 p30 -106.43 146.77 30.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.031 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.4 p -131.83 172.88 11.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.63 102.43 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.0 143.35 48.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.09 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.413 ' CE2' HD23 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -106.02 22.18 16.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.414 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.466 ' HA ' HG12 ' A' ' 12' ' ' ILE . 4.1 m-20 -55.59 -16.19 3.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.114 0.483 . . . . 0.0 111.408 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.73 -16.74 56.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.389 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.6 -8.91 2.7 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.261 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.466 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.1 pp -61.09 -19.84 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 117.626 0.713 . . . . 0.0 111.852 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.435 ' HB2' ' HE1' ' A' ' 13' ' ' MET . 0.0 OUTLIER -84.72 8.5 16.85 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.789 178.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.11 -43.5 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.33 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.413 HD23 ' CE2' ' A' ' 8' ' ' TYR . 6.8 mp -67.19 -80.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.68 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.74 11.19 32.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.064 0.459 . . . . 0.0 111.17 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -112.62 -17.17 8.2 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.145 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -128.54 80.83 1.99 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.027 0.442 . . . . 0.0 110.42 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -142.51 13.71 1.96 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.36 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -86.51 6.23 31.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 0.0 111.095 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.34 -177.15 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.344 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 t0 65.29 13.35 8.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.197 0.522 . . . . 0.0 110.017 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -138.35 9.74 2.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.815 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -90.14 -55.92 3.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.621 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -120.63 110.89 16.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.815 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.23 -127.33 0.09 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.132 0.492 . . . . 0.0 110.311 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 171.44 27.32 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.894 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -75.31 -29.91 60.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -118.17 14.77 14.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.335 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.71 143.42 28.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.933 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -87.91 144.9 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.074 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.3 p -109.91 134.61 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.828 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -110.21 115.27 29.42 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.929 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 33.64 75.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.017 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.1 t -88.47 148.99 23.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.857 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -113.37 7.95 17.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.354 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.3 m -67.59 153.52 43.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.957 0.408 . . . . 0.0 111.124 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.441 HG23 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -102.23 112.61 36.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.676 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.7 t -129.11 152.05 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.436 0.636 . . . . 0.0 112.436 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.779 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -159.84 129.96 5.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.778 178.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.84 134.42 54.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.281 0.562 . . . . 0.0 111.998 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.53 ' HB3' HG12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -126.29 140.32 52.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.434 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -52.53 129.0 27.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.46 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -75.29 90.0 2.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.498 0.666 . . . . 0.0 110.617 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 47' ' ' GLU . 3.3 m -126.01 171.09 11.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.442 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.54 -16.25 0.21 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.048 0.451 . . . . 0.0 110.047 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.483 ' HG3' ' CG ' ' A' ' 96' ' ' LEU . 6.8 tt0 -72.6 -63.47 1.15 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.175 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.575 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 1.6 mp -61.31 -44.16 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.294 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -40.82 -59.05 1.51 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.807 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.4 m -75.56 -62.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.941 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.641 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -44.34 -48.42 9.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.398 -179.075 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -57.62 -47.77 84.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.879 0.371 . . . . 0.0 110.432 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -53.21 -49.47 66.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.253 0.549 . . . . 0.0 109.601 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.3 OUTLIER -69.86 -82.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.54 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.574 HG21 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -21.66 -58.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.646 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.4 mp -73.51 -66.3 0.71 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -63.32 -30.54 71.66 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 72.0 p -62.89 -66.8 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.283 0.563 . . . . 0.0 110.611 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.625 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 65.6 m-20 -83.66 -44.86 14.07 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.646 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 66.9 m-85 -70.07 -21.63 63.14 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -93.84 -47.97 6.5 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.864 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.5 OUTLIER -58.01 -48.57 79.63 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.752 0.31 . . . . 0.0 110.814 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.439 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER 179.31 99.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.289 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.625 ' HB ' ' O ' ' A' ' 59' ' ' ASP . 0.9 OUTLIER -172.23 -50.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.764 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 177.41 143.97 0.27 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 0.0 111.935 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -85.29 -3.31 9.45 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.824 2.349 . . . . 0.0 111.71 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.526 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 1.1 t -82.84 -109.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.44 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.531 ' CG1' ' CD2' ' A' ' 60' ' ' TYR . 10.0 p 26.8 49.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 121.379 0.609 . . . . 0.0 111.606 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -82.05 139.0 34.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.133 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 78' ' ' TRP . 0.5 OUTLIER -97.67 153.45 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.031 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -142.38 116.12 9.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.249 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -86.17 114.51 23.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.735 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 5.7 mmt180 -95.64 -111.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.968 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.9 -38.23 64.43 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.867 0.365 . . . . 0.0 111.128 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.46 -37.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.417 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.95 162.55 23.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.752 0.311 . . . . 0.0 110.551 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.575 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 10.3 m95 -94.11 142.84 26.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.521 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.488 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 9.0 m0 -107.56 108.73 20.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.133 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.779 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.04 113.58 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.173 0.511 . . . . 0.0 110.338 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -122.39 140.23 52.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.526 ' HA ' ' OG1' ' A' ' 67' ' ' THR . . . -142.86 138.65 30.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.765 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.55 108.2 10.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.046 0.45 . . . . 0.0 111.455 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 104.03 -62.31 0.4 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.082 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.441 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 178.04 162.13 0.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.066 0.46 . . . . 0.0 111.353 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.421 HG21 ' HB2' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -136.67 159.61 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.13 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 0.1 OUTLIER -142.75 118.2 10.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.146 0.498 . . . . 0.0 111.468 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.612 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 17.4 t -94.4 128.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.826 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 2.6 m-20 -77.3 151.97 34.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.153 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 22.5 t -106.26 100.62 10.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.136 0.493 . . . . 0.0 109.906 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 9.3 t0 160.3 -35.69 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.823 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -70.83 -72.87 0.19 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.943 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.641 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.3 tt -56.56 -57.85 7.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.0 p -45.43 -36.61 4.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.755 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -58.34 -46.79 85.56 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.122 0.486 . . . . 0.0 110.239 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -90.26 -17.2 27.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.474 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.483 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -99.77 13.17 34.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.81 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' A' ' 100' ' ' PHE . . . 118.99 67.94 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.18 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -33.56 150.41 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.208 0.528 . . . . 0.0 111.99 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.52 19.02 10.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.373 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.412 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -77.24 -166.52 0.74 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.049 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -93.5 -169.47 2.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.882 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.569 HG21 ' CD1' ' A' ' 123' ' ' PHE . 1.4 p -111.64 -34.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.118 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -79.91 3.91 18.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.477 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.6 -38.22 80.66 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.705 0.288 . . . . 0.0 110.947 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -64.05 -43.04 96.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.765 0.316 . . . . 0.0 110.76 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.463 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 1.3 tp -106.73 26.03 10.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.218 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.0 p -73.69 -24.39 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.9 0.381 . . . . 0.0 110.947 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -171.57 -86.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.458 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 110' ' ' SER . 43.0 t 55.9 160.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.056 0.455 . . . . 0.0 111.601 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.417 ' N ' HG13 ' A' ' 109' ' ' VAL . 30.3 t -55.14 -47.89 74.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.053 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.56 150.93 9.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -156.73 74.31 0.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.049 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' A' ' 113' ' ' ILE . 5.1 mm -62.34 106.2 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.349 0.595 . . . . 0.0 111.23 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 148.39 140.28 3.3 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.046 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 126' ' ' THR . 61.3 ttp85 -76.7 126.01 30.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.614 0.245 . . . . 0.0 110.643 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.456 ' CB ' HG22 ' A' ' 125' ' ' ILE . . . -104.43 125.36 50.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.031 0.443 . . . . 0.0 112.007 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 1.7 p90 -128.32 120.79 27.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.8 t -98.37 161.25 13.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.343 0.592 . . . . 0.0 112.008 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -169.94 133.6 1.21 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.32 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.92 -110.78 1.21 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.681 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -134.33 84.02 2.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 7.6 mttt 153.73 117.39 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.489 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.612 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -104.72 137.75 42.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.063 0.458 . . . . 0.0 110.84 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 55.2 m -112.72 126.05 54.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.028 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.456 HG22 ' CB ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -110.94 117.42 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.859 0.838 . . . . 0.0 111.131 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 115' ' ' ARG . 5.2 t -115.23 154.27 29.36 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.995 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.5 t -147.55 25.85 1.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.343 0.592 . . . . 0.0 109.679 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -121.22 48.52 1.64 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.044 -178.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.2 mp -124.79 17.17 8.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.202 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 17.6 ttp 65.63 16.43 10.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.303 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -100.04 62.71 0.66 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.458 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.64 45.47 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.354 . . . . 0.0 110.9 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 59.35 28.42 17.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.0 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.46 -51.78 7.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.688 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.56 -17.11 22.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.2 mt -73.75 -154.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.591 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 72.87 -56.7 0.65 Allowed 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.819 0.343 . . . . 0.0 111.03 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.54 -166.28 1.3 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.46 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.6 t80 61.52 114.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.704 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -101.14 154.57 18.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.128 179.986 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 mtm . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.755 0.312 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.11 112.54 1.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.8 m -58.55 177.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.165 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -112.36 133.53 54.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.1 p -78.63 -171.88 2.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 60.42 38.45 19.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.34 -174.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.121 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.13 21.04 7.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.465 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.494 ' HA ' HG12 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -54.02 -19.48 4.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.256 0.55 . . . . 0.0 111.461 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.86 -21.72 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.529 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.51 -10.72 4.85 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.233 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.0 pp -61.16 -21.35 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-N 117.595 0.697 . . . . 0.0 111.842 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.57 8.99 22.62 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.775 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.412 ' HA2' ' CB ' ' A' ' 18' ' ' LYS . . . -136.09 -49.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.502 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mp -61.67 -81.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 110.866 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 10.04 26.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.007 0.432 . . . . 0.0 111.431 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.93 -26.45 3.83 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.961 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -128.9 81.49 2.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.142 0.496 . . . . 0.0 110.332 179.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -116.97 -27.27 6.6 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.367 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -92.76 15.47 14.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.363 . . . . 0.0 111.402 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.63 -6.37 58.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.221 0.534 . . . . 0.0 111.768 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -88.97 12.06 16.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.444 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -138.85 13.13 2.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.204 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -88.47 -54.26 4.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.164 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -120.95 110.37 16.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.397 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.38 -11.55 40.2 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.121 0.486 . . . . 0.0 111.967 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -79.15 8.47 5.79 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.026 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -88.62 -18.61 27.63 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.439 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -94.33 15.29 17.9 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.344 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -106.19 141.85 36.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.879 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.99 133.31 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.019 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.09 134.56 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.895 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -110.36 115.15 29.17 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.753 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 33.39 62.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.066 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.8 m -117.74 110.23 17.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.031 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.0 36.76 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.815 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.8 m -70.07 139.92 52.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -86.27 99.32 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.879 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.9 t -107.52 146.07 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.255 0.55 . . . . 0.0 112.321 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 6.3 mp -150.34 109.8 4.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.058 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.51 128.09 64.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.327 0.584 . . . . 0.0 112.193 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.507 ' HB3' HD13 ' A' ' 48' ' ' ILE . 24.8 mt -127.07 140.26 52.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.6 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.29 125.72 14.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.744 0.307 . . . . 0.0 111.765 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.487 ' HD2' ' CE2' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -57.36 87.71 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.267 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.635 ' C ' ' H ' ' A' ' 47' ' ' GLU . 33.2 m -125.02 170.16 11.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.381 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.37 11.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.635 ' H ' ' C ' ' A' ' 45' ' ' SER . 1.9 tt0 -98.84 -57.68 2.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.976 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.595 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 0.8 OUTLIER -61.23 -44.49 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.302 0.573 . . . . 0.0 109.613 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -39.43 -62.0 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.126 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 56.7 m -65.41 -74.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.62 ' CD2' ' HB ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -40.97 -58.78 1.62 Allowed 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.574 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.6 tp -41.72 -46.67 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.02 0.438 . . . . 0.0 109.963 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.459 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -57.36 -53.49 57.49 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.476 ' HA ' HG21 ' A' ' 58' ' ' THR . 35.5 mt-10 -66.55 -94.61 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.949 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.613 HG21 ' H ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -18.55 -58.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.747 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -62.96 -77.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.459 ' CD2' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -63.68 -16.08 60.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.476 HG21 ' HA ' ' A' ' 54' ' ' GLU . 6.3 p -65.01 -74.38 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.297 0.57 . . . . 0.0 110.137 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.572 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 8.7 m-20 -82.56 -32.71 28.39 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.858 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.747 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 78.1 m-85 -71.81 -32.04 67.18 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.78 -46.08 11.74 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.026 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 58' ' ' THR . 10.1 ttpt -57.85 -48.85 78.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.84 0.352 . . . . 0.0 110.821 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.448 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER 179.55 101.63 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 59' ' ' ASP . 0.9 OUTLIER -177.55 -52.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.063 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -177.1 138.99 0.43 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.772 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.48 3.07 8.09 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.673 2.249 . . . . 0.0 112.275 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 1.3 t -91.81 -114.1 0.09 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.108 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.565 HG13 ' CD2' ' A' ' 60' ' ' TYR . 8.4 p 28.46 43.47 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.115 0.484 . . . . 0.0 112.246 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.42 138.86 31.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.054 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.22 151.04 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-O 121.243 0.544 . . . . 0.0 111.659 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.764 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -143.42 116.89 9.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.02 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -80.19 124.29 28.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.461 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.441 ' HG3' ' CD2' ' A' ' 78' ' ' TRP . 5.2 mmt-85 -111.45 -117.4 0.3 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.64 -82.98 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -133.12 17.53 4.56 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.187 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.7 155.99 44.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.786 0.326 . . . . 0.0 110.688 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.595 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 73.7 m95 -76.4 125.89 30.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.29 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.764 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.1 m0 -96.62 106.59 18.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.663 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.58 122.12 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.194 -178.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -128.58 136.22 50.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.692 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.484 ' HA ' ' OG1' ' A' ' 67' ' ' THR . . . -142.75 153.48 43.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.835 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.0 129.52 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.644 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.96 -67.62 2.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.256 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.495 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 179.31 157.14 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.636 -179.272 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.411 HG12 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.97 154.76 15.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 11.7 pt-20 -141.03 124.57 16.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.05 0.452 . . . . 0.0 111.304 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.55 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 39.1 t -94.35 129.37 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.922 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 6.8 m-20 -76.41 151.78 36.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.911 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.452 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 27.8 t -108.9 100.79 9.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.138 0.495 . . . . 0.0 109.908 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.5 m-20 160.17 -36.13 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.17 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -71.28 -69.19 0.39 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.0 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.62 ' HB ' ' CD2' ' A' ' 51' ' ' PHE . 1.1 tt -59.21 -51.49 71.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.713 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.9 p -52.74 -33.59 48.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.454 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -62.22 -46.58 88.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.973 0.416 . . . . 0.0 111.078 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -90.18 -20.07 23.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.056 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.447 HD22 ' HG3' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -98.19 10.03 41.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.961 0.41 . . . . 0.0 111.018 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.42 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 129.67 69.11 0.11 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.231 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.5 158.82 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.072 0.463 . . . . 0.0 111.24 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 63.32 17.62 10.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.902 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER -75.66 -168.57 0.87 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.706 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -130.39 150.9 51.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.999 0.428 . . . . 0.0 111.236 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.539 HG21 ' CD1' ' A' ' 123' ' ' PHE . 7.7 p -64.66 166.79 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.779 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' A' ' 102' ' ' VAL . 1.2 m-85 71.62 7.16 5.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.049 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -79.7 -30.06 40.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 110.329 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.51 ' CE1' ' CD2' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -80.85 -0.58 39.58 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.278 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.71 29.5 1.12 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.832 0.349 . . . . 0.0 110.792 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.2 -32.88 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.246 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -174.73 36.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.736 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.9 m -69.5 167.91 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.563 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.1 m -47.52 -47.25 27.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.22 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.34 166.27 2.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 1.2 t 177.31 103.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.295 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.5 mm -81.93 117.49 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.389 0.614 . . . . 0.0 111.155 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.31 141.82 3.95 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.994 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.94 119.76 21.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.68 0.276 . . . . 0.0 110.492 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -107.28 125.39 51.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.978 0.418 . . . . 0.0 111.86 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 20.2 p90 -132.28 125.68 31.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.712 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.421 HG21 ' CE2' ' A' ' 103' ' ' TYR . 14.0 t -91.17 150.26 21.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.306 0.574 . . . . 0.0 111.985 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 pp -155.31 115.7 3.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.568 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.34 -106.75 1.11 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.535 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.47 83.52 2.02 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.1 OUTLIER 153.94 99.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.034 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.55 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 3.2 p90 -90.96 133.5 35.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.082 0.468 . . . . 0.0 110.721 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 2.4 p -108.0 141.02 40.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.436 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -118.38 117.4 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.913 0.863 . . . . 0.0 110.825 178.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 115' ' ' ARG . 4.5 t -97.95 155.99 16.83 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.52 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.439 ' CB ' HG11 ' A' ' 38' ' ' VAL . 13.2 t -147.28 20.52 1.21 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.257 0.551 . . . . 0.0 109.857 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.48 107.66 12.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.117 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.53 101.49 0.33 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.604 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 9.9 ttt -139.6 15.68 2.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.306 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.76 -51.1 3.33 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.535 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 tp 61.85 117.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.857 0.36 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -137.14 35.35 2.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.985 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.1 tpt85 -53.88 -46.75 71.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 110.658 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.0 30.86 7.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.316 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.7 mt -138.86 -159.09 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.766 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 71.77 -56.93 0.63 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.873 0.368 . . . . 0.0 111.244 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -129.15 140.93 51.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -155.04 65.38 0.65 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -129.04 148.64 51.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.101 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.867 0.365 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 t -144.28 -167.7 2.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.827 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.4 m -57.9 175.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.18 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -73.07 130.04 39.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.93 98.91 10.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -134.59 106.62 7.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.449 ' CB ' ' HA3' ' A' ' 11' ' ' GLY . . . -142.15 -179.94 6.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 0.0 111.318 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -66.34 131.67 46.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.948 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.438 ' HA ' ' CD1' ' A' ' 12' ' ' ILE . 1.1 m-20 41.54 -75.06 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.638 0.733 . . . . 0.0 112.566 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.692 ' N ' ' O ' ' A' ' 8' ' ' TYR . . . -59.64 -7.97 1.78 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.598 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' A' ' 7' ' ' ALA . . . -113.37 -19.63 6.58 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.792 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.486 ' C ' ' HG3' ' A' ' 13' ' ' MET . 2.0 pp -108.18 66.88 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.486 ' HG3' ' C ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -139.47 14.96 2.56 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.884 178.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.431 ' HA2' ' CB ' ' A' ' 18' ' ' LYS . . . -127.7 -41.8 0.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.24 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 mp -60.85 -75.41 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.782 0.325 . . . . 0.0 110.749 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 9.39 43.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.84 -24.48 5.51 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.859 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.431 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -128.0 81.3 2.01 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.106 0.479 . . . . 0.0 110.074 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -121.12 -36.87 3.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.374 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.47 14.93 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.541 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.28 -173.68 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.901 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.56 13.9 5.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.03 0.443 . . . . 0.0 110.657 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -143.11 10.78 1.74 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.035 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.27 -52.9 4.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.191 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -121.05 110.22 15.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.445 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.69 -10.97 41.14 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.139 0.495 . . . . 0.0 111.93 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.85 8.2 4.9 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.888 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -84.89 -20.28 30.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.496 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -160.12 98.36 1.3 Allowed 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.104 0.478 . . . . 0.0 110.61 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -107.5 156.82 18.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.847 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.9 p -104.14 142.67 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.6 p -109.97 134.47 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.808 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.412 ' O ' ' C ' ' A' ' 34' ' ' GLU . 22.6 m170 -110.43 115.08 29.01 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.915 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 33' ' ' HIS . 1.0 OUTLIER 25.96 62.19 0.07 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.307 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -120.52 112.01 18.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.952 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -93.47 -19.1 21.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.7 m -72.24 145.42 47.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.024 0.44 . . . . 0.0 111.125 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.514 HG23 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -89.32 102.31 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.154 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 t -116.23 153.33 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.331 0.586 . . . . 0.0 111.669 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.869 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -173.1 128.26 0.46 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.285 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.464 ' CG1' ' CD1' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -112.44 134.71 54.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.177 0.513 . . . . 0.0 111.662 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB3' HG12 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -126.52 139.96 52.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.465 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.45 129.17 21.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.51 ' HD3' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -75.72 90.17 2.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.796 0.808 . . . . 0.0 110.433 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 47' ' ' GLU . 1.1 t -126.27 171.01 11.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.449 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.11 -14.47 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.529 ' HG2' ' N ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -71.79 -61.56 1.74 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.221 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.6 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 1.5 mp -64.64 -43.22 96.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.092 0.472 . . . . 0.0 109.844 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -40.05 -58.18 1.49 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.727 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.411 ' HB ' HD13 ' A' ' 95' ' ' LEU . 1.2 m -78.11 -61.98 1.82 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.106 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.636 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -45.01 -44.44 9.96 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.517 -178.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.556 ' HA ' ' CG2' ' A' ' 55' ' ' ILE . 1.6 tp -62.2 -47.45 93.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.041 0.448 . . . . 0.0 109.868 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.629 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -53.91 -37.31 63.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.102 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.422 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.9 OUTLIER -83.8 -75.57 0.33 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.53 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.632 HG21 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -31.22 -54.07 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.62 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -76.92 -41.21 44.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -177.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.629 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.44 -47.18 12.56 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.498 -178.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.674 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 51.4 p -52.72 -68.91 0.13 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.485 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.445 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 0.5 OUTLIER -91.87 -33.8 14.78 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.62 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 7.5 m-85 -82.99 -3.12 56.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.455 -0.898 . . . . 0.0 113.091 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 2.3 tptt -115.99 -42.52 3.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.104 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.674 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -58.87 -51.27 70.76 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.573 0.225 . . . . 0.0 111.311 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.439 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -179.42 89.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.235 0.54 . . . . 0.0 111.862 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.454 ' CG1' ' CE1' ' A' ' 60' ' ' TYR . 24.4 t -160.12 -52.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.19 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 4.8 m-20 171.54 132.22 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.267 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 65' ' ' ASN . 4.7 Cg_exo -78.57 -18.36 12.14 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.658 2.239 . . . . 0.0 111.929 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -51.94 -50.84 60.38 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.4 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.567 ' CG1' ' HG ' ' A' ' 56' ' ' LEU . 78.2 t -43.83 87.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.651 0.262 . . . . 0.0 111.43 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 67' ' ' THR . 18.1 p30 -116.56 138.9 51.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.803 0.335 . . . . 0.0 111.613 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 78' ' ' TRP . 1.3 p -102.71 153.69 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.102 0.477 . . . . 0.0 111.662 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -142.82 129.72 20.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.432 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.51 114.89 20.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.935 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -89.92 -146.76 0.18 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.734 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.15 -22.42 60.88 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 111.398 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.14 -35.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.627 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.5 159.7 17.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 110.795 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.6 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 45.8 m95 -83.46 142.67 30.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.447 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.557 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 7.6 m0 -112.58 110.34 20.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.483 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.869 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -100.41 118.48 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.209 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -126.6 136.76 52.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.487 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.444 ' CB ' HG22 ' A' ' 85' ' ' ILE . . . -143.63 158.85 43.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.827 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.42 135.96 49.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.229 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.69 -69.43 2.92 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.143 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.514 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 178.76 160.9 0.66 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.965 0.412 . . . . 0.0 111.245 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.56 HG12 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -152.04 157.04 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.582 179.226 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 7.3 pt-20 -141.38 125.6 17.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.039 0.447 . . . . 0.0 111.708 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.517 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 6.2 t -94.76 127.21 46.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.546 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.408 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 5.3 m-20 -76.44 152.42 36.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.102 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.543 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -107.47 100.06 9.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.392 0.615 . . . . 0.0 109.671 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.439 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER 164.6 -36.3 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.115 -179.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -73.09 -72.25 0.26 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.666 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.636 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -55.86 -59.66 2.49 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.908 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.453 ' CB ' ' CZ ' ' A' ' 100' ' ' PHE . 16.3 p -44.03 -37.08 2.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -57.47 -48.68 78.55 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.141 0.496 . . . . 0.0 110.401 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.411 HD13 ' HB ' ' A' ' 50' ' ' THR . 2.7 tm? -90.75 -19.13 23.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.555 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.479 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -91.07 9.65 30.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . 110.47 74.24 0.76 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.593 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -38.63 162.94 0.0 OUTLIER 'General case' 0 CA--C 1.526 0.037 0 CA-C-O 121.14 0.495 . . . . 0.0 111.377 -179.348 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.439 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 19.1 pt20 47.84 98.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.66 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.453 ' CZ ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -160.04 -152.69 0.3 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.603 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -124.2 124.36 42.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.887 0.375 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.435 HG21 ' CD1' ' A' ' 123' ' ' PHE . 12.5 p -53.79 166.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.242 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 80.48 -2.21 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -60.47 -30.45 69.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.467 ' CD1' ' CE2' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -76.94 -30.02 55.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.34 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.442 HD22 ' CE1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -108.97 21.44 17.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.207 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.2 p -87.32 -37.08 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 0.0 111.277 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 168.82 88.48 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.802 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.55 83.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.11 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.8 t 66.74 -63.99 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.195 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.68 163.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.995 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 20.5 p -160.16 83.39 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' A' ' 113' ' ' ILE . 8.4 mm -66.58 110.27 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.56 0.695 . . . . 0.0 111.192 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 146.61 148.09 4.7 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.597 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 126' ' ' THR . 1.8 mmm180 -76.6 120.05 21.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.452 ' CB ' HG22 ' A' ' 125' ' ' ILE . . . -108.14 125.22 51.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.063 0.459 . . . . 0.0 112.144 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 11.4 p90 -136.33 118.52 15.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.412 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.7 t -91.21 134.92 34.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.189 0.519 . . . . 0.0 111.731 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.6 pp -134.01 115.92 14.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.797 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.05 -106.16 0.84 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.992 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 89' ' ' CYS . 0.5 OUTLIER -133.16 83.97 2.1 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.073 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.499 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.2 OUTLIER 152.25 95.14 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.455 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.517 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 24.0 p90 -88.12 126.62 35.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.015 0.436 . . . . 0.0 111.151 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 12.2 p -102.87 136.14 43.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.149 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.56 ' CD1' HG12 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -116.09 118.4 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.778 0.799 . . . . 0.0 111.232 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 115' ' ' ARG . 11.3 t -98.2 156.1 16.85 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.16 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' A' ' 127' ' ' SER . 0.5 OUTLIER -140.13 13.61 2.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.448 0.642 . . . . 0.0 109.54 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.17 -72.82 0.67 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.104 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.9 tp 63.83 17.03 10.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.453 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.5 ttt -93.57 15.75 15.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.237 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -118.48 41.0 2.13 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.479 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mp -66.31 176.78 1.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -112.8 26.75 10.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.945 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -54.21 49.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.928 0.394 . . . . 0.0 110.686 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.34 -28.58 12.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.691 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -163.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.83 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 70.87 -56.17 0.63 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.884 0.373 . . . . 0.0 111.262 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.59 119.76 18.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.2 93.39 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -126.39 171.06 11.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.119 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.758 0.314 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.7 t -61.77 174.7 0.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.68 -54.17 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.168 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -102.26 133.49 47.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.23 -56.16 7.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 59.97 93.35 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.003 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.54 163.44 28.02 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.517 0.675 . . . . 0.0 111.573 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.46 ' C ' ' H ' ' A' ' 10' ' ' ALA . 64.9 t80 -73.82 166.58 23.07 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.924 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.418 ' HA ' HG12 ' A' ' 12' ' ' ILE . 3.6 m-20 -51.01 -10.53 0.07 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.429 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' A' ' 8' ' ' TYR . . . -84.14 -16.93 41.78 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.638 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.18 -13.11 2.44 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.959 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 9' ' ' ASP . 1.9 pp -56.73 -23.61 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 117.732 0.766 . . . . 0.0 111.854 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.73 8.21 17.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.866 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 18' ' ' LYS . . . -135.55 -38.07 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.469 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.66 -74.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.672 0.272 . . . . 0.0 111.127 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.5 9.13 41.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.582 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.88 -24.85 4.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.135 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.459 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 4.5 tmtt? -130.93 85.63 2.29 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.698 0.761 . . . . 0.0 110.321 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -128.04 2.51 5.89 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.471 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.2 18.0 7.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.877 0.37 . . . . 0.0 111.536 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.88 -178.16 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.042 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.96 11.08 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.904 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -145.12 10.99 1.33 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.041 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -98.83 -55.35 2.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.338 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -121.05 110.26 16.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.524 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.67 -109.51 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.514 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -55.9 -21.69 21.76 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.368 0.604 . . . . 0.0 111.577 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.12 -19.91 66.21 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.672 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -178.87 106.45 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.55 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.61 165.65 14.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.4 p -87.28 145.52 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.6 p -109.89 134.7 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.91 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 34' ' ' GLU . 56.1 p-80 -110.14 115.07 29.07 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.715 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 33' ' ' HIS . 1.3 mt-10 29.4 54.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.104 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.8 p -71.69 129.14 37.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.939 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.05 -26.31 11.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.888 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 m -67.69 140.85 56.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.449 ' CG1' ' CG2' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -97.18 131.22 44.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.987 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 113' ' ' ILE . 8.9 t -129.88 140.06 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 5.6 tp -128.5 104.33 7.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.481 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.417 ' CG2' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -111.74 126.85 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.24 0.543 . . . . 0.0 111.259 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 1.5 mt -126.69 140.9 52.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.684 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.7 OUTLIER -51.81 119.07 3.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.666 0.27 . . . . 0.0 111.054 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HD2' ' NE1' ' A' ' 77' ' ' TRP . 0.1 OUTLIER -46.79 91.97 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.529 ' C ' ' H ' ' A' ' 47' ' ' GLU . 13.6 m -125.38 169.36 12.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.914 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -67.03 3.69 1.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.561 ' HG2' ' CD1' ' A' ' 48' ' ' ILE . 1.4 tt0 -90.02 -59.32 2.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.801 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.604 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 0.5 OUTLIER -55.33 -43.72 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 121.171 0.51 . . . . 0.0 109.878 179.287 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -42.45 -61.59 1.17 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.342 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 83.8 m -68.43 -75.43 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.578 ' CD1' ' CG2' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -39.12 -62.02 0.69 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 119.687 -0.197 . . . . 0.0 111.5 -178.317 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -42.16 -46.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.983 0.421 . . . . 0.0 110.049 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.452 ' O ' ' CD2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -56.66 -53.64 55.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.459 ' HA ' HG21 ' A' ' 58' ' ' THR . 8.3 mt-10 -66.91 -94.42 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.016 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.631 HG21 ' H ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -18.74 -61.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.757 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -61.46 -76.22 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.486 ' HA ' HD11 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -64.12 -15.49 59.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 3.3 p -63.37 -75.39 0.08 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.204 0.525 . . . . 0.0 110.013 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.581 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 2.1 p30 -85.77 -31.47 22.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.768 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.757 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 86.1 m-85 -73.64 -29.46 62.35 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.23 -0.588 . . . . 0.0 112.048 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -86.43 -45.05 11.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.641 179.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.5 ttmt -55.58 -51.65 66.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.432 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.443 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER 179.62 100.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.939 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.581 ' HB ' ' O ' ' A' ' 59' ' ' ASP . 0.9 OUTLIER -177.52 -55.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.348 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.472 ' N ' HG13 ' A' ' 64' ' ' VAL . 4.4 m-20 178.69 129.92 0.22 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.846 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -86.63 -16.9 3.56 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.86 2.373 . . . . 0.0 112.111 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 82' ' ' ASN . 1.8 t -55.26 -39.49 69.86 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.551 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.629 HG13 ' CD1' ' A' ' 60' ' ' TYR . 11.6 p -66.02 65.81 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.406 0.622 . . . . 0.0 110.893 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -101.04 143.32 31.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.887 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.414 HG22 ' CD1' ' A' ' 79' ' ' ILE . 0.5 OUTLIER -95.65 149.67 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.483 0.658 . . . . 0.0 111.693 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.56 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 1.6 tp10 -143.66 125.97 15.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.529 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -84.66 115.45 22.67 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.225 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.427 ' HB2' ' CG ' ' A' ' 78' ' ' TRP . 0.1 OUTLIER -96.38 -114.39 0.13 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.417 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.77 -80.54 0.05 OUTLIER 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.783 0.325 . . . . 0.0 111.581 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.82 -24.84 2.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.037 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -102.52 162.6 12.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.752 0.31 . . . . 0.0 110.842 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.604 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 83.4 m95 -76.05 122.72 24.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.269 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.56 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.6 m0 -96.56 107.63 20.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.683 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.676 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -96.94 137.48 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.435 -178.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -128.81 136.0 49.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.316 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.403 ' O ' HG22 ' A' ' 38' ' ' VAL . . . -143.31 157.89 44.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.712 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -104.82 135.41 46.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.4 . . . . 0.0 110.701 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.63 -67.08 0.28 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.786 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 126' ' ' THR . 0.0 OUTLIER 178.14 173.57 0.62 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.116 0.484 . . . . 0.0 111.311 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.469 ' O ' ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -152.36 162.37 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.419 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 0.4 OUTLIER -129.23 121.94 28.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.183 0.516 . . . . 0.0 111.551 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.606 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 55.0 t -94.36 125.29 47.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.564 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -76.81 151.82 35.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.028 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.465 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 17.1 t -108.5 100.68 9.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 3.1 m-20 161.01 -32.95 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.09 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -74.34 -70.81 0.37 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.009 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.554 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -58.46 -51.61 69.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.589 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.2 p -52.68 -35.29 55.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.523 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -60.15 -44.65 94.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.928 0.394 . . . . 0.0 110.806 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -90.27 -21.6 22.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.761 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.466 HD22 ' HG3' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.46 12.26 35.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.901 0.382 . . . . 0.0 111.218 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.16 66.44 0.13 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.591 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.34 152.56 0.02 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 65.48 18.12 11.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.46 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -166.15 0.25 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.994 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -121.88 140.7 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' A' ' 123' ' ' PHE . 11.9 p -56.82 163.59 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.004 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.448 ' CE2' ' CG2' ' A' ' 118' ' ' THR . 0.9 OUTLIER 70.07 9.67 7.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.278 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.43 -32.48 24.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.365 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.43 ' CE2' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -66.66 -33.03 74.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.511 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.62 33.3 5.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.707 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.9 p -63.24 -40.55 89.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.414 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -174.65 81.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.856 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 t -127.73 165.67 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.036 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 t -43.3 -46.16 6.22 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.477 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.417 ' CB ' ' CG2' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -172.49 151.08 2.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.825 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 35.5 p -156.27 99.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.242 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.453 HD12 HG12 ' A' ' 125' ' ' ILE . 1.1 mp 59.75 -77.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.542 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 112' ' ' THR . . . 170.98 -100.07 0.15 Allowed Glycine 0 C--N 1.309 -0.925 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.173 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -93.25 129.76 39.2 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.469 ' CA ' HG21 ' A' ' 125' ' ' ILE . . . -122.47 136.37 54.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 36.5 p90 -136.44 116.74 13.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.253 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.448 ' CG2' ' CE2' ' A' ' 103' ' ' TYR . 14.1 t -86.38 151.19 23.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.818 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 pp -159.96 116.21 2.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.822 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.63 -110.47 2.8 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.713 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -132.85 83.85 2.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 1.9 mtpp 152.52 95.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.795 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.606 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 6.5 p90 -88.31 124.07 33.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.177 0.513 . . . . 0.0 110.785 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.443 ' HB ' ' CZ ' ' A' ' 117' ' ' TYR . 17.2 m -98.37 125.85 43.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.463 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.469 HG21 ' CA ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -102.05 117.23 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.009 0.909 . . . . 0.0 111.02 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' ARG . 9.7 t -97.43 155.38 16.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.967 -1.469 . . . . 0.0 110.513 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.429 ' OG ' HG11 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -136.83 14.85 3.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 109.668 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -121.85 -64.91 1.17 Allowed 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.298 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.8 tp 63.93 17.71 10.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.273 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 ttm -91.28 15.12 12.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.322 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -97.69 -19.37 25.0 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.548 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.3 mp -76.75 119.62 20.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.381 . . . . 0.0 110.933 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -125.61 32.82 5.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -50.03 34.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -111.77 -15.55 13.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.197 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 136' ' ' LEU . 3.9 tt -86.3 4.5 38.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.1 0.476 . . . . 0.0 111.531 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.08 -23.63 0.52 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.306 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -150.35 19.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.645 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -49.67 127.86 16.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.195 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -76.26 162.15 28.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.071 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.856 0.36 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.53 142.36 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.5 t -74.49 -40.04 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -102.31 130.22 48.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 t -103.42 62.79 0.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -109.0 149.95 28.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.78 155.69 48.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.161 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.428 ' CE2' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -101.71 22.63 12.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.367 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.465 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.5 p30 -53.36 -20.14 4.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.524 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.24 -16.91 60.43 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.779 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.12 -9.92 2.33 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.377 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.465 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.1 pp -60.48 -19.73 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 117.466 0.633 . . . . 0.0 112.087 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.41 ' HB2' ' HE1' ' A' ' 13' ' ' MET . 0.0 OUTLIER -84.14 8.81 14.39 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.015 178.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -136.68 -52.77 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.401 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.428 HD23 ' CE2' ' A' ' 8' ' ' TYR . 11.0 mp -59.51 -80.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.308 . . . . 0.0 110.867 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 10.76 30.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 111.18 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.33 -21.18 5.95 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.05 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -128.05 80.69 1.98 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 110.373 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.468 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 17.7 t0 -128.04 -25.42 3.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.346 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 19' ' ' ASP . 9.2 p90 47.93 74.82 0.15 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.722 0.772 . . . . 0.0 111.11 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.29 -9.65 59.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.505 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.82 11.49 22.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.81 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -138.53 12.72 2.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.117 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.23 -53.61 3.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.498 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -120.34 110.5 16.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.604 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.78 -116.2 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.062 0.458 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.54 14.86 9.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.484 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -70.4 -29.84 66.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.643 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -159.35 97.61 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.494 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -110.83 166.34 11.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.053 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -102.76 151.81 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.114 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.82 134.94 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.88 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.41 ' O ' ' C ' ' A' ' 34' ' ' GLU . 29.0 m-70 -110.14 115.08 29.1 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.801 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 33' ' ' HIS . 0.7 OUTLIER 28.02 72.57 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.207 179.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.91 129.0 35.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.692 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.32 27.85 0.25 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.993 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.8 m -88.61 148.4 24.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.789 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.46 HG23 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -93.0 103.13 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.402 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 t -111.72 149.78 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.092 0.472 . . . . 0.0 111.423 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 5.7 mp -155.06 105.19 2.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.397 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -113.22 127.56 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.141 0.496 . . . . 0.0 112.269 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.509 ' HB2' ' CD1' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -128.53 147.19 50.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.181 178.137 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -48.86 132.28 18.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.13 89.95 0.46 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.499 0.666 . . . . 0.0 110.683 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -126.15 170.86 11.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.515 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -51.65 -14.24 0.32 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.534 ' HG2' ' CD1' ' A' ' 48' ' ' ILE . 11.6 tt0 -66.72 -70.98 0.21 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.252 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.614 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 0.8 OUTLIER -59.15 -43.65 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 121.183 0.516 . . . . 0.0 109.727 178.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -39.6 -59.06 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.407 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.6 m -78.85 -62.02 1.83 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.064 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.626 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -43.96 -47.26 8.5 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.324 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.62 ' HA ' ' CG2' ' A' ' 55' ' ' ILE . 1.7 tp -61.55 -47.11 94.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.025 0.44 . . . . 0.0 110.34 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.63 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 pt-20 -53.85 -41.72 67.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.567 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' O ' ' CG2' ' A' ' 58' ' ' THR . 1.0 OUTLIER -81.32 -66.86 0.83 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.0 0.429 . . . . 0.0 111.0 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.62 ' CG2' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -37.25 -58.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.63 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -75.13 -35.9 61.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -177.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -81.87 -46.82 13.58 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.65 -178.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.694 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 68.7 p -52.17 -70.17 0.09 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.381 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.445 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 2.5 m-20 -92.79 -32.52 14.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.63 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 2.4 m-85 -80.53 -6.01 57.58 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.839 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -113.96 -41.24 3.58 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.933 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.694 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.2 ttmt -57.61 -51.17 70.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.66 0.267 . . . . 0.0 111.43 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.453 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER 179.4 88.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 111.395 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 59' ' ' ASP . 20.9 t -156.44 -54.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.399 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.424 ' HB3' HG21 ' A' ' 67' ' ' THR . 4.6 m-20 169.86 149.36 0.14 Allowed Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.912 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -89.76 -20.72 1.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.192 2.595 . . . . 0.0 112.88 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -46.89 -65.52 0.55 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.211 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.579 HG12 ' CG ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -42.1 87.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.117 179.324 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.1 p30 -116.07 142.28 47.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.474 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.441 HG22 HD11 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.74 149.72 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.083 0.468 . . . . 0.0 111.029 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.713 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 17.1 mt-10 -143.35 116.05 8.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.35 114.34 26.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.905 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -101.06 -80.88 0.49 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.67 -73.36 0.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.87 0.366 . . . . 0.0 111.422 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.08 -42.15 0.19 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.518 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -83.27 164.26 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.394 . . . . 0.0 110.737 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.614 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 30.5 m95 -88.38 136.31 33.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.325 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.713 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 12.5 m0 -103.94 107.1 17.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.485 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.713 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -96.47 121.7 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -126.73 136.29 52.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.027 0.442 . . . . 0.0 111.654 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.427 ' CB ' HG22 ' A' ' 85' ' ' ILE . . . -143.53 158.67 43.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.783 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.55 139.17 47.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.866 0.365 . . . . 0.0 111.243 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.79 -69.56 3.03 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.025 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.46 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -179.05 158.4 0.91 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.948 0.404 . . . . 0.0 111.128 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.467 HG12 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -146.03 152.23 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 0.7 OUTLIER -135.41 123.01 22.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 111.428 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.543 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 24.3 t -94.61 136.68 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.826 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 8.6 t70 -76.72 152.03 35.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.957 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 10.6 t -109.59 101.08 10.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.155 0.502 . . . . 0.0 109.888 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.3 m-20 160.21 -36.38 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.3 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -71.76 -71.96 0.25 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.198 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.626 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.1 tt -57.71 -56.65 14.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.1 t -45.6 -35.94 4.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.655 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.436 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.2 mm-40 -60.93 -46.82 89.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.095 0.474 . . . . 0.0 110.508 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.88 -14.66 33.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.528 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.457 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -103.32 10.55 37.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.439 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 140.13 67.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.673 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -32.48 135.0 0.09 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.019 0.438 . . . . 0.0 111.618 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.23 17.3 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.602 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.5 OUTLIER -70.13 -171.62 0.47 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.591 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -132.99 151.68 52.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.061 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 123' ' ' PHE . 11.5 p -57.82 160.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.016 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 79.7 9.7 1.48 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.138 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -92.94 -23.33 18.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.958 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.504 ' CE1' ' CE2' ' A' ' 123' ' ' PHE . 1.0 OUTLIER -79.62 -37.89 35.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.134 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.79 29.67 6.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p -81.63 -44.49 20.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.995 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -179.98 88.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.77 81.41 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.065 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 t 68.95 -63.59 0.36 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.978 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m 174.05 160.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 2.0 p -163.91 94.8 0.77 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.0 mm -71.35 120.03 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.231 0.538 . . . . 0.0 111.13 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.94 137.2 3.45 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.032 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.1 OUTLIER -77.42 119.59 21.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.644 0.259 . . . . 0.0 110.321 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.56 125.46 49.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 0.0 112.014 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 13.1 p90 -128.91 121.18 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.364 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.4 t -95.96 153.56 17.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.363 0.602 . . . . 0.0 112.128 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.473 ' O ' ' CD2' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -163.59 123.7 2.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.436 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.04 -109.88 2.85 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.121 -1.037 . . . . 0.0 111.487 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -138.37 83.95 2.0 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 2.0 mtpm? 154.29 100.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.674 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.543 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 1.7 p90 -88.76 137.29 32.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.972 0.415 . . . . 0.0 111.006 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 23.9 m -110.6 129.38 55.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.246 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -110.22 117.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.859 0.838 . . . . 0.0 110.814 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.9 t -96.52 156.46 16.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.552 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.408 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.46 16.92 2.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.495 0.664 . . . . 0.0 109.555 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -120.46 167.91 11.87 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.296 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.3 mp 62.61 107.05 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.2 0.524 . . . . 0.0 110.938 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.67 15.28 20.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.402 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.46 33.8 3.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.618 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.8 mp -64.7 116.41 6.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.77 0.319 . . . . 0.0 110.858 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -150.82 93.79 1.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.937 0.398 . . . . 0.0 111.061 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.61 -55.5 3.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.697 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -106.87 17.46 23.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 136' ' ' LEU . 0.3 OUTLIER -135.85 11.4 3.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.942 0.401 . . . . 0.0 111.36 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -48.4 -31.08 5.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.257 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -123.03 109.29 13.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -166.68 162.24 16.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.97 178.32 6.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.067 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.1 mtt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.758 0.314 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.7 p -78.95 -26.1 43.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.037 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.4 t 66.82 135.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.147 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -126.29 145.75 50.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t -156.23 97.98 1.82 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -69.27 97.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.836 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.03 174.73 10.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.461 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -127.15 29.39 5.6 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 120.977 0.418 . . . . 0.0 111.365 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.547 ' HA ' ' CD1' ' A' ' 12' ' ' ILE . 1.6 p-10 -55.36 -23.01 21.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.98 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.55 -32.21 42.13 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.833 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.461 ' HA3' ' CD1' ' A' ' 8' ' ' TYR . . . -73.44 -40.52 47.71 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.286 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.593 ' O ' ' N ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -108.27 9.85 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 120.234 -0.587 . . . . 0.0 111.764 178.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.519 ' CE ' ' HA ' ' A' ' 13' ' ' MET . 0.0 OUTLIER 59.2 -62.99 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.647 0.737 . . . . 0.0 112.344 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -166.78 25.04 0.14 Allowed Glycine 0 C--N 1.3 -1.451 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.934 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.2 mt -82.64 -81.89 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.665 0.269 . . . . 0.0 110.958 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.03 8.57 37.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.033 0.444 . . . . 0.0 111.159 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.83 -20.89 5.56 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.049 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -128.49 81.01 2.0 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.339 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.01 8.95 3.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.534 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.506 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -84.08 2.15 40.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.163 0.506 . . . . 0.0 111.04 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.65 -170.76 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.063 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 t70 62.32 14.28 6.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.163 0.506 . . . . 0.0 110.339 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -133.42 9.52 4.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.955 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.75 -53.69 4.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.57 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -120.99 111.89 18.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.771 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.48 -117.93 0.07 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.027 0.442 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 62.47 17.04 9.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.382 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.26 -20.89 29.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -93.35 14.57 18.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.853 0.358 . . . . 0.0 111.363 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -121.32 151.3 40.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.831 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 p -116.63 137.25 51.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.335 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 p -109.93 135.2 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.808 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.414 ' O ' ' C ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -109.82 115.29 29.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.192 0.52 . . . . 0.0 110.756 -179.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 33' ' ' HIS . 1.2 mt-10 27.74 61.23 0.11 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.28 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.4 t -81.95 148.67 28.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.966 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.35 58.54 4.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.472 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.412 HG21 ' N ' ' A' ' 38' ' ' VAL . 88.4 m -93.46 148.24 22.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.266 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -85.69 97.9 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.477 179.379 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.31 150.85 13.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.337 0.589 . . . . 0.0 112.163 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.802 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.12 119.79 3.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.764 178.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.46 126.51 70.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.173 0.511 . . . . 0.0 111.85 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.468 ' HB3' HD13 ' A' ' 48' ' ' ILE . 7.6 mp -126.76 140.43 52.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.606 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -48.45 133.06 16.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.497 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -78.32 87.62 4.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.502 0.668 . . . . 0.0 110.99 -179.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 47' ' ' GLU . 21.8 m -126.4 170.99 11.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.887 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -14.12 0.17 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.289 0.566 . . . . 0.0 109.583 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HG3' ' CD2' ' A' ' 96' ' ' LEU . 12.2 tt0 -70.12 -71.6 0.23 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.327 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.585 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -59.18 -45.0 93.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.136 0.493 . . . . 0.0 110.073 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -38.78 -53.4 1.68 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.059 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 73.8 m -72.48 -74.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.643 ' CD1' HG23 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -41.23 -44.47 2.63 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.585 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -56.04 -48.08 79.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.223 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 3.0 pt-20 -52.14 -50.31 61.99 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HA ' HG21 ' A' ' 58' ' ' THR . 6.9 mt-10 -68.76 -87.89 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.536 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.643 HG23 ' CD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.13 -62.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -65.6 -70.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -64.4 -23.85 67.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.554 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 15.5 p -60.42 -70.95 0.15 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.337 0.589 . . . . 0.0 110.784 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.481 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -86.88 -36.72 18.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.345 -178.054 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.735 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 97.7 m-85 -76.66 -13.57 60.04 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -103.94 -41.02 6.0 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.198 178.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 58' ' ' THR . 3.8 ttpt -68.32 -50.07 56.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.071 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.461 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -177.4 87.0 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 121.379 0.609 . . . . 0.0 112.524 179.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.735 ' HB ' ' HA ' ' A' ' 60' ' ' TYR . 25.4 t -161.92 -54.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.495 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.428 ' HB3' HG21 ' A' ' 67' ' ' THR . 4.6 m-20 169.48 144.38 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.4 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -86.26 -20.87 2.62 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.897 2.398 . . . . 0.0 112.485 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 69' ' ' ASN . 4.6 t -51.77 -48.74 63.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.234 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.587 ' CG1' ' HG ' ' A' ' 56' ' ' LEU . 54.3 t -53.56 82.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.872 0.367 . . . . 0.0 110.635 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 67' ' ' THR . 19.5 p30 -116.06 142.73 46.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.495 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -96.82 153.89 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.267 0.556 . . . . 0.0 111.575 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -142.05 124.48 15.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.501 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.24 114.22 18.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.959 0.409 . . . . 0.0 110.771 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.457 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -90.49 -150.83 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.644 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.94 -49.74 76.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.673 0.273 . . . . 0.0 111.065 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.08 15.82 1.02 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.203 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.57 161.17 38.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.953 0.376 . . . . 0.0 111.081 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.566 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 63.4 m95 -85.44 143.37 28.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.499 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.3 m0 -116.72 105.7 12.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.634 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.802 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.52 112.22 30.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 0.0 110.155 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -112.34 135.41 53.06 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.218 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.45 ' CB ' HG22 ' A' ' 85' ' ' ILE . . . -144.65 158.65 43.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.015 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 67' ' ' THR . 0.0 OUTLIER -104.6 148.64 26.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.98 0.419 . . . . 0.0 111.298 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.94 -70.11 0.3 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.171 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.48 ' HA ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 178.97 159.68 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.371 . . . . 0.0 110.935 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.456 HG12 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.6 160.3 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 9.1 pt-20 -138.91 127.63 23.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.166 0.507 . . . . 0.0 111.636 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.627 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 27.5 t -94.52 146.2 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.533 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -88.98 152.04 21.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.043 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.454 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 42.7 t -109.49 101.03 10.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.234 0.54 . . . . 0.0 109.908 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 0.9 OUTLIER 161.11 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.226 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.34 -69.52 0.53 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.958 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.584 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.3 tt -62.2 -56.02 20.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.314 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.0 t -45.24 -32.43 1.93 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.389 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -63.5 -61.28 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.002 0.43 . . . . 0.0 110.493 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -17.24 60.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.909 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.531 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -101.89 8.32 41.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.293 -179.237 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.45 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 143.04 65.93 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.562 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -33.57 133.61 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.968 0.413 . . . . 0.0 111.736 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 70.14 17.34 7.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.638 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.45 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -66.33 -175.5 0.36 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.61 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -85.5 -95.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.769 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.408 HG21 ' CD1' ' A' ' 123' ' ' PHE . 10.1 p 179.4 -35.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.682 0.277 . . . . 0.0 111.284 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.448 ' CE2' ' CG2' ' A' ' 118' ' ' THR . 5.0 m-85 -72.81 -2.67 21.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.079 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -46.18 -39.44 9.69 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.874 0.369 . . . . 0.0 110.584 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.447 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -75.47 143.51 42.55 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.915 179.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 tt 62.06 18.57 10.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.187 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.8 -42.27 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.794 0.33 . . . . 0.0 111.038 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -179.95 51.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.703 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -113.08 85.87 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.487 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.8 -65.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.151 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 109' ' ' VAL . 6.6 t 168.65 172.37 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.765 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER 179.27 120.87 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.882 0.372 . . . . 0.0 111.505 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.1 mm -87.52 122.83 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.331 0.586 . . . . 0.0 111.059 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.87 141.6 3.88 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.984 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 126' ' ' THR . 41.7 mtt-85 -77.24 120.11 21.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.36 123.84 48.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.162 0.506 . . . . 0.0 112.156 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.473 ' CZ ' ' OG1' ' A' ' 124' ' ' THR . 13.5 p90 -137.73 119.49 15.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.369 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.448 ' CG2' ' CE2' ' A' ' 103' ' ' TYR . 14.7 t -93.99 136.24 34.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.118 0.485 . . . . 0.0 111.85 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.1 pp -135.07 118.75 17.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.76 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.73 -106.63 1.02 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.88 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.37 83.4 2.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.881 0.372 . . . . 0.0 110.118 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 3.7 mttt 152.3 97.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.592 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.627 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 15.1 p90 -88.26 126.31 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.423 . . . . 0.0 111.124 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 19.6 p -102.13 137.38 40.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.867 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.456 ' CD1' HG12 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -119.36 118.24 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.78 0.8 . . . . 0.0 111.268 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 115' ' ' ARG . 10.3 t -98.04 156.06 16.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.472 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.429 ' CB ' HG11 ' A' ' 38' ' ' VAL . 13.2 t -143.4 19.83 1.88 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.41 0.624 . . . . 0.0 109.489 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -122.87 -166.33 1.43 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.019 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 69.21 109.87 0.05 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.201 0.524 . . . . 0.0 110.952 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 6.9 ttp -107.88 16.21 23.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.207 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -58.0 -65.25 3.66 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.566 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.95 114.23 6.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.363 . . . . 0.0 110.8 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.4 p30 -88.86 58.35 4.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.964 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -48.5 78.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.778 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.05 17.35 9.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.251 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.89 12.42 14.72 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.026 0.441 . . . . 0.0 110.899 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -54.58 -28.94 49.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.234 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -132.25 123.9 27.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.991 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -153.35 -173.28 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -139.37 164.44 29.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.144 -179.929 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 mtm . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.826 0.345 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.75 -39.77 4.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.6 t 68.37 -68.45 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.162 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -74.8 150.9 39.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.954 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 60.94 39.82 16.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -162.86 41.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 59.76 -174.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.038 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.443 ' CZ ' ' CD2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -113.19 22.78 13.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.253 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.41 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.9 p30 -52.6 -20.93 3.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.259 0.552 . . . . 0.0 111.511 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.42 -16.16 60.89 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.763 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.99 -10.98 1.89 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.308 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.41 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.0 pp -58.66 -20.84 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 117.482 0.641 . . . . 0.0 112.019 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.41 ' HB2' ' HE1' ' A' ' 13' ' ' MET . 0.0 OUTLIER -82.05 7.53 13.08 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.972 178.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.3 24.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.718 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.443 ' CD2' ' CZ ' ' A' ' 8' ' ' TYR . 7.2 mp -133.62 -83.09 0.46 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.66 0.266 . . . . 0.0 110.673 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.71 7.57 38.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.142 0.496 . . . . 0.0 111.017 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -119.29 -25.17 2.76 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.536 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.89 85.48 2.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.7 0.762 . . . . 0.0 110.008 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -138.65 12.77 2.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.466 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.01 13.96 5.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.856 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.99 -174.29 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.783 0.325 . . . . 0.0 110.776 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.0 t0 62.09 13.84 6.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.997 0.427 . . . . 0.0 110.84 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -148.46 12.49 0.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.23 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -99.11 -52.7 3.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.344 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -120.98 110.46 16.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.399 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.64 -116.9 0.07 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.093 0.473 . . . . 0.0 110.953 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t70 66.14 15.48 10.1 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.329 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -87.95 -19.9 26.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.958 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -93.44 15.15 16.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.431 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -81.86 137.86 35.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.84 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 p -82.27 148.19 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.099 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.96 134.77 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.67 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -109.89 115.22 29.41 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.798 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 31.01 65.36 0.16 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.043 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -68.66 146.2 53.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.749 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.96 -26.72 9.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.314 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.0 m -90.66 142.86 27.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 0.0 111.178 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.459 HG11 ' CB ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -93.97 92.75 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.858 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.43 145.26 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.363 0.602 . . . . 0.0 111.99 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.778 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.22 129.48 7.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.008 179.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.94 129.36 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.213 0.53 . . . . 0.0 111.731 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.499 ' HB3' HG12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -127.24 140.3 52.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.874 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -49.27 127.54 15.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HD3' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -73.14 92.2 1.7 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.73 0.776 . . . . 0.0 110.74 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.444 ' C ' ' N ' ' A' ' 47' ' ' GLU . 6.9 m -126.2 171.12 11.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.207 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -49.95 -16.8 0.31 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.608 ' HG2' ' N ' ' A' ' 48' ' ' ILE . 12.5 tt0 -65.46 -74.26 0.11 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.509 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.608 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 2.2 mp -54.7 -31.92 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.2 0.524 . . . . 0.0 109.912 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -47.5 -61.68 1.81 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.51 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.9 m -82.09 -44.78 16.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.056 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -52.52 -48.85 65.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.737 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.573 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.6 tp -62.53 -48.52 87.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.061 0.458 . . . . 0.0 109.964 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.676 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -50.54 -47.47 57.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.402 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' O ' ' OG1' ' A' ' 58' ' ' THR . 28.7 mt-10 -77.77 -71.05 0.44 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.343 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.573 HG23 ' CE1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -30.64 -59.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.667 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -78.91 -50.16 11.65 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.676 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 3.1 mm? -65.03 -48.25 74.56 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 119.312 0.96 . . . . 0.0 111.376 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 46.0 p -53.0 -71.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.018 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.435 ' N ' ' OG1' ' A' ' 58' ' ' THR . 9.1 m-20 -62.35 -18.17 60.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.964 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.667 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -51.24 -78.1 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.694 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -19.7 64.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.086 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 58' ' ' THR . 4.8 ttpp -59.73 -70.38 0.17 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.021 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.91 21.73 0.17 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.522 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 65' ' ' ASN . 43.1 t -98.38 -78.36 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.625 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.526 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 4.8 m-20 154.51 170.82 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.048 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 80.8 Cg_endo -88.62 -7.39 5.62 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.972 2.448 . . . . 0.0 111.955 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -64.62 -85.33 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.878 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -28.97 86.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.635 0.731 . . . . 0.0 111.815 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.2 p30 -115.91 143.28 45.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.563 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.413 ' CG2' ' HB3' ' A' ' 77' ' ' TRP . 1.5 p -96.27 151.0 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.321 0.581 . . . . 0.0 111.559 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 16.4 pt-20 -144.92 135.38 24.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.551 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -79.85 114.56 18.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.783 0.325 . . . . 0.0 110.434 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -85.09 -78.47 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.996 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.31 -66.73 0.68 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.0 3.85 8.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.676 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.6 158.1 44.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.808 0.337 . . . . 0.0 110.823 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.605 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 78.2 m95 -77.29 142.99 39.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.546 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.584 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.5 m0 -114.8 109.85 18.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.356 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.778 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -100.02 116.17 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.191 0.52 . . . . 0.0 111.382 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -111.72 134.63 53.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.122 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.425 ' HB2' HG21 ' A' ' 85' ' ' ILE . . . -144.43 158.76 43.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.898 0.38 . . . . 0.0 111.556 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -109.18 143.34 38.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.921 179.198 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.93 -69.05 0.62 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.483 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.449 ' HA ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -177.07 152.31 0.89 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.213 0.53 . . . . 0.0 111.728 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.477 HG12 ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -125.79 160.47 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 17.2 pt-20 -147.24 125.86 12.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.499 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 38.2 t -95.48 146.9 6.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.673 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 8.9 p30 -101.54 151.82 21.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.639 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.628 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 1.2 t -105.34 99.85 9.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.296 0.57 . . . . 0.0 110.186 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.1 m-20 159.75 -37.58 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.954 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -69.93 -75.82 0.11 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.635 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.547 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.6 tt -52.88 -56.42 7.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.505 ' CB ' ' CE1' ' A' ' 100' ' ' PHE . 56.0 p -46.14 -43.3 14.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.0 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -51.14 -45.81 61.75 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 109.959 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.2 -18.77 23.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.591 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.474 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.32 19.31 13.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.193 0.521 . . . . 0.0 110.746 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 98' ' ' ARG . . . 99.79 68.56 0.88 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.494 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -30.05 148.07 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.084 0.468 . . . . 0.0 111.895 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 55.3 105.59 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.412 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -175.46 -158.85 0.07 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.632 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.09 132.39 35.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.165 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.475 HG21 ' CD1' ' A' ' 123' ' ' PHE . 5.9 p -81.51 -28.59 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.806 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.462 ' CE2' ' CG2' ' A' ' 118' ' ' THR . 4.0 m-85 -77.44 -2.82 37.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.749 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.02 -35.87 5.17 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-O 120.876 0.369 . . . . 0.0 110.62 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.454 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -80.66 134.35 35.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.152 179.31 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 3.9 tt 75.46 7.68 3.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.862 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.4 p -86.02 -36.84 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.828 0.347 . . . . 0.0 111.255 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -178.43 48.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.616 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -113.41 86.17 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.261 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.97 -65.78 0.21 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.942 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 109' ' ' VAL . 5.9 t 165.44 169.81 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.524 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -179.18 133.84 0.12 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.976 0.417 . . . . 0.0 111.513 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.0 mm -104.85 113.71 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.54 0.686 . . . . 0.0 110.94 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 152.45 146.85 4.45 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.132 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.29 127.25 32.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.64 0.257 . . . . 0.0 110.594 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.408 ' CB ' HG22 ' A' ' 125' ' ' ILE . . . -115.72 124.66 51.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.088 0.47 . . . . 0.0 111.766 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 23.6 p90 -136.92 118.95 15.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.854 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.462 ' CG2' ' CE2' ' A' ' 103' ' ' TYR . 11.0 t -95.35 152.66 18.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.217 0.532 . . . . 0.0 111.498 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.7 pp -148.41 116.46 6.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.893 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.06 -104.17 0.37 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.188 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.628 ' ND2' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -129.61 83.97 2.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.24 0.543 . . . . 0.0 109.653 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 8.6 mttt 148.73 112.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.998 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.564 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 9.5 p90 -109.18 124.38 50.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.069 0.461 . . . . 0.0 110.817 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 7.3 p -100.49 141.72 32.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.643 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.454 HG12 ' CZ ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -120.82 117.61 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.87 0.843 . . . . 0.0 111.296 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 115' ' ' ARG . 12.8 t -103.61 155.47 18.52 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.105 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.459 ' CB ' HG11 ' A' ' 38' ' ' VAL . 30.1 t -144.41 18.96 1.71 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.301 0.572 . . . . 0.0 109.855 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -123.97 -27.15 3.94 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.459 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 65.27 107.94 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.189 0.518 . . . . 0.0 110.796 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 67.9 mtm -93.76 16.07 14.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.49 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -106.67 46.59 1.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.539 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 18.6 mt -91.74 55.36 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.936 0.398 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.403 ' HA ' ' CD1' ' A' ' 136' ' ' LEU . 70.6 m-20 59.92 28.89 18.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.022 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -52.66 57.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.702 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -115.4 31.33 6.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.614 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -128.21 -161.65 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.83 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 71.63 -55.94 0.65 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.335 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -114.61 111.0 20.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.11 177.36 7.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -132.16 133.71 44.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.087 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.808 0.337 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 t 56.96 -169.16 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 t -133.4 -53.38 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.027 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -98.62 151.47 20.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -58.6 -26.87 64.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.954 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.2 m120 64.94 90.69 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.91 103.11 4.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.102 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -64.18 -134.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.387 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -46.41 -26.42 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.126 0.489 . . . . 0.0 112.318 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.58 -26.5 62.63 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.527 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 8' ' ' TYR . . . -94.28 -26.22 14.52 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.731 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.436 HG13 ' N ' ' A' ' 13' ' ' MET . 0.7 OUTLIER -92.29 -26.33 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.79 0.805 . . . . 0.0 110.664 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.436 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER 28.7 46.07 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.79 -1.55 . . . . 0.0 113.34 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.2 -89.41 0.08 OUTLIER Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.184 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -44.01 -69.61 0.13 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.738 0.304 . . . . 0.0 111.415 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.61 -6.42 27.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.192 0.52 . . . . 0.0 111.642 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.16 -13.35 42.75 Favored Glycine 0 C--N 1.313 -0.723 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.704 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.45 81.55 2.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.133 0.492 . . . . 0.0 110.632 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -137.6 12.01 2.96 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.354 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.05 15.16 6.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.71 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.98 -171.69 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.849 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.71 14.22 4.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.06 0.457 . . . . 0.0 110.568 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -141.25 11.29 2.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.978 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.74 -45.05 14.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.515 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -120.4 110.85 17.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.644 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.52 -115.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.937 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 t0 67.04 15.34 10.1 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.377 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -76.5 -26.37 55.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.771 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -144.61 17.1 1.65 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.367 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -97.5 165.91 11.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.93 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.29 150.72 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.052 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.406 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 10.9 p -109.95 134.42 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.861 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.406 ' O ' ' C ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -110.42 115.11 29.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.251 0.548 . . . . 0.0 110.867 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 33' ' ' HIS . 0.9 OUTLIER 29.04 71.04 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.198 179.36 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.406 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 3.9 t -76.22 142.65 41.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.933 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -107.28 27.97 8.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.9 m -69.11 143.56 54.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.071 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.502 HG23 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -87.64 98.89 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.69 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 113' ' ' ILE . 7.2 t -117.17 152.82 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.314 0.578 . . . . 0.0 111.881 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.767 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -164.53 128.09 2.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.085 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.42 130.7 65.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.251 0.548 . . . . 0.0 111.927 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.537 ' HB3' HG12 ' A' ' 48' ' ' ILE . 9.0 tp -128.04 140.49 51.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.816 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -47.17 124.53 6.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.569 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.466 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -71.68 90.36 1.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.501 0.667 . . . . 0.0 110.655 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.475 ' C ' ' N ' ' A' ' 47' ' ' GLU . 3.7 m -125.72 171.79 10.34 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.198 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -48.11 -17.77 0.15 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.269 0.557 . . . . 0.0 109.526 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.556 ' HG2' ' N ' ' A' ' 48' ' ' ILE . 25.7 tt0 -63.23 -77.42 0.05 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.468 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.59 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 2.3 mp -54.62 -31.74 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -47.03 -60.23 2.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.276 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.9 m -84.17 -45.59 12.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.054 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.617 ' CE1' HG23 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -51.44 -47.64 62.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.513 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.5 tp -63.66 -49.04 83.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.062 0.458 . . . . 0.0 109.818 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -50.78 -45.04 58.9 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.802 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.455 ' O ' ' OG1' ' A' ' 58' ' ' THR . 3.2 mt-10 -77.25 -77.19 0.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.695 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.617 HG23 ' CE1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -30.98 -55.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.641 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 7.0 tt -71.28 -60.52 2.19 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 2.6 mm? -66.85 -48.23 69.5 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 51.8 p -51.98 -71.82 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.062 0.458 . . . . 0.0 110.279 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.438 ' N ' ' OG1' ' A' ' 58' ' ' THR . 6.3 m-20 -60.59 -23.21 64.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.891 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.641 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -47.32 -78.0 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -67.91 -26.17 65.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.297 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.0 ttpp -52.02 -66.54 0.37 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.872 0.367 . . . . 0.0 111.281 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -169.76 30.39 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.255 0.55 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 65' ' ' ASN . 24.1 t -101.68 -78.63 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.348 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 64' ' ' VAL . 5.1 m-20 154.49 165.92 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 O-C-N 123.523 0.514 . . . . 0.0 110.946 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 94.7 Cg_endo -86.19 -3.54 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.79 2.327 . . . . 0.0 111.922 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.461 ' O ' ' C ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -68.82 -86.75 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.44 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.555 HG23 ' HG ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -24.29 89.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.559 0.695 . . . . 0.0 111.895 -179.405 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -116.04 143.1 45.92 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.04 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 77' ' ' TRP . 1.5 p -96.73 153.06 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.146 0.498 . . . . 0.0 111.547 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 27.6 tt0 -143.83 133.09 23.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.991 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.65 114.37 21.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.295 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -94.3 -81.67 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.318 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.42 -69.21 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.835 0.35 . . . . 0.0 111.354 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.55 5.45 7.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.034 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.66 153.91 43.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 110.889 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.59 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 82.7 m95 -76.83 143.07 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.62 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.51 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.3 m0 -111.3 105.03 13.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.339 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.767 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.81 110.56 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.028 0.442 . . . . 0.0 110.824 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -112.13 135.71 52.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.066 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -144.09 156.9 44.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.417 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.423 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 0.5 OUTLIER -109.07 128.93 55.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.449 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.04 -67.67 3.12 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.327 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.502 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -178.61 152.38 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.252 0.548 . . . . 0.0 111.619 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.473 HG12 ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -127.08 160.21 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 2.3 pt-20 -149.39 125.69 10.81 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.547 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.595 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 62.1 t -95.3 146.48 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.476 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 6.7 t70 -95.72 151.41 19.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.408 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.491 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 7.6 t -104.01 100.02 9.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.111 0.482 . . . . 0.0 110.082 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.2 m-20 157.7 -36.43 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.337 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -76.41 0.1 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.543 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.528 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 2.8 tt -54.05 -56.5 9.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.357 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.9 p -47.58 -36.05 10.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.876 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.45 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -57.83 -46.21 85.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.109 0.481 . . . . 0.0 110.053 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.5 -18.46 25.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.626 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 47' ' ' GLU . 1.1 mm? -98.67 14.03 30.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.054 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.6 68.09 0.37 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.063 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -33.07 149.86 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.088 0.47 . . . . 0.0 111.97 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.63 17.99 9.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.324 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -165.36 0.4 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.939 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -96.0 -162.76 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.574 HG21 ' CD1' ' A' ' 123' ' ' PHE . 1.5 p -117.44 -32.07 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.084 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -81.58 5.77 17.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.579 0.228 . . . . 0.0 111.474 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.6 -39.32 87.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.651 0.262 . . . . 0.0 110.811 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.414 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -66.87 -14.03 62.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.13 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.01 35.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.786 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.8 p -87.18 -32.94 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.112 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -176.85 38.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.407 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.6 m -69.56 165.81 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.644 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.9 m -54.51 -46.79 73.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.004 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.3 140.85 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 1.4 p -149.75 75.35 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 39' ' ' VAL . 4.9 mm -58.99 106.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.48 0.657 . . . . 0.0 111.007 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.56 144.98 4.26 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.878 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 126' ' ' THR . 19.6 mtm180 -76.55 125.8 29.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.801 0.334 . . . . 0.0 110.736 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.418 ' CB ' HG22 ' A' ' 125' ' ' ILE . . . -104.04 125.28 50.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.965 0.412 . . . . 0.0 111.658 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 13.9 p90 -133.91 120.58 20.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.772 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.5 t -97.11 158.45 15.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.237 0.541 . . . . 0.0 111.929 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.0 pp -157.42 118.06 3.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.793 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.8 -106.35 0.86 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.817 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -132.55 83.85 2.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.5 OUTLIER 152.37 110.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.191 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.595 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 2.1 p90 -101.6 132.33 47.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.236 0.541 . . . . 0.0 111.132 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 30.4 m -106.98 134.43 50.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.747 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.418 HG22 ' CB ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -117.32 117.45 55.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.711 0.767 . . . . 0.0 111.011 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.9 t -109.57 155.16 21.76 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.943 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.433 ' CB ' HG12 ' A' ' 38' ' ' VAL . 28.8 t -142.63 21.97 1.99 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.354 0.597 . . . . 0.0 109.705 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -124.0 45.04 2.57 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.106 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.23 16.45 2.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.297 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 55.1 mtm -95.81 15.76 19.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.295 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -157.07 68.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.584 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.53 -53.99 46.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 110.855 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 61.41 42.6 11.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.993 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -56.53 15.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.717 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.85 32.0 5.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.689 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 13.7 mt -109.57 -145.52 0.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.806 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -39.91 -41.7 1.21 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -113.25 103.74 11.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.025 0.44 . . . . 0.0 111.018 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -155.89 -164.42 1.71 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.969 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.08 163.17 2.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.949 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.064 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.799 0.333 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 p -166.58 95.41 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.851 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 p -153.66 129.46 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.77 146.97 34.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p -61.58 -34.47 75.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.933 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -134.66 155.51 50.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -164.44 142.29 6.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.44 ' CE1' ' HA3' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -103.32 20.7 17.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.322 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' HA ' HG12 ' A' ' 12' ' ' ILE . 28.8 m-20 -54.1 -18.33 3.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.135 0.493 . . . . 0.0 111.666 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.37 -22.52 54.73 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.625 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.44 ' HA3' ' CE1' ' A' ' 8' ' ' TYR . . . -125.29 -7.63 5.78 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.266 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.496 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.2 pp -61.33 -18.64 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 117.567 0.683 . . . . 0.0 111.793 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.19 9.33 13.07 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.91 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.99 -46.92 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.319 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -74.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.68 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -101.83 11.42 38.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.095 0.474 . . . . 0.0 111.161 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -112.55 -16.08 9.05 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.081 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.03 80.71 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.026 0.441 . . . . 0.0 110.531 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -142.67 7.61 1.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.669 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.84 18.19 7.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.812 0.339 . . . . 0.0 111.426 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.46 -174.26 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.908 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.2 t0 62.42 12.95 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.101 0.477 . . . . 0.0 110.912 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -143.78 10.64 1.59 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.961 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -98.32 -50.45 4.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.714 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.11 113.47 20.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.238 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.56 -116.58 0.08 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.099 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 t0 66.53 15.58 10.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.484 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -60.22 -29.13 68.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.921 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.15 106.89 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.189 0.518 . . . . 0.0 110.869 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -89.63 154.61 19.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.918 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -100.04 139.96 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.041 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.4 p -109.89 134.75 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.858 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.93 115.23 29.41 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.834 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 33.18 61.2 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.116 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 t -81.29 146.13 30.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.807 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.55 16.24 16.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.22 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.5 m -120.47 144.56 47.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.859 0.362 . . . . 0.0 111.007 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.439 HG11 ' CB ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -101.45 106.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.498 179.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 113' ' ' ILE . 12.4 t -121.47 150.32 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 121.42 0.629 . . . . 0.0 112.252 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.765 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -164.78 130.96 2.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.865 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.403 HG21 ' HB3' ' A' ' 111' ' ' SER . 0.0 OUTLIER -112.65 128.92 69.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.262 0.553 . . . . 0.0 111.863 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.674 ' HB3' ' CG1' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -128.18 148.4 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.356 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.61 153.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.852 0.358 . . . . 0.0 111.381 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.438 ' HA ' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -90.7 22.35 3.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.599 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -71.52 171.64 11.0 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.068 -178.544 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -49.39 -14.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.57 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 1.4 tt0 -63.82 -76.82 0.06 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.674 ' CG1' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -55.96 -44.31 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.365 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -39.65 -58.61 1.28 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.907 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.5 m -84.16 -56.47 3.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.892 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.667 ' CE2' ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -47.15 -50.42 20.47 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.615 ' HB ' HG21 ' A' ' 48' ' ' ILE . 1.8 tp -59.43 -48.2 88.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.818 0.342 . . . . 0.0 110.179 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.492 ' O ' ' CD2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -50.51 -52.38 39.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.339 0.59 . . . . 0.0 109.604 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.485 ' HA ' HG21 ' A' ' 58' ' ' THR . 13.2 mm-40 -69.05 -81.18 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.649 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.604 HG21 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -23.27 -58.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.725 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.5 mp -73.25 -66.2 0.71 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -62.94 -33.33 75.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 70.0 p -60.89 -67.7 0.38 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.267 0.556 . . . . 0.0 110.905 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.604 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 0.1 OUTLIER -85.69 -42.81 13.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.725 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 52.0 m-85 -69.94 -24.28 63.33 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -92.59 -50.99 5.33 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.722 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.0 ttmt -60.81 -41.37 95.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.422 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 p30 179.72 104.0 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.888 0.375 . . . . 0.0 111.698 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.604 ' HB ' ' O ' ' A' ' 59' ' ' ASP . 0.9 OUTLIER 177.85 -53.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.138 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.406 ' N ' HG13 ' A' ' 64' ' ' VAL . 4.3 m-20 -179.53 143.07 0.38 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 111.876 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.04 -4.0 10.4 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.742 2.295 . . . . 0.0 111.858 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -83.52 -108.17 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.533 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.524 ' CG1' ' CD2' ' A' ' 60' ' ' TYR . 9.5 p 27.01 49.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.296 0.57 . . . . 0.0 111.657 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -82.25 137.72 34.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.124 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -98.06 154.0 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.228 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 2.4 mm-40 -142.23 120.12 11.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.059 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -78.85 114.0 17.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.418 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.432 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 2.2 tpt180 -98.08 -145.28 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.914 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.73 -19.9 44.33 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 120.605 0.24 . . . . 0.0 111.436 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.26 -50.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.593 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.49 156.14 29.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.381 . . . . 0.0 110.738 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.63 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 38.3 m95 -81.84 143.69 31.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.391 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.471 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 9.4 m0 -108.84 107.16 17.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.383 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.765 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.2 109.55 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.1 0.476 . . . . 0.0 110.051 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -118.35 141.7 48.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.184 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.529 ' HA ' ' OG1' ' A' ' 67' ' ' THR . . . -143.38 157.95 44.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.52 120.85 40.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.953 0.406 . . . . 0.0 111.595 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.07 -65.46 1.93 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.085 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.411 ' CA ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -178.53 155.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 0.0 110.769 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.431 HG12 ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -133.3 156.81 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 3.3 pt-20 -144.79 123.69 12.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.212 0.53 . . . . 0.0 111.664 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.62 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 28.8 t -94.3 146.28 6.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.553 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 0.8 OUTLIER -89.93 152.03 21.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.329 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 41.4 t -114.48 101.12 8.83 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.459 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 7.7 t0 161.55 -28.69 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.436 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -86.58 -69.11 0.7 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.649 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.605 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 0.9 OUTLIER -52.8 -80.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.494 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.585 ' N ' HG12 ' A' ' 92' ' ' ILE . 6.5 p -19.94 -55.68 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 76.5 mm-40 -54.79 -47.15 74.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 0.0 111.799 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER -89.96 -28.81 18.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.895 -178.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.489 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -56.9 -19.93 20.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 98' ' ' ARG . . . -177.99 -44.98 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.01 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER 171.11 -171.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -58.81 100.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.055 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.413 ' CB ' ' HB2' ' A' ' 93' ' ' SER . 0.1 OUTLIER -114.77 -165.7 1.04 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.98 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.65 -173.87 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 0.0 111.045 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.547 HG21 ' CD1' ' A' ' 123' ' ' PHE . 4.3 p -83.89 173.37 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.944 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 102' ' ' VAL . 0.5 OUTLIER 69.91 9.77 7.23 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.697 -179.044 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -80.14 -35.0 37.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.291 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.459 ' HB3' ' CE2' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -63.57 -52.97 58.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.703 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -97.93 31.78 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.986 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.91 -44.76 57.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.069 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.76 96.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.818 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.4 ' CG1' ' HG ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -134.38 -171.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.96 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.84 -40.28 20.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.403 ' HB3' HG21 ' A' ' 41' ' ' VAL . 2.2 t 171.83 157.54 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.817 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 63.0 p -156.51 75.95 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.119 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 39' ' ' VAL . 6.2 mm -59.95 108.17 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.386 0.612 . . . . 0.0 111.084 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.43 141.91 3.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.011 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 126' ' ' THR . 34.9 mtm105 -77.05 120.21 21.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.657 0.265 . . . . 0.0 110.409 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.54 126.41 51.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.096 0.475 . . . . 0.0 112.263 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.442 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 5.7 p90 -136.14 125.39 24.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.603 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.5 t -91.21 159.11 16.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.185 0.517 . . . . 0.0 111.961 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 pp -161.25 116.82 2.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.916 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.78 -109.13 1.85 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.689 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -129.1 83.1 2.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 11.5 mttt 151.34 120.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.525 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.62 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 1.3 p90 -108.45 135.5 49.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.845 0.355 . . . . 0.0 110.528 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 19.3 p -109.81 134.65 51.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.685 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.95 117.48 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.839 0.828 . . . . 0.0 110.6 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 115' ' ' ARG . 10.7 t -99.51 156.74 16.88 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.651 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.439 ' CB ' HG11 ' A' ' 38' ' ' VAL . 2.7 m -142.71 20.88 2.0 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.335 0.588 . . . . 0.0 109.653 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -122.58 143.79 49.52 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.986 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 64.17 107.13 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.232 0.539 . . . . 0.0 110.756 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.8 ttt -125.62 15.19 8.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.248 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -84.6 -68.17 1.4 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.521 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.98 100.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.781 0.324 . . . . 0.0 110.85 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -118.42 36.66 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.076 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -59.72 -51.03 71.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.662 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.16 32.02 6.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.569 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.6 mt -134.49 -159.42 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.765 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 72.33 -55.77 0.66 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.378 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -149.73 153.62 37.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.853 0.359 . . . . 0.0 110.974 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.31 93.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -59.4 125.78 25.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.99 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.075 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 mtm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.755 0.312 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.87 35.83 1.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.1 t -76.32 110.22 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -83.64 147.9 27.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.1 t -153.96 -79.25 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.35 96.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.9 116.07 31.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.233 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -63.65 -133.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.344 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.403 ' HA ' HG12 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -46.96 -22.09 0.29 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.32 -16.27 61.37 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.404 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.76 -1.56 3.34 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.322 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.408 HD13 ' HG3' ' A' ' 13' ' ' MET . 2.0 pp -67.97 -15.94 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-O 121.424 0.631 . . . . 0.0 111.912 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.408 ' HG3' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -84.49 9.12 14.28 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.916 178.203 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.23 -48.69 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.678 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -79.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 110.902 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -93.06 11.3 28.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.032 0.444 . . . . 0.0 111.242 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.96 -20.94 5.5 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.233 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -129.52 80.63 1.97 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.023 0.44 . . . . 0.0 110.623 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -145.52 9.76 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.738 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.28 17.28 10.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.893 0.377 . . . . 0.0 111.224 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.0 -9.49 58.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.673 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.3 11.3 24.04 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.865 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -142.7 12.48 1.89 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.965 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -102.85 -53.54 2.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.136 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -121.09 110.32 16.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.28 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.63 -115.26 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.043 0.449 . . . . 0.0 111.109 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 t0 69.17 15.64 8.62 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.272 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.75 -26.31 44.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.998 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -175.27 104.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.62 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -139.3 159.37 42.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.787 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.9 p -117.96 124.43 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.218 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 p -110.1 134.68 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.667 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 34' ' ' GLU . 9.7 m-70 -110.36 115.08 29.03 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.924 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 33' ' ' HIS . 0.1 OUTLIER 25.35 48.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.41 179.487 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.99 129.36 37.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.58 34.31 0.86 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.9 m -85.75 155.8 20.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.115 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.46 ' CG2' ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -110.9 107.18 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.59 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 113' ' ' ILE . 11.6 t -119.48 152.45 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.401 0.62 . . . . 0.0 112.108 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.762 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -165.55 128.69 2.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.968 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.07 132.43 60.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.337 0.589 . . . . 0.0 111.739 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.564 ' HB3' ' CG1' ' A' ' 48' ' ' ILE . 1.1 tp -127.96 140.17 52.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.513 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -48.88 128.44 15.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.426 0.155 . . . . 0.0 110.761 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.487 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -78.72 86.94 4.64 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.545 0.688 . . . . 0.0 110.441 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -126.03 171.41 10.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.403 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.35 -14.35 0.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.201 0.524 . . . . 0.0 109.739 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' HG2' ' N ' ' A' ' 48' ' ' ILE . 2.6 tt0 -72.53 -63.83 1.08 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.088 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.583 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 1.0 OUTLIER -61.66 -44.92 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.169 0.509 . . . . 0.0 110.139 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -42.44 -55.89 3.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.588 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.442 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 75.8 m -67.0 -77.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.598 ' CD2' ' CG2' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -39.7 -55.15 1.96 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.102 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.543 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.5 tp -45.81 -45.7 5.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.076 0.465 . . . . 0.0 109.839 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.62 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.4 pt-20 -57.12 -40.54 77.28 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.467 ' O ' ' C ' ' A' ' 55' ' ' ILE . 2.9 mp0 -81.75 -91.8 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.547 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.598 ' CG2' ' CD2' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.78 -54.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.852 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -72.71 -42.53 64.09 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -83.14 -45.93 13.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.279 0.561 . . . . 0.0 110.696 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.615 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 69.5 p -53.61 -70.47 0.09 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.993 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.588 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 5.4 m-20 -89.66 -30.43 18.11 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.852 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 32.0 m-85 -80.15 -24.67 40.26 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.524 1.056 . . . . 0.0 111.566 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -90.39 -47.66 7.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.052 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -56.08 -47.46 77.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.752 0.31 . . . . 0.0 111.226 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -179.52 102.2 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.983 0.42 . . . . 0.0 111.282 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 59' ' ' ASP . 0.9 OUTLIER -179.92 -57.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.718 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.456 ' N ' HG13 ' A' ' 64' ' ' VAL . 1.1 m120 178.65 127.8 0.21 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.608 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -85.21 -17.33 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.658 2.239 . . . . 0.0 111.908 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ASN . 1.8 t -57.41 -49.91 74.69 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.561 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.473 ' CG1' ' CD1' ' A' ' 60' ' ' TYR . 2.9 p -42.73 87.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.09 0.472 . . . . 0.0 111.194 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.2 p30 -115.25 142.57 46.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.303 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.422 ' CG2' ' HB3' ' A' ' 77' ' ' TRP . 0.7 OUTLIER -96.97 153.2 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 121.187 0.518 . . . . 0.0 111.622 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -142.9 123.34 13.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.121 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -79.86 114.35 18.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.295 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -93.73 -71.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.368 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.09 -69.94 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.128 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.24 4.55 9.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.814 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.48 149.78 39.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.834 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.583 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 74.9 m95 -77.45 142.72 39.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.571 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.563 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.7 m0 -107.67 106.63 17.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.27 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.762 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.19 110.87 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 0.0 110.142 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -116.51 135.52 53.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.046 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.433 ' HB2' HG21 ' A' ' 85' ' ' ILE . . . -144.46 159.26 43.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.793 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -96.8 148.32 23.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.959 0.409 . . . . 0.0 111.352 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.87 -69.73 0.42 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.343 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.46 ' HA ' ' CG2' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -179.58 161.46 1.03 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.913 0.387 . . . . 0.0 110.883 -179.377 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.481 HG12 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -141.08 155.77 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.801 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 13.2 pt-20 -140.31 124.01 17.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.018 0.437 . . . . 0.0 111.481 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.61 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 24.8 t -93.67 143.86 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.581 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 6.3 t70 -88.25 151.73 22.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.012 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 54.0 t -111.78 100.51 8.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.047 0.451 . . . . 0.0 109.86 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 3.1 t70 162.41 -36.14 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.932 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.24 -68.05 0.56 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.984 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.555 ' HB ' ' CD2' ' A' ' 51' ' ' PHE . 1.6 tt -59.32 -55.67 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.591 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.9 p -48.81 -32.92 9.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.599 0.238 . . . . 0.0 111.628 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.2 mm-40 -62.55 -47.64 82.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.754 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -90.05 -17.21 28.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.703 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.484 ' CD1' ' HG3' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.26 8.35 44.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.832 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 131.23 70.08 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.177 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -31.23 147.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.059 0.457 . . . . 0.0 111.836 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 64.21 18.22 11.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.082 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -71.87 -167.14 0.26 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.086 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -100.79 -164.08 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.664 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.602 HG21 ' CD1' ' A' ' 123' ' ' PHE . 1.5 p -113.15 -33.56 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.041 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -80.1 5.59 13.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.327 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -59.4 -41.74 90.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.647 0.26 . . . . 0.0 110.968 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -60.73 -28.11 68.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.774 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.441 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 3.1 tp -131.5 40.6 3.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.028 0.442 . . . . 0.0 110.938 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.9 p -87.19 -36.29 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 178.65 69.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.486 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.26 179.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.062 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -46.54 -43.84 17.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.067 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 170.68 165.25 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.982 0.42 . . . . 0.0 111.301 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 42.4 p -159.08 80.67 0.77 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.85 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 39' ' ' VAL . 5.1 mm -58.95 105.09 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.49 0.662 . . . . 0.0 111.286 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' A' ' 126' ' ' THR . . . 144.34 144.72 4.23 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.965 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.75 120.04 21.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.58 0.229 . . . . 0.0 110.493 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.81 125.31 45.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.97 0.414 . . . . 0.0 112.037 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 1.7 p90 -131.45 122.36 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.361 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.2 t -103.33 158.9 16.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 111.882 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -167.78 134.32 2.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.356 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.45 -109.89 1.58 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.674 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.43 83.73 2.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 7.3 mttt 153.39 122.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.503 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.61 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -107.93 139.55 42.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.933 0.396 . . . . 0.0 110.444 179.214 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 37.6 m -114.24 130.04 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.44 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.481 ' CD1' HG12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -112.31 117.78 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.794 0.806 . . . . 0.0 110.74 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.4 t -98.31 156.34 16.77 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.504 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.414 ' OG ' HG23 ' A' ' 38' ' ' VAL . 71.7 p -150.0 30.96 0.7 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.65 -44.17 7.94 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.899 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.1 mp 62.09 106.57 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.18 0.514 . . . . 0.0 110.905 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 25.8 mtm -94.2 15.21 17.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.326 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.5 96.15 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.542 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.68 -48.84 75.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.918 0.39 . . . . 0.0 110.792 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.33 30.1 4.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.82 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -33.55 51.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.838 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -104.93 11.18 33.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.315 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.47 -5.58 11.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.057 0.456 . . . . 0.0 111.621 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -85.62 2.91 43.19 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.659 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 175.39 117.7 0.02 OUTLIER 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -141.08 179.22 6.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -175.3 141.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.963 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.084 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.765 0.317 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 m 62.62 119.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.3 m -63.34 -30.19 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.182 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.01 131.12 36.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.9 m -126.74 153.26 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -132.42 129.74 39.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.988 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -161.65 175.05 12.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.049 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.4 ' CE2' HD23 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -148.12 21.91 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.465 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.424 ' HA ' HG12 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -55.91 -15.69 3.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.064 0.459 . . . . 0.0 111.484 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.52 -17.23 54.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.413 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.66 -8.55 3.1 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.169 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.2 pp -60.52 -20.07 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 117.527 0.663 . . . . 0.0 111.871 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.41 ' HB2' ' HE1' ' A' ' 13' ' ' MET . 0.0 OUTLIER -84.76 8.64 16.49 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.742 177.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 18' ' ' LYS . . . -131.91 -34.37 0.39 Allowed Glycine 0 CA--C 1.518 0.268 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.477 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.4 HD23 ' CE2' ' A' ' 8' ' ' TYR . 8.8 mp -77.15 -80.24 0.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.745 0.307 . . . . 0.0 111.002 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.48 9.94 29.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.967 0.413 . . . . 0.0 111.535 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.95 -27.14 2.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.948 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 1.4 tmtt? -130.14 85.29 2.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.719 0.771 . . . . 0.0 110.242 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -134.83 8.14 3.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.683 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 62.59 18.24 10.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.842 0.354 . . . . 0.0 111.384 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.29 -177.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.4 t0 63.87 12.0 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.79 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -146.41 11.58 1.15 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.943 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -83.37 -44.43 14.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.389 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -121.04 110.47 16.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.625 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.09 -123.71 0.07 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.158 0.504 . . . . 0.0 110.434 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.68 19.12 0.13 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.753 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -69.51 -25.56 64.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 66.2 16.09 10.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.258 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -120.04 136.15 54.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.923 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.5 p -87.42 140.34 15.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.094 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 p -109.87 134.57 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.411 ' O ' ' C ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -110.46 114.95 28.77 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.673 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 33' ' ' HIS . 0.3 OUTLIER 26.41 59.65 0.08 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.345 179.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.7 m -119.51 112.49 19.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -106.59 43.86 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.4 m -75.23 146.36 41.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.478 ' CG1' ' HB2' ' A' ' 127' ' ' SER . 0.2 OUTLIER -90.58 102.36 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.103 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.9 139.42 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.115 0.483 . . . . 0.0 111.543 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 8.9 mp -136.42 104.27 5.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.036 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -109.62 127.03 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.363 0.602 . . . . 0.0 111.961 -179.462 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.495 ' HB3' HD13 ' A' ' 48' ' ' ILE . 4.5 mt -127.67 145.41 50.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.746 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.0 119.99 4.9 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.488 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.77 91.08 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.427 0.632 . . . . 0.0 110.888 -178.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 47' ' ' GLU . 50.0 m -125.93 170.3 11.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.451 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -53.65 -11.79 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.142 0.496 . . . . 0.0 109.793 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.581 ' HG2' ' N ' ' A' ' 48' ' ' ILE . 1.9 tt0 -75.11 -65.47 0.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.492 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.596 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 0.4 OUTLIER -58.27 -44.47 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.3 0.571 . . . . 0.0 109.67 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -43.87 -53.72 5.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.345 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.9 m -79.93 -64.96 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.196 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.645 ' O ' HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -45.07 -46.9 11.83 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.372 -178.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.4 tp -61.44 -48.48 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.163 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.627 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -50.76 -38.99 51.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.048 0.451 . . . . 0.0 109.822 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' A' ' 55' ' ' ILE . 2.8 mt-10 -82.89 -87.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.781 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.645 HG21 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.9 -56.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 179.472 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.657 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -72.98 -42.53 63.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.74 -46.35 13.27 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.623 -179.103 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.64 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 51.4 p -49.24 -72.61 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.57 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.442 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 0.9 OUTLIER -94.05 -25.92 16.99 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -177.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.657 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 7.7 m-85 -87.41 -1.37 57.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 119.306 -0.957 . . . . 0.0 112.737 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 2.5 tptt -118.06 -41.59 2.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.683 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.9 OUTLIER -58.91 -51.66 69.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.263 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.494 ' N ' HD21 ' A' ' 63' ' ' ASN . 0.1 OUTLIER -178.93 90.21 0.02 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.39 0.614 . . . . 0.0 112.012 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 59' ' ' ASP . 24.6 t -161.77 -53.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.505 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 177.62 141.67 0.25 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.396 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.48 -23.34 2.82 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.77 2.314 . . . . 0.0 112.152 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 69' ' ' ASN . 9.6 t -55.19 -38.44 68.38 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.302 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.615 ' CG1' ' HG ' ' A' ' 56' ' ' LEU . 82.2 t -61.9 74.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.64 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 67' ' ' THR . 16.0 p30 -116.0 142.29 46.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.973 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.41 HG22 HD11 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.54 149.38 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.389 0.614 . . . . 0.0 111.682 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.65 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.2 OUTLIER -143.75 123.53 13.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.573 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -88.44 114.84 25.47 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.107 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.407 ' NH1' ' CZ3' ' A' ' 78' ' ' TRP . 11.6 tpt180 -99.86 -100.04 0.24 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.618 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.31 -78.66 0.1 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.844 0.354 . . . . 0.0 111.27 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.68 -40.04 0.34 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.3 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.85 158.85 19.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.787 0.327 . . . . 0.0 110.545 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.596 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 75.4 m95 -77.43 126.32 30.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.527 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.65 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.7 m0 -96.69 109.97 22.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.289 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.702 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -96.52 136.68 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -129.11 135.72 49.26 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.021 0.438 . . . . 0.0 112.153 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.463 ' CB ' HG23 ' A' ' 85' ' ' ILE . . . -144.5 158.48 43.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.756 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.406 ' N ' ' OG1' ' A' ' 67' ' ' THR . 0.4 OUTLIER -115.06 127.39 55.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.95 0.405 . . . . 0.0 111.251 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 84.25 -68.31 3.54 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.902 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.453 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 178.42 160.71 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.014 0.435 . . . . 0.0 111.347 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.48 HG12 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -151.53 160.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.436 179.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.515 ' CB ' ' HA ' ' A' ' 124' ' ' THR . 0.3 OUTLIER -136.09 125.22 24.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.165 0.507 . . . . 0.0 111.693 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 99.6 t -92.31 144.65 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.524 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.418 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 5.7 m-20 -87.95 152.64 21.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.441 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.461 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 51.9 t -112.16 100.55 8.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.157 0.503 . . . . 0.0 109.743 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.464 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 10.0 t70 165.21 -36.51 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.773 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -74.96 -69.31 0.48 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.59 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.531 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 0.7 OUTLIER -63.99 -54.51 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.3 p -44.12 -30.69 0.8 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.133 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 3.2 mm-40 -68.51 -71.54 0.21 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.125 0.488 . . . . 0.0 110.235 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -19.94 63.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.134 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.526 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -98.06 -1.76 41.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.58 0.229 . . . . 0.0 111.395 -179.461 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.466 ' HA3' ' CD2' ' A' ' 100' ' ' PHE . . . 152.56 66.03 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.87 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -28.02 137.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.782 0.433 . . . . 0.0 112.123 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 64.17 19.66 11.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.541 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.466 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -58.55 -162.9 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.107 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -105.58 -85.74 0.48 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.998 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.526 HG21 ' CD1' ' A' ' 123' ' ' PHE . 2.0 p 179.54 -54.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.667 0.27 . . . . 0.0 111.554 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.434 ' CE2' HG23 ' A' ' 118' ' ' THR . 6.8 m-85 -64.98 -13.24 57.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.652 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -47.36 -29.98 2.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.598 0.237 . . . . 0.0 111.469 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.518 ' CD1' ' CE2' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -71.19 -30.09 65.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.034 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.438 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 0.9 OUTLIER -134.71 42.28 2.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.969 0.414 . . . . 0.0 110.92 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.1 p -83.19 -45.67 18.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.119 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -160.05 31.0 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 34.7 m -59.49 165.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.578 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.55 -46.27 66.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.023 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.59 163.37 3.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -177.18 85.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.138 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.4 mm -60.45 113.45 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.359 0.599 . . . . 0.0 110.779 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.73 140.93 3.79 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.702 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 26.3 ttp180 -79.65 119.62 22.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.622 0.249 . . . . 0.0 110.715 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.417 ' CB ' HG21 ' A' ' 125' ' ' ILE . . . -101.28 125.29 47.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.015 0.436 . . . . 0.0 111.776 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.48 ' CZ ' ' HB ' ' A' ' 124' ' ' THR . 30.9 p90 -132.71 116.55 16.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.521 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.434 HG23 ' CE2' ' A' ' 103' ' ' TYR . 14.8 t -83.03 163.17 21.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.313 0.577 . . . . 0.0 111.992 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 pp -170.16 115.57 0.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.578 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.64 -107.1 1.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.571 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.26 83.66 2.04 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER 152.04 109.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.598 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.573 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 1.1 p90 -95.16 139.74 31.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.873 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.515 ' HA ' ' CB ' ' A' ' 86' ' ' GLU . 45.1 m -111.31 127.18 55.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.359 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.48 ' CD1' HG12 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -108.6 118.14 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.857 0.837 . . . . 0.0 110.737 178.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 115' ' ' ARG . 2.6 t -96.82 155.8 16.62 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.728 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.478 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -149.07 23.74 0.94 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.267 0.556 . . . . 0.0 109.615 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -121.77 -167.53 1.55 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.316 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.5 mp 64.76 107.13 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.224 0.535 . . . . 0.0 110.852 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 mtp -115.91 15.66 16.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.311 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 113.74 107.67 2.79 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.548 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.3 mp -140.19 -59.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.802 0.334 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 60.2 24.52 13.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.079 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.77 -58.39 5.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.593 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -117.05 32.51 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.482 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.7 tp -92.18 -147.61 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.846 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -40.88 -32.81 0.25 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.771 0.319 . . . . 0.0 111.626 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -106.8 102.25 11.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.997 0.427 . . . . 0.0 110.909 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.408 ' O ' ' CG ' ' A' ' 140' ' ' HIS . 0.1 OUTLIER -166.8 -176.51 3.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.914 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.408 ' CG ' ' O ' ' A' ' 139' ' ' TYR . 54.8 m80 -160.68 125.76 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.95 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.088 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.842 0.354 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 m -147.13 -64.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.5 t -83.68 77.51 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -100.93 151.09 22.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.4 m -61.22 136.76 58.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 63.12 116.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.071 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -123.37 -168.82 1.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.957 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.416 ' CE1' ' HA3' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -138.34 20.55 2.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.581 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.442 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.3 m-20 -57.31 -13.78 3.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.149 0.5 . . . . 0.0 111.566 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.17 -18.65 52.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.443 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' A' ' 8' ' ' TYR . . . -130.31 -9.42 2.98 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.232 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.2 pp -59.06 -20.78 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 117.637 0.719 . . . . 0.0 111.883 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.41 ' HB2' ' HE1' ' A' ' 13' ' ' MET . 0.0 OUTLIER -85.76 9.33 16.78 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.915 178.118 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.81 -50.52 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.623 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.55 -77.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.752 0.311 . . . . 0.0 111.056 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.22 10.73 28.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.021 0.439 . . . . 0.0 111.397 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.68 -22.47 4.33 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.134 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.85 80.74 1.99 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.12 0.486 . . . . 0.0 110.408 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -138.02 9.06 2.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.61 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 63.3 18.51 11.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.359 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.34 -178.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t70 63.58 13.03 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.12 0.485 . . . . 0.0 110.617 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -152.27 13.84 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.214 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -89.84 -46.6 8.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.358 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -118.5 110.37 17.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.453 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.78 -114.87 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.109 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 t0 74.2 15.26 3.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.407 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.64 -21.67 54.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.07 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 68.02 15.08 9.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.378 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -96.64 136.33 37.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.783 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -118.13 138.96 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.295 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.6 p -109.92 135.01 50.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.808 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -109.87 115.29 29.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.191 0.52 . . . . 0.0 110.73 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 35.78 61.92 0.68 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.963 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.39 108.91 5.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.891 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -151.48 31.62 0.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.0 m -115.79 141.76 47.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -88.88 93.75 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.992 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.67 147.54 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.225 0.536 . . . . 0.0 111.854 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.822 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.64 120.59 3.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.884 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.54 130.29 67.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.339 0.59 . . . . 0.0 112.116 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.47 ' HB3' HG12 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -127.05 139.86 52.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.429 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -54.29 132.03 42.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.484 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -61.88 89.22 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.505 0.669 . . . . 0.0 109.975 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.474 ' C ' ' H ' ' A' ' 47' ' ' GLU . 14.8 m -125.86 170.62 11.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.905 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -52.77 -11.75 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 109.931 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.519 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 3.6 tt0 -69.33 -75.5 0.11 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.245 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.63 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 3.8 mm -53.81 -39.87 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 24.4 m120 -43.48 -57.74 2.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.376 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.5 m -85.73 -57.63 2.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.605 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.61 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -47.23 -45.53 23.58 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.766 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.63 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.3 tp -65.56 -49.23 79.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.863 0.363 . . . . 0.0 110.272 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.681 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.3 pt-20 -53.41 -40.55 65.2 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.098 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' O ' ' CG2' ' A' ' 58' ' ' THR . 23.7 mm-40 -80.37 -70.08 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.942 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.601 HG23 ' CE1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -37.86 -59.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.668 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -72.52 -36.61 68.38 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.681 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -84.0 -46.81 11.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.517 -0.739 . . . . 0.0 110.916 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.69 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 71.6 p -50.0 -70.86 0.08 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.223 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 7.3 m-20 -94.35 -29.3 15.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.668 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 2.3 m-85 -83.83 -1.61 54.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.534 -0.867 . . . . 0.0 112.711 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.574 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -118.87 -40.41 2.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.785 178.518 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.69 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -58.23 -50.2 74.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.707 0.289 . . . . 0.0 111.289 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.452 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER 179.57 89.29 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.212 0.53 . . . . 0.0 111.276 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.471 ' CG1' ' CE1' ' A' ' 60' ' ' TYR . 9.7 t -158.94 -58.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.54 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.46 ' HB3' HG21 ' A' ' 67' ' ' THR . 3.8 m-20 174.25 145.92 0.21 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.894 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -89.14 -19.36 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.046 2.497 . . . . 0.0 112.462 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -47.15 -64.26 0.83 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.321 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.592 HG13 ' CD1' ' A' ' 60' ' ' TYR . 1.7 p -41.73 87.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 121.048 0.451 . . . . 0.0 110.96 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.8 p30 -116.22 142.57 46.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.479 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.0 153.23 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.105 0.479 . . . . 0.0 111.531 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.6 OUTLIER -142.65 118.74 10.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.241 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.27 114.64 24.05 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.445 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.422 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 3.8 mmp_? -101.58 -117.42 0.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.239 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.35 76.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.79 0.329 . . . . 0.0 111.272 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.88 -37.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.641 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -82.79 162.0 21.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.961 0.41 . . . . 0.0 110.618 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.547 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 50.0 m95 -86.01 140.56 30.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.742 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.574 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.4 m0 -110.97 108.7 18.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.39 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.822 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.47 116.21 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.629 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -119.46 136.39 54.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.08 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.432 ' HB2' ' CG2' ' A' ' 85' ' ' ILE . . . -143.41 158.71 43.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.69 137.6 44.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 111.358 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.07 -69.83 3.19 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.926 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.438 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 179.86 158.62 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 0.0 111.041 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.459 HG12 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.85 160.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 0.1 OUTLIER -140.71 125.2 17.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 111.643 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.628 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 18.0 t -94.66 138.55 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.641 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.51 152.24 28.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.207 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 46.9 t -113.11 100.85 8.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 109.958 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.5 m-20 161.88 -37.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.27 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -72.5 -68.59 0.46 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.697 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.61 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -58.55 -58.26 7.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.273 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.7 p -45.28 -34.14 2.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.553 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -47.34 86.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 110.359 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.11 -17.0 28.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.785 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.519 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -98.01 9.47 42.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.933 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 129.28 69.69 0.12 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.309 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -34.8 149.09 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.059 0.457 . . . . 0.0 111.439 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.88 17.66 10.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.149 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.432 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -69.57 -167.84 0.15 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.679 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -131.2 135.16 47.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.84 0.353 . . . . 0.0 110.966 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.497 HG21 ' CD1' ' A' ' 123' ' ' PHE . 8.1 p -51.14 166.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.934 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 79.38 1.87 2.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.895 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -73.77 -31.71 63.44 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.984 0.421 . . . . 0.0 110.232 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -64.82 -26.03 68.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.772 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 0.5 OUTLIER -127.69 30.65 5.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.624 179.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.2 p -83.05 -34.71 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.166 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -178.12 39.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.797 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.0 m -70.86 172.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.374 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.52 -44.43 56.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.166 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.2 m 172.95 157.7 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -178.95 122.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.926 0.393 . . . . 0.0 111.639 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.4 mm -92.56 121.12 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.3 0.571 . . . . 0.0 111.005 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.46 143.07 3.78 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.954 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -77.78 120.23 22.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.783 0.325 . . . . 0.0 110.39 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.09 125.22 47.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.065 0.46 . . . . 0.0 111.929 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 4.8 p90 -136.08 121.36 19.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.462 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.3 t -105.0 142.45 34.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.339 0.59 . . . . 0.0 111.995 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -148.24 125.69 11.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.652 179.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.99 -110.84 3.68 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.671 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.49 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.09 83.84 2.05 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.1 OUTLIER 153.22 101.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.747 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.628 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 8.4 p90 -88.67 128.88 35.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.102 0.477 . . . . 0.0 110.98 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 29.9 m -103.07 132.48 49.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.117 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.459 ' CD1' HG12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -114.88 118.67 59.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.924 0.869 . . . . 0.0 110.979 179.146 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 115' ' ' ARG . 5.4 t -96.3 156.28 16.41 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.456 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.437 ' HB3' HG11 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -138.05 14.84 2.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.383 0.611 . . . . 0.0 109.542 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.04 -22.88 8.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.62 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.9 mp -92.42 16.06 12.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.348 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.99 15.72 23.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.288 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -104.34 -102.13 2.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.497 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.409 ' CD2' ' N ' ' A' ' 132' ' ' LEU . 0.9 OUTLIER -121.55 61.31 0.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.781 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -114.53 32.98 5.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.933 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -65.13 -49.92 68.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.828 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.04 -7.95 28.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.382 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.411 HD11 ' CD1' ' A' ' 139' ' ' TYR . 5.3 mt 61.48 118.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.823 0.344 . . . . 0.0 110.95 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -96.93 -43.08 7.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.805 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -150.22 108.72 3.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.818 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.411 ' CD1' HD11 ' A' ' 136' ' ' LEU . 17.4 p90 -138.29 28.14 2.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.036 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.78 156.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.864 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.145 -179.974 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mmm . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.798 0.332 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -102.13 -73.78 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.7 m -112.64 -35.61 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.155 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -127.18 146.04 50.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 t -147.6 168.88 20.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -75.44 -177.02 3.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.91 121.62 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.179 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.29 21.71 15.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.378 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.411 ' HA ' HG12 ' A' ' 12' ' ' ILE . 11.0 m-20 -55.1 -16.77 3.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.114 0.483 . . . . 0.0 111.538 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.31 -16.09 58.08 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.485 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.73 -9.02 2.33 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.241 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.411 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.1 pp -60.39 -20.39 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 CA-C-N 117.574 0.687 . . . . 0.0 111.811 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.92 7.55 15.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.877 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.96 21.07 0.44 Allowed Glycine 0 CA--C 1.519 0.332 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.57 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.6 -83.49 0.63 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.661 0.267 . . . . 0.0 110.608 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.0 9.26 40.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.084 0.468 . . . . 0.0 110.938 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.11 -15.76 8.25 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.985 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.01 81.26 2.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.017 0.437 . . . . 0.0 110.216 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -140.53 10.8 2.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.635 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.67 14.44 7.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.3 -169.86 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.844 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.12 14.97 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.041 0.448 . . . . 0.0 110.541 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -138.09 10.35 2.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.066 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.47 -57.49 2.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.582 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -120.14 110.88 17.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.627 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.51 -117.5 0.07 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.29 16.74 9.71 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.267 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -73.16 -27.92 61.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.012 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.18 14.29 25.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.441 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -141.43 152.32 44.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.953 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -110.83 135.32 50.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.991 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.0 p -109.9 134.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.855 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.408 ' O ' ' C ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -110.28 115.29 29.43 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.809 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 33' ' ' HIS . 1.2 mt-10 28.57 58.12 0.12 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.102 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.9 m -101.13 129.82 47.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.073 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -151.87 36.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.558 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.2 m -72.93 145.38 46.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.206 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -99.41 99.18 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.606 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.9 t -112.0 152.44 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.33 0.586 . . . . 0.0 112.389 -178.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.59 107.88 3.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.527 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.489 HG11 ' HA ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -113.4 125.93 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.031 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.468 ' HB2' HD13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -128.63 148.66 50.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.133 178.127 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.32 127.53 17.51 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HA ' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -66.3 90.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.535 0.684 . . . . 0.0 111.043 -179.023 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.464 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -125.94 171.36 10.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.956 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.89 -17.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.548 ' HG2' ' CD1' ' A' ' 48' ' ' ILE . 8.2 tt0 -62.02 -72.31 0.13 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.239 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.595 ' CG2' ' CD1' ' A' ' 77' ' ' TRP . 0.3 OUTLIER -59.75 -40.66 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -40.83 -59.48 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.409 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.405 ' CG2' ' HG ' ' A' ' 95' ' ' LEU . 2.4 m -79.47 -61.87 1.87 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.877 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.62 ' CD1' ' HB ' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -43.82 -45.52 7.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.237 -179.184 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.595 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -62.63 -47.23 93.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.862 0.363 . . . . 0.0 110.284 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -54.23 -41.18 68.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.516 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' O ' ' OG1' ' A' ' 58' ' ' THR . 7.4 mt-10 -81.07 -68.64 0.67 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.043 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.617 HG23 ' CE1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -37.17 -57.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.611 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -74.85 -38.41 61.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.635 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.49 -46.88 12.86 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.884 -178.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.666 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 50.6 p -53.54 -69.81 0.11 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.489 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.452 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 20.5 m-20 -91.72 -29.66 16.7 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.611 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 8.4 m-85 -87.15 -2.07 58.36 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.427 -0.909 . . . . 0.0 113.236 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -117.75 -40.71 2.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 178.348 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -62.08 -49.98 73.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.478 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -177.71 90.49 0.03 OUTLIER 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.507 0.67 . . . . 0.0 112.297 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 63' ' ' ASN . 20.2 t -162.05 -54.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.076 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 170.49 143.45 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.482 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.64 -16.43 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.981 2.454 . . . . 0.0 112.237 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.43 ' O ' ' ND2' ' A' ' 69' ' ' ASN . 14.7 t -53.16 -39.47 63.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.286 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.597 ' CG1' ' HG ' ' A' ' 56' ' ' LEU . 63.5 t -61.81 86.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.826 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 67' ' ' THR . 8.9 m-80 -115.43 142.44 46.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.859 0.361 . . . . 0.0 111.056 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.84 153.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 121.235 0.541 . . . . 0.0 111.548 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.6 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -142.08 117.98 10.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.787 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.3 114.52 18.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.645 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.5 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -95.23 -146.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.083 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.2 -73.57 0.08 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.629 0.252 . . . . 0.0 111.637 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . -126.42 12.48 7.07 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.479 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.83 158.66 43.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.086 0.443 . . . . 0.0 111.091 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.595 ' CD1' ' CG2' ' A' ' 48' ' ' ILE . 58.7 m95 -80.73 142.75 33.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.229 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.6 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.0 m0 -115.79 108.5 16.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.635 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.736 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -96.89 127.21 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 135.83 49.66 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.947 0.403 . . . . 0.0 111.241 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.563 ' CB ' HG23 ' A' ' 85' ' ' ILE . . . -143.86 159.05 43.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.849 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -106.97 148.3 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.076 0.465 . . . . 0.0 111.328 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 68.08 -69.85 0.32 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.331 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.557 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 177.92 160.71 0.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.922 0.391 . . . . 0.0 111.02 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.563 HG23 ' CB ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -149.55 160.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.956 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 1.0 OUTLIER -138.14 126.1 22.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.128 0.49 . . . . 0.0 111.414 -179.501 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.63 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 23.0 t -94.49 146.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.603 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.417 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 8.8 t70 -90.11 152.15 21.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.103 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.472 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 49.8 t -109.46 100.74 9.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.295 0.569 . . . . 0.0 109.745 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 0.7 OUTLIER 162.45 -35.98 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.979 -179.257 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -74.26 -71.85 0.31 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.748 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.62 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.0 OUTLIER -57.11 -56.35 15.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.1 p -46.62 -35.62 6.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.734 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.9 OUTLIER -60.19 -46.21 90.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.098 0.475 . . . . 0.0 110.367 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.405 ' HG ' ' CG2' ' A' ' 50' ' ' THR . 1.1 tm? -90.17 -17.62 27.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.601 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.462 ' CD1' ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -99.7 12.33 36.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.974 0.416 . . . . 0.0 110.999 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.418 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 126.29 69.52 0.18 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.279 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -35.11 148.61 0.02 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.08 0.467 . . . . 0.0 111.66 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 64.8 17.48 11.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.342 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -69.65 -177.58 1.26 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.607 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -81.81 -91.87 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 123' ' ' PHE . 2.7 p 179.42 -42.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.688 0.28 . . . . 0.0 111.1 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.445 ' CE2' ' CG2' ' A' ' 118' ' ' THR . 4.9 m-85 -71.71 -6.69 43.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.367 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.71 -34.24 18.26 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.782 0.325 . . . . 0.0 111.026 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.533 ' CD1' ' CE2' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -60.54 -34.95 74.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.631 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 5.6 tp -133.21 41.89 3.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.473 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.9 p -81.59 -39.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.298 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -166.14 31.47 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.002 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.5 m -65.07 174.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.295 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -55.96 -42.47 76.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.401 ' O ' ' CG2' ' A' ' 112' ' ' THR . 0.9 OUTLIER 171.65 151.72 0.06 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 111' ' ' SER . 65.8 p -159.88 98.51 1.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.906 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.1 mm -65.89 127.31 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 0.0 110.966 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.81 144.48 5.37 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.041 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.84 120.55 22.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.7 0.286 . . . . 0.0 110.414 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.428 ' CB ' HG22 ' A' ' 125' ' ' ILE . . . -106.9 124.59 49.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.129 0.49 . . . . 0.0 112.263 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.499 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 2.0 p90 -137.04 119.29 15.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.296 178.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.445 ' CG2' ' CE2' ' A' ' 103' ' ' TYR . 10.9 t -99.81 142.71 30.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.251 0.548 . . . . 0.0 111.969 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.38 133.11 19.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.507 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 56.9 -112.02 3.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.611 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.503 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.9 84.06 2.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.4 OUTLIER 152.11 100.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.526 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.63 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 14.2 p90 -88.28 133.08 34.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.17 0.509 . . . . 0.0 110.949 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -107.93 130.67 55.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.858 -179.458 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.546 ' CD1' HG12 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -112.82 118.58 58.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.891 0.853 . . . . 0.0 111.368 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 115' ' ' ARG . 9.1 t -97.24 155.59 16.79 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.087 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.485 ' HB2' HG12 ' A' ' 38' ' ' VAL . 2.2 m -146.02 19.28 1.43 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.256 0.551 . . . . 0.0 109.842 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -123.68 -178.45 4.04 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.246 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 63.05 17.66 10.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.26 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.9 ttt -95.56 15.81 18.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.379 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -137.93 -88.86 0.21 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.447 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mp 63.69 -78.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.78 0.324 . . . . 0.0 111.015 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -109.76 35.17 3.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.806 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.7 mmm-85 -63.94 -44.51 92.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.64 24.91 11.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.013 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.459 HD11 ' N ' ' A' ' 136' ' ' LEU . 0.3 OUTLIER -136.99 11.87 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 111.434 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -50.0 -28.8 7.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.205 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.03 15.86 3.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.289 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -85.54 103.71 14.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.863 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -98.23 167.22 11.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.158 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.514 ' HA ' HG12 ' A' ' 12' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.224 0.535 . . . . 0.0 111.49 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -75.5 -15.89 60.36 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.848 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.03 -9.25 2.2 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.333 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.514 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.1 pp -60.4 -19.2 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-N 117.538 0.669 . . . . 0.0 112.069 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.49 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -83.91 9.64 11.69 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.041 178.256 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.04 -43.8 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.732 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.58 -80.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 110.989 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.43 -14.49 26.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.438 0.637 . . . . 0.0 111.512 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.8 -18.03 62.35 Favored Glycine 0 C--N 1.312 -0.805 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.895 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.22 81.11 1.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 110.878 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 9.2 t0 -138.67 8.36 2.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.515 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.46 ' CG ' ' O ' ' A' ' 19' ' ' ASP . 13.3 p90 46.91 73.93 0.17 Allowed 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.8 0.81 . . . . 0.0 111.087 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.56 -8.44 38.19 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.602 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -90.13 11.85 19.64 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.032 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.239 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.88 0.371 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.0 m -74.37 145.23 43.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.884 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.719 HG11 HG23 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -86.26 106.32 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.884 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.75 HG22 ' HG2' ' A' ' 80' ' ' LYS . 13.5 t -118.3 154.09 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.328 0.585 . . . . 0.0 111.832 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.699 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -177.93 125.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.265 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -112.03 135.22 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.668 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.77 HD23 HD11 ' A' ' 48' ' ' ILE . 3.5 tp -125.73 139.52 53.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.639 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -50.76 139.61 16.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.129 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.466 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -87.52 87.65 7.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.396 0.617 . . . . 0.0 110.462 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.43 ' C ' ' N ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -125.78 170.64 11.39 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.543 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.67 -12.13 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.993 0.425 . . . . 0.0 110.34 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.818 ' CD ' HD11 ' A' ' 96' ' ' LEU . 1.4 tt0 -80.82 -58.11 3.24 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.342 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.813 HG21 ' CD1' ' A' ' 77' ' ' TRP . 1.4 mp -63.86 -44.89 98.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.963 0.411 . . . . 0.0 110.241 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -40.49 -59.85 1.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.058 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.74 HG21 ' HG ' ' A' ' 95' ' ' LEU . 58.5 m -69.96 -68.47 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.007 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.882 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -42.66 -47.01 5.23 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.595 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.5 tp -55.87 -47.97 79.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.165 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.485 ' O ' ' CD2' ' A' ' 57' ' ' LEU . 1.6 pt-20 -53.29 -48.78 68.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 109.755 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.798 ' HA ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -70.64 -81.6 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.67 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.882 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -22.02 -57.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.7 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.4 mp -74.22 -66.0 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.576 ' N ' HD13 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -63.41 -33.12 74.85 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -177.251 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.798 HG23 ' HA ' ' A' ' 54' ' ' GLU . 70.0 p -62.93 -66.2 0.58 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.338 0.59 . . . . 0.0 110.757 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.62 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -83.24 -46.35 12.78 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.805 ' CG ' HG11 ' A' ' 68' ' ' VAL . 49.6 m-85 -69.04 -24.71 64.21 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -90.99 -51.48 5.32 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.657 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 58' ' ' THR . 13.6 ttpt -60.68 -43.16 98.05 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.271 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.698 ' O ' HG23 ' A' ' 64' ' ' VAL . 10.2 p-10 179.76 103.8 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.103 0.477 . . . . 0.0 111.753 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER 178.51 -52.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.027 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.465 ' N ' HG12 ' A' ' 64' ' ' VAL . 5.1 m-20 178.86 141.56 0.28 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.738 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.55 -10.41 10.87 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.698 2.265 . . . . 0.0 111.956 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.516 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -78.3 -106.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.61 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.805 HG11 ' CG ' ' A' ' 60' ' ' TYR . 9.7 p 26.56 49.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.359 0.599 . . . . 0.0 111.629 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -82.32 136.52 35.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.199 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.75 153.76 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.041 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 7.9 mm-40 -142.44 116.28 9.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.188 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -86.38 114.52 23.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.571 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.445 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 21.4 mmt180 -103.17 -120.67 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.973 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.78 -54.04 50.92 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.862 0.363 . . . . 0.0 111.133 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.83 -39.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.644 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -79.93 162.5 24.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.673 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.813 ' CD1' HG21 ' A' ' 48' ' ' ILE . 22.8 m95 -90.92 142.71 27.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.154 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.511 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.4 m0 -106.52 102.4 11.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.266 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.847 ' N ' HD13 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -97.01 107.41 19.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.174 0.511 . . . . 0.0 110.411 -179.184 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.75 ' HG2' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -121.9 143.71 49.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.455 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.564 ' HB3' HG22 ' A' ' 85' ' ' ILE . . . -143.4 158.51 43.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.296 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.41 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.4 OUTLIER -102.94 132.84 48.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.865 0.364 . . . . 0.0 111.438 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.52 -68.21 3.47 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.001 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.493 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -176.46 152.89 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 110.691 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.817 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -133.69 157.92 42.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.795 ' HB2' HG22 ' A' ' 124' ' ' THR . 12.5 pt-20 -147.75 122.27 9.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.467 . . . . 0.0 111.825 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.773 HG13 HG13 ' A' ' 55' ' ' ILE . 29.2 t -94.74 137.16 23.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.59 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 18.0 p30 -84.31 151.93 24.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.893 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.465 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 21.4 t -109.83 100.55 9.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.131 0.491 . . . . 0.0 109.849 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 0.8 OUTLIER 161.5 -35.87 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.079 -179.36 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.02 -70.35 0.36 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.826 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.62 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.5 tt -57.8 -58.93 4.23 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.191 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.516 ' H ' HG23 ' A' ' 92' ' ' ILE . 4.9 t -44.75 -34.76 2.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.798 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.6 mm-40 -60.9 -48.22 82.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.542 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 95' ' ' LEU . 1.5 tm? -90.23 -16.98 28.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.725 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.818 HD11 ' CD ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.33 10.19 41.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 98' ' ' ARG . . . 125.46 70.72 0.19 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.117 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -30.72 147.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.149 0.5 . . . . 0.0 111.834 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.45 17.91 11.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.038 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -165.19 0.05 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.933 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.21 -167.88 1.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.035 HG23 ' CD1' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -113.14 -43.89 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.719 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -2.57 16.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.36 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.83 -40.79 22.25 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.878 0.37 . . . . 0.0 110.264 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.608 ' HE2' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -83.4 146.36 28.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.788 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.839 HD12 ' HB ' ' A' ' 112' ' ' THR . 3.5 tt 64.51 14.76 9.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 111.179 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 108' ' ' ASP . 14.2 p -74.17 -44.88 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.813 0.34 . . . . 0.0 111.07 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.484 ' N ' HG13 ' A' ' 107' ' ' VAL . 1.6 p30 178.54 54.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.67 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.587 HG21 HD11 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -98.0 -166.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.468 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -43.61 -40.15 3.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.154 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.472 ' HB3' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER 170.52 149.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.846 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.839 ' HB ' HD12 ' A' ' 106' ' ' LEU . 37.1 p -157.75 84.9 0.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 113' ' ' ILE . 10.4 mm -77.16 114.5 17.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.434 0.635 . . . . 0.0 111.395 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 143.89 142.01 3.87 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.029 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 126' ' ' THR . 23.4 ttt180 -77.1 120.1 21.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.614 0.245 . . . . 0.0 110.44 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.807 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -104.76 125.39 50.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.077 0.465 . . . . 0.0 112.202 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.581 ' HE1' HD23 ' A' ' 119' ' ' LEU . 3.5 p90 -131.63 127.42 36.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.101 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.877 ' OG1' HG21 ' A' ' 102' ' ' VAL . 11.7 t -100.26 149.35 23.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.344 0.592 . . . . 0.0 112.097 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.656 ' O ' HD12 ' A' ' 119' ' ' LEU . 3.3 pp -146.62 118.11 7.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.663 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.14 -104.29 0.51 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.981 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -133.06 83.68 2.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.028 0.442 . . . . 0.0 109.932 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.3 OUTLIER 152.95 115.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.471 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 1.035 ' CD1' HG23 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -104.21 138.46 40.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.988 0.423 . . . . 0.0 110.789 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.795 HG22 ' HB2' ' A' ' 86' ' ' GLU . 17.8 p -114.13 133.33 55.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.315 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.817 HD13 ' CD1' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -113.82 117.56 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.819 0.818 . . . . 0.0 110.565 179.099 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 115' ' ' ARG . 8.8 t -100.54 156.37 17.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.748 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.449 ' CB ' ' HA ' ' A' ' 38' ' ' VAL . 8.9 t -142.36 17.27 2.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.348 0.594 . . . . 0.0 109.555 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 N--CA 1.446 -0.655 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.14 -178.714 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.526 ' HA ' HG12 ' A' ' 12' ' ' ILE . 4.1 m-20 . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.114 0.483 . . . . 0.0 111.408 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.491 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -78.73 -16.74 56.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.389 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.6 -8.91 2.7 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.261 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.526 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.1 pp -61.09 -19.84 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 117.626 0.713 . . . . 0.0 111.852 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.491 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.72 8.5 16.85 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.789 178.07 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.11 -43.5 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.33 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.19 -80.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.68 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.74 11.19 32.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.064 0.459 . . . . 0.0 111.17 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -112.62 -17.17 8.2 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.145 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -128.54 80.83 1.99 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.027 0.442 . . . . 0.0 110.42 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -142.51 13.71 1.96 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.36 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -86.51 6.23 31.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 0.0 111.095 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.34 -177.15 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.344 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 t0 65.29 13.35 8.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.197 0.522 . . . . 0.0 110.017 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.815 179.939 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 CA--C 1.53 0.195 0 CA-C-O 120.613 0.244 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.537 HG21 ' HD2' ' A' ' 80' ' ' LYS . 16.3 m -67.59 153.52 43.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.957 0.408 . . . . 0.0 111.124 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.888 HG21 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -102.23 112.61 36.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.676 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 80' ' ' LYS . 20.7 t -129.11 152.05 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.436 0.636 . . . . 0.0 112.436 -178.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.788 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -159.84 129.96 5.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.778 178.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.84 134.42 54.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.281 0.562 . . . . 0.0 111.998 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.017 HD23 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -126.29 140.32 52.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.434 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -52.53 129.0 27.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.46 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -75.29 90.0 2.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.498 0.666 . . . . 0.0 110.617 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 47' ' ' GLU . 3.3 m -126.01 171.09 11.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.442 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.54 -16.25 0.21 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.048 0.451 . . . . 0.0 110.047 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.889 ' HG2' HD12 ' A' ' 48' ' ' ILE . 6.8 tt0 -72.6 -63.47 1.15 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.175 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.017 HD11 HD23 ' A' ' 42' ' ' LEU . 1.6 mp -61.31 -44.16 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.294 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -40.82 -59.05 1.51 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.807 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.711 HG21 ' HG ' ' A' ' 95' ' ' LEU . 15.4 m -75.56 -62.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.941 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.875 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -44.34 -48.42 9.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.398 -179.075 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -57.62 -47.77 84.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.879 0.371 . . . . 0.0 110.432 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -53.21 -49.47 66.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.253 0.549 . . . . 0.0 109.601 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.761 ' HA ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -69.86 -82.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.54 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.875 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -21.66 -58.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.706 ' N ' HG23 ' A' ' 55' ' ' ILE . 1.4 mp -73.51 -66.3 0.71 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.605 ' N ' HD13 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -63.32 -30.54 71.66 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.454 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.761 HG23 ' HA ' ' A' ' 54' ' ' GLU . 72.0 p -62.89 -66.8 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.283 0.563 . . . . 0.0 110.611 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.631 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 65.6 m-20 -83.66 -44.86 14.07 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.894 ' CG ' HG11 ' A' ' 68' ' ' VAL . 66.9 m-85 -70.07 -21.63 63.14 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -93.84 -47.97 6.5 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.864 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.58 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.5 OUTLIER -58.01 -48.57 79.63 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.752 0.31 . . . . 0.0 110.814 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.582 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.4 OUTLIER 179.31 99.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.289 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 59' ' ' ASP . 0.9 OUTLIER -172.23 -50.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.764 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.455 ' N ' HG12 ' A' ' 64' ' ' VAL . 4.1 m-20 177.41 143.97 0.27 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 0.0 111.935 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -85.29 -3.31 9.45 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.824 2.349 . . . . 0.0 111.71 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.547 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 1.1 t -82.84 -109.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.44 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.894 HG11 ' CG ' ' A' ' 60' ' ' TYR . 10.0 p 26.8 49.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 121.379 0.609 . . . . 0.0 111.606 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -82.05 139.0 34.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.133 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 78' ' ' TRP . 0.5 OUTLIER -97.67 153.45 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.031 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -142.38 116.12 9.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.249 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -86.17 114.51 23.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.735 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 5.7 mmt180 -95.64 -111.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.968 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.9 -38.23 64.43 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.867 0.365 . . . . 0.0 111.128 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.46 -37.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.417 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.95 162.55 23.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.752 0.311 . . . . 0.0 110.551 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.844 ' CD1' HG21 ' A' ' 48' ' ' ILE . 10.3 m95 -94.11 142.84 26.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.521 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.488 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 9.0 m0 -107.56 108.73 20.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.133 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.803 ' N ' HD13 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -98.04 113.58 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.173 0.511 . . . . 0.0 110.338 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.537 ' HD2' HG21 ' A' ' 37' ' ' THR . 3.6 tttt -122.39 140.23 52.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.84 ' HB3' HG22 ' A' ' 85' ' ' ILE . . . -142.86 138.65 30.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.765 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.453 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.3 OUTLIER -77.55 108.2 10.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.046 0.45 . . . . 0.0 111.455 -179.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 104.03 -62.31 0.4 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.082 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.888 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 178.04 162.13 0.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.066 0.46 . . . . 0.0 111.353 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.84 HG22 ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -136.67 159.61 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.13 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.744 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.1 OUTLIER -142.75 118.2 10.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.146 0.498 . . . . 0.0 111.468 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.836 HG13 HG13 ' A' ' 55' ' ' ILE . 17.4 t -94.4 128.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.826 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 2.6 m-20 -77.3 151.97 34.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.153 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 22.5 t -106.26 100.62 10.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.136 0.493 . . . . 0.0 109.906 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 9.3 t0 160.3 -35.69 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.823 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -70.83 -72.87 0.19 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.943 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.658 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.3 tt -56.56 -57.85 7.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.503 ' H ' HG23 ' A' ' 92' ' ' ILE . 35.0 p -45.43 -36.61 4.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.755 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -58.34 -46.79 85.56 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.122 0.486 . . . . 0.0 110.239 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.842 HD13 ' O ' ' A' ' 95' ' ' LEU . 2.0 tm? -90.26 -17.2 27.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.474 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.752 HD11 ' CG ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -99.77 13.17 34.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.81 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 100' ' ' PHE . . . 118.99 67.94 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.18 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -33.56 150.41 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.208 0.528 . . . . 0.0 111.99 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.52 19.02 10.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.373 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.407 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -77.24 -166.52 0.74 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.049 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -93.5 -169.47 2.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.882 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.895 HG23 ' CD1' ' A' ' 123' ' ' PHE . 1.4 p -111.64 -34.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.118 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -79.91 3.91 18.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.477 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.774 ' O ' HG12 ' A' ' 107' ' ' VAL . 3.5 m-20 -59.6 -38.22 80.66 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.705 0.288 . . . . 0.0 110.947 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.473 ' CE1' ' HB2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -64.05 -43.04 96.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.765 0.316 . . . . 0.0 110.76 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.841 HD22 ' HB3' ' A' ' 116' ' ' ALA . 1.3 tp -106.73 26.03 10.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.218 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.774 HG12 ' O ' ' A' ' 104' ' ' ASP . 15.0 p -73.69 -24.39 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.9 0.381 . . . . 0.0 110.947 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -171.57 -86.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.458 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 110' ' ' SER . 43.0 t 55.9 160.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.056 0.455 . . . . 0.0 111.601 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.508 ' N ' HG12 ' A' ' 109' ' ' VAL . 30.3 t -55.14 -47.89 74.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.053 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.56 150.93 9.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.733 HG22 ' HB2' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -156.73 74.31 0.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.049 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 113' ' ' ILE . 5.1 mm -62.34 106.2 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.349 0.595 . . . . 0.0 111.23 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 148.39 140.28 3.3 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.046 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 126' ' ' THR . 61.3 ttp85 -76.7 126.01 30.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.614 0.245 . . . . 0.0 110.643 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.841 ' HB3' HD22 ' A' ' 106' ' ' LEU . . . -104.43 125.36 50.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.031 0.443 . . . . 0.0 112.007 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 1.7 p90 -128.32 120.79 27.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.814 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.8 t -98.37 161.25 13.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.343 0.592 . . . . 0.0 112.008 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.786 ' O ' HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -169.94 133.6 1.21 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.32 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.92 -110.78 1.21 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.681 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -134.33 84.02 2.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.478 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 88' ' ' ASP . 7.6 mttt 153.73 117.39 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.489 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.895 ' CD1' HG23 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -104.72 137.75 42.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.063 0.458 . . . . 0.0 110.84 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.744 HG23 ' HB3' ' A' ' 86' ' ' GLU . 55.2 m -112.72 126.05 54.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.028 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.748 HD11 HG23 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -110.94 117.42 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.859 0.838 . . . . 0.0 111.131 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 115' ' ' ARG . 5.2 t -115.23 154.27 29.36 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.995 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.754 ' CB ' HG13 ' A' ' 38' ' ' VAL . 6.5 t -147.55 25.85 1.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.343 0.592 . . . . 0.0 109.679 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.653 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.044 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.556 ' HA ' HG12 ' A' ' 12' ' ' ILE . 0.6 OUTLIER . . . . . 0 CA--C 1.52 -0.207 0 CA-C-O 121.256 0.55 . . . . 0.0 111.461 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.86 -21.72 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.529 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.51 -10.72 4.85 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.233 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.556 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.0 pp -61.16 -21.35 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-N 117.595 0.697 . . . . 0.0 111.842 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.465 ' HE3' ' HB2' ' A' ' 13' ' ' MET . 0.0 OUTLIER -87.57 8.99 22.62 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.775 178.051 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.414 ' HA2' ' CB ' ' A' ' 18' ' ' LYS . . . -136.09 -49.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.502 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mp -61.67 -81.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 110.866 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 10.04 26.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.007 0.432 . . . . 0.0 111.431 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.93 -26.45 3.83 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.961 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HG3' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -128.9 81.49 2.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.142 0.496 . . . . 0.0 110.332 179.249 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -116.97 -27.27 6.6 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.367 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -92.76 15.47 14.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.363 . . . . 0.0 111.402 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HB2' ' HG3' ' A' ' 18' ' ' LYS . . . -80.63 -6.37 58.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.221 0.534 . . . . 0.0 111.768 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -88.97 12.06 16.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.444 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.204 179.69 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.876 0.37 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.8 m -70.07 139.92 52.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.614 HG11 HG23 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -86.27 99.32 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.879 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.791 ' C ' HD12 ' A' ' 40' ' ' LEU . 3.9 t -107.52 146.07 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.255 0.55 . . . . 0.0 112.321 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.791 HD12 ' C ' ' A' ' 39' ' ' VAL . 6.3 mp -150.34 109.8 4.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.058 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.412 HG23 ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -108.51 128.09 64.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.327 0.584 . . . . 0.0 112.193 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.72 HD13 HD11 ' A' ' 48' ' ' ILE . 24.8 mt -127.07 140.26 52.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.6 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.29 125.72 14.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.744 0.307 . . . . 0.0 111.765 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HD2' ' CE2' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -57.36 87.71 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.267 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.609 ' C ' ' H ' ' A' ' 47' ' ' GLU . 33.2 m -125.02 170.16 11.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.381 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.37 11.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.834 ' CB ' HD21 ' A' ' 96' ' ' LEU . 1.9 tt0 -98.84 -57.68 2.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.976 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.768 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.8 OUTLIER -61.23 -44.49 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.302 0.573 . . . . 0.0 109.613 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -39.43 -62.0 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.126 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.845 HG21 ' HG ' ' A' ' 95' ' ' LEU . 56.7 m -65.41 -74.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.952 ' CD2' HG21 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -40.97 -58.78 1.62 Allowed 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.249 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.602 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.6 tp -41.72 -46.67 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.02 0.438 . . . . 0.0 109.963 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.536 ' O ' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -57.36 -53.49 57.49 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.622 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.683 ' HA ' HG23 ' A' ' 58' ' ' THR . 35.5 mt-10 -66.55 -94.61 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.949 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.952 HG21 ' CD2' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -18.55 -58.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.753 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -62.96 -77.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.671 ' N ' HD13 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -63.68 -16.08 60.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.683 HG23 ' HA ' ' A' ' 54' ' ' GLU . 6.3 p -65.01 -74.38 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.297 0.57 . . . . 0.0 110.137 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.582 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 8.7 m-20 -82.56 -32.71 28.39 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.858 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 1.027 ' CG ' HG11 ' A' ' 68' ' ' VAL . 78.1 m-85 -71.81 -32.04 67.18 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -84.78 -46.08 11.74 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.026 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 58' ' ' THR . 10.1 ttpt -57.85 -48.85 78.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.84 0.352 . . . . 0.0 110.821 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.69 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.4 OUTLIER 179.55 101.63 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -177.55 -52.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.063 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.498 ' N ' HG12 ' A' ' 64' ' ' VAL . 5.7 m-20 -177.1 138.99 0.43 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.772 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.48 3.07 8.09 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.673 2.249 . . . . 0.0 112.275 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.498 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 1.3 t -91.81 -114.1 0.09 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.108 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.027 HG11 ' CG ' ' A' ' 60' ' ' TYR . 8.4 p 28.46 43.47 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.115 0.484 . . . . 0.0 112.246 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.42 138.86 31.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.054 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.22 151.04 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-O 121.243 0.544 . . . . 0.0 111.659 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.771 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -143.42 116.89 9.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.02 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -80.19 124.29 28.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.461 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.464 ' HG3' ' CD2' ' A' ' 78' ' ' TRP . 5.2 mmt-85 -111.45 -117.4 0.3 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.64 -82.98 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -133.12 17.53 4.56 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.187 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.7 155.99 44.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.786 0.326 . . . . 0.0 110.688 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.768 ' CD1' HG21 ' A' ' 48' ' ' ILE . 73.7 m95 -76.4 125.89 30.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.29 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.771 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.1 m0 -96.62 106.59 18.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.663 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.58 122.12 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.194 -178.463 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -128.58 136.22 50.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.692 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 67' ' ' THR . . . -142.75 153.48 43.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.835 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.465 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.4 OUTLIER -105.0 129.52 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.644 -179.8 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.96 -67.62 2.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.256 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.499 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 179.31 157.14 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.636 -179.272 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.816 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.97 154.76 15.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.633 ' HB2' HG22 ' A' ' 124' ' ' THR . 11.7 pt-20 -141.03 124.57 16.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.05 0.452 . . . . 0.0 111.304 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.951 HG13 HG13 ' A' ' 55' ' ' ILE . 39.1 t -94.35 129.37 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.922 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 6.8 m-20 -76.41 151.78 36.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.911 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.452 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 27.8 t -108.9 100.79 9.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.138 0.495 . . . . 0.0 109.908 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.5 m-20 160.17 -36.13 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.17 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -71.28 -69.19 0.39 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.0 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.642 ' HB ' ' CD2' ' A' ' 51' ' ' PHE . 1.1 tt -59.21 -51.49 71.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.713 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.448 ' N ' HG23 ' A' ' 92' ' ' ILE . 44.9 p -52.74 -33.59 48.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.454 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -62.22 -46.58 88.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.973 0.416 . . . . 0.0 111.078 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.868 HD13 ' O ' ' A' ' 95' ' ' LEU . 2.5 tm? -90.18 -20.07 23.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.056 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.834 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -98.19 10.03 41.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.961 0.41 . . . . 0.0 111.018 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.42 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 129.67 69.11 0.11 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.231 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.5 158.82 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.072 0.463 . . . . 0.0 111.24 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 63.32 17.62 10.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.902 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER -75.66 -168.57 0.87 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.706 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -130.39 150.9 51.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.999 0.428 . . . . 0.0 111.236 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.82 HG21 ' OG1' ' A' ' 118' ' ' THR . 7.7 p -64.66 166.79 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.779 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.661 ' CE2' HG22 ' A' ' 118' ' ' THR . 1.2 m-85 71.62 7.16 5.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.049 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -79.7 -30.06 40.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 110.329 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.51 ' CE1' ' CD2' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -80.85 -0.58 39.58 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.278 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.71 29.5 1.12 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.832 0.349 . . . . 0.0 110.792 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 103' ' ' TYR . 7.3 p -87.2 -32.88 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.246 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -174.73 36.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.736 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.616 HG11 HD21 ' A' ' 42' ' ' LEU . 18.9 m -69.5 167.91 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.563 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.1 m -47.52 -47.25 27.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.22 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.412 ' CB ' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -177.34 166.27 2.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 1.2 t 177.31 103.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.295 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 113' ' ' ILE . 10.5 mm -81.93 117.49 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.389 0.614 . . . . 0.0 111.155 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.31 141.82 3.95 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.994 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.94 119.76 21.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.68 0.276 . . . . 0.0 110.492 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.794 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -107.28 125.39 51.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.978 0.418 . . . . 0.0 111.86 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.499 ' HE1' HD23 ' A' ' 119' ' ' LEU . 20.2 p90 -132.28 125.68 31.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.712 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.82 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.0 t -91.17 150.26 21.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.306 0.574 . . . . 0.0 111.985 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.554 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.4 pp -155.31 115.7 3.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.568 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.34 -106.75 1.11 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.535 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.47 83.52 2.02 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.1 OUTLIER 153.94 99.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.034 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.77 ' CD1' HG23 ' A' ' 102' ' ' VAL . 3.2 p90 -90.96 133.5 35.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.082 0.468 . . . . 0.0 110.721 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.633 HG22 ' HB2' ' A' ' 86' ' ' GLU . 2.4 p -108.0 141.02 40.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.436 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.872 HD11 HG23 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -118.38 117.4 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.913 0.863 . . . . 0.0 110.825 178.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 115' ' ' ARG . 4.5 t -97.95 155.99 16.83 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.52 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.439 ' CB ' ' HA ' ' A' ' 38' ' ' VAL . 13.2 t -147.28 20.52 1.21 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.257 0.551 . . . . 0.0 109.857 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.651 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.117 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.731 ' HA ' HD11 ' A' ' 12' ' ' ILE . 1.1 m-20 . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 121.638 0.733 . . . . 0.0 112.566 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.572 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -59.64 -7.97 1.78 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.598 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.37 -19.63 6.58 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.792 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.731 HD11 ' HA ' ' A' ' 9' ' ' ASP . 2.0 pp -108.18 66.88 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.572 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -139.47 14.96 2.56 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.884 178.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.436 ' HA2' ' CB ' ' A' ' 18' ' ' LYS . . . -127.7 -41.8 0.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.24 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.405 HD12 ' H ' ' A' ' 15' ' ' LEU . 5.4 mp -60.85 -75.41 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.782 0.325 . . . . 0.0 110.749 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 9.39 43.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.84 -24.48 5.51 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.859 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.436 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -128.0 81.3 2.01 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.106 0.479 . . . . 0.0 110.074 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -121.12 -36.87 3.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.374 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.47 14.93 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.541 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.28 -173.68 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.901 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.56 13.9 5.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.03 0.443 . . . . 0.0 110.657 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.035 179.766 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.696 0.284 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.7 m -72.24 145.42 47.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.024 0.44 . . . . 0.0 111.125 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.614 HG22 ' HB3' ' A' ' 127' ' ' SER . 0.2 OUTLIER -89.32 102.31 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.154 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.605 HG22 ' HG2' ' A' ' 80' ' ' LYS . 9.6 t -116.23 153.33 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.331 0.586 . . . . 0.0 111.669 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.881 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -173.1 128.26 0.46 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.285 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.464 ' CG1' ' CD1' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -112.44 134.71 54.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.177 0.513 . . . . 0.0 111.662 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.994 HD23 HD11 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -126.52 139.96 52.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.465 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.45 129.17 21.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.492 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -75.72 90.17 2.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.796 0.808 . . . . 0.0 110.433 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.445 ' C ' ' N ' ' A' ' 47' ' ' GLU . 1.1 t -126.27 171.01 11.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.449 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.11 -14.47 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.886 ' HG2' HD12 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -71.79 -61.56 1.74 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.221 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.994 HD11 HD23 ' A' ' 42' ' ' LEU . 1.5 mp -64.64 -43.22 96.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.092 0.472 . . . . 0.0 109.844 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -40.05 -58.18 1.49 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.727 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.435 HG21 ' HG ' ' A' ' 95' ' ' LEU . 1.2 m -78.11 -61.98 1.82 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.106 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.827 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -45.01 -44.44 9.96 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.517 -178.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.588 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.6 tp -62.2 -47.45 93.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.041 0.448 . . . . 0.0 109.868 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -53.91 -37.31 63.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.102 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.756 ' HA ' HG23 ' A' ' 58' ' ' THR . 0.9 OUTLIER -83.8 -75.57 0.33 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.53 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.827 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -31.22 -54.07 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.673 ' N ' HG23 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -76.92 -41.21 44.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -177.123 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.44 -47.18 12.56 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.498 -178.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.756 HG23 ' HA ' ' A' ' 54' ' ' GLU . 51.4 p -52.72 -68.91 0.13 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.485 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.445 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 0.5 OUTLIER -91.87 -33.8 14.78 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.349 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.852 ' CD1' HG21 ' A' ' 68' ' ' VAL . 7.5 m-85 -82.99 -3.12 56.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.455 -0.898 . . . . 0.0 113.091 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 2.3 tptt -115.99 -42.52 3.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.104 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.695 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -58.87 -51.27 70.76 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.573 0.225 . . . . 0.0 111.311 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.545 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -179.42 89.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.235 0.54 . . . . 0.0 111.862 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.626 HG11 ' CE1' ' A' ' 60' ' ' TYR . 24.4 t -160.12 -52.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.19 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 4.8 m-20 171.54 132.22 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.267 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 65' ' ' ASN . 4.7 Cg_exo -78.57 -18.36 12.14 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.658 2.239 . . . . 0.0 111.929 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -51.94 -50.84 60.38 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.4 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.852 HG21 ' CD1' ' A' ' 60' ' ' TYR . 78.2 t -43.83 87.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.651 0.262 . . . . 0.0 111.43 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 67' ' ' THR . 18.1 p30 -116.56 138.9 51.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.803 0.335 . . . . 0.0 111.613 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 78' ' ' TRP . 1.3 p -102.71 153.69 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.102 0.477 . . . . 0.0 111.662 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -142.82 129.72 20.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.432 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.51 114.89 20.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.935 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.477 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -89.92 -146.76 0.18 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.734 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.15 -22.42 60.88 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 111.398 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.14 -35.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.627 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -89.5 159.7 17.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 110.795 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.788 ' CD1' HG21 ' A' ' 48' ' ' ILE . 45.8 m95 -83.46 142.67 30.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.447 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.555 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 7.6 m0 -112.58 110.34 20.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.483 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.881 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -100.41 118.48 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.209 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.605 ' HG2' HG22 ' A' ' 39' ' ' VAL . 6.8 mtpt -126.6 136.76 52.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.487 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -143.63 158.85 43.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.827 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.42 135.96 49.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.229 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.69 -69.43 2.92 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.143 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER 178.76 160.9 0.66 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.965 0.412 . . . . 0.0 111.245 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.9 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -152.04 157.04 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.582 179.226 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.768 ' HB2' HG22 ' A' ' 124' ' ' THR . 7.3 pt-20 -141.38 125.6 17.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.039 0.447 . . . . 0.0 111.708 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.786 HG13 HG13 ' A' ' 55' ' ' ILE . 6.2 t -94.76 127.21 46.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.546 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.425 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 5.3 m-20 -76.44 152.42 36.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.102 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.543 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -107.47 100.06 9.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.392 0.615 . . . . 0.0 109.671 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.439 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER 164.6 -36.3 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.115 -179.351 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -73.09 -72.25 0.26 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.666 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.651 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -55.86 -59.66 2.49 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.908 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.535 ' H ' HG23 ' A' ' 92' ' ' ILE . 16.3 p -44.03 -37.08 2.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -57.47 -48.68 78.55 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.141 0.496 . . . . 0.0 110.401 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.761 HD13 ' O ' ' A' ' 95' ' ' LEU . 2.7 tm? -90.75 -19.13 23.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.555 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.793 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -91.07 9.65 30.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . 110.47 74.24 0.76 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.593 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -38.63 162.94 0.0 OUTLIER 'General case' 0 CA--C 1.526 0.037 0 CA-C-O 121.14 0.495 . . . . 0.0 111.377 -179.348 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.45 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 19.1 pt20 47.84 98.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.66 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' A' ' 93' ' ' SER . 0.0 OUTLIER -160.04 -152.69 0.3 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.603 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -124.2 124.36 42.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.887 0.375 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.714 HG21 ' OG1' ' A' ' 118' ' ' THR . 12.5 p -53.79 166.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.242 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.532 ' N ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER 80.48 -2.21 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.39 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.812 ' O ' HG12 ' A' ' 107' ' ' VAL . 7.5 t70 -60.47 -30.45 69.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.746 ' CE1' HD23 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -76.94 -30.02 55.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.34 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.746 HD23 ' CE1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -108.97 21.44 17.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.207 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.812 HG12 ' O ' ' A' ' 104' ' ' ASP . 13.2 p -87.32 -37.08 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 0.0 111.277 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.532 ' OD2' HG22 ' A' ' 107' ' ' VAL . 0.9 OUTLIER 168.82 88.48 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.802 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.55 83.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.11 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.8 t 66.74 -63.99 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.195 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.529 ' O ' HG23 ' A' ' 112' ' ' THR . 0.1 OUTLIER 175.68 163.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.995 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 111' ' ' SER . 20.5 p -160.16 83.39 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 113' ' ' ILE . 8.4 mm -66.58 110.27 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.56 0.695 . . . . 0.0 111.192 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 146.61 148.09 4.7 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.597 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.461 ' HB2' HG23 ' A' ' 126' ' ' THR . 1.8 mmm180 -76.6 120.05 21.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.56 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -108.14 125.22 51.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.063 0.459 . . . . 0.0 112.144 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.505 ' HE1' HD23 ' A' ' 119' ' ' LEU . 11.4 p90 -136.33 118.52 15.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.412 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.714 ' OG1' HG21 ' A' ' 102' ' ' VAL . 13.7 t -91.21 134.92 34.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.189 0.519 . . . . 0.0 111.731 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.583 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.6 pp -134.01 115.92 14.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.797 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.05 -106.16 0.84 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.992 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 89' ' ' CYS . 0.5 OUTLIER -133.16 83.97 2.1 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.073 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.499 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.2 OUTLIER 152.25 95.14 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.455 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.541 ' CD1' HG23 ' A' ' 102' ' ' VAL . 24.0 p90 -88.12 126.62 35.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.015 0.436 . . . . 0.0 111.151 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.768 HG22 ' HB2' ' A' ' 86' ' ' GLU . 12.2 p -102.87 136.14 43.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.149 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -116.09 118.4 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.778 0.799 . . . . 0.0 111.232 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 115' ' ' ARG . 11.3 t -98.2 156.1 16.85 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.16 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.614 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -140.13 13.61 2.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.448 0.642 . . . . 0.0 109.54 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.445 -0.701 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.104 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.471 ' HA ' HG12 ' A' ' 12' ' ' ILE . 3.6 m-20 . . . . . 0 N--CA 1.461 0.109 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.426 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -84.14 -16.93 41.78 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.638 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.18 -13.11 2.44 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.959 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 9' ' ' ASP . 1.9 pp -56.73 -23.61 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 117.732 0.766 . . . . 0.0 111.854 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.426 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.73 8.21 17.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.866 178.166 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 18' ' ' LYS . . . -135.55 -38.07 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.469 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.66 -74.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.672 0.272 . . . . 0.0 111.127 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.5 9.13 41.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.582 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.88 -24.85 4.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.135 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.499 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 4.5 tmtt? -130.93 85.63 2.29 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.698 0.761 . . . . 0.0 110.321 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -128.04 2.51 5.89 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.471 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.2 18.0 7.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.877 0.37 . . . . 0.0 111.536 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.88 -178.16 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.042 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.96 11.08 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.904 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.041 179.763 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.85 0.357 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 m -67.69 140.85 56.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.661 HG11 HG22 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -97.18 131.22 44.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.987 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 113' ' ' ILE . 8.9 t -129.88 140.06 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 5.6 tp -128.5 104.33 7.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.481 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.417 ' CG2' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -111.74 126.85 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.24 0.543 . . . . 0.0 111.259 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.549 HD22 HD11 ' A' ' 48' ' ' ILE . 1.5 mt -126.69 140.9 52.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.684 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.7 OUTLIER -51.81 119.07 3.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.666 0.27 . . . . 0.0 111.054 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HD2' ' NE1' ' A' ' 77' ' ' TRP . 0.1 OUTLIER -46.79 91.97 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 47' ' ' GLU . 13.6 m -125.38 169.36 12.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.914 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -67.03 3.69 1.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.764 ' CB ' HD21 ' A' ' 96' ' ' LEU . 1.4 tt0 -90.02 -59.32 2.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.801 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.756 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.5 OUTLIER -55.33 -43.72 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 121.171 0.51 . . . . 0.0 109.878 179.287 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -42.45 -61.59 1.17 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.342 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.811 HG21 ' HG ' ' A' ' 95' ' ' LEU . 83.8 m -68.43 -75.43 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.957 ' CD1' HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -39.12 -62.02 0.69 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 119.687 -0.197 . . . . 0.0 111.5 -178.317 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.585 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -42.16 -46.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.983 0.421 . . . . 0.0 110.049 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' O ' HD22 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -56.66 -53.64 55.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.469 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.657 ' HA ' HG23 ' A' ' 58' ' ' THR . 8.3 mt-10 -66.91 -94.42 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.016 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.957 HG21 ' CD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -18.74 -61.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.775 ' N ' HD13 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -61.46 -76.22 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.675 ' N ' HD13 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -64.12 -15.49 59.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.691 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.657 HG23 ' HA ' ' A' ' 54' ' ' GLU . 3.3 p -63.37 -75.39 0.08 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.204 0.525 . . . . 0.0 110.013 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.591 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 2.1 p30 -85.77 -31.47 22.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.768 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.992 ' CG ' HG11 ' A' ' 68' ' ' VAL . 86.1 m-85 -73.64 -29.46 62.35 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.23 -0.588 . . . . 0.0 112.048 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.632 ' CE ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -86.43 -45.05 11.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.641 179.532 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.5 ttmt -55.58 -51.65 66.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.432 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.685 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.4 OUTLIER 179.62 100.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.939 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -177.52 -55.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.348 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.556 ' N ' HG12 ' A' ' 64' ' ' VAL . 4.4 m-20 178.69 129.92 0.22 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.846 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -86.63 -16.9 3.56 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.86 2.373 . . . . 0.0 112.111 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.7 HG21 ' OD1' ' A' ' 82' ' ' ASN . 1.8 t -55.26 -39.49 69.86 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.551 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.992 HG11 ' CG ' ' A' ' 60' ' ' TYR . 11.6 p -66.02 65.81 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.406 0.622 . . . . 0.0 110.893 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -101.04 143.32 31.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.887 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.438 HG23 ' CD1' ' A' ' 79' ' ' ILE . 0.5 OUTLIER -95.65 149.67 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.483 0.658 . . . . 0.0 111.693 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 1.6 tp10 -143.66 125.97 15.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.529 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -84.66 115.45 22.67 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.225 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HB2' ' CG ' ' A' ' 78' ' ' TRP . 0.1 OUTLIER -96.38 -114.39 0.13 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.417 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.77 -80.54 0.05 OUTLIER 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.783 0.325 . . . . 0.0 111.581 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.82 -24.84 2.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.037 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -102.52 162.6 12.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.752 0.31 . . . . 0.0 110.842 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.756 ' CD1' HG21 ' A' ' 48' ' ' ILE . 83.4 m95 -76.05 122.72 24.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.269 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.573 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.6 m0 -96.56 107.63 20.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.683 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.676 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -96.94 137.48 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.435 -178.191 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -128.81 136.0 49.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.316 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -143.31 157.89 44.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.712 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.7 ' OD1' HG21 ' A' ' 67' ' ' THR . 1.2 p-10 -104.82 135.41 46.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.4 . . . . 0.0 110.701 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.63 -67.08 0.28 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.786 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 126' ' ' THR . 0.0 OUTLIER 178.14 173.57 0.62 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.116 0.484 . . . . 0.0 111.311 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.987 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -152.36 162.37 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.419 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.733 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.4 OUTLIER -129.23 121.94 28.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.183 0.516 . . . . 0.0 111.551 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.949 HG23 HD11 ' A' ' 125' ' ' ILE . 55.0 t -94.36 125.29 47.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.564 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -76.81 151.82 35.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.028 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.465 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 17.1 t -108.5 100.68 9.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 3.1 m-20 161.01 -32.95 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.09 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -74.34 -70.81 0.37 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.009 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.575 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -58.46 -51.61 69.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.589 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.426 ' N ' HG23 ' A' ' 92' ' ' ILE . 24.2 p -52.68 -35.29 55.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.523 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -60.15 -44.65 94.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.928 0.394 . . . . 0.0 110.806 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.821 HD13 ' O ' ' A' ' 95' ' ' LEU . 3.4 tm? -90.27 -21.6 22.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.761 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.764 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.46 12.26 35.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.901 0.382 . . . . 0.0 111.218 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.16 66.44 0.13 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.591 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.34 152.56 0.02 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 65.48 18.12 11.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.46 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -166.15 0.25 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.994 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -121.88 140.7 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.717 HG21 ' OG1' ' A' ' 118' ' ' THR . 11.9 p -56.82 163.59 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.004 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.552 ' CE2' HG22 ' A' ' 118' ' ' THR . 0.9 OUTLIER 70.07 9.67 7.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.278 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.43 -32.48 24.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.365 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.531 ' HD1' HD23 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -66.66 -33.03 74.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.511 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.531 HD23 ' HD1' ' A' ' 105' ' ' PHE . 0.6 OUTLIER -124.62 33.3 5.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.707 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 108' ' ' ASP . 14.9 p -63.24 -40.55 89.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.414 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.41 ' N ' HG13 ' A' ' 107' ' ' VAL . 23.0 t0 -174.65 81.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.856 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.515 HG11 HD23 ' A' ' 42' ' ' LEU . 3.4 t -127.73 165.67 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.036 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.476 ' N ' HG12 ' A' ' 109' ' ' VAL . 15.1 t -43.3 -46.16 6.22 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.477 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.417 ' CB ' ' CG2' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -172.49 151.08 2.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.825 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.84 ' C ' HD12 ' A' ' 113' ' ' ILE . 35.5 p -156.27 99.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.242 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.84 HD12 ' C ' ' A' ' 112' ' ' THR . 1.1 mp 59.75 -77.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.542 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 112' ' ' THR . . . 170.98 -100.07 0.15 Allowed Glycine 0 C--N 1.309 -0.925 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.173 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.535 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -93.25 129.76 39.2 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.319 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.815 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -122.47 136.37 54.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 36.5 p90 -136.44 116.74 13.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.253 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.717 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.1 t -86.38 151.19 23.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.818 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.4 pp -159.96 116.21 2.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.822 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.63 -110.47 2.8 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.713 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -132.85 83.85 2.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 1.9 mtpp 152.52 95.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.795 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.62 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 6.5 p90 -88.31 124.07 33.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.177 0.513 . . . . 0.0 110.785 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.733 HG23 ' HB3' ' A' ' 86' ' ' GLU . 17.2 m -98.37 125.85 43.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.463 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.987 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -102.05 117.23 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.009 0.909 . . . . 0.0 111.02 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.451 ' HA ' ' HB2' ' A' ' 84' ' ' LYS . 9.7 t -97.43 155.38 16.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.967 -1.469 . . . . 0.0 110.513 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.583 ' CB ' HG13 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -136.83 14.85 3.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 109.668 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.446 -0.675 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.298 -178.352 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.526 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.5 p30 . . . . . 0 CA--C 1.519 -0.212 0 CA-C-O 121.169 0.509 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.507 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -75.24 -16.91 60.43 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.779 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.12 -9.92 2.33 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.377 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.526 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.1 pp -60.48 -19.73 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 117.466 0.633 . . . . 0.0 112.087 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.507 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.14 8.81 14.39 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.015 178.357 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -136.68 -52.77 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.401 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.51 -80.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.308 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 10.76 30.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 111.18 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.33 -21.18 5.95 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.05 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -128.05 80.69 1.98 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 110.373 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.468 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 17.7 t0 -128.04 -25.42 3.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.346 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 19' ' ' ASP . 9.2 p90 47.93 74.82 0.15 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.722 0.772 . . . . 0.0 111.11 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.29 -9.65 59.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.505 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.82 11.49 22.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.81 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.117 179.791 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.814 0.34 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.8 m -88.61 148.4 24.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.789 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.747 HG13 ' HB3' ' A' ' 127' ' ' SER . 0.2 OUTLIER -93.0 103.13 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.402 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.719 ' C ' HD12 ' A' ' 40' ' ' LEU . 4.3 t -111.72 149.78 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.092 0.472 . . . . 0.0 111.423 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.719 HD12 ' C ' ' A' ' 39' ' ' VAL . 5.7 mp -155.06 105.19 2.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.397 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -113.22 127.56 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.141 0.496 . . . . 0.0 112.269 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.769 HD13 HG13 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -128.53 147.19 50.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.181 178.137 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -48.86 132.28 18.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.13 89.95 0.46 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.499 0.666 . . . . 0.0 110.683 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.441 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -126.15 170.86 11.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.515 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -51.65 -14.24 0.32 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.759 ' CG ' HD11 ' A' ' 96' ' ' LEU . 11.6 tt0 -66.72 -70.98 0.21 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.252 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.825 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.8 OUTLIER -59.15 -43.65 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 121.183 0.516 . . . . 0.0 109.727 178.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -39.6 -59.06 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.407 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.649 HG21 ' HG ' ' A' ' 95' ' ' LEU . 8.6 m -78.85 -62.02 1.83 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.064 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.891 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -43.96 -47.26 8.5 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.324 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.622 ' HA ' ' CG2' ' A' ' 55' ' ' ILE . 1.7 tp -61.55 -47.11 94.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.025 0.44 . . . . 0.0 110.34 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 pt-20 -53.85 -41.72 67.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.567 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' ' 58' ' ' THR . 1.0 OUTLIER -81.32 -66.86 0.83 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.0 0.429 . . . . 0.0 111.0 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.891 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -37.25 -58.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.829 HD12 HD12 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -75.13 -35.9 61.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -177.011 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -81.87 -46.82 13.58 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.65 -178.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.72 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 68.7 p -52.17 -70.17 0.09 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.381 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.445 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 2.5 m-20 -92.79 -32.52 14.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.933 ' CG ' HG11 ' A' ' 68' ' ' VAL . 2.4 m-85 -80.53 -6.01 57.58 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.839 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -113.96 -41.24 3.58 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.933 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.72 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.2 ttmt -57.61 -51.17 70.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.66 0.267 . . . . 0.0 111.43 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.448 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.4 OUTLIER 179.4 88.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 111.395 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.624 HG11 ' CE1' ' A' ' 60' ' ' TYR . 20.9 t -156.44 -54.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.399 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.472 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.6 m-20 169.86 149.36 0.14 Allowed Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.912 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -89.76 -20.72 1.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.192 2.595 . . . . 0.0 112.88 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.57 HG23 ' H ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -46.89 -65.52 0.55 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.211 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.933 HG11 ' CG ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -42.1 87.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.117 179.324 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.1 p30 -116.07 142.28 47.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.474 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.808 HG23 HD12 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.74 149.72 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.083 0.468 . . . . 0.0 111.029 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.711 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 17.1 mt-10 -143.35 116.05 8.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.35 114.34 26.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.905 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -101.06 -80.88 0.49 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.67 -73.36 0.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.87 0.366 . . . . 0.0 111.422 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.08 -42.15 0.19 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.518 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -83.27 164.26 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.394 . . . . 0.0 110.737 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.825 ' CD1' HG21 ' A' ' 48' ' ' ILE . 30.5 m95 -88.38 136.31 33.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.325 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.711 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 12.5 m0 -103.94 107.1 17.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.485 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.808 HD12 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -96.47 121.7 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -126.73 136.29 52.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.027 0.442 . . . . 0.0 111.654 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . . . -143.53 158.67 43.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.783 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.55 139.17 47.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.866 0.365 . . . . 0.0 111.243 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.79 -69.56 3.03 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.025 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -179.05 158.4 0.91 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.948 0.404 . . . . 0.0 111.128 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.827 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -146.03 152.23 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.368 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.714 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.7 OUTLIER -135.41 123.01 22.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 111.428 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.822 HG23 HD11 ' A' ' 125' ' ' ILE . 24.3 t -94.61 136.68 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.826 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 8.6 t70 -76.72 152.03 35.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.957 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 10.6 t -109.59 101.08 10.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.155 0.502 . . . . 0.0 109.888 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.3 m-20 160.21 -36.38 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.3 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -71.76 -71.96 0.25 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.198 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.643 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.1 tt -57.71 -56.65 14.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.475 ' H ' HG23 ' A' ' 92' ' ' ILE . 5.1 t -45.6 -35.94 4.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.655 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.436 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.2 mm-40 -60.93 -46.82 89.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.095 0.474 . . . . 0.0 110.508 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.778 HD13 ' O ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -89.88 -14.66 33.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.528 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.759 HD11 ' CG ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -103.32 10.55 37.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.439 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 140.13 67.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.673 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -32.48 135.0 0.09 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.019 0.438 . . . . 0.0 111.618 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.23 17.3 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.602 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.5 OUTLIER -70.13 -171.62 0.47 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.591 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -132.99 151.68 52.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.061 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.877 HG23 ' CD1' ' A' ' 123' ' ' PHE . 11.5 p -57.82 160.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.016 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.511 ' N ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER 79.7 9.7 1.48 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.138 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.444 ' O ' HG12 ' A' ' 107' ' ' VAL . 1.7 t70 -92.94 -23.33 18.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.958 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.504 ' CE1' ' CE2' ' A' ' 123' ' ' PHE . 1.0 OUTLIER -79.62 -37.89 35.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.134 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -105.79 29.67 6.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 108' ' ' ASP . 13.9 p -81.63 -44.49 20.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.995 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.477 ' N ' HG13 ' A' ' 107' ' ' VAL . 2.2 m-20 -179.98 88.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.481 HG21 HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -141.77 81.41 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.065 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 t 68.95 -63.59 0.36 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.978 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.652 ' O ' HG23 ' A' ' 112' ' ' THR . 1.3 m 174.05 160.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 111' ' ' SER . 2.0 p -163.91 94.8 0.77 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 113' ' ' ILE . 13.0 mm -71.35 120.03 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.231 0.538 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.94 137.2 3.45 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.032 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.1 OUTLIER -77.42 119.59 21.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.644 0.259 . . . . 0.0 110.321 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.79 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -102.56 125.46 49.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 0.0 112.014 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 13.1 p90 -128.91 121.18 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.364 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.747 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.4 t -95.96 153.56 17.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.363 0.602 . . . . 0.0 112.128 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.873 HD22 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -163.59 123.7 2.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.436 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.04 -109.88 2.85 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.121 -1.037 . . . . 0.0 111.487 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -138.37 83.95 2.0 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 2.0 mtpm? 154.29 100.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.674 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.877 ' CD1' HG23 ' A' ' 102' ' ' VAL . 1.7 p90 -88.76 137.29 32.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.972 0.415 . . . . 0.0 111.006 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.714 HG23 ' HB3' ' A' ' 86' ' ' GLU . 23.9 m -110.6 129.38 55.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.246 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.827 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -110.22 117.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.859 0.838 . . . . 0.0 110.814 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.9 t -96.52 156.46 16.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.552 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.747 ' HB3' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.46 16.92 2.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.495 0.664 . . . . 0.0 109.555 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 N--CA 1.445 -0.692 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.296 -178.827 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.573 ' HA ' HD12 ' A' ' 12' ' ' ILE . 1.6 p-10 . . . . . 0 CA--C 1.513 -0.48 0 CA-C-O 121.209 0.528 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.55 -32.21 42.13 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.833 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.44 -40.52 47.71 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.286 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.593 ' O ' ' N ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -108.27 9.85 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 120.234 -0.587 . . . . 0.0 111.764 178.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.529 ' CE ' ' HA ' ' A' ' 13' ' ' MET . 0.0 OUTLIER 59.2 -62.99 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.647 0.737 . . . . 0.0 112.344 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -166.78 25.04 0.14 Allowed Glycine 0 C--N 1.3 -1.451 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.934 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.2 mt -82.64 -81.89 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.665 0.269 . . . . 0.0 110.958 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.03 8.57 37.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.033 0.444 . . . . 0.0 111.159 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.83 -20.89 5.56 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.049 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -128.49 81.01 2.0 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.339 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.01 8.95 3.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.534 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.506 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -84.08 2.15 40.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.163 0.506 . . . . 0.0 111.04 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.65 -170.76 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.063 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 t70 62.32 14.28 6.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.163 0.506 . . . . 0.0 110.339 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.955 179.748 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.985 0.421 . . . . 0.0 110.472 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 81' ' ' ALA . 88.4 m -93.46 148.24 22.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.266 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -85.69 97.9 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.477 179.379 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.7 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.4 t -111.31 150.85 13.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.337 0.589 . . . . 0.0 112.163 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.809 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.12 119.79 3.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.764 178.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.678 ' C ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -113.46 126.51 70.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.173 0.511 . . . . 0.0 111.85 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.722 HD23 HD11 ' A' ' 48' ' ' ILE . 7.6 mp -126.76 140.43 52.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.606 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -48.45 133.06 16.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.497 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -78.32 87.62 4.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.502 0.668 . . . . 0.0 110.99 -179.244 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.481 ' C ' ' N ' ' A' ' 47' ' ' GLU . 21.8 m -126.4 170.99 11.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.887 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -14.12 0.17 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.289 0.566 . . . . 0.0 109.583 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.802 ' HG3' HD21 ' A' ' 96' ' ' LEU . 12.2 tt0 -70.12 -71.6 0.23 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.327 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.726 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.6 OUTLIER -59.18 -45.0 93.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.136 0.493 . . . . 0.0 110.073 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -38.78 -53.4 1.68 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.059 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.766 HG21 HD13 ' A' ' 95' ' ' LEU . 73.8 m -72.48 -74.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.941 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -41.23 -44.47 2.63 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.615 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -56.04 -48.08 79.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.223 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 3.0 pt-20 -52.14 -50.31 61.99 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.692 ' HA ' HG23 ' A' ' 58' ' ' THR . 6.9 mt-10 -68.76 -87.89 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.536 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.941 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.13 -62.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.882 ' HG ' HG12 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -65.6 -70.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.512 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.582 ' N ' HD13 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -64.4 -23.85 67.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.541 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.692 HG23 ' HA ' ' A' ' 54' ' ' GLU . 15.5 p -60.42 -70.95 0.15 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.337 0.589 . . . . 0.0 110.784 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -86.88 -36.72 18.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.345 -178.054 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.961 ' CE1' HG21 ' A' ' 68' ' ' VAL . 97.7 m-85 -76.66 -13.57 60.04 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.496 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -103.94 -41.02 6.0 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.198 178.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.585 ' HB2' ' O ' ' A' ' 58' ' ' THR . 3.8 ttpt -68.32 -50.07 56.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.071 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.592 ' O ' HG23 ' A' ' 64' ' ' VAL . 13.2 p-10 -177.4 87.0 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 121.379 0.609 . . . . 0.0 112.524 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.757 ' HB ' ' HA ' ' A' ' 60' ' ' TYR . 25.4 t -161.92 -54.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.495 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.564 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.6 m-20 169.48 144.38 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.4 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -86.26 -20.87 2.62 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.897 2.398 . . . . 0.0 112.485 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 65' ' ' ASN . 4.6 t -51.77 -48.74 63.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.234 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.961 HG21 ' CE1' ' A' ' 60' ' ' TYR . 54.3 t -53.56 82.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.872 0.367 . . . . 0.0 110.635 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 67' ' ' THR . 19.5 p30 -116.06 142.73 46.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.495 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.554 HG23 HG23 ' A' ' 79' ' ' ILE . 0.8 OUTLIER -96.82 153.89 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.267 0.556 . . . . 0.0 111.575 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -142.05 124.48 15.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.501 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.24 114.22 18.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.959 0.409 . . . . 0.0 110.771 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.464 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -90.49 -150.83 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.644 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.94 -49.74 76.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.673 0.273 . . . . 0.0 111.065 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.08 15.82 1.02 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.203 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.57 161.17 38.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.953 0.376 . . . . 0.0 111.081 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.726 ' CD1' HG21 ' A' ' 48' ' ' ILE . 63.4 m95 -85.44 143.37 28.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.496 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.3 m0 -116.72 105.7 12.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.634 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.809 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.52 112.22 30.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 0.0 110.155 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -112.34 135.41 53.06 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.218 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.651 ' O ' HG23 ' A' ' 37' ' ' THR . . . -144.65 158.65 43.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.015 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 67' ' ' THR . 1.3 p-10 -104.6 148.64 26.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.98 0.419 . . . . 0.0 111.298 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.94 -70.11 0.3 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.171 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.542 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 178.97 159.68 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.371 . . . . 0.0 110.935 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.837 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.6 160.3 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.799 ' HB2' HG22 ' A' ' 124' ' ' THR . 9.1 pt-20 -138.91 127.63 23.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.166 0.507 . . . . 0.0 111.636 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.695 HG13 HG13 ' A' ' 55' ' ' ILE . 27.5 t -94.52 146.2 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.533 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -88.98 152.04 21.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.043 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.603 ' HB2' HG23 ' A' ' 102' ' ' VAL . 42.7 t -109.49 101.03 10.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.234 0.54 . . . . 0.0 109.908 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 0.9 OUTLIER 161.11 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.226 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 94' ' ' GLU . 2.6 mm-40 -77.34 -69.52 0.53 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.958 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.602 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.3 tt -62.2 -56.02 20.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.314 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.488 ' H ' HG23 ' A' ' 92' ' ' ILE . 7.0 t -45.24 -32.43 1.93 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.389 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -63.5 -61.28 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.002 0.43 . . . . 0.0 110.493 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 50' ' ' THR . 0.2 OUTLIER -75.31 -17.24 60.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.909 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.802 HD21 ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -101.89 8.32 41.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.293 -179.237 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.45 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 143.04 65.93 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.562 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -33.57 133.61 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.968 0.413 . . . . 0.0 111.736 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 70.14 17.34 7.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.638 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.45 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -66.33 -175.5 0.36 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.61 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -85.5 -95.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.769 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.603 HG23 ' HB2' ' A' ' 89' ' ' CYS . 10.1 p 179.4 -35.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.682 0.277 . . . . 0.0 111.284 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.727 ' CE2' HG22 ' A' ' 118' ' ' THR . 5.0 m-85 -72.81 -2.67 21.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.079 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.534 ' O ' HG12 ' A' ' 107' ' ' VAL . 1.8 p30 -46.18 -39.44 9.69 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.874 0.369 . . . . 0.0 110.584 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.465 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -75.47 143.51 42.55 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.915 179.21 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 116' ' ' ALA . 3.7 tt 62.06 18.57 10.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.187 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 104' ' ' ASP . 7.6 p -82.8 -42.27 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.794 0.33 . . . . 0.0 111.038 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.433 ' N ' HG13 ' A' ' 107' ' ' VAL . 2.0 t70 -179.95 51.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.703 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -113.08 85.87 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.487 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.8 -65.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.151 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 109' ' ' VAL . 6.6 t 168.65 172.37 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.765 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER 179.27 120.87 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.882 0.372 . . . . 0.0 111.505 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.1 mm -87.52 122.83 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.331 0.586 . . . . 0.0 111.059 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.87 141.6 3.88 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.984 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 126' ' ' THR . 41.7 mtt-85 -77.24 120.11 21.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.667 ' HB3' HD22 ' A' ' 106' ' ' LEU . . . -105.36 123.84 48.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.162 0.506 . . . . 0.0 112.156 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.568 ' HE1' HD23 ' A' ' 119' ' ' LEU . 13.5 p90 -137.73 119.49 15.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.369 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.727 HG22 ' CE2' ' A' ' 103' ' ' TYR . 14.7 t -93.99 136.24 34.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.118 0.485 . . . . 0.0 111.85 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.595 ' O ' HD12 ' A' ' 119' ' ' LEU . 3.1 pp -135.07 118.75 17.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.76 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.73 -106.63 1.02 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.88 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.37 83.4 2.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.881 0.372 . . . . 0.0 110.118 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 3.7 mttt 152.3 97.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.592 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.641 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 15.1 p90 -88.26 126.31 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.423 . . . . 0.0 111.124 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.799 HG22 ' HB2' ' A' ' 86' ' ' GLU . 19.6 p -102.13 137.38 40.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.867 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.837 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -119.36 118.24 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.78 0.8 . . . . 0.0 111.268 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 115' ' ' ARG . 10.3 t -98.04 156.06 16.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.472 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.432 ' CB ' ' HA ' ' A' ' 38' ' ' VAL . 13.2 t -143.4 19.83 1.88 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.41 0.624 . . . . 0.0 109.489 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 N--CA 1.446 -0.644 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.019 -178.633 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.469 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.9 p30 . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 121.259 0.552 . . . . 0.0 111.511 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.513 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -74.42 -16.16 60.89 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.763 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.99 -10.98 1.89 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.308 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.507 ' C ' HD12 ' A' ' 12' ' ' ILE . 2.0 pp -58.66 -20.84 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 117.482 0.641 . . . . 0.0 112.019 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.513 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -82.05 7.53 13.08 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.972 178.233 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.786 ' O ' HD12 ' A' ' 15' ' ' LEU . . . -162.3 24.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.718 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 14' ' ' GLY . 7.2 mp -133.62 -83.09 0.46 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.66 0.266 . . . . 0.0 110.673 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.71 7.57 38.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.142 0.496 . . . . 0.0 111.017 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -119.29 -25.17 2.76 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.536 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.89 85.48 2.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.7 0.762 . . . . 0.0 110.008 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -138.65 12.77 2.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.466 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.01 13.96 5.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.856 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.99 -174.29 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.783 0.325 . . . . 0.0 110.776 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.0 t0 62.09 13.84 6.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.997 0.427 . . . . 0.0 110.84 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.23 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.705 0.288 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.0 m -90.66 142.86 27.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 0.0 111.178 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -93.97 92.75 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.858 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.43 145.26 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.363 0.602 . . . . 0.0 111.99 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.774 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.22 129.48 7.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.008 179.049 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -112.94 129.36 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.213 0.53 . . . . 0.0 111.731 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.947 HD23 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -127.24 140.3 52.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.874 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.682 ' O ' HD13 ' A' ' 48' ' ' ILE . 18.2 mttp -49.27 127.54 15.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -73.14 92.2 1.7 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.73 0.776 . . . . 0.0 110.74 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.444 ' C ' ' N ' ' A' ' 47' ' ' GLU . 6.9 m -126.2 171.12 11.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.207 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -49.95 -16.8 0.31 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.831 ' CB ' HD21 ' A' ' 96' ' ' LEU . 12.5 tt0 -65.46 -74.26 0.11 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.509 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.947 HD11 HD23 ' A' ' 42' ' ' LEU . 2.2 mp -54.7 -31.92 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.2 0.524 . . . . 0.0 109.912 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -47.5 -61.68 1.81 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.51 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.7 ' CB ' HD22 ' A' ' 95' ' ' LEU . 32.9 m -82.09 -44.78 16.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.056 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.783 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -52.52 -48.85 65.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.737 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.705 HG13 HD23 ' A' ' 56' ' ' LEU . 1.6 tp -62.53 -48.52 87.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.061 0.458 . . . . 0.0 109.964 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.697 ' O ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -50.54 -47.47 57.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.402 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.721 ' HA ' HG23 ' A' ' 58' ' ' THR . 28.7 mt-10 -77.77 -71.05 0.44 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.343 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.88 HG13 HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -30.64 -59.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.776 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.96 ' HG ' HD22 ' A' ' 57' ' ' LEU . 0.7 OUTLIER -78.91 -50.16 11.65 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.172 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.96 HD22 ' HG ' ' A' ' 56' ' ' LEU . 3.1 mm? -65.03 -48.25 74.56 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 119.312 0.96 . . . . 0.0 111.376 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.721 HG23 ' HA ' ' A' ' 54' ' ' GLU . 46.0 p -53.0 -71.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.018 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.465 ' HB3' HG23 ' A' ' 64' ' ' VAL . 9.1 m-20 -62.35 -18.17 60.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.964 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.694 ' HE1' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -51.24 -78.1 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.694 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -19.7 64.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.086 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 58' ' ' THR . 4.8 ttpp -59.73 -70.38 0.17 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.021 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.91 21.73 0.17 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.522 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 65' ' ' ASN . 43.1 t -98.38 -78.36 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.625 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.782 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.8 m-20 154.51 170.82 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.048 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 80.8 Cg_endo -88.62 -7.39 5.62 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.972 2.448 . . . . 0.0 111.955 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.782 HG22 ' HB3' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -64.62 -85.33 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.878 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -28.97 86.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.635 0.731 . . . . 0.0 111.815 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.2 p30 -115.91 143.28 45.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.563 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.555 HG23 HG23 ' A' ' 79' ' ' ILE . 1.5 p -96.27 151.0 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.321 0.581 . . . . 0.0 111.559 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 16.4 pt-20 -144.92 135.38 24.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.551 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -79.85 114.56 18.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.783 0.325 . . . . 0.0 110.434 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -85.09 -78.47 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.996 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.31 -66.73 0.68 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . -125.0 3.85 8.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.676 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.6 158.1 44.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.808 0.337 . . . . 0.0 110.823 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.652 ' CD1' HG21 ' A' ' 48' ' ' ILE . 78.2 m95 -77.29 142.99 39.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.546 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.583 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.5 m0 -114.8 109.85 18.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.356 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.774 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -100.02 116.17 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.191 0.52 . . . . 0.0 111.382 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -111.72 134.63 53.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.122 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.613 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . . . -144.43 158.76 43.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.898 0.38 . . . . 0.0 111.556 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.489 ' OD1' HG21 ' A' ' 67' ' ' THR . 1.0 OUTLIER -109.18 143.34 38.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.921 179.198 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.93 -69.05 0.62 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.483 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.53 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -177.07 152.31 0.89 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.213 0.53 . . . . 0.0 111.728 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.732 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -125.79 160.47 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.696 ' HB2' HG22 ' A' ' 124' ' ' THR . 17.2 pt-20 -147.24 125.86 12.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.499 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.88 HG13 HG13 ' A' ' 55' ' ' ILE . 38.2 t -95.48 146.9 6.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.673 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 8.9 p30 -101.54 151.82 21.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.639 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.471 ' O ' ' OD1' ' A' ' 121' ' ' ASN . 1.2 t -105.34 99.85 9.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.296 0.57 . . . . 0.0 110.186 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.1 m-20 159.75 -37.58 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.954 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -69.93 -75.82 0.11 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.635 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.637 HD12 ' CD2' ' A' ' 51' ' ' PHE . 1.6 tt -52.88 -56.42 7.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.521 ' H ' HG23 ' A' ' 92' ' ' ILE . 56.0 p -46.14 -43.3 14.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.0 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -51.14 -45.81 61.75 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 109.959 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.7 HD22 ' CB ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -91.2 -18.77 23.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.591 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.831 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.32 19.31 13.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.193 0.521 . . . . 0.0 110.746 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 98' ' ' ARG . . . 99.79 68.56 0.88 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.494 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -30.05 148.07 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.084 0.468 . . . . 0.0 111.895 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 55.3 105.59 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.412 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -175.46 -158.85 0.07 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.632 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.09 132.39 35.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.165 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.473 HG21 ' OG1' ' A' ' 118' ' ' THR . 5.9 p -81.51 -28.59 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.806 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.702 ' CE2' HG22 ' A' ' 118' ' ' THR . 4.0 m-85 -77.44 -2.82 37.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.749 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.788 ' O ' HG12 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -46.02 -35.87 5.17 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-O 120.876 0.369 . . . . 0.0 110.62 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.542 ' CE2' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -80.66 134.35 35.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.152 179.31 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.801 ' O ' HD23 ' A' ' 106' ' ' LEU . 3.9 tt 75.46 7.68 3.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.862 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.788 HG12 ' O ' ' A' ' 104' ' ' ASP . 11.4 p -86.02 -36.84 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.828 0.347 . . . . 0.0 111.255 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -178.43 48.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.616 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.676 HG21 HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -113.41 86.17 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.261 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.97 -65.78 0.21 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.942 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.528 ' C ' HG22 ' A' ' 112' ' ' THR . 5.9 t 165.44 169.81 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.524 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -179.18 133.84 0.12 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.976 0.417 . . . . 0.0 111.513 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 113' ' ' ILE . 5.0 mm -104.85 113.71 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.54 0.686 . . . . 0.0 110.94 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 152.45 146.85 4.45 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.132 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.29 127.25 32.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.64 0.257 . . . . 0.0 110.594 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.711 ' HB2' HD13 ' A' ' 106' ' ' LEU . . . -115.72 124.66 51.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.088 0.47 . . . . 0.0 111.766 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 23.6 p90 -136.92 118.95 15.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.854 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.702 HG22 ' CE2' ' A' ' 103' ' ' TYR . 11.0 t -95.35 152.66 18.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.217 0.532 . . . . 0.0 111.498 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.614 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.7 pp -148.41 116.46 6.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.893 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.06 -104.17 0.37 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.188 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.2 OUTLIER -129.61 83.97 2.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.24 0.543 . . . . 0.0 109.653 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 8.6 mttt 148.73 112.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.998 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.575 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 9.5 p90 -109.18 124.38 50.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.069 0.461 . . . . 0.0 110.817 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.696 HG22 ' HB2' ' A' ' 86' ' ' GLU . 7.3 p -100.49 141.72 32.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.643 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.818 HD11 HG23 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -120.82 117.61 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.87 0.843 . . . . 0.0 111.296 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 115' ' ' ARG . 12.8 t -103.61 155.47 18.52 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.105 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.466 ' CB ' HG13 ' A' ' 38' ' ' VAL . 30.1 t -144.41 18.96 1.71 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.301 0.572 . . . . 0.0 109.855 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 N--CA 1.447 -0.606 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.459 -178.647 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.434 ' O ' ' HE3' ' A' ' 13' ' ' MET . 1.5 m-20 . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 121.126 0.489 . . . . 0.0 112.318 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.58 -26.5 62.63 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.527 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.28 -26.22 14.52 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.731 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.472 ' CD1' ' H ' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -92.29 -26.33 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.79 0.805 . . . . 0.0 110.664 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.439 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER 28.7 46.07 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.79 -1.55 . . . . 0.0 113.34 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.472 ' H ' ' CD1' ' A' ' 12' ' ' ILE . . . -149.2 -89.41 0.08 OUTLIER Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.184 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.58 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.7 mm? -44.01 -69.61 0.13 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.738 0.304 . . . . 0.0 111.415 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.426 ' H ' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -99.61 -6.42 27.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.192 0.52 . . . . 0.0 111.642 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.16 -13.35 42.75 Favored Glycine 0 C--N 1.313 -0.723 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.704 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.45 81.55 2.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.133 0.492 . . . . 0.0 110.632 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -137.6 12.01 2.96 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.354 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.05 15.16 6.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.71 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.98 -171.69 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.849 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.71 14.22 4.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.06 0.457 . . . . 0.0 110.568 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.978 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.837 0.351 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.9 m -69.11 143.56 54.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.071 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.582 HG13 ' CB ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -87.64 98.89 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.69 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 113' ' ' ILE . 7.2 t -117.17 152.82 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.314 0.578 . . . . 0.0 111.881 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.777 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -164.53 128.09 2.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.085 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.42 130.7 65.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.251 0.548 . . . . 0.0 111.927 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.032 HD23 HD11 ' A' ' 48' ' ' ILE . 9.0 tp -128.04 140.49 51.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.816 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.665 ' O ' HD13 ' A' ' 48' ' ' ILE . 7.6 ttmm -47.17 124.53 6.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.569 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.476 ' HA ' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -71.68 90.36 1.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.501 0.667 . . . . 0.0 110.655 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.475 ' C ' ' N ' ' A' ' 47' ' ' GLU . 3.7 m -125.72 171.79 10.34 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.198 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -48.11 -17.77 0.15 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.269 0.557 . . . . 0.0 109.526 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.795 ' HA ' HD21 ' A' ' 96' ' ' LEU . 25.7 tt0 -63.23 -77.42 0.05 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.468 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.032 HD11 HD23 ' A' ' 42' ' ' LEU . 2.3 mp -54.62 -31.74 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -47.03 -60.23 2.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.276 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.604 ' CB ' HD22 ' A' ' 95' ' ' LEU . 3.9 m -84.17 -45.59 12.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.054 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.825 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -51.44 -47.64 62.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.513 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.689 HD13 HG23 ' A' ' 48' ' ' ILE . 1.5 tp -63.66 -49.04 83.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.062 0.458 . . . . 0.0 109.818 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -50.78 -45.04 58.9 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.802 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.789 ' HA ' HG23 ' A' ' 58' ' ' THR . 3.2 mt-10 -77.25 -77.19 0.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.695 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.853 HG13 HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -30.98 -55.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.689 ' N ' HG23 ' A' ' 55' ' ' ILE . 7.0 tt -71.28 -60.52 2.19 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 57' ' ' LEU . 2.6 mm? -66.85 -48.23 69.5 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.789 HG23 ' HA ' ' A' ' 54' ' ' GLU . 51.8 p -51.98 -71.82 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.062 0.458 . . . . 0.0 110.279 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.492 ' HB2' HG21 ' A' ' 64' ' ' VAL . 6.3 m-20 -60.59 -23.21 64.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.891 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.709 ' HE1' HG13 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.32 -78.0 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -67.91 -26.17 65.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.297 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.0 ttpp -52.02 -66.54 0.37 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.872 0.367 . . . . 0.0 111.281 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -169.76 30.39 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.255 0.55 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 65' ' ' ASN . 24.1 t -101.68 -78.63 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.348 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.784 ' HB3' HG22 ' A' ' 67' ' ' THR . 5.1 m-20 154.49 165.92 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 O-C-N 123.523 0.514 . . . . 0.0 110.946 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.464 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 94.7 Cg_endo -86.19 -3.54 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.79 2.327 . . . . 0.0 111.922 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.784 HG22 ' HB3' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -68.82 -86.75 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.44 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.709 HG13 ' HE1' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -24.29 89.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.559 0.695 . . . . 0.0 111.895 -179.405 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -116.04 143.1 45.92 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.04 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.538 HG23 HG23 ' A' ' 79' ' ' ILE . 1.5 p -96.73 153.06 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.146 0.498 . . . . 0.0 111.547 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.512 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 27.6 tt0 -143.83 133.09 23.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.991 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.65 114.37 21.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.295 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -94.3 -81.67 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.318 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.42 -69.21 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.835 0.35 . . . . 0.0 111.354 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . -126.55 5.45 7.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.034 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.66 153.91 43.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 110.889 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.641 ' CD1' HG21 ' A' ' 48' ' ' ILE . 82.7 m95 -76.83 143.07 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.62 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.512 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.3 m0 -111.3 105.03 13.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.339 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.777 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.81 110.56 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.028 0.442 . . . . 0.0 110.824 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -112.13 135.71 52.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.066 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.657 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . . . -144.09 156.9 44.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.417 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.423 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 0.5 OUTLIER -109.07 128.93 55.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.449 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.04 -67.67 3.12 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.327 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.61 152.38 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.252 0.548 . . . . 0.0 111.619 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.74 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -127.08 160.21 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.745 ' HB3' HG23 ' A' ' 124' ' ' THR . 2.3 pt-20 -149.39 125.69 10.81 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.547 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.853 HG13 HG13 ' A' ' 55' ' ' ILE . 62.1 t -95.3 146.48 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.476 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 122' ' ' LYS . 6.7 t70 -95.72 151.41 19.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.408 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.491 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 7.6 t -104.01 100.02 9.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.111 0.482 . . . . 0.0 110.082 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.2 m-20 157.7 -36.43 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.337 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 94' ' ' GLU . 0.9 OUTLIER -69.88 -76.41 0.1 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.543 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.573 HD12 ' CD2' ' A' ' 51' ' ' PHE . 2.8 tt -54.05 -56.5 9.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.357 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.512 ' H ' HG23 ' A' ' 92' ' ' ILE . 16.9 p -47.58 -36.05 10.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.876 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.45 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -57.83 -46.21 85.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.109 0.481 . . . . 0.0 110.053 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.604 HD22 ' CB ' ' A' ' 50' ' ' THR . 0.7 OUTLIER -90.5 -18.46 25.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.626 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.795 HD21 ' HA ' ' A' ' 47' ' ' GLU . 1.1 mm? -98.67 14.03 30.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.054 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.6 68.09 0.37 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.063 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -33.07 149.86 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.088 0.47 . . . . 0.0 111.97 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.63 17.99 9.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.324 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -165.36 0.4 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.939 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -96.0 -162.76 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.933 HG23 ' CD1' ' A' ' 123' ' ' PHE . 1.5 p -117.44 -32.07 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.084 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -81.58 5.77 17.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.579 0.228 . . . . 0.0 111.474 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 107' ' ' VAL . 11.6 t70 -60.6 -39.32 87.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.651 0.262 . . . . 0.0 110.811 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.528 ' HE2' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -66.87 -14.03 62.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.13 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -143.01 35.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.786 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 104' ' ' ASP . 10.8 p -87.18 -32.94 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.112 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -176.85 38.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.407 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.605 HG21 HG23 ' A' ' 112' ' ' THR . 25.6 m -69.56 165.81 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.644 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.9 m -54.51 -46.79 73.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.004 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.3 140.85 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.605 HG23 HG21 ' A' ' 109' ' ' VAL . 1.4 p -149.75 75.35 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.504 HD13 ' HA ' ' A' ' 113' ' ' ILE . 4.9 mm -58.99 106.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.48 0.657 . . . . 0.0 111.007 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.56 144.98 4.26 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.878 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 126' ' ' THR . 19.6 mtm180 -76.55 125.8 29.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.801 0.334 . . . . 0.0 110.736 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.68 ' HB2' HD13 ' A' ' 106' ' ' LEU . . . -104.04 125.28 50.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.965 0.412 . . . . 0.0 111.658 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 13.9 p90 -133.91 120.58 20.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.772 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.849 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.5 t -97.11 158.45 15.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.237 0.541 . . . . 0.0 111.929 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 119' ' ' LEU . 3.0 pp -157.42 118.06 3.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.793 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.8 -106.35 0.86 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.817 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -132.55 83.85 2.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.5 OUTLIER 152.37 110.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.191 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.933 ' CD1' HG23 ' A' ' 102' ' ' VAL . 2.1 p90 -101.6 132.33 47.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.236 0.541 . . . . 0.0 111.132 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.745 HG23 ' HB3' ' A' ' 86' ' ' GLU . 30.4 m -106.98 134.43 50.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.747 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.763 ' H ' HD12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -117.32 117.45 55.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.711 0.767 . . . . 0.0 111.011 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.9 t -109.57 155.16 21.76 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.943 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.582 ' CB ' HG13 ' A' ' 38' ' ' VAL . 28.8 t -142.63 21.97 1.99 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.354 0.597 . . . . 0.0 109.705 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.446 -0.674 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.106 -178.806 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.555 ' HA ' HG12 ' A' ' 12' ' ' ILE . 28.8 m-20 . . . . . 0 CA--C 1.519 -0.222 0 CA-C-O 121.135 0.493 . . . . 0.0 111.666 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.37 -22.52 54.73 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.625 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.29 -7.63 5.78 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.266 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.555 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.2 pp -61.33 -18.64 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 117.567 0.683 . . . . 0.0 111.793 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.423 ' HE2' ' H ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -84.19 9.33 13.07 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.91 178.187 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.99 -46.92 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.319 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -74.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.68 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -101.83 11.42 38.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.095 0.474 . . . . 0.0 111.161 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -112.55 -16.08 9.05 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.081 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.03 80.71 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.026 0.441 . . . . 0.0 110.531 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -142.67 7.61 1.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.669 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.84 18.19 7.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.812 0.339 . . . . 0.0 111.426 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.46 -174.26 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.908 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.2 t0 62.42 12.95 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.101 0.477 . . . . 0.0 110.912 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.961 179.728 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.664 0.268 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.5 m -120.47 144.56 47.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.859 0.362 . . . . 0.0 111.007 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.677 HG11 HG23 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -101.45 106.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.498 179.389 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 113' ' ' ILE . 12.4 t -121.47 150.32 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 121.42 0.629 . . . . 0.0 112.252 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.77 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -164.78 130.96 2.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.865 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 111' ' ' SER . 0.0 OUTLIER -112.65 128.92 69.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.262 0.553 . . . . 0.0 111.863 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.931 ' HG ' HG11 ' A' ' 109' ' ' VAL . 0.5 OUTLIER -128.18 148.4 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.356 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.61 153.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.852 0.358 . . . . 0.0 111.381 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.444 ' HA ' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -90.7 22.35 3.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.599 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.449 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -71.52 171.64 11.0 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.068 -178.544 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -49.39 -14.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.57 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.982 ' HG3' HD21 ' A' ' 96' ' ' LEU . 1.4 tt0 -63.82 -76.82 0.06 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.989 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -55.96 -44.31 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.365 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -39.65 -58.61 1.28 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.907 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.878 ' HB ' HD11 ' A' ' 95' ' ' LEU . 27.5 m -84.16 -56.47 3.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.892 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.916 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -47.15 -50.42 20.47 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.547 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.8 tp -59.43 -48.2 88.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.818 0.342 . . . . 0.0 110.179 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.788 ' O ' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -50.51 -52.38 39.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.339 0.59 . . . . 0.0 109.604 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.751 ' HA ' HG23 ' A' ' 58' ' ' THR . 13.2 mm-40 -69.05 -81.18 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.649 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.916 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -23.27 -58.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.74 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.5 mp -73.25 -66.2 0.71 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.788 HD22 ' O ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -62.94 -33.33 75.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.751 HG23 ' HA ' ' A' ' 54' ' ' GLU . 70.0 p -60.89 -67.7 0.38 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.267 0.556 . . . . 0.0 110.905 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.614 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 0.1 OUTLIER -85.69 -42.81 13.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.805 ' CG ' HG11 ' A' ' 68' ' ' VAL . 52.0 m-85 -69.94 -24.28 63.33 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -92.59 -50.99 5.33 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.722 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.0 ttmt -60.81 -41.37 95.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.422 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.71 ' O ' HG23 ' A' ' 64' ' ' VAL . 8.5 p-10 179.72 104.0 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.888 0.375 . . . . 0.0 111.698 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER 177.85 -53.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.138 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.517 ' N ' HG12 ' A' ' 64' ' ' VAL . 4.3 m-20 -179.53 143.07 0.38 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 111.876 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.04 -4.0 10.4 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.742 2.295 . . . . 0.0 111.858 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.552 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -83.52 -108.17 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.533 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.805 HG11 ' CG ' ' A' ' 60' ' ' TYR . 9.5 p 27.01 49.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.296 0.57 . . . . 0.0 111.657 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -82.25 137.72 34.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.124 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -98.06 154.0 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.228 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 2.4 mm-40 -142.23 120.12 11.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.059 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -78.85 114.0 17.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.418 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.447 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 2.2 tpt180 -98.08 -145.28 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.914 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.73 -19.9 44.33 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 120.605 0.24 . . . . 0.0 111.436 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.26 -50.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.593 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.49 156.14 29.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.381 . . . . 0.0 110.738 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.989 ' CD1' HG21 ' A' ' 48' ' ' ILE . 38.3 m95 -81.84 143.69 31.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.391 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.467 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 9.4 m0 -108.84 107.16 17.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.383 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.77 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.2 109.55 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.1 0.476 . . . . 0.0 110.051 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -118.35 141.7 48.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.184 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB3' HG22 ' A' ' 85' ' ' ILE . . . -143.38 157.95 44.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.52 120.85 40.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.953 0.406 . . . . 0.0 111.595 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.07 -65.46 1.93 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.085 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.596 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -178.53 155.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 0.0 110.769 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.783 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -133.3 156.81 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.689 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.823 ' HB2' HG22 ' A' ' 124' ' ' THR . 3.3 pt-20 -144.79 123.69 12.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.212 0.53 . . . . 0.0 111.664 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.758 HG23 HD11 ' A' ' 125' ' ' ILE . 28.8 t -94.3 146.28 6.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.553 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 0.8 OUTLIER -89.93 152.03 21.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.329 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 41.4 t -114.48 101.12 8.83 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 7.7 t0 161.55 -28.69 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.436 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -86.58 -69.11 0.7 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.649 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.819 HD12 ' CD2' ' A' ' 51' ' ' PHE . 0.9 OUTLIER -52.8 -80.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.494 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.607 ' N ' HG12 ' A' ' 92' ' ' ILE . 6.5 p -19.94 -55.68 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 76.5 mm-40 -54.79 -47.15 74.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 0.0 111.799 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.878 HD11 ' HB ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -89.96 -28.81 18.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.895 -178.703 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.982 HD21 ' HG3' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -56.9 -19.93 20.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.99 -44.98 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.01 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER 171.11 -171.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -58.81 100.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.055 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CB ' ' HB2' ' A' ' 93' ' ' SER . 0.1 OUTLIER -114.77 -165.7 1.04 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.98 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.65 -173.87 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 0.0 111.045 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.8 HG21 ' OG1' ' A' ' 118' ' ' THR . 4.3 p -83.89 173.37 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.944 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.642 ' H ' HG22 ' A' ' 102' ' ' VAL . 0.5 OUTLIER 69.91 9.77 7.23 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.697 -179.044 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.586 ' O ' HG12 ' A' ' 107' ' ' VAL . 8.7 p-10 -80.14 -35.0 37.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.291 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.582 ' CE1' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -63.57 -52.97 58.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.703 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -97.93 31.78 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.986 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 104' ' ' ASP . 14.5 p -72.91 -44.76 57.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.069 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.489 ' N ' HG13 ' A' ' 107' ' ' VAL . 0.4 OUTLIER 173.76 96.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.818 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.931 HG11 ' HG ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -134.38 -171.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.96 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.1 OUTLIER -47.84 -40.28 20.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.909 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.5 ' HB3' HG23 ' A' ' 41' ' ' VAL . 2.2 t 171.83 157.54 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.817 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 63.0 p -156.51 75.95 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.119 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 113' ' ' ILE . 6.2 mm -59.95 108.17 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.386 0.612 . . . . 0.0 111.084 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.43 141.91 3.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.011 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 126' ' ' THR . 34.9 mtm105 -77.05 120.21 21.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.657 0.265 . . . . 0.0 110.409 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.734 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -104.54 126.41 51.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.096 0.475 . . . . 0.0 112.263 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.457 ' HE1' HD23 ' A' ' 119' ' ' LEU . 5.7 p90 -136.14 125.39 24.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.603 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.8 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.5 t -91.21 159.11 16.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.185 0.517 . . . . 0.0 111.961 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.5 pp -161.25 116.82 2.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.916 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.78 -109.13 1.85 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.689 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -129.1 83.1 2.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 11.5 mttt 151.34 120.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.525 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.68 ' CD1' HG23 ' A' ' 102' ' ' VAL . 1.3 p90 -108.45 135.5 49.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.845 0.355 . . . . 0.0 110.528 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.823 HG22 ' HB2' ' A' ' 86' ' ' GLU . 19.3 p -109.81 134.65 51.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.685 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.783 HD13 ' CD1' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -114.95 117.48 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.839 0.828 . . . . 0.0 110.6 178.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 115' ' ' ARG . 10.7 t -99.51 156.74 16.88 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.651 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.442 ' HB2' HG13 ' A' ' 38' ' ' VAL . 2.7 m -142.71 20.88 2.0 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.335 0.588 . . . . 0.0 109.653 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 N--CA 1.446 -0.666 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.986 -178.573 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.461 ' HA ' HG12 ' A' ' 12' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.544 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -73.32 -16.27 61.37 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.404 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.76 -1.56 3.34 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.322 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.521 ' C ' HD12 ' A' ' 12' ' ' ILE . 2.0 pp -67.97 -15.94 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-O 121.424 0.631 . . . . 0.0 111.912 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.544 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.49 9.12 14.28 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.916 178.203 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.23 -48.69 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.678 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -79.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 110.902 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -93.06 11.3 28.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.032 0.444 . . . . 0.0 111.242 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.96 -20.94 5.5 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.233 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -129.52 80.63 1.97 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.023 0.44 . . . . 0.0 110.623 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -145.52 9.76 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.738 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.28 17.28 10.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.893 0.377 . . . . 0.0 111.224 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.0 -9.49 58.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.673 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.3 11.3 24.04 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.865 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 1.2 tm0? . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.965 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.832 0.349 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.402 ' C ' ' HG ' ' A' ' 127' ' ' SER . 15.9 m -85.75 155.8 20.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.115 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.745 HG13 ' HB3' ' A' ' 127' ' ' SER . 0.2 OUTLIER -110.9 107.18 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.59 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.572 HG22 ' HG2' ' A' ' 80' ' ' LYS . 11.6 t -119.48 152.45 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.401 0.62 . . . . 0.0 112.108 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.769 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -165.55 128.69 2.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.968 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.542 HG23 ' OG ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -112.07 132.43 60.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.337 0.589 . . . . 0.0 111.739 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.098 HD23 HD11 ' A' ' 48' ' ' ILE . 1.1 tp -127.96 140.17 52.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.513 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -48.88 128.44 15.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.426 0.155 . . . . 0.0 110.761 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.487 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -78.72 86.94 4.64 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.545 0.688 . . . . 0.0 110.441 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.46 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -126.03 171.41 10.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.403 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.35 -14.35 0.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.201 0.524 . . . . 0.0 109.739 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.679 ' HG3' HD21 ' A' ' 96' ' ' LEU . 2.6 tt0 -72.53 -63.83 1.08 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.088 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.098 HD11 HD23 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -61.66 -44.92 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.169 0.509 . . . . 0.0 110.139 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -42.44 -55.89 3.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.588 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.815 HG21 ' HG ' ' A' ' 95' ' ' LEU . 75.8 m -67.0 -77.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.967 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -39.7 -55.15 1.96 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.102 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.57 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.5 tp -45.81 -45.7 5.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.076 0.465 . . . . 0.0 109.839 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.631 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.4 pt-20 -57.12 -40.54 77.28 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.743 ' HA ' HG23 ' A' ' 58' ' ' THR . 2.9 mp0 -81.75 -91.8 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.547 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.967 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.78 -54.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.879 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -72.71 -42.53 64.09 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.631 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -83.14 -45.93 13.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.279 0.561 . . . . 0.0 110.696 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.743 HG23 ' HA ' ' A' ' 54' ' ' GLU . 69.5 p -53.61 -70.47 0.09 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.993 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.591 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 5.4 m-20 -89.66 -30.43 18.11 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.879 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 32.0 m-85 -80.15 -24.67 40.26 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.524 1.056 . . . . 0.0 111.566 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 2.2 tptt -90.39 -47.66 7.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.052 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.641 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -56.08 -47.46 77.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.752 0.31 . . . . 0.0 111.226 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.703 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -179.52 102.2 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.983 0.42 . . . . 0.0 111.282 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -179.92 -57.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.718 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.574 ' N ' HG12 ' A' ' 64' ' ' VAL . 4.0 m-80 178.65 127.8 0.21 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.608 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -85.21 -17.33 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.658 2.239 . . . . 0.0 111.908 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ASN . 1.8 t -57.41 -49.91 74.69 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.561 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.827 HG11 ' CD1' ' A' ' 60' ' ' TYR . 2.9 p -42.73 87.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.09 0.472 . . . . 0.0 111.194 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.2 p30 -115.25 142.57 46.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.303 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.44 HG23 HG23 ' A' ' 79' ' ' ILE . 0.7 OUTLIER -96.97 153.2 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 121.187 0.518 . . . . 0.0 111.622 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -142.9 123.34 13.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.121 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -79.86 114.35 18.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.295 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -93.73 -71.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.368 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.09 -69.94 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.128 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.24 4.55 9.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.814 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.48 149.78 39.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.834 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.835 ' CD1' HG21 ' A' ' 48' ' ' ILE . 74.9 m95 -77.45 142.72 39.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.571 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.564 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.7 m0 -107.67 106.63 17.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.27 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.769 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.19 110.87 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 0.0 110.142 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.572 ' HG2' HG22 ' A' ' 39' ' ' VAL . 5.0 mtpt -116.51 135.52 53.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.046 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.56 ' HB3' ' CG2' ' A' ' 85' ' ' ILE . . . -144.46 159.26 43.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.793 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -96.8 148.32 23.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.959 0.409 . . . . 0.0 111.352 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.87 -69.73 0.42 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.343 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.729 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -179.58 161.46 1.03 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.913 0.387 . . . . 0.0 110.883 -179.377 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.812 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -141.08 155.77 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.801 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.7 ' HB3' HG23 ' A' ' 124' ' ' THR . 13.2 pt-20 -140.31 124.01 17.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.018 0.437 . . . . 0.0 111.481 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.882 HG13 HG13 ' A' ' 55' ' ' ILE . 24.8 t -93.67 143.86 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.581 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 6.3 t70 -88.25 151.73 22.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.012 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 54.0 t -111.78 100.51 8.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.047 0.451 . . . . 0.0 109.86 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 3.1 t70 162.41 -36.14 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.932 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.24 -68.05 0.56 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.984 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.574 ' HB ' ' CD2' ' A' ' 51' ' ' PHE . 1.6 tt -59.32 -55.67 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.591 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.501 ' H ' HG23 ' A' ' 92' ' ' ILE . 19.9 p -48.81 -32.92 9.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.599 0.238 . . . . 0.0 111.628 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.2 mm-40 -62.55 -47.64 82.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.754 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.861 HD13 ' O ' ' A' ' 95' ' ' LEU . 2.3 tm? -90.05 -17.21 28.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.703 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.679 HD21 ' HG3' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.26 8.35 44.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.832 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 131.23 70.08 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.177 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -31.23 147.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.059 0.457 . . . . 0.0 111.836 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 64.21 18.22 11.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.082 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -71.87 -167.14 0.26 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.086 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -100.79 -164.08 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.664 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.901 HG23 ' CD1' ' A' ' 123' ' ' PHE . 1.5 p -113.15 -33.56 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.041 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.513 ' CZ ' HG22 ' A' ' 118' ' ' THR . 20.3 m-85 -80.1 5.59 13.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.327 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.459 ' O ' HG12 ' A' ' 107' ' ' VAL . 25.1 p-10 -59.4 -41.74 90.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.647 0.26 . . . . 0.0 110.968 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.542 ' HE2' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -60.73 -28.11 68.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.774 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.542 HD13 ' OG1' ' A' ' 112' ' ' THR . 3.1 tp -131.5 40.6 3.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.028 0.442 . . . . 0.0 110.938 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 104' ' ' ASP . 14.9 p -87.19 -36.29 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 178.65 69.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.486 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.604 HG11 ' HG ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -113.26 179.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.062 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.517 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.9 OUTLIER -46.54 -43.84 17.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.067 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.542 ' OG ' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER 170.68 165.25 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.982 0.42 . . . . 0.0 111.301 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 42.4 p -159.08 80.67 0.77 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.85 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 113' ' ' ILE . 5.1 mm -58.95 105.09 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.49 0.662 . . . . 0.0 111.286 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' A' ' 126' ' ' THR . . . 144.34 144.72 4.23 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.965 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.75 120.04 21.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.58 0.229 . . . . 0.0 110.493 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -99.81 125.31 45.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.97 0.414 . . . . 0.0 112.037 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 1.7 p90 -131.45 122.36 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.361 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.81 ' OG1' HG21 ' A' ' 102' ' ' VAL . 15.2 t -103.33 158.9 16.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 111.882 -178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.617 ' O ' HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -167.78 134.32 2.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.356 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.45 -109.89 1.58 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.674 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.43 83.73 2.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.712 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 7.3 mttt 153.39 122.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.503 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.901 ' CD1' HG23 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -107.93 139.55 42.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.933 0.396 . . . . 0.0 110.444 179.214 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.7 HG23 ' HB3' ' A' ' 86' ' ' GLU . 37.6 m -114.24 130.04 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.44 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.812 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -112.31 117.78 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.794 0.806 . . . . 0.0 110.74 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.4 t -98.31 156.34 16.77 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.504 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.745 ' HB3' HG13 ' A' ' 38' ' ' VAL . 71.7 p -150.0 30.96 0.7 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.562 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.899 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.483 ' HA ' HG12 ' A' ' 12' ' ' ILE . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.125 0 CA-C-O 121.064 0.459 . . . . 0.0 111.484 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.471 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -79.52 -17.23 54.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.413 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.66 -8.55 3.1 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.169 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.483 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.2 pp -60.52 -20.07 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 117.527 0.663 . . . . 0.0 111.871 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.471 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.76 8.64 16.49 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.742 177.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 18' ' ' LYS . . . -131.91 -34.37 0.39 Allowed Glycine 0 CA--C 1.518 0.268 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.477 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mp -77.15 -80.24 0.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.745 0.307 . . . . 0.0 111.002 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.48 9.94 29.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.967 0.413 . . . . 0.0 111.535 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.95 -27.14 2.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.948 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 1.4 tmtt? -130.14 85.29 2.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.719 0.771 . . . . 0.0 110.242 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -134.83 8.14 3.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.683 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 62.59 18.24 10.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.842 0.354 . . . . 0.0 111.384 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.29 -177.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.4 t0 63.87 12.0 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.79 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.943 179.845 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.882 0.373 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 81' ' ' ALA . 30.4 m -75.23 146.36 41.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.831 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -90.58 102.36 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.103 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.823 ' C ' HD12 ' A' ' 40' ' ' LEU . 2.9 t -107.9 139.42 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.115 0.483 . . . . 0.0 111.543 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.823 HD12 ' C ' ' A' ' 39' ' ' VAL . 8.9 mp -136.42 104.27 5.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.036 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.62 127.03 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.363 0.602 . . . . 0.0 111.961 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.647 HD13 HD11 ' A' ' 48' ' ' ILE . 4.5 mt -127.67 145.41 50.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.746 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.0 119.99 4.9 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.488 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.77 91.08 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.427 0.632 . . . . 0.0 110.888 -178.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.445 ' C ' ' H ' ' A' ' 47' ' ' GLU . 50.0 m -125.93 170.3 11.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.451 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -53.65 -11.79 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.142 0.496 . . . . 0.0 109.793 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.655 ' HB2' HD11 ' A' ' 96' ' ' LEU . 1.9 tt0 -75.11 -65.47 0.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.492 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.695 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.4 OUTLIER -58.27 -44.47 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.3 0.571 . . . . 0.0 109.67 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -43.87 -53.72 5.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.345 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.528 HG21 ' CD1' ' A' ' 95' ' ' LEU . 25.9 m -79.93 -64.96 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.196 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.923 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -45.07 -46.9 11.83 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.372 -178.809 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.4 tp -61.44 -48.48 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.163 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -50.76 -38.99 51.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.048 0.451 . . . . 0.0 109.822 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.708 ' CA ' HG23 ' A' ' 58' ' ' THR . 2.8 mt-10 -82.89 -87.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.781 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.923 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.9 -56.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 179.472 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.0 ' HG ' HG12 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -72.98 -42.53 63.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.822 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.74 -46.35 13.27 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.623 -179.103 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.708 HG23 ' CA ' ' A' ' 54' ' ' GLU . 51.4 p -49.24 -72.61 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.57 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.442 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 0.9 OUTLIER -94.05 -25.92 16.99 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -177.404 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 1.006 ' CD2' HG11 ' A' ' 68' ' ' VAL . 7.7 m-85 -87.41 -1.37 57.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 119.306 -0.957 . . . . 0.0 112.737 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.584 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 2.5 tptt -118.06 -41.59 2.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.683 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.66 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.9 OUTLIER -58.91 -51.66 69.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.263 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.593 ' O ' HG23 ' A' ' 64' ' ' VAL . 22.3 p-10 -178.93 90.21 0.02 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.39 0.614 . . . . 0.0 112.012 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 63' ' ' ASN . 24.6 t -161.77 -53.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.505 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.491 ' HB3' HG22 ' A' ' 67' ' ' THR . 5.0 m-20 177.62 141.67 0.25 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.396 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.48 -23.34 2.82 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.77 2.314 . . . . 0.0 112.152 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.491 HG22 ' HB3' ' A' ' 65' ' ' ASN . 9.6 t -55.19 -38.44 68.38 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.302 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.006 HG11 ' CD2' ' A' ' 60' ' ' TYR . 82.2 t -61.9 74.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.64 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 67' ' ' THR . 16.0 p30 -116.0 142.29 46.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.973 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.544 HG23 HD12 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.54 149.38 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.389 0.614 . . . . 0.0 111.682 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.663 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.2 OUTLIER -143.75 123.53 13.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.573 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -88.44 114.84 25.47 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.107 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.407 ' NH1' ' CZ3' ' A' ' 78' ' ' TRP . 11.6 tpt180 -99.86 -100.04 0.24 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.618 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.31 -78.66 0.1 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.844 0.354 . . . . 0.0 111.27 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.68 -40.04 0.34 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.3 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.85 158.85 19.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.787 0.327 . . . . 0.0 110.545 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.695 ' CD1' HG21 ' A' ' 48' ' ' ILE . 75.4 m95 -77.43 126.32 30.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.527 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.663 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.7 m0 -96.69 109.97 22.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.289 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.702 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -96.52 136.68 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.086 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -129.11 135.72 49.26 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.021 0.438 . . . . 0.0 112.153 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.831 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . . . -144.5 158.48 43.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.756 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.406 ' N ' ' OG1' ' A' ' 67' ' ' THR . 0.4 OUTLIER -115.06 127.39 55.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.95 0.405 . . . . 0.0 111.251 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 84.25 -68.31 3.54 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.902 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER 178.42 160.71 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.014 0.435 . . . . 0.0 111.347 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.907 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -151.53 160.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.436 179.128 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.726 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.3 OUTLIER -136.09 125.22 24.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.165 0.507 . . . . 0.0 111.693 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.604 HG23 HD11 ' A' ' 125' ' ' ILE . 99.6 t -92.31 144.65 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.524 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.43 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 5.7 m-20 -87.95 152.64 21.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.441 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 51.9 t -112.16 100.55 8.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.157 0.503 . . . . 0.0 109.743 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 10.0 t70 165.21 -36.51 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.773 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 94' ' ' GLU . 7.4 mt-10 -74.96 -69.31 0.48 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.59 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.549 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 0.7 OUTLIER -63.99 -54.51 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.671 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.475 ' H ' HG23 ' A' ' 92' ' ' ILE . 18.3 p -44.12 -30.69 0.8 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.133 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 3.2 mm-40 -68.51 -71.54 0.21 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.125 0.488 . . . . 0.0 110.235 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.528 ' CD1' HG21 ' A' ' 50' ' ' THR . 0.3 OUTLIER -62.31 -19.94 63.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.134 -179.625 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -98.06 -1.76 41.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.58 0.229 . . . . 0.0 111.395 -179.461 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.463 ' HA3' ' CD2' ' A' ' 100' ' ' PHE . . . 152.56 66.03 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.87 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -28.02 137.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.782 0.433 . . . . 0.0 112.123 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 64.17 19.66 11.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.541 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.463 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -58.55 -162.9 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.107 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -105.58 -85.74 0.48 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.998 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.848 HG21 ' OG1' ' A' ' 118' ' ' THR . 2.0 p 179.54 -54.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.667 0.27 . . . . 0.0 111.554 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.451 ' H ' HG13 ' A' ' 102' ' ' VAL . 6.8 m-85 -64.98 -13.24 57.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.652 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -47.36 -29.98 2.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.598 0.237 . . . . 0.0 111.469 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.622 ' O ' HG11 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -71.19 -30.09 65.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.034 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.661 HD22 ' HB3' ' A' ' 116' ' ' ALA . 0.9 OUTLIER -134.71 42.28 2.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.969 0.414 . . . . 0.0 110.92 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 108' ' ' ASP . 12.1 p -83.19 -45.67 18.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.119 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.487 ' N ' HG13 ' A' ' 107' ' ' VAL . 6.1 m-20 -160.05 31.0 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.622 HG11 ' O ' ' A' ' 105' ' ' PHE . 34.7 m -59.49 165.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.578 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.55 -46.27 66.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.023 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.741 ' O ' HG23 ' A' ' 112' ' ' THR . 0.5 OUTLIER -174.59 163.37 3.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.741 HG23 ' O ' ' A' ' 111' ' ' SER . 0.5 OUTLIER -177.18 85.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.138 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 113' ' ' ILE . 7.4 mm -60.45 113.45 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.359 0.599 . . . . 0.0 110.779 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.73 140.93 3.79 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.702 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.817 ' HB3' HG22 ' A' ' 126' ' ' THR . 26.3 ttp180 -79.65 119.62 22.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.622 0.249 . . . . 0.0 110.715 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.672 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -101.28 125.29 47.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.015 0.436 . . . . 0.0 111.776 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 30.9 p90 -132.71 116.55 16.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.521 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.848 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.8 t -83.03 163.17 21.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.313 0.577 . . . . 0.0 111.992 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.4 pp -170.16 115.57 0.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.578 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.64 -107.1 1.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.571 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.26 83.66 2.04 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.905 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER 152.04 109.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.598 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.706 ' CD1' HG23 ' A' ' 102' ' ' VAL . 1.1 p90 -95.16 139.74 31.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.873 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.726 HG23 ' HB3' ' A' ' 86' ' ' GLU . 45.1 m -111.31 127.18 55.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.359 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.907 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -108.6 118.14 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.857 0.837 . . . . 0.0 110.737 178.898 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.817 HG22 ' HB3' ' A' ' 115' ' ' ARG . 2.6 t -96.82 155.8 16.62 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.728 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.775 ' HB2' HG13 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -149.07 23.74 0.94 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.267 0.556 . . . . 0.0 109.615 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.447 -0.578 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.316 -178.374 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.5 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.3 m-20 . . . . . 0 CA--C 1.52 -0.188 0 CA-C-O 121.149 0.5 . . . . 0.0 111.566 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.463 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -79.17 -18.65 52.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.443 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.31 -9.42 2.98 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.232 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.5 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.2 pp -59.06 -20.78 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 117.637 0.719 . . . . 0.0 111.883 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.463 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -85.76 9.33 16.78 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.915 178.118 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.402 ' HA2' ' CB ' ' A' ' 18' ' ' LYS . . . -142.81 -50.52 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.623 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.55 -77.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.752 0.311 . . . . 0.0 111.056 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.22 10.73 28.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.021 0.439 . . . . 0.0 111.397 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.68 -22.47 4.33 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.134 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.402 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -128.85 80.74 1.99 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.12 0.486 . . . . 0.0 110.408 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -138.02 9.06 2.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.61 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 63.3 18.51 11.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.359 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.34 -178.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t70 63.58 13.03 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.12 0.485 . . . . 0.0 110.617 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.214 179.992 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.885 0.374 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.0 m -115.79 141.76 47.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.759 HG13 ' HB3' ' A' ' 127' ' ' SER . 0.2 OUTLIER -88.88 93.75 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.992 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.727 HG22 ' HG2' ' A' ' 80' ' ' LYS . 3.7 t -105.67 147.54 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.225 0.536 . . . . 0.0 111.854 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.83 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.64 120.59 3.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.884 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.54 130.29 67.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.339 0.59 . . . . 0.0 112.116 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.982 HD22 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -127.05 139.86 52.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.429 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -54.29 132.03 42.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.484 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -61.88 89.22 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.505 0.669 . . . . 0.0 109.975 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 47' ' ' GLU . 14.8 m -125.86 170.62 11.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.905 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -52.77 -11.75 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 109.931 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.835 ' CB ' HD21 ' A' ' 96' ' ' LEU . 3.6 tt0 -69.33 -75.5 0.11 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.245 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.982 HD11 HD22 ' A' ' 42' ' ' LEU . 3.8 mm -53.81 -39.87 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 24.4 m120 -43.48 -57.74 2.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.376 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.75 ' CB ' HD22 ' A' ' 95' ' ' LEU . 53.5 m -85.73 -57.63 2.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.605 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.933 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -47.23 -45.53 23.58 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.766 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.666 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.3 tp -65.56 -49.23 79.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.863 0.363 . . . . 0.0 110.272 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.3 pt-20 -53.41 -40.55 65.2 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.098 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.714 ' O ' HG23 ' A' ' 58' ' ' THR . 23.7 mm-40 -80.37 -70.08 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.942 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.933 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -37.86 -59.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.724 ' N ' HG23 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -72.52 -36.61 68.38 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.69 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -84.0 -46.81 11.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.517 -0.739 . . . . 0.0 110.916 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.715 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 71.6 p -50.0 -70.86 0.08 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.223 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 7.3 m-20 -94.35 -29.3 15.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.953 ' CG ' HG11 ' A' ' 68' ' ' VAL . 2.3 m-85 -83.83 -1.61 54.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.534 -0.867 . . . . 0.0 112.711 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.598 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -118.87 -40.41 2.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.785 178.518 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.715 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -58.23 -50.2 74.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.707 0.289 . . . . 0.0 111.289 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.527 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.4 OUTLIER 179.57 89.29 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.212 0.53 . . . . 0.0 111.276 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.622 HG11 ' CE1' ' A' ' 60' ' ' TYR . 9.7 t -158.94 -58.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.54 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.481 ' HB3' HG22 ' A' ' 67' ' ' THR . 3.8 m-20 174.25 145.92 0.21 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.894 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -89.14 -19.36 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.046 2.497 . . . . 0.0 112.462 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.15 -64.26 0.83 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.321 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.953 HG11 ' CG ' ' A' ' 60' ' ' TYR . 1.7 p -41.73 87.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 121.048 0.451 . . . . 0.0 110.96 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.8 p30 -116.22 142.57 46.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.479 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.507 HG23 HG23 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -97.0 153.23 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.105 0.479 . . . . 0.0 111.531 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.57 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.6 OUTLIER -142.65 118.74 10.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.241 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.27 114.64 24.05 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.445 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.44 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 3.8 mmp_? -101.58 -117.42 0.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.239 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.35 76.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.79 0.329 . . . . 0.0 111.272 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.88 -37.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.641 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -82.79 162.0 21.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.961 0.41 . . . . 0.0 110.618 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.636 ' CD1' HG21 ' A' ' 48' ' ' ILE . 50.0 m95 -86.01 140.56 30.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.742 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.57 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.4 m0 -110.97 108.7 18.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.39 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.83 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.47 116.21 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.629 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.727 ' HG2' HG22 ' A' ' 39' ' ' VAL . 11.4 mtmt -119.46 136.39 54.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.08 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.422 ' HB3' ' CG2' ' A' ' 85' ' ' ILE . . . -143.41 158.71 43.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.69 137.6 44.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 111.358 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.07 -69.83 3.19 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.926 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.406 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 179.86 158.62 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 0.0 111.041 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.747 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.85 160.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.745 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.1 OUTLIER -140.71 125.2 17.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 111.643 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.881 HG13 HG13 ' A' ' 55' ' ' ILE . 18.0 t -94.66 138.55 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.641 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 5.3 m-20 -80.51 152.24 28.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.207 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 46.9 t -113.11 100.85 8.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 109.958 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.5 m-20 161.88 -37.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.27 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 94' ' ' GLU . 6.8 mt-10 -72.5 -68.59 0.46 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.697 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.625 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -58.55 -58.26 7.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.273 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.533 ' H ' HG23 ' A' ' 92' ' ' ILE . 44.7 p -45.28 -34.14 2.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.553 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 0.5 OUTLIER -61.26 -47.34 86.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 110.359 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.75 HD22 ' CB ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -90.11 -17.0 28.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.785 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.835 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -98.01 9.47 42.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.933 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 129.28 69.69 0.12 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.309 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -34.8 149.09 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.059 0.457 . . . . 0.0 111.439 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.88 17.66 10.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.149 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.432 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -69.57 -167.84 0.15 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.679 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -131.2 135.16 47.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.84 0.353 . . . . 0.0 110.966 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.772 HG21 ' OG1' ' A' ' 118' ' ' THR . 8.1 p -51.14 166.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.934 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.51 ' H ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER 79.38 1.87 2.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.895 -179.169 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.799 ' O ' HG12 ' A' ' 107' ' ' VAL . 8.2 t0 -73.77 -31.71 63.44 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.984 0.421 . . . . 0.0 110.232 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.469 ' CE1' ' HB2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -64.82 -26.03 68.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.772 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 0.5 OUTLIER -127.69 30.65 5.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.624 179.571 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.799 HG12 ' O ' ' A' ' 104' ' ' ASP . 9.2 p -83.05 -34.71 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.166 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.569 ' OD1' HG13 ' A' ' 107' ' ' VAL . 49.8 p30 -178.12 39.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.797 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.612 HG11 HD11 ' A' ' 42' ' ' LEU . 12.0 m -70.86 172.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.374 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.52 -44.43 56.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.166 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.2 m 172.95 157.7 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -178.95 122.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.926 0.393 . . . . 0.0 111.639 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 113' ' ' ILE . 9.4 mm -92.56 121.12 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.3 0.571 . . . . 0.0 111.005 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.46 143.07 3.78 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.954 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -77.78 120.23 22.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.783 0.325 . . . . 0.0 110.39 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -101.09 125.22 47.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.065 0.46 . . . . 0.0 111.929 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 4.8 p90 -136.08 121.36 19.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.462 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.772 ' OG1' HG21 ' A' ' 102' ' ' VAL . 15.3 t -105.0 142.45 34.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.339 0.59 . . . . 0.0 111.995 -178.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.857 HD22 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -148.24 125.69 11.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.652 179.134 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.99 -110.84 3.68 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.671 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.49 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.09 83.84 2.05 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.1 OUTLIER 153.22 101.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.747 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.641 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 8.4 p90 -88.67 128.88 35.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.102 0.477 . . . . 0.0 110.98 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.745 HG23 ' HB3' ' A' ' 86' ' ' GLU . 29.9 m -103.07 132.48 49.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.117 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.795 HD11 HG23 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -114.88 118.67 59.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.924 0.869 . . . . 0.0 110.979 179.146 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 115' ' ' ARG . 5.4 t -96.3 156.28 16.41 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.456 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.759 ' HB3' HG13 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -138.05 14.84 2.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.383 0.611 . . . . 0.0 109.542 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.642 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.62 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.468 ' HA ' HG12 ' A' ' 12' ' ' ILE . 11.0 m-20 . . . . . 0 CA--C 1.521 -0.166 0 CA-C-O 121.114 0.483 . . . . 0.0 111.538 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.504 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -78.31 -16.09 58.08 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.485 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.73 -9.02 2.33 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.241 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.49 ' C ' HD12 ' A' ' 12' ' ' ILE . 2.1 pp -60.39 -20.39 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 CA-C-N 117.574 0.687 . . . . 0.0 111.811 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.504 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -82.92 7.55 15.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.877 178.143 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.96 21.07 0.44 Allowed Glycine 0 CA--C 1.519 0.332 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.57 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.6 -83.49 0.63 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.661 0.267 . . . . 0.0 110.608 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.0 9.26 40.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.084 0.468 . . . . 0.0 110.938 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.11 -15.76 8.25 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.985 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.01 81.26 2.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.017 0.437 . . . . 0.0 110.216 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -140.53 10.8 2.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.635 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.67 14.44 7.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.3 -169.86 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.844 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.12 14.97 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.041 0.448 . . . . 0.0 110.541 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.066 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.937 0.399 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.2 m -72.93 145.38 46.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.206 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.825 HG13 ' OG ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -99.41 99.18 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.606 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.792 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.9 t -112.0 152.44 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.33 0.586 . . . . 0.0 112.389 -178.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.792 HD23 ' O ' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -148.59 107.88 3.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.527 178.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -113.4 125.93 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.031 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.916 HD13 HG13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -128.63 148.66 50.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.133 178.127 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.32 127.53 17.51 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.489 ' HA ' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -66.3 90.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.535 0.684 . . . . 0.0 111.043 -179.023 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.464 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -125.94 171.36 10.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.956 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.89 -17.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.669 ' HG3' HD11 ' A' ' 96' ' ' LEU . 8.2 tt0 -62.02 -72.31 0.13 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.239 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.916 HG13 HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -59.75 -40.66 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -40.83 -59.48 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.409 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.655 HG21 ' HG ' ' A' ' 95' ' ' LEU . 2.4 m -79.47 -61.87 1.87 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.877 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.869 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -43.82 -45.52 7.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.237 -179.184 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -62.63 -47.23 93.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.862 0.363 . . . . 0.0 110.284 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.643 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -54.23 -41.18 68.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.516 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.637 ' O ' HG23 ' A' ' 58' ' ' THR . 7.4 mt-10 -81.07 -68.64 0.67 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.043 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.869 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -37.17 -57.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.705 ' N ' HG23 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -74.85 -38.41 61.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.643 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.49 -46.88 12.86 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.884 -178.472 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.695 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 50.6 p -53.54 -69.81 0.11 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.489 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.452 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 20.5 m-20 -91.72 -29.66 16.7 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.82 ' CD1' HG21 ' A' ' 68' ' ' VAL . 8.4 m-85 -87.15 -2.07 58.36 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.427 -0.909 . . . . 0.0 113.236 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.567 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -117.75 -40.71 2.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 178.348 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.695 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -62.08 -49.98 73.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.611 ' O ' HG23 ' A' ' 64' ' ' VAL . 14.1 p-10 -177.71 90.49 0.03 OUTLIER 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.507 0.67 . . . . 0.0 112.297 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.687 HG11 ' CE1' ' A' ' 60' ' ' TYR . 20.2 t -162.05 -54.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.076 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.555 ' HB3' HG22 ' A' ' 67' ' ' THR . 5.6 m-20 170.49 143.45 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.482 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.479 ' O ' ' ND2' ' A' ' 69' ' ' ASN . 85.0 Cg_endo -85.64 -16.43 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.981 2.454 . . . . 0.0 112.237 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 65' ' ' ASN . 14.7 t -53.16 -39.47 63.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.286 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.82 HG21 ' CD1' ' A' ' 60' ' ' TYR . 63.5 t -61.81 86.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.826 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 66' ' ' PRO . 7.7 m120 -115.43 142.44 46.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.859 0.361 . . . . 0.0 111.056 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.657 HG23 HD12 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -96.84 153.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 121.235 0.541 . . . . 0.0 111.548 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -142.08 117.98 10.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.787 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.3 114.52 18.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.645 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.518 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -95.23 -146.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.083 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.2 -73.57 0.08 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.629 0.252 . . . . 0.0 111.637 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . -126.42 12.48 7.07 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.479 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -142.83 158.66 43.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.086 0.443 . . . . 0.0 111.091 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.658 ' O ' HG12 ' A' ' 41' ' ' VAL . 58.7 m95 -80.73 142.75 33.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.229 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.606 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.0 m0 -115.79 108.5 16.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.635 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.822 ' N ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -96.89 127.21 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 135.83 49.66 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.947 0.403 . . . . 0.0 111.241 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.575 ' CB ' HG21 ' A' ' 85' ' ' ILE . . . -143.86 159.05 43.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.849 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -106.97 148.3 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.076 0.465 . . . . 0.0 111.328 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 68.08 -69.85 0.32 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.331 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER 177.92 160.71 0.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.922 0.391 . . . . 0.0 111.02 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.956 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -149.55 160.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.956 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.548 ' CB ' ' HB ' ' A' ' 124' ' ' THR . 1.0 OUTLIER -138.14 126.1 22.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.128 0.49 . . . . 0.0 111.414 -179.501 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.643 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 23.0 t -94.49 146.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.603 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.433 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 8.8 t70 -90.11 152.15 21.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.103 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.472 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 49.8 t -109.46 100.74 9.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.295 0.569 . . . . 0.0 109.745 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 0.7 OUTLIER 162.45 -35.98 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.979 -179.257 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -74.26 -71.85 0.31 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.748 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.637 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.0 OUTLIER -57.11 -56.35 15.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.803 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.449 ' H ' HG23 ' A' ' 92' ' ' ILE . 15.1 p -46.62 -35.62 6.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.734 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.9 OUTLIER -60.19 -46.21 90.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.098 0.475 . . . . 0.0 110.367 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.814 HD13 ' O ' ' A' ' 95' ' ' LEU . 1.1 tm? -90.17 -17.62 27.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.601 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.669 HD11 ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -99.7 12.33 36.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.974 0.416 . . . . 0.0 110.999 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.418 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 126.29 69.52 0.18 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.279 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -35.11 148.61 0.02 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.08 0.467 . . . . 0.0 111.66 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 64.8 17.48 11.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.342 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -69.65 -177.58 1.26 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.607 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -81.81 -91.87 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.689 HG21 ' OG1' ' A' ' 118' ' ' THR . 2.7 p 179.42 -42.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.688 0.28 . . . . 0.0 111.1 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.684 ' CE2' HG22 ' A' ' 118' ' ' THR . 4.9 m-85 -71.71 -6.69 43.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.367 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.71 -34.24 18.26 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.782 0.325 . . . . 0.0 111.026 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.533 ' CD1' ' CE2' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -60.54 -34.95 74.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.631 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.503 HD13 ' OG1' ' A' ' 112' ' ' THR . 5.6 tp -133.21 41.89 3.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.473 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.9 p -81.59 -39.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.298 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -166.14 31.47 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.002 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.402 HG11 HD23 ' A' ' 42' ' ' LEU . 29.5 m -65.07 174.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.295 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -55.96 -42.47 76.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.9 OUTLIER 171.65 151.72 0.06 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.503 ' OG1' HD13 ' A' ' 106' ' ' LEU . 65.8 p -159.88 98.51 1.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.906 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 113' ' ' ILE . 17.1 mm -65.89 127.31 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 0.0 110.966 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.81 144.48 5.37 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.041 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.521 ' HB2' HG23 ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.84 120.55 22.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.7 0.286 . . . . 0.0 110.414 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.457 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -106.9 124.59 49.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.129 0.49 . . . . 0.0 112.263 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.529 ' CZ ' HG23 ' A' ' 124' ' ' THR . 2.0 p90 -137.04 119.29 15.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.296 178.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.689 ' OG1' HG21 ' A' ' 102' ' ' VAL . 10.9 t -99.81 142.71 30.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.251 0.548 . . . . 0.0 111.969 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.831 ' O ' HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -146.38 133.11 19.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.507 179.23 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 56.9 -112.02 3.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.611 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.503 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.9 84.06 2.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.4 OUTLIER 152.11 100.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.526 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.643 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 14.2 p90 -88.28 133.08 34.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.17 0.509 . . . . 0.0 110.949 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.548 ' HB ' ' CB ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -107.93 130.67 55.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.858 -179.458 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.956 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -112.82 118.58 58.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.891 0.853 . . . . 0.0 111.368 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.521 HG23 ' HB2' ' A' ' 115' ' ' ARG . 9.1 t -97.24 155.59 16.79 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.087 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.825 ' OG ' HG13 ' A' ' 38' ' ' VAL . 2.2 m -146.02 19.28 1.43 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.256 0.551 . . . . 0.0 109.842 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 N--CA 1.445 -0.698 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.246 -178.755 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mtp . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.841 0.353 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.0 t -92.54 79.56 4.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.49 97.9 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -78.27 145.44 35.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.3 t -144.29 123.21 12.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.026 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -130.98 95.14 3.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 62.43 -174.73 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.998 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.879 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -146.07 21.49 1.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.447 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.514 ' HA ' HG12 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -53.4 -20.78 4.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.224 0.535 . . . . 0.0 111.49 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -75.5 -15.89 60.36 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.848 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.03 -9.25 2.2 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.333 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.1 pp -60.4 -19.2 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-N 117.538 0.669 . . . . 0.0 112.069 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.49 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -83.91 9.64 11.69 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.041 178.256 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.04 -43.8 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.732 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.58 -80.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 110.989 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.43 -14.49 26.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.438 0.637 . . . . 0.0 111.512 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.8 -18.03 62.35 Favored Glycine 0 C--N 1.312 -0.805 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.895 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.22 81.11 1.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 110.878 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 9.2 t0 -138.67 8.36 2.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.515 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.46 ' CG ' ' O ' ' A' ' 19' ' ' ASP . 13.3 p90 46.91 73.93 0.17 Allowed 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.8 0.81 . . . . 0.0 111.087 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.56 -8.44 38.19 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.602 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -90.13 11.85 19.64 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.032 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -138.32 12.79 2.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.239 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -95.53 -54.38 3.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.525 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -120.98 111.13 17.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.519 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.36 -115.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.112 0.482 . . . . 0.0 111.028 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 t70 71.25 15.57 6.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.377 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -56.4 -26.74 54.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.918 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -177.49 105.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.106 0.479 . . . . 0.0 110.435 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -99.29 162.15 13.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.004 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -93.38 141.65 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.003 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 11.2 p -110.04 134.69 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.817 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -110.18 115.3 29.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.859 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 33.35 85.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.147 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.403 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -121.33 144.06 48.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.892 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -103.44 28.23 6.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.027 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.0 m -74.37 145.23 43.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.884 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.719 HG11 HG23 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -86.26 106.32 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.884 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.75 HG22 ' HG2' ' A' ' 80' ' ' LYS . 13.5 t -118.3 154.09 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.328 0.585 . . . . 0.0 111.832 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.699 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -177.93 125.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.265 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -112.03 135.22 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.668 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.77 HD23 HD11 ' A' ' 48' ' ' ILE . 3.5 tp -125.73 139.52 53.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.639 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -50.76 139.61 16.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.129 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.466 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -87.52 87.65 7.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.396 0.617 . . . . 0.0 110.462 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.43 ' C ' ' N ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -125.78 170.64 11.39 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.543 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.67 -12.13 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.993 0.425 . . . . 0.0 110.34 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.818 ' CD ' HD11 ' A' ' 96' ' ' LEU . 1.4 tt0 -80.82 -58.11 3.24 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.342 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.813 HG21 ' CD1' ' A' ' 77' ' ' TRP . 1.4 mp -63.86 -44.89 98.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.963 0.411 . . . . 0.0 110.241 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -40.49 -59.85 1.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.058 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.74 HG21 ' HG ' ' A' ' 95' ' ' LEU . 58.5 m -69.96 -68.47 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.007 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.882 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -42.66 -47.01 5.23 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.595 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.5 tp -55.87 -47.97 79.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.165 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.485 ' O ' ' CD2' ' A' ' 57' ' ' LEU . 1.6 pt-20 -53.29 -48.78 68.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 109.755 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.798 ' HA ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -70.64 -81.6 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.67 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.882 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -22.02 -57.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.7 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.4 mp -74.22 -66.0 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.576 ' N ' HD13 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -63.41 -33.12 74.85 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -177.251 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.798 HG23 ' HA ' ' A' ' 54' ' ' GLU . 70.0 p -62.93 -66.2 0.58 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.338 0.59 . . . . 0.0 110.757 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.62 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -83.24 -46.35 12.78 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.805 ' CG ' HG11 ' A' ' 68' ' ' VAL . 49.6 m-85 -69.04 -24.71 64.21 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -90.99 -51.48 5.32 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.657 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 58' ' ' THR . 13.6 ttpt -60.68 -43.16 98.05 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.271 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.698 ' O ' HG23 ' A' ' 64' ' ' VAL . 10.2 p-10 179.76 103.8 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.103 0.477 . . . . 0.0 111.753 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER 178.51 -52.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.027 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.465 ' N ' HG12 ' A' ' 64' ' ' VAL . 5.1 m-20 178.86 141.56 0.28 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.738 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.55 -10.41 10.87 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.698 2.265 . . . . 0.0 111.956 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.516 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -78.3 -106.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.61 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.805 HG11 ' CG ' ' A' ' 60' ' ' TYR . 9.7 p 26.56 49.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.359 0.599 . . . . 0.0 111.629 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -82.32 136.52 35.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.199 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.75 153.76 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.041 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 7.9 mm-40 -142.44 116.28 9.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.188 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -86.38 114.52 23.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.571 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.445 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 21.4 mmt180 -103.17 -120.67 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.973 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.78 -54.04 50.92 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.862 0.363 . . . . 0.0 111.133 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.83 -39.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.644 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -79.93 162.5 24.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.673 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.813 ' CD1' HG21 ' A' ' 48' ' ' ILE . 22.8 m95 -90.92 142.71 27.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.154 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.511 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.4 m0 -106.52 102.4 11.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.266 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.847 ' N ' HD13 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -97.01 107.41 19.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.174 0.511 . . . . 0.0 110.411 -179.184 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.75 ' HG2' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -121.9 143.71 49.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.455 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.564 ' HB3' HG22 ' A' ' 85' ' ' ILE . . . -143.4 158.51 43.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.296 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.41 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.4 OUTLIER -102.94 132.84 48.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.865 0.364 . . . . 0.0 111.438 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.52 -68.21 3.47 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.001 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.493 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -176.46 152.89 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 110.691 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.817 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -133.69 157.92 42.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.795 ' HB2' HG22 ' A' ' 124' ' ' THR . 12.5 pt-20 -147.75 122.27 9.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.467 . . . . 0.0 111.825 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.773 HG13 HG13 ' A' ' 55' ' ' ILE . 29.2 t -94.74 137.16 23.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.59 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 18.0 p30 -84.31 151.93 24.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.893 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.465 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 21.4 t -109.83 100.55 9.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.131 0.491 . . . . 0.0 109.849 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 0.8 OUTLIER 161.5 -35.87 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.079 -179.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.02 -70.35 0.36 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.826 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.62 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.5 tt -57.8 -58.93 4.23 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.191 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.516 ' H ' HG23 ' A' ' 92' ' ' ILE . 4.9 t -44.75 -34.76 2.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.798 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.6 mm-40 -60.9 -48.22 82.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.542 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 95' ' ' LEU . 1.5 tm? -90.23 -16.98 28.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.725 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.818 HD11 ' CD ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.33 10.19 41.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 98' ' ' ARG . . . 125.46 70.72 0.19 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.117 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -30.72 147.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.149 0.5 . . . . 0.0 111.834 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.45 17.91 11.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.038 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -165.19 0.05 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.933 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.21 -167.88 1.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.035 HG23 ' CD1' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -113.14 -43.89 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.719 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -2.57 16.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.36 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.83 -40.79 22.25 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.878 0.37 . . . . 0.0 110.264 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.608 ' HE2' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -83.4 146.36 28.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.788 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.839 HD12 ' HB ' ' A' ' 112' ' ' THR . 3.5 tt 64.51 14.76 9.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 111.179 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 108' ' ' ASP . 14.2 p -74.17 -44.88 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.813 0.34 . . . . 0.0 111.07 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.484 ' N ' HG13 ' A' ' 107' ' ' VAL . 1.6 p30 178.54 54.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.67 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.587 HG21 HD11 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -98.0 -166.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.468 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -43.61 -40.15 3.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.154 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.472 ' HB3' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER 170.52 149.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.846 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.839 ' HB ' HD12 ' A' ' 106' ' ' LEU . 37.1 p -157.75 84.9 0.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 113' ' ' ILE . 10.4 mm -77.16 114.5 17.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.434 0.635 . . . . 0.0 111.395 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 143.89 142.01 3.87 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.029 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 126' ' ' THR . 23.4 ttt180 -77.1 120.1 21.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.614 0.245 . . . . 0.0 110.44 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.807 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -104.76 125.39 50.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.077 0.465 . . . . 0.0 112.202 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.581 ' HE1' HD23 ' A' ' 119' ' ' LEU . 3.5 p90 -131.63 127.42 36.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.101 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.877 ' OG1' HG21 ' A' ' 102' ' ' VAL . 11.7 t -100.26 149.35 23.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.344 0.592 . . . . 0.0 112.097 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.656 ' O ' HD12 ' A' ' 119' ' ' LEU . 3.3 pp -146.62 118.11 7.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.663 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.14 -104.29 0.51 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.981 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -133.06 83.68 2.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.028 0.442 . . . . 0.0 109.932 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.3 OUTLIER 152.95 115.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.471 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 1.035 ' CD1' HG23 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -104.21 138.46 40.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.988 0.423 . . . . 0.0 110.789 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.795 HG22 ' HB2' ' A' ' 86' ' ' GLU . 17.8 p -114.13 133.33 55.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.315 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.817 HD13 ' CD1' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -113.82 117.56 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.819 0.818 . . . . 0.0 110.565 179.099 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 115' ' ' ARG . 8.8 t -100.54 156.37 17.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.748 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.449 ' CB ' ' HA ' ' A' ' 38' ' ' VAL . 8.9 t -142.36 17.27 2.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.348 0.594 . . . . 0.0 109.555 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -124.75 -49.4 1.75 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.14 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.8 tp 63.86 18.08 10.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.301 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 12.4 ttp 69.34 15.7 8.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.246 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 78.3 102.82 0.2 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.493 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -29.97 65.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 110.93 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -113.64 69.72 0.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -33.51 23.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.809 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -109.64 -17.55 13.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.138 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.673 HD22 ' N ' ' A' ' 136' ' ' LEU . 0.2 OUTLIER -105.58 15.12 27.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.968 0.413 . . . . 0.0 111.177 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.35 -31.88 1.81 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.294 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -139.91 133.01 29.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -160.77 109.18 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.966 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -139.8 177.39 7.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.077 179.965 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.813 0.339 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 t -174.71 91.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 t -74.84 151.22 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.946 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.4 p30 -106.43 146.77 30.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.031 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.4 p -131.83 172.88 11.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.63 102.43 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.0 143.35 48.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.09 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.896 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -106.02 22.18 16.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.414 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.526 ' HA ' HG12 ' A' ' 12' ' ' ILE . 4.1 m-20 -55.59 -16.19 3.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.114 0.483 . . . . 0.0 111.408 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.491 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -78.73 -16.74 56.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.389 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.6 -8.91 2.7 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.261 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.896 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.1 pp -61.09 -19.84 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 117.626 0.713 . . . . 0.0 111.852 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.491 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.72 8.5 16.85 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.789 178.07 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.11 -43.5 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.33 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.19 -80.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.68 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.74 11.19 32.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.064 0.459 . . . . 0.0 111.17 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -112.62 -17.17 8.2 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.145 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -128.54 80.83 1.99 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.027 0.442 . . . . 0.0 110.42 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -142.51 13.71 1.96 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.36 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -86.51 6.23 31.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 0.0 111.095 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.34 -177.15 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.344 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 t0 65.29 13.35 8.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.197 0.522 . . . . 0.0 110.017 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -138.35 9.74 2.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.815 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -90.14 -55.92 3.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.621 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -120.63 110.89 16.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.815 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.23 -127.33 0.09 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.132 0.492 . . . . 0.0 110.311 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 171.44 27.32 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.894 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -75.31 -29.91 60.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -118.17 14.77 14.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.335 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.71 143.42 28.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.933 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -87.91 144.9 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.074 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.408 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 10.3 p -109.91 134.61 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.828 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -110.21 115.27 29.42 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.929 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 33.64 75.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.017 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.408 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 39.1 t -88.47 148.99 23.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.857 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -113.37 7.95 17.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.354 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.537 HG21 ' HD2' ' A' ' 80' ' ' LYS . 16.3 m -67.59 153.52 43.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.957 0.408 . . . . 0.0 111.124 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.888 HG21 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -102.23 112.61 36.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.676 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 80' ' ' LYS . 20.7 t -129.11 152.05 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.436 0.636 . . . . 0.0 112.436 -178.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.788 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -159.84 129.96 5.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.778 178.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.84 134.42 54.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.281 0.562 . . . . 0.0 111.998 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.017 HD23 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -126.29 140.32 52.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.434 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -52.53 129.0 27.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.46 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -75.29 90.0 2.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.498 0.666 . . . . 0.0 110.617 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 47' ' ' GLU . 3.3 m -126.01 171.09 11.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.442 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.54 -16.25 0.21 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.048 0.451 . . . . 0.0 110.047 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.889 ' HG2' HD12 ' A' ' 48' ' ' ILE . 6.8 tt0 -72.6 -63.47 1.15 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.175 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.017 HD11 HD23 ' A' ' 42' ' ' LEU . 1.6 mp -61.31 -44.16 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.294 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -40.82 -59.05 1.51 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.807 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.711 HG21 ' HG ' ' A' ' 95' ' ' LEU . 15.4 m -75.56 -62.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.941 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.875 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -44.34 -48.42 9.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.398 -179.075 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -57.62 -47.77 84.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.879 0.371 . . . . 0.0 110.432 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -53.21 -49.47 66.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.253 0.549 . . . . 0.0 109.601 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.761 ' HA ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -69.86 -82.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.54 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.875 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -21.66 -58.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.706 ' N ' HG23 ' A' ' 55' ' ' ILE . 1.4 mp -73.51 -66.3 0.71 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.605 ' N ' HD13 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -63.32 -30.54 71.66 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.454 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.761 HG23 ' HA ' ' A' ' 54' ' ' GLU . 72.0 p -62.89 -66.8 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.283 0.563 . . . . 0.0 110.611 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.631 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 65.6 m-20 -83.66 -44.86 14.07 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.894 ' CG ' HG11 ' A' ' 68' ' ' VAL . 66.9 m-85 -70.07 -21.63 63.14 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -93.84 -47.97 6.5 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.864 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.58 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.5 OUTLIER -58.01 -48.57 79.63 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.752 0.31 . . . . 0.0 110.814 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.582 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.4 OUTLIER 179.31 99.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.289 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 59' ' ' ASP . 0.9 OUTLIER -172.23 -50.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.764 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.455 ' N ' HG12 ' A' ' 64' ' ' VAL . 4.1 m-20 177.41 143.97 0.27 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 0.0 111.935 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -85.29 -3.31 9.45 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.824 2.349 . . . . 0.0 111.71 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.547 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 1.1 t -82.84 -109.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.44 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.894 HG11 ' CG ' ' A' ' 60' ' ' TYR . 10.0 p 26.8 49.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 121.379 0.609 . . . . 0.0 111.606 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -82.05 139.0 34.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.133 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 78' ' ' TRP . 0.5 OUTLIER -97.67 153.45 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.031 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -142.38 116.12 9.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.249 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -86.17 114.51 23.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.735 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 5.7 mmt180 -95.64 -111.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.968 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.9 -38.23 64.43 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.867 0.365 . . . . 0.0 111.128 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.46 -37.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.417 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.95 162.55 23.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.752 0.311 . . . . 0.0 110.551 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.844 ' CD1' HG21 ' A' ' 48' ' ' ILE . 10.3 m95 -94.11 142.84 26.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.521 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.488 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 9.0 m0 -107.56 108.73 20.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.133 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.803 ' N ' HD13 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -98.04 113.58 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.173 0.511 . . . . 0.0 110.338 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.537 ' HD2' HG21 ' A' ' 37' ' ' THR . 3.6 tttt -122.39 140.23 52.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.84 ' HB3' HG22 ' A' ' 85' ' ' ILE . . . -142.86 138.65 30.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.765 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.453 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.3 OUTLIER -77.55 108.2 10.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.046 0.45 . . . . 0.0 111.455 -179.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 104.03 -62.31 0.4 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.082 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.888 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 178.04 162.13 0.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.066 0.46 . . . . 0.0 111.353 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.84 HG22 ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -136.67 159.61 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.13 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.744 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.1 OUTLIER -142.75 118.2 10.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.146 0.498 . . . . 0.0 111.468 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.836 HG13 HG13 ' A' ' 55' ' ' ILE . 17.4 t -94.4 128.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.826 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 2.6 m-20 -77.3 151.97 34.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.153 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 22.5 t -106.26 100.62 10.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.136 0.493 . . . . 0.0 109.906 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 9.3 t0 160.3 -35.69 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.823 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -70.83 -72.87 0.19 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.943 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.658 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.3 tt -56.56 -57.85 7.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.503 ' H ' HG23 ' A' ' 92' ' ' ILE . 35.0 p -45.43 -36.61 4.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.755 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -58.34 -46.79 85.56 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.122 0.486 . . . . 0.0 110.239 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.842 HD13 ' O ' ' A' ' 95' ' ' LEU . 2.0 tm? -90.26 -17.2 27.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.474 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.752 HD11 ' CG ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -99.77 13.17 34.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.81 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 100' ' ' PHE . . . 118.99 67.94 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.18 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -33.56 150.41 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.208 0.528 . . . . 0.0 111.99 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.52 19.02 10.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.373 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.407 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -77.24 -166.52 0.74 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.049 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -93.5 -169.47 2.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.882 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.895 HG23 ' CD1' ' A' ' 123' ' ' PHE . 1.4 p -111.64 -34.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.118 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -79.91 3.91 18.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.477 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.774 ' O ' HG12 ' A' ' 107' ' ' VAL . 3.5 m-20 -59.6 -38.22 80.66 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.705 0.288 . . . . 0.0 110.947 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.473 ' CE1' ' HB2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -64.05 -43.04 96.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.765 0.316 . . . . 0.0 110.76 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.841 HD22 ' HB3' ' A' ' 116' ' ' ALA . 1.3 tp -106.73 26.03 10.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.218 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.774 HG12 ' O ' ' A' ' 104' ' ' ASP . 15.0 p -73.69 -24.39 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.9 0.381 . . . . 0.0 110.947 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -171.57 -86.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.458 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 110' ' ' SER . 43.0 t 55.9 160.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.056 0.455 . . . . 0.0 111.601 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.508 ' N ' HG12 ' A' ' 109' ' ' VAL . 30.3 t -55.14 -47.89 74.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.053 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.56 150.93 9.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.733 HG22 ' HB2' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -156.73 74.31 0.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.049 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 113' ' ' ILE . 5.1 mm -62.34 106.2 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.349 0.595 . . . . 0.0 111.23 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 148.39 140.28 3.3 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.046 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 126' ' ' THR . 61.3 ttp85 -76.7 126.01 30.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.614 0.245 . . . . 0.0 110.643 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.841 ' HB3' HD22 ' A' ' 106' ' ' LEU . . . -104.43 125.36 50.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.031 0.443 . . . . 0.0 112.007 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 1.7 p90 -128.32 120.79 27.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.814 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.8 t -98.37 161.25 13.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.343 0.592 . . . . 0.0 112.008 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.786 ' O ' HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -169.94 133.6 1.21 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.32 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.92 -110.78 1.21 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.681 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -134.33 84.02 2.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.478 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 88' ' ' ASP . 7.6 mttt 153.73 117.39 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.489 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.895 ' CD1' HG23 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -104.72 137.75 42.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.063 0.458 . . . . 0.0 110.84 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.744 HG23 ' HB3' ' A' ' 86' ' ' GLU . 55.2 m -112.72 126.05 54.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.028 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.748 HD11 HG23 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -110.94 117.42 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.859 0.838 . . . . 0.0 111.131 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 115' ' ' ARG . 5.2 t -115.23 154.27 29.36 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.995 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.754 ' CB ' HG13 ' A' ' 38' ' ' VAL . 6.5 t -147.55 25.85 1.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.343 0.592 . . . . 0.0 109.679 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -121.22 48.52 1.64 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.044 -178.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.2 mp -124.79 17.17 8.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.202 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 17.6 ttp 65.63 16.43 10.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.303 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -100.04 62.71 0.66 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.458 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.64 45.47 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.354 . . . . 0.0 110.9 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.579 ' HA ' HD12 ' A' ' 136' ' ' LEU . 15.9 m-20 59.35 28.42 17.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.0 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.46 -51.78 7.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.688 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.56 -17.11 22.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 133' ' ' ASP . 9.2 mt -73.75 -154.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.591 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 72.87 -56.7 0.65 Allowed 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.819 0.343 . . . . 0.0 111.03 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.54 -166.28 1.3 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.46 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.6 t80 61.52 114.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.704 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -101.14 154.57 18.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.128 179.986 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 mtm . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.755 0.312 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.11 112.54 1.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.8 m -58.55 177.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.165 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -112.36 133.53 54.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.1 p -78.63 -171.88 2.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 60.42 38.45 19.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.34 -174.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.121 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.902 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -126.13 21.04 7.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.465 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.556 ' HA ' HG12 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -54.02 -19.48 4.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.256 0.55 . . . . 0.0 111.461 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.86 -21.72 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.529 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.51 -10.72 4.85 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.233 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.902 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.0 pp -61.16 -21.35 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-N 117.595 0.697 . . . . 0.0 111.842 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.465 ' HE3' ' HB2' ' A' ' 13' ' ' MET . 0.0 OUTLIER -87.57 8.99 22.62 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.775 178.051 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.414 ' HA2' ' CB ' ' A' ' 18' ' ' LYS . . . -136.09 -49.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.502 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.408 HD22 ' CE2' ' A' ' 8' ' ' TYR . 2.2 mp -61.67 -81.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 10.04 26.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.007 0.432 . . . . 0.0 111.431 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.93 -26.45 3.83 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.961 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HG3' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -128.9 81.49 2.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.142 0.496 . . . . 0.0 110.332 179.249 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -116.97 -27.27 6.6 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.367 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -92.76 15.47 14.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.363 . . . . 0.0 111.402 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HB2' ' HG3' ' A' ' 18' ' ' LYS . . . -80.63 -6.37 58.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.221 0.534 . . . . 0.0 111.768 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -88.97 12.06 16.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.444 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -138.85 13.13 2.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.204 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -88.47 -54.26 4.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.164 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -120.95 110.37 16.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.397 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.38 -11.55 40.2 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.121 0.486 . . . . 0.0 111.967 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -79.15 8.47 5.79 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.026 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -88.62 -18.61 27.63 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.439 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -94.33 15.29 17.9 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.344 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -106.19 141.85 36.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.879 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.99 133.31 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.019 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.09 134.56 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.895 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -110.36 115.15 29.17 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.753 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 33.39 62.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.066 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.8 m -117.74 110.23 17.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.031 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.0 36.76 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.815 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.8 m -70.07 139.92 52.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.614 HG11 HG23 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -86.27 99.32 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.879 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.791 ' C ' HD12 ' A' ' 40' ' ' LEU . 3.9 t -107.52 146.07 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.255 0.55 . . . . 0.0 112.321 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.791 HD12 ' C ' ' A' ' 39' ' ' VAL . 6.3 mp -150.34 109.8 4.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.058 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.412 HG23 ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -108.51 128.09 64.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.327 0.584 . . . . 0.0 112.193 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.72 HD13 HD11 ' A' ' 48' ' ' ILE . 24.8 mt -127.07 140.26 52.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.6 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.29 125.72 14.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.744 0.307 . . . . 0.0 111.765 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HD2' ' CE2' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -57.36 87.71 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.267 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.609 ' C ' ' H ' ' A' ' 47' ' ' GLU . 33.2 m -125.02 170.16 11.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.381 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.37 11.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.834 ' CB ' HD21 ' A' ' 96' ' ' LEU . 1.9 tt0 -98.84 -57.68 2.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.976 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.768 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.8 OUTLIER -61.23 -44.49 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.302 0.573 . . . . 0.0 109.613 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -39.43 -62.0 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.126 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.845 HG21 ' HG ' ' A' ' 95' ' ' LEU . 56.7 m -65.41 -74.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.952 ' CD2' HG21 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -40.97 -58.78 1.62 Allowed 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.249 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.602 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.6 tp -41.72 -46.67 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.02 0.438 . . . . 0.0 109.963 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.536 ' O ' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -57.36 -53.49 57.49 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.622 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.683 ' HA ' HG23 ' A' ' 58' ' ' THR . 35.5 mt-10 -66.55 -94.61 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.949 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.952 HG21 ' CD2' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -18.55 -58.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.753 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -62.96 -77.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.671 ' N ' HD13 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -63.68 -16.08 60.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.683 HG23 ' HA ' ' A' ' 54' ' ' GLU . 6.3 p -65.01 -74.38 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.297 0.57 . . . . 0.0 110.137 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.582 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 8.7 m-20 -82.56 -32.71 28.39 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.858 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 1.027 ' CG ' HG11 ' A' ' 68' ' ' VAL . 78.1 m-85 -71.81 -32.04 67.18 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -84.78 -46.08 11.74 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.026 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 58' ' ' THR . 10.1 ttpt -57.85 -48.85 78.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.84 0.352 . . . . 0.0 110.821 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.69 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.4 OUTLIER 179.55 101.63 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -177.55 -52.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.063 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.498 ' N ' HG12 ' A' ' 64' ' ' VAL . 5.7 m-20 -177.1 138.99 0.43 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.772 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.48 3.07 8.09 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.673 2.249 . . . . 0.0 112.275 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.498 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 1.3 t -91.81 -114.1 0.09 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.108 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.027 HG11 ' CG ' ' A' ' 60' ' ' TYR . 8.4 p 28.46 43.47 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.115 0.484 . . . . 0.0 112.246 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.42 138.86 31.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.054 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.22 151.04 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-O 121.243 0.544 . . . . 0.0 111.659 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.771 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -143.42 116.89 9.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.02 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -80.19 124.29 28.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.461 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.464 ' HG3' ' CD2' ' A' ' 78' ' ' TRP . 5.2 mmt-85 -111.45 -117.4 0.3 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.64 -82.98 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -133.12 17.53 4.56 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.187 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.7 155.99 44.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.786 0.326 . . . . 0.0 110.688 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.768 ' CD1' HG21 ' A' ' 48' ' ' ILE . 73.7 m95 -76.4 125.89 30.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.29 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.771 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.1 m0 -96.62 106.59 18.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.663 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.58 122.12 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.194 -178.463 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -128.58 136.22 50.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.692 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 67' ' ' THR . . . -142.75 153.48 43.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.835 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.465 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.4 OUTLIER -105.0 129.52 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.644 -179.8 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.96 -67.62 2.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.256 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.499 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 179.31 157.14 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.636 -179.272 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.816 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.97 154.76 15.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.633 ' HB2' HG22 ' A' ' 124' ' ' THR . 11.7 pt-20 -141.03 124.57 16.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.05 0.452 . . . . 0.0 111.304 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.951 HG13 HG13 ' A' ' 55' ' ' ILE . 39.1 t -94.35 129.37 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.922 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 6.8 m-20 -76.41 151.78 36.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.911 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.452 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 27.8 t -108.9 100.79 9.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.138 0.495 . . . . 0.0 109.908 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.5 m-20 160.17 -36.13 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.17 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -71.28 -69.19 0.39 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.0 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.642 ' HB ' ' CD2' ' A' ' 51' ' ' PHE . 1.1 tt -59.21 -51.49 71.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.713 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.448 ' N ' HG23 ' A' ' 92' ' ' ILE . 44.9 p -52.74 -33.59 48.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.454 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -62.22 -46.58 88.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.973 0.416 . . . . 0.0 111.078 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.868 HD13 ' O ' ' A' ' 95' ' ' LEU . 2.5 tm? -90.18 -20.07 23.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.056 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.834 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -98.19 10.03 41.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.961 0.41 . . . . 0.0 111.018 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.42 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 129.67 69.11 0.11 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.231 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.5 158.82 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.072 0.463 . . . . 0.0 111.24 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 63.32 17.62 10.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.902 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER -75.66 -168.57 0.87 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.706 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -130.39 150.9 51.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.999 0.428 . . . . 0.0 111.236 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.82 HG21 ' OG1' ' A' ' 118' ' ' THR . 7.7 p -64.66 166.79 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.779 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.661 ' CE2' HG22 ' A' ' 118' ' ' THR . 1.2 m-85 71.62 7.16 5.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.049 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -79.7 -30.06 40.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 110.329 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.51 ' CE1' ' CD2' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -80.85 -0.58 39.58 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.278 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.71 29.5 1.12 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.832 0.349 . . . . 0.0 110.792 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 103' ' ' TYR . 7.3 p -87.2 -32.88 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.246 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -174.73 36.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.736 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.616 HG11 HD21 ' A' ' 42' ' ' LEU . 18.9 m -69.5 167.91 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.563 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.1 m -47.52 -47.25 27.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.22 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.412 ' CB ' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -177.34 166.27 2.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 1.2 t 177.31 103.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.295 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 113' ' ' ILE . 10.5 mm -81.93 117.49 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.389 0.614 . . . . 0.0 111.155 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.31 141.82 3.95 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.994 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.94 119.76 21.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.68 0.276 . . . . 0.0 110.492 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.794 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -107.28 125.39 51.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.978 0.418 . . . . 0.0 111.86 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.499 ' HE1' HD23 ' A' ' 119' ' ' LEU . 20.2 p90 -132.28 125.68 31.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.712 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.82 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.0 t -91.17 150.26 21.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.306 0.574 . . . . 0.0 111.985 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.554 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.4 pp -155.31 115.7 3.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.568 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.34 -106.75 1.11 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.535 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.47 83.52 2.02 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.1 OUTLIER 153.94 99.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.034 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.77 ' CD1' HG23 ' A' ' 102' ' ' VAL . 3.2 p90 -90.96 133.5 35.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.082 0.468 . . . . 0.0 110.721 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.633 HG22 ' HB2' ' A' ' 86' ' ' GLU . 2.4 p -108.0 141.02 40.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.436 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.872 HD11 HG23 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -118.38 117.4 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.913 0.863 . . . . 0.0 110.825 178.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 115' ' ' ARG . 4.5 t -97.95 155.99 16.83 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.52 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.439 ' CB ' ' HA ' ' A' ' 38' ' ' VAL . 13.2 t -147.28 20.52 1.21 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.257 0.551 . . . . 0.0 109.857 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.537 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -122.48 107.66 12.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.117 -178.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 128' ' ' GLU . 0.5 OUTLIER -169.53 101.49 0.33 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.604 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 9.9 ttt -139.6 15.68 2.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.306 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.76 -51.1 3.33 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.535 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 tp 61.85 117.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.857 0.36 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.535 ' HA ' HD12 ' A' ' 136' ' ' LEU . 32.5 m-20 -137.14 35.35 2.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.985 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.1 tpt85 -53.88 -46.75 71.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 110.658 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.0 30.86 7.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.316 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 133' ' ' ASP . 1.7 mt -138.86 -159.09 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.766 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 71.77 -56.93 0.63 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.873 0.368 . . . . 0.0 111.244 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -129.15 140.93 51.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -155.04 65.38 0.65 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -129.04 148.64 51.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.101 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.867 0.365 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 t -144.28 -167.7 2.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.827 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.4 m -57.9 175.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.18 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -73.07 130.04 39.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.66 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -95.93 98.91 10.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -134.59 106.62 7.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.724 ' HB3' ' HA3' ' A' ' 11' ' ' GLY . . . -142.15 -179.94 6.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 0.0 111.318 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -66.34 131.67 46.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.948 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.731 ' HA ' HD11 ' A' ' 12' ' ' ILE . 1.1 m-20 41.54 -75.06 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.638 0.733 . . . . 0.0 112.566 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.692 ' N ' ' O ' ' A' ' 8' ' ' TYR . . . -59.64 -7.97 1.78 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.598 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.724 ' HA3' ' HB3' ' A' ' 7' ' ' ALA . . . -113.37 -19.63 6.58 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.792 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.731 HD11 ' HA ' ' A' ' 9' ' ' ASP . 2.0 pp -108.18 66.88 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.572 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -139.47 14.96 2.56 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.884 178.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.436 ' HA2' ' CB ' ' A' ' 18' ' ' LYS . . . -127.7 -41.8 0.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.24 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.66 HD11 ' O ' ' A' ' 5' ' ' SER . 5.4 mp -60.85 -75.41 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.782 0.325 . . . . 0.0 110.749 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 9.39 43.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.84 -24.48 5.51 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.859 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -128.0 81.3 2.01 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.106 0.479 . . . . 0.0 110.074 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -121.12 -36.87 3.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.374 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.47 14.93 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.541 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.28 -173.68 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.901 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.56 13.9 5.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.03 0.443 . . . . 0.0 110.657 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -143.11 10.78 1.74 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.035 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.27 -52.9 4.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.191 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -121.05 110.22 15.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.445 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.69 -10.97 41.14 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.139 0.495 . . . . 0.0 111.93 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.85 8.2 4.9 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.888 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -84.89 -20.28 30.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.496 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -160.12 98.36 1.3 Allowed 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.104 0.478 . . . . 0.0 110.61 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -107.5 156.82 18.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.847 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.9 p -104.14 142.67 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 12.6 p -109.97 134.47 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.808 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.412 ' O ' ' C ' ' A' ' 34' ' ' GLU . 22.6 m170 -110.43 115.08 29.01 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.915 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 33' ' ' HIS . 1.0 OUTLIER 25.96 62.19 0.07 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.307 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.403 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 16.1 m -120.52 112.01 18.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.952 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -93.47 -19.1 21.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.7 m -72.24 145.42 47.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.024 0.44 . . . . 0.0 111.125 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.614 HG22 ' HB3' ' A' ' 127' ' ' SER . 0.2 OUTLIER -89.32 102.31 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.154 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.605 HG22 ' HG2' ' A' ' 80' ' ' LYS . 9.6 t -116.23 153.33 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.331 0.586 . . . . 0.0 111.669 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.881 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -173.1 128.26 0.46 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.285 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.464 ' CG1' ' CD1' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -112.44 134.71 54.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.177 0.513 . . . . 0.0 111.662 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.994 HD23 HD11 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -126.52 139.96 52.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.465 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.45 129.17 21.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.492 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -75.72 90.17 2.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.796 0.808 . . . . 0.0 110.433 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.445 ' C ' ' N ' ' A' ' 47' ' ' GLU . 1.1 t -126.27 171.01 11.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.449 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.11 -14.47 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.886 ' HG2' HD12 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -71.79 -61.56 1.74 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.221 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.994 HD11 HD23 ' A' ' 42' ' ' LEU . 1.5 mp -64.64 -43.22 96.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.092 0.472 . . . . 0.0 109.844 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -40.05 -58.18 1.49 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.727 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.435 HG21 ' HG ' ' A' ' 95' ' ' LEU . 1.2 m -78.11 -61.98 1.82 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.106 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.827 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -45.01 -44.44 9.96 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.517 -178.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.588 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.6 tp -62.2 -47.45 93.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.041 0.448 . . . . 0.0 109.868 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -53.91 -37.31 63.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.102 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.756 ' HA ' HG23 ' A' ' 58' ' ' THR . 0.9 OUTLIER -83.8 -75.57 0.33 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.53 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.827 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -31.22 -54.07 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.673 ' N ' HG23 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -76.92 -41.21 44.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -177.123 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.44 -47.18 12.56 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.498 -178.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.756 HG23 ' HA ' ' A' ' 54' ' ' GLU . 51.4 p -52.72 -68.91 0.13 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.485 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.445 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 0.5 OUTLIER -91.87 -33.8 14.78 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.349 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.852 ' CD1' HG21 ' A' ' 68' ' ' VAL . 7.5 m-85 -82.99 -3.12 56.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.455 -0.898 . . . . 0.0 113.091 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 2.3 tptt -115.99 -42.52 3.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.104 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.695 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -58.87 -51.27 70.76 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.573 0.225 . . . . 0.0 111.311 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.545 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -179.42 89.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.235 0.54 . . . . 0.0 111.862 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.626 HG11 ' CE1' ' A' ' 60' ' ' TYR . 24.4 t -160.12 -52.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.19 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 4.8 m-20 171.54 132.22 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.267 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 65' ' ' ASN . 4.7 Cg_exo -78.57 -18.36 12.14 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.658 2.239 . . . . 0.0 111.929 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -51.94 -50.84 60.38 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.4 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.852 HG21 ' CD1' ' A' ' 60' ' ' TYR . 78.2 t -43.83 87.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.651 0.262 . . . . 0.0 111.43 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 67' ' ' THR . 18.1 p30 -116.56 138.9 51.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.803 0.335 . . . . 0.0 111.613 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 78' ' ' TRP . 1.3 p -102.71 153.69 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.102 0.477 . . . . 0.0 111.662 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -142.82 129.72 20.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.432 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.51 114.89 20.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.935 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.477 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -89.92 -146.76 0.18 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.734 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.15 -22.42 60.88 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 111.398 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.14 -35.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.627 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -89.5 159.7 17.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 110.795 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.788 ' CD1' HG21 ' A' ' 48' ' ' ILE . 45.8 m95 -83.46 142.67 30.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.447 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.555 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 7.6 m0 -112.58 110.34 20.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.483 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.881 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -100.41 118.48 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.209 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.605 ' HG2' HG22 ' A' ' 39' ' ' VAL . 6.8 mtpt -126.6 136.76 52.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.487 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -143.63 158.85 43.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.827 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.42 135.96 49.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.229 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.69 -69.43 2.92 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.143 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER 178.76 160.9 0.66 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.965 0.412 . . . . 0.0 111.245 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.9 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -152.04 157.04 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.582 179.226 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.768 ' HB2' HG22 ' A' ' 124' ' ' THR . 7.3 pt-20 -141.38 125.6 17.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.039 0.447 . . . . 0.0 111.708 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.786 HG13 HG13 ' A' ' 55' ' ' ILE . 6.2 t -94.76 127.21 46.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.546 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.425 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 5.3 m-20 -76.44 152.42 36.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.102 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.543 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -107.47 100.06 9.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.392 0.615 . . . . 0.0 109.671 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.439 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER 164.6 -36.3 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.115 -179.351 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -73.09 -72.25 0.26 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.666 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.651 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -55.86 -59.66 2.49 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.908 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.535 ' H ' HG23 ' A' ' 92' ' ' ILE . 16.3 p -44.03 -37.08 2.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -57.47 -48.68 78.55 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.141 0.496 . . . . 0.0 110.401 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.761 HD13 ' O ' ' A' ' 95' ' ' LEU . 2.7 tm? -90.75 -19.13 23.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.555 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.793 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -91.07 9.65 30.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . 110.47 74.24 0.76 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.593 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -38.63 162.94 0.0 OUTLIER 'General case' 0 CA--C 1.526 0.037 0 CA-C-O 121.14 0.495 . . . . 0.0 111.377 -179.348 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.45 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 19.1 pt20 47.84 98.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.66 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' A' ' 93' ' ' SER . 0.0 OUTLIER -160.04 -152.69 0.3 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.603 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -124.2 124.36 42.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.887 0.375 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.714 HG21 ' OG1' ' A' ' 118' ' ' THR . 12.5 p -53.79 166.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.242 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.532 ' N ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER 80.48 -2.21 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.39 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.812 ' O ' HG12 ' A' ' 107' ' ' VAL . 7.5 t70 -60.47 -30.45 69.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.746 ' CE1' HD23 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -76.94 -30.02 55.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.34 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.746 HD23 ' CE1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -108.97 21.44 17.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.207 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.812 HG12 ' O ' ' A' ' 104' ' ' ASP . 13.2 p -87.32 -37.08 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 0.0 111.277 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.532 ' OD2' HG22 ' A' ' 107' ' ' VAL . 0.9 OUTLIER 168.82 88.48 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.802 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.55 83.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.11 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.8 t 66.74 -63.99 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.195 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.529 ' O ' HG23 ' A' ' 112' ' ' THR . 0.1 OUTLIER 175.68 163.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.995 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 111' ' ' SER . 20.5 p -160.16 83.39 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 113' ' ' ILE . 8.4 mm -66.58 110.27 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.56 0.695 . . . . 0.0 111.192 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 146.61 148.09 4.7 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.597 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.461 ' HB2' HG23 ' A' ' 126' ' ' THR . 1.8 mmm180 -76.6 120.05 21.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.56 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -108.14 125.22 51.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.063 0.459 . . . . 0.0 112.144 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.505 ' HE1' HD23 ' A' ' 119' ' ' LEU . 11.4 p90 -136.33 118.52 15.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.412 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.714 ' OG1' HG21 ' A' ' 102' ' ' VAL . 13.7 t -91.21 134.92 34.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.189 0.519 . . . . 0.0 111.731 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.583 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.6 pp -134.01 115.92 14.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.797 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.05 -106.16 0.84 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.992 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 89' ' ' CYS . 0.5 OUTLIER -133.16 83.97 2.1 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.073 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.499 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.2 OUTLIER 152.25 95.14 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.455 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.541 ' CD1' HG23 ' A' ' 102' ' ' VAL . 24.0 p90 -88.12 126.62 35.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.015 0.436 . . . . 0.0 111.151 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.768 HG22 ' HB2' ' A' ' 86' ' ' GLU . 12.2 p -102.87 136.14 43.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.149 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -116.09 118.4 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.778 0.799 . . . . 0.0 111.232 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 115' ' ' ARG . 11.3 t -98.2 156.1 16.85 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.16 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.614 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -140.13 13.61 2.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.448 0.642 . . . . 0.0 109.54 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.17 -72.82 0.67 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.104 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.428 HD13 HG21 ' A' ' 126' ' ' THR . 3.9 tp 63.83 17.03 10.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.453 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.5 ttt -93.57 15.75 15.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.237 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -118.48 41.0 2.13 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.479 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mp -66.31 176.78 1.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -112.8 26.75 10.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.945 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -54.21 49.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.928 0.394 . . . . 0.0 110.686 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.34 -28.58 12.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.691 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -163.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.83 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 70.87 -56.17 0.63 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.884 0.373 . . . . 0.0 111.262 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.59 119.76 18.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.2 93.39 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -126.39 171.06 11.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.119 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.758 0.314 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.7 t -61.77 174.7 0.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.68 -54.17 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.168 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -102.26 133.49 47.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.23 -56.16 7.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 59.97 93.35 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.003 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.536 ' O ' HG22 ' A' ' 12' ' ' ILE . . . -73.54 163.44 28.02 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.517 0.675 . . . . 0.0 111.573 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 12' ' ' ILE . 64.9 t80 -73.82 166.58 23.07 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.924 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.471 ' HA ' HG12 ' A' ' 12' ' ' ILE . 3.6 m-20 -51.01 -10.53 0.07 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.429 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.426 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -84.14 -16.93 41.78 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.638 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.18 -13.11 2.44 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.959 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 8' ' ' TYR . 1.9 pp -56.73 -23.61 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 117.732 0.766 . . . . 0.0 111.854 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.426 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.73 8.21 17.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.866 178.166 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 18' ' ' LYS . . . -135.55 -38.07 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.469 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.66 -74.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.672 0.272 . . . . 0.0 111.127 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.5 9.13 41.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.582 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.88 -24.85 4.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.135 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.499 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 4.5 tmtt? -130.93 85.63 2.29 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.698 0.761 . . . . 0.0 110.321 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -128.04 2.51 5.89 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.471 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.2 18.0 7.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.877 0.37 . . . . 0.0 111.536 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.88 -178.16 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.042 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.96 11.08 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.904 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -145.12 10.99 1.33 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.041 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -98.83 -55.35 2.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.338 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -121.05 110.26 16.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.524 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.67 -109.51 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.514 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -55.9 -21.69 21.76 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.368 0.604 . . . . 0.0 111.577 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.12 -19.91 66.21 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.672 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -178.87 106.45 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.55 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.61 165.65 14.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.4 p -87.28 145.52 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.487 HG21 ' OG ' ' A' ' 35' ' ' SER . 10.6 p -109.89 134.7 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.91 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 34' ' ' GLU . 56.1 p-80 -110.14 115.07 29.07 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.715 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 33' ' ' HIS . 1.3 mt-10 29.4 54.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.104 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.487 ' OG ' HG21 ' A' ' 32' ' ' VAL . 12.8 p -71.69 129.14 37.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.939 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.05 -26.31 11.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.888 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 m -67.69 140.85 56.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.661 HG11 HG22 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -97.18 131.22 44.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.987 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 113' ' ' ILE . 8.9 t -129.88 140.06 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 5.6 tp -128.5 104.33 7.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.481 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.417 ' CG2' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -111.74 126.85 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.24 0.543 . . . . 0.0 111.259 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.549 HD22 HD11 ' A' ' 48' ' ' ILE . 1.5 mt -126.69 140.9 52.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.684 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.7 OUTLIER -51.81 119.07 3.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.666 0.27 . . . . 0.0 111.054 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HD2' ' NE1' ' A' ' 77' ' ' TRP . 0.1 OUTLIER -46.79 91.97 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 47' ' ' GLU . 13.6 m -125.38 169.36 12.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.914 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -67.03 3.69 1.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.764 ' CB ' HD21 ' A' ' 96' ' ' LEU . 1.4 tt0 -90.02 -59.32 2.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.801 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.756 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.5 OUTLIER -55.33 -43.72 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 121.171 0.51 . . . . 0.0 109.878 179.287 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -42.45 -61.59 1.17 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.342 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.811 HG21 ' HG ' ' A' ' 95' ' ' LEU . 83.8 m -68.43 -75.43 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.957 ' CD1' HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -39.12 -62.02 0.69 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 119.687 -0.197 . . . . 0.0 111.5 -178.317 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.585 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -42.16 -46.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.983 0.421 . . . . 0.0 110.049 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' O ' HD22 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -56.66 -53.64 55.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.469 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.657 ' HA ' HG23 ' A' ' 58' ' ' THR . 8.3 mt-10 -66.91 -94.42 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.016 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.957 HG21 ' CD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -18.74 -61.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.775 ' N ' HD13 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -61.46 -76.22 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.675 ' N ' HD13 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -64.12 -15.49 59.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.691 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.657 HG23 ' HA ' ' A' ' 54' ' ' GLU . 3.3 p -63.37 -75.39 0.08 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.204 0.525 . . . . 0.0 110.013 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.591 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 2.1 p30 -85.77 -31.47 22.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.768 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.992 ' CG ' HG11 ' A' ' 68' ' ' VAL . 86.1 m-85 -73.64 -29.46 62.35 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.23 -0.588 . . . . 0.0 112.048 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.632 ' CE ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -86.43 -45.05 11.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.641 179.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.5 ttmt -55.58 -51.65 66.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.432 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.685 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.4 OUTLIER 179.62 100.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.939 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -177.52 -55.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.348 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.556 ' N ' HG12 ' A' ' 64' ' ' VAL . 4.4 m-20 178.69 129.92 0.22 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.846 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -86.63 -16.9 3.56 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.86 2.373 . . . . 0.0 112.111 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.7 HG21 ' OD1' ' A' ' 82' ' ' ASN . 1.8 t -55.26 -39.49 69.86 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.551 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.992 HG11 ' CG ' ' A' ' 60' ' ' TYR . 11.6 p -66.02 65.81 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.406 0.622 . . . . 0.0 110.893 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -101.04 143.32 31.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.887 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.438 HG23 ' CD1' ' A' ' 79' ' ' ILE . 0.5 OUTLIER -95.65 149.67 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.483 0.658 . . . . 0.0 111.693 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 1.6 tp10 -143.66 125.97 15.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.529 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -84.66 115.45 22.67 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.225 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HB2' ' CG ' ' A' ' 78' ' ' TRP . 0.1 OUTLIER -96.38 -114.39 0.13 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.417 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.77 -80.54 0.05 OUTLIER 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.783 0.325 . . . . 0.0 111.581 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.82 -24.84 2.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.037 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -102.52 162.6 12.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.752 0.31 . . . . 0.0 110.842 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.756 ' CD1' HG21 ' A' ' 48' ' ' ILE . 83.4 m95 -76.05 122.72 24.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.269 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.573 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.6 m0 -96.56 107.63 20.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.683 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.676 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -96.94 137.48 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.435 -178.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -128.81 136.0 49.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.316 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -143.31 157.89 44.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.712 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.7 ' OD1' HG21 ' A' ' 67' ' ' THR . 1.2 p-10 -104.82 135.41 46.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.4 . . . . 0.0 110.701 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.63 -67.08 0.28 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.786 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 126' ' ' THR . 0.0 OUTLIER 178.14 173.57 0.62 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.116 0.484 . . . . 0.0 111.311 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.987 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -152.36 162.37 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.419 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.733 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.4 OUTLIER -129.23 121.94 28.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.183 0.516 . . . . 0.0 111.551 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.949 HG23 HD11 ' A' ' 125' ' ' ILE . 55.0 t -94.36 125.29 47.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.564 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -76.81 151.82 35.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.028 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.465 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 17.1 t -108.5 100.68 9.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 3.1 m-20 161.01 -32.95 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.09 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -74.34 -70.81 0.37 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.009 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.575 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -58.46 -51.61 69.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.589 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.426 ' N ' HG23 ' A' ' 92' ' ' ILE . 24.2 p -52.68 -35.29 55.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.523 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -60.15 -44.65 94.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.928 0.394 . . . . 0.0 110.806 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.821 HD13 ' O ' ' A' ' 95' ' ' LEU . 3.4 tm? -90.27 -21.6 22.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.761 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.764 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.46 12.26 35.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.901 0.382 . . . . 0.0 111.218 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.16 66.44 0.13 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.591 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.34 152.56 0.02 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 65.48 18.12 11.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.46 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -166.15 0.25 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.994 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -121.88 140.7 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.717 HG21 ' OG1' ' A' ' 118' ' ' THR . 11.9 p -56.82 163.59 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.004 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.552 ' CE2' HG22 ' A' ' 118' ' ' THR . 0.9 OUTLIER 70.07 9.67 7.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.278 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.43 -32.48 24.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.365 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.531 ' HD1' HD23 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -66.66 -33.03 74.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.511 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.531 HD23 ' HD1' ' A' ' 105' ' ' PHE . 0.6 OUTLIER -124.62 33.3 5.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.707 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 108' ' ' ASP . 14.9 p -63.24 -40.55 89.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.414 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.41 ' N ' HG13 ' A' ' 107' ' ' VAL . 23.0 t0 -174.65 81.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.856 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.515 HG11 HD23 ' A' ' 42' ' ' LEU . 3.4 t -127.73 165.67 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.036 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.476 ' N ' HG12 ' A' ' 109' ' ' VAL . 15.1 t -43.3 -46.16 6.22 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.477 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.417 ' CB ' ' CG2' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -172.49 151.08 2.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.825 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.84 ' C ' HD12 ' A' ' 113' ' ' ILE . 35.5 p -156.27 99.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.242 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.84 HD12 ' C ' ' A' ' 112' ' ' THR . 1.1 mp 59.75 -77.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.542 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 112' ' ' THR . . . 170.98 -100.07 0.15 Allowed Glycine 0 C--N 1.309 -0.925 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.173 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.535 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -93.25 129.76 39.2 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.319 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.815 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -122.47 136.37 54.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 36.5 p90 -136.44 116.74 13.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.253 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.717 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.1 t -86.38 151.19 23.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.818 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.4 pp -159.96 116.21 2.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.822 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.63 -110.47 2.8 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.713 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -132.85 83.85 2.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 1.9 mtpp 152.52 95.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.795 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.62 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 6.5 p90 -88.31 124.07 33.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.177 0.513 . . . . 0.0 110.785 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.733 HG23 ' HB3' ' A' ' 86' ' ' GLU . 17.2 m -98.37 125.85 43.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.463 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.987 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -102.05 117.23 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.009 0.909 . . . . 0.0 111.02 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.451 ' HA ' ' HB2' ' A' ' 84' ' ' LYS . 9.7 t -97.43 155.38 16.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.967 -1.469 . . . . 0.0 110.513 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.583 ' CB ' HG13 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -136.83 14.85 3.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 109.668 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -121.85 -64.91 1.17 Allowed 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.298 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.8 tp 63.93 17.71 10.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.273 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 ttm -91.28 15.12 12.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.322 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -97.69 -19.37 25.0 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.548 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.3 mp -76.75 119.62 20.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.381 . . . . 0.0 110.933 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -125.61 32.82 5.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -50.03 34.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -111.77 -15.55 13.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.197 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.61 ' O ' HD23 ' A' ' 136' ' ' LEU . 3.9 tt -86.3 4.5 38.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.1 0.476 . . . . 0.0 111.531 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.08 -23.63 0.52 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.306 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -150.35 19.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.645 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.405 ' HB2' ' HA ' ' A' ' 136' ' ' LEU . 0.1 OUTLIER -49.67 127.86 16.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.195 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -76.26 162.15 28.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.071 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.856 0.36 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.53 142.36 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.5 t -74.49 -40.04 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -102.31 130.22 48.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 t -103.42 62.79 0.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -109.0 149.95 28.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.78 155.69 48.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.161 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.897 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -101.71 22.63 12.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.367 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.526 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.5 p30 -53.36 -20.14 4.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.524 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.507 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -75.24 -16.91 60.43 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.779 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.12 -9.92 2.33 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.377 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.897 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.1 pp -60.48 -19.73 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 117.466 0.633 . . . . 0.0 112.087 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.507 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.14 8.81 14.39 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.015 178.357 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -136.68 -52.77 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.401 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.51 -80.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.308 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 10.76 30.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 111.18 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.33 -21.18 5.95 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.05 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -128.05 80.69 1.98 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 110.373 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.468 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 17.7 t0 -128.04 -25.42 3.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.346 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 19' ' ' ASP . 9.2 p90 47.93 74.82 0.15 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.722 0.772 . . . . 0.0 111.11 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.29 -9.65 59.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.505 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.82 11.49 22.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.81 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -138.53 12.72 2.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.117 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.23 -53.61 3.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.498 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -120.34 110.5 16.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.604 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.78 -116.2 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.062 0.458 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.54 14.86 9.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.484 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -70.4 -29.84 66.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.643 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -159.35 97.61 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.494 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -110.83 166.34 11.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.053 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -102.76 151.81 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.114 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.82 134.94 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.88 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.41 ' O ' ' C ' ' A' ' 34' ' ' GLU . 29.0 m-70 -110.14 115.08 29.1 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.801 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 33' ' ' HIS . 0.7 OUTLIER 28.02 72.57 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.207 179.403 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.91 129.0 35.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.692 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.32 27.85 0.25 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.993 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.8 m -88.61 148.4 24.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.789 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.747 HG13 ' HB3' ' A' ' 127' ' ' SER . 0.2 OUTLIER -93.0 103.13 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.402 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.719 ' C ' HD12 ' A' ' 40' ' ' LEU . 4.3 t -111.72 149.78 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.092 0.472 . . . . 0.0 111.423 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.719 HD12 ' C ' ' A' ' 39' ' ' VAL . 5.7 mp -155.06 105.19 2.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.397 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -113.22 127.56 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.141 0.496 . . . . 0.0 112.269 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.769 HD13 HG13 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -128.53 147.19 50.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.181 178.137 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -48.86 132.28 18.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.13 89.95 0.46 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.499 0.666 . . . . 0.0 110.683 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.441 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -126.15 170.86 11.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.515 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -51.65 -14.24 0.32 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.759 ' CG ' HD11 ' A' ' 96' ' ' LEU . 11.6 tt0 -66.72 -70.98 0.21 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.252 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.825 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.8 OUTLIER -59.15 -43.65 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 121.183 0.516 . . . . 0.0 109.727 178.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -39.6 -59.06 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.407 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.649 HG21 ' HG ' ' A' ' 95' ' ' LEU . 8.6 m -78.85 -62.02 1.83 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.064 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.891 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -43.96 -47.26 8.5 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.324 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.622 ' HA ' ' CG2' ' A' ' 55' ' ' ILE . 1.7 tp -61.55 -47.11 94.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.025 0.44 . . . . 0.0 110.34 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 pt-20 -53.85 -41.72 67.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.567 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' ' 58' ' ' THR . 1.0 OUTLIER -81.32 -66.86 0.83 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.0 0.429 . . . . 0.0 111.0 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.891 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -37.25 -58.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.829 HD12 HD12 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -75.13 -35.9 61.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -177.011 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -81.87 -46.82 13.58 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.65 -178.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.72 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 68.7 p -52.17 -70.17 0.09 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.381 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.445 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 2.5 m-20 -92.79 -32.52 14.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.933 ' CG ' HG11 ' A' ' 68' ' ' VAL . 2.4 m-85 -80.53 -6.01 57.58 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.839 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -113.96 -41.24 3.58 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.933 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.72 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.2 ttmt -57.61 -51.17 70.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.66 0.267 . . . . 0.0 111.43 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.448 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.4 OUTLIER 179.4 88.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 111.395 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.624 HG11 ' CE1' ' A' ' 60' ' ' TYR . 20.9 t -156.44 -54.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.399 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.472 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.6 m-20 169.86 149.36 0.14 Allowed Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.912 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -89.76 -20.72 1.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.192 2.595 . . . . 0.0 112.88 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.57 HG23 ' H ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -46.89 -65.52 0.55 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.211 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.933 HG11 ' CG ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -42.1 87.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.117 179.324 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.1 p30 -116.07 142.28 47.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.474 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.808 HG23 HD12 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.74 149.72 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.083 0.468 . . . . 0.0 111.029 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.711 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 17.1 mt-10 -143.35 116.05 8.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.35 114.34 26.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.905 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -101.06 -80.88 0.49 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.67 -73.36 0.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.87 0.366 . . . . 0.0 111.422 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.08 -42.15 0.19 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.518 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -83.27 164.26 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.394 . . . . 0.0 110.737 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.825 ' CD1' HG21 ' A' ' 48' ' ' ILE . 30.5 m95 -88.38 136.31 33.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.325 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.711 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 12.5 m0 -103.94 107.1 17.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.485 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.808 HD12 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -96.47 121.7 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -126.73 136.29 52.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.027 0.442 . . . . 0.0 111.654 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . . . -143.53 158.67 43.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.783 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.55 139.17 47.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.866 0.365 . . . . 0.0 111.243 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.79 -69.56 3.03 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.025 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -179.05 158.4 0.91 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.948 0.404 . . . . 0.0 111.128 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.827 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -146.03 152.23 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.714 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.7 OUTLIER -135.41 123.01 22.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 111.428 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.822 HG23 HD11 ' A' ' 125' ' ' ILE . 24.3 t -94.61 136.68 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.826 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 8.6 t70 -76.72 152.03 35.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.957 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 10.6 t -109.59 101.08 10.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.155 0.502 . . . . 0.0 109.888 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.3 m-20 160.21 -36.38 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.3 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -71.76 -71.96 0.25 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.198 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.643 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.1 tt -57.71 -56.65 14.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.475 ' H ' HG23 ' A' ' 92' ' ' ILE . 5.1 t -45.6 -35.94 4.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.655 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.436 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.2 mm-40 -60.93 -46.82 89.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.095 0.474 . . . . 0.0 110.508 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.778 HD13 ' O ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -89.88 -14.66 33.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.528 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.759 HD11 ' CG ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -103.32 10.55 37.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.439 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 140.13 67.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.673 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -32.48 135.0 0.09 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.019 0.438 . . . . 0.0 111.618 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.23 17.3 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.602 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.5 OUTLIER -70.13 -171.62 0.47 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.591 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -132.99 151.68 52.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.061 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.877 HG23 ' CD1' ' A' ' 123' ' ' PHE . 11.5 p -57.82 160.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.016 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.511 ' N ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER 79.7 9.7 1.48 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.138 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.444 ' O ' HG12 ' A' ' 107' ' ' VAL . 1.7 t70 -92.94 -23.33 18.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.958 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.504 ' CE1' ' CE2' ' A' ' 123' ' ' PHE . 1.0 OUTLIER -79.62 -37.89 35.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.134 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -105.79 29.67 6.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 108' ' ' ASP . 13.9 p -81.63 -44.49 20.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.995 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.477 ' N ' HG13 ' A' ' 107' ' ' VAL . 2.2 m-20 -179.98 88.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.481 HG21 HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -141.77 81.41 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.065 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 t 68.95 -63.59 0.36 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.978 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.652 ' O ' HG23 ' A' ' 112' ' ' THR . 1.3 m 174.05 160.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 111' ' ' SER . 2.0 p -163.91 94.8 0.77 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 113' ' ' ILE . 13.0 mm -71.35 120.03 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.231 0.538 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.94 137.2 3.45 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.032 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.1 OUTLIER -77.42 119.59 21.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.644 0.259 . . . . 0.0 110.321 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.79 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -102.56 125.46 49.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 0.0 112.014 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 13.1 p90 -128.91 121.18 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.364 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.747 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.4 t -95.96 153.56 17.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.363 0.602 . . . . 0.0 112.128 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.873 HD22 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -163.59 123.7 2.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.436 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.04 -109.88 2.85 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.121 -1.037 . . . . 0.0 111.487 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -138.37 83.95 2.0 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 2.0 mtpm? 154.29 100.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.674 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.877 ' CD1' HG23 ' A' ' 102' ' ' VAL . 1.7 p90 -88.76 137.29 32.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.972 0.415 . . . . 0.0 111.006 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.714 HG23 ' HB3' ' A' ' 86' ' ' GLU . 23.9 m -110.6 129.38 55.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.246 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.827 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -110.22 117.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.859 0.838 . . . . 0.0 110.814 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.9 t -96.52 156.46 16.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.552 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.747 ' HB3' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.46 16.92 2.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.495 0.664 . . . . 0.0 109.555 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -120.46 167.91 11.87 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.296 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.3 mp 62.61 107.05 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.2 0.524 . . . . 0.0 110.938 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.67 15.28 20.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.402 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.46 33.8 3.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.618 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.8 mp -64.7 116.41 6.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.77 0.319 . . . . 0.0 110.858 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -150.82 93.79 1.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.937 0.398 . . . . 0.0 111.061 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.61 -55.5 3.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.697 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.432 ' C ' HD12 ' A' ' 136' ' ' LEU . 4.1 mttm -106.87 17.46 23.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.715 ' N ' HD12 ' A' ' 136' ' ' LEU . 0.3 OUTLIER -135.85 11.4 3.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.942 0.401 . . . . 0.0 111.36 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -48.4 -31.08 5.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.257 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -123.03 109.29 13.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -166.68 162.24 16.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.97 178.32 6.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.067 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.1 mtt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.758 0.314 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.7 p -78.95 -26.1 43.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.037 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.4 t 66.82 135.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.147 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -126.29 145.75 50.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t -156.23 97.98 1.82 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -69.27 97.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.836 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.03 174.73 10.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.468 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -127.15 29.39 5.6 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 120.977 0.418 . . . . 0.0 111.365 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.573 ' HA ' HD12 ' A' ' 12' ' ' ILE . 1.6 p-10 -55.36 -23.01 21.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.98 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.55 -32.21 42.13 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.833 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.468 ' HA3' ' CD1' ' A' ' 8' ' ' TYR . . . -73.44 -40.52 47.71 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.286 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.593 ' O ' ' N ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -108.27 9.85 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 120.234 -0.587 . . . . 0.0 111.764 178.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.529 ' CE ' ' HA ' ' A' ' 13' ' ' MET . 0.0 OUTLIER 59.2 -62.99 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.647 0.737 . . . . 0.0 112.344 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -166.78 25.04 0.14 Allowed Glycine 0 C--N 1.3 -1.451 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.934 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.2 mt -82.64 -81.89 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.665 0.269 . . . . 0.0 110.958 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.03 8.57 37.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.033 0.444 . . . . 0.0 111.159 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.83 -20.89 5.56 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.049 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -128.49 81.01 2.0 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.339 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.01 8.95 3.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.534 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.506 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -84.08 2.15 40.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.163 0.506 . . . . 0.0 111.04 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.65 -170.76 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.063 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 t70 62.32 14.28 6.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.163 0.506 . . . . 0.0 110.339 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -133.42 9.52 4.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.955 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.75 -53.69 4.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.57 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -120.99 111.89 18.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.771 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.48 -117.93 0.07 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.027 0.442 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 62.47 17.04 9.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.382 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.26 -20.89 29.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -93.35 14.57 18.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.853 0.358 . . . . 0.0 111.363 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -121.32 151.3 40.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.831 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 p -116.63 137.25 51.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.335 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 p -109.93 135.2 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.808 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.414 ' O ' ' C ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -109.82 115.29 29.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.192 0.52 . . . . 0.0 110.756 -179.586 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 33' ' ' HIS . 1.2 mt-10 27.74 61.23 0.11 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.28 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.4 t -81.95 148.67 28.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.966 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.35 58.54 4.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.472 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 81' ' ' ALA . 88.4 m -93.46 148.24 22.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.266 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -85.69 97.9 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.477 179.379 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.7 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.4 t -111.31 150.85 13.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.337 0.589 . . . . 0.0 112.163 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.809 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.12 119.79 3.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.764 178.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.678 ' C ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -113.46 126.51 70.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.173 0.511 . . . . 0.0 111.85 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.722 HD23 HD11 ' A' ' 48' ' ' ILE . 7.6 mp -126.76 140.43 52.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.606 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -48.45 133.06 16.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.497 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -78.32 87.62 4.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.502 0.668 . . . . 0.0 110.99 -179.244 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.481 ' C ' ' N ' ' A' ' 47' ' ' GLU . 21.8 m -126.4 170.99 11.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.887 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -14.12 0.17 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.289 0.566 . . . . 0.0 109.583 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.802 ' HG3' HD21 ' A' ' 96' ' ' LEU . 12.2 tt0 -70.12 -71.6 0.23 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.327 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.726 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.6 OUTLIER -59.18 -45.0 93.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.136 0.493 . . . . 0.0 110.073 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -38.78 -53.4 1.68 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.059 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.766 HG21 HD13 ' A' ' 95' ' ' LEU . 73.8 m -72.48 -74.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.941 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -41.23 -44.47 2.63 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.615 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -56.04 -48.08 79.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.223 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 3.0 pt-20 -52.14 -50.31 61.99 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.692 ' HA ' HG23 ' A' ' 58' ' ' THR . 6.9 mt-10 -68.76 -87.89 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.536 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.941 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.13 -62.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.882 ' HG ' HG12 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -65.6 -70.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.512 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.582 ' N ' HD13 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -64.4 -23.85 67.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.541 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.692 HG23 ' HA ' ' A' ' 54' ' ' GLU . 15.5 p -60.42 -70.95 0.15 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.337 0.589 . . . . 0.0 110.784 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -86.88 -36.72 18.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.345 -178.054 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.961 ' CE1' HG21 ' A' ' 68' ' ' VAL . 97.7 m-85 -76.66 -13.57 60.04 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.496 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -103.94 -41.02 6.0 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.198 178.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.585 ' HB2' ' O ' ' A' ' 58' ' ' THR . 3.8 ttpt -68.32 -50.07 56.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.071 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.592 ' O ' HG23 ' A' ' 64' ' ' VAL . 13.2 p-10 -177.4 87.0 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 121.379 0.609 . . . . 0.0 112.524 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.757 ' HB ' ' HA ' ' A' ' 60' ' ' TYR . 25.4 t -161.92 -54.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.495 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.564 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.6 m-20 169.48 144.38 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.4 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -86.26 -20.87 2.62 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.897 2.398 . . . . 0.0 112.485 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 65' ' ' ASN . 4.6 t -51.77 -48.74 63.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.234 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.961 HG21 ' CE1' ' A' ' 60' ' ' TYR . 54.3 t -53.56 82.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.872 0.367 . . . . 0.0 110.635 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 67' ' ' THR . 19.5 p30 -116.06 142.73 46.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.495 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.554 HG23 HG23 ' A' ' 79' ' ' ILE . 0.8 OUTLIER -96.82 153.89 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.267 0.556 . . . . 0.0 111.575 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -142.05 124.48 15.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.501 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.24 114.22 18.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.959 0.409 . . . . 0.0 110.771 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.464 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -90.49 -150.83 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.644 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.94 -49.74 76.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.673 0.273 . . . . 0.0 111.065 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.08 15.82 1.02 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.203 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.57 161.17 38.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.953 0.376 . . . . 0.0 111.081 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.726 ' CD1' HG21 ' A' ' 48' ' ' ILE . 63.4 m95 -85.44 143.37 28.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.496 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.3 m0 -116.72 105.7 12.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.634 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.809 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.52 112.22 30.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 0.0 110.155 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -112.34 135.41 53.06 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.218 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.651 ' O ' HG23 ' A' ' 37' ' ' THR . . . -144.65 158.65 43.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.015 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 67' ' ' THR . 1.3 p-10 -104.6 148.64 26.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.98 0.419 . . . . 0.0 111.298 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.94 -70.11 0.3 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.171 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.542 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 178.97 159.68 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.371 . . . . 0.0 110.935 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.837 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.6 160.3 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.799 ' HB2' HG22 ' A' ' 124' ' ' THR . 9.1 pt-20 -138.91 127.63 23.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.166 0.507 . . . . 0.0 111.636 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.695 HG13 HG13 ' A' ' 55' ' ' ILE . 27.5 t -94.52 146.2 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.533 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -88.98 152.04 21.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.043 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.603 ' HB2' HG23 ' A' ' 102' ' ' VAL . 42.7 t -109.49 101.03 10.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.234 0.54 . . . . 0.0 109.908 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 0.9 OUTLIER 161.11 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.226 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 94' ' ' GLU . 2.6 mm-40 -77.34 -69.52 0.53 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.958 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.602 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.3 tt -62.2 -56.02 20.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.314 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.488 ' H ' HG23 ' A' ' 92' ' ' ILE . 7.0 t -45.24 -32.43 1.93 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.389 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -63.5 -61.28 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.002 0.43 . . . . 0.0 110.493 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 50' ' ' THR . 0.2 OUTLIER -75.31 -17.24 60.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.909 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.802 HD21 ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -101.89 8.32 41.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.293 -179.237 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.45 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 143.04 65.93 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.562 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -33.57 133.61 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.968 0.413 . . . . 0.0 111.736 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 70.14 17.34 7.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.638 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.45 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -66.33 -175.5 0.36 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.61 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -85.5 -95.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.769 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.603 HG23 ' HB2' ' A' ' 89' ' ' CYS . 10.1 p 179.4 -35.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.682 0.277 . . . . 0.0 111.284 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.727 ' CE2' HG22 ' A' ' 118' ' ' THR . 5.0 m-85 -72.81 -2.67 21.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.079 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.534 ' O ' HG12 ' A' ' 107' ' ' VAL . 1.8 p30 -46.18 -39.44 9.69 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.874 0.369 . . . . 0.0 110.584 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.465 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -75.47 143.51 42.55 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.915 179.21 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 116' ' ' ALA . 3.7 tt 62.06 18.57 10.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.187 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 104' ' ' ASP . 7.6 p -82.8 -42.27 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.794 0.33 . . . . 0.0 111.038 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.433 ' N ' HG13 ' A' ' 107' ' ' VAL . 2.0 t70 -179.95 51.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.703 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -113.08 85.87 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.487 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.8 -65.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.151 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 109' ' ' VAL . 6.6 t 168.65 172.37 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.765 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER 179.27 120.87 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.882 0.372 . . . . 0.0 111.505 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.1 mm -87.52 122.83 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.331 0.586 . . . . 0.0 111.059 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.87 141.6 3.88 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.984 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 126' ' ' THR . 41.7 mtt-85 -77.24 120.11 21.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.667 ' HB3' HD22 ' A' ' 106' ' ' LEU . . . -105.36 123.84 48.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.162 0.506 . . . . 0.0 112.156 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.568 ' HE1' HD23 ' A' ' 119' ' ' LEU . 13.5 p90 -137.73 119.49 15.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.369 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.727 HG22 ' CE2' ' A' ' 103' ' ' TYR . 14.7 t -93.99 136.24 34.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.118 0.485 . . . . 0.0 111.85 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.595 ' O ' HD12 ' A' ' 119' ' ' LEU . 3.1 pp -135.07 118.75 17.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.76 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.73 -106.63 1.02 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.88 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.37 83.4 2.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.881 0.372 . . . . 0.0 110.118 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 3.7 mttt 152.3 97.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.592 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.641 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 15.1 p90 -88.26 126.31 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.423 . . . . 0.0 111.124 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.799 HG22 ' HB2' ' A' ' 86' ' ' GLU . 19.6 p -102.13 137.38 40.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.867 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.837 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -119.36 118.24 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.78 0.8 . . . . 0.0 111.268 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 115' ' ' ARG . 10.3 t -98.04 156.06 16.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.472 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.432 ' CB ' ' HA ' ' A' ' 38' ' ' VAL . 13.2 t -143.4 19.83 1.88 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.41 0.624 . . . . 0.0 109.489 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -122.87 -166.33 1.43 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.019 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 69.21 109.87 0.05 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.201 0.524 . . . . 0.0 110.952 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 6.9 ttp -107.88 16.21 23.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.207 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -58.0 -65.25 3.66 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.566 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.95 114.23 6.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.363 . . . . 0.0 110.8 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.4 p30 -88.86 58.35 4.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.964 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -48.5 78.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.778 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.406 ' H ' HD22 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -124.05 17.35 9.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.251 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.601 HD22 ' N ' ' A' ' 136' ' ' LEU . 0.9 OUTLIER -116.89 12.42 14.72 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.026 0.441 . . . . 0.0 110.899 179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -54.58 -28.94 49.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.234 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -132.25 123.9 27.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.991 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -153.35 -173.28 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -139.37 164.44 29.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.144 -179.929 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 mtm . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.826 0.345 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.75 -39.77 4.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.6 t 68.37 -68.45 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.162 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -74.8 150.9 39.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.954 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 60.94 39.82 16.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -162.86 41.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 59.76 -174.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.038 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.886 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -113.19 22.78 13.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.253 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.469 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.9 p30 -52.6 -20.93 3.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.259 0.552 . . . . 0.0 111.511 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.513 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -74.42 -16.16 60.89 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.763 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.99 -10.98 1.89 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.308 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.886 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.0 pp -58.66 -20.84 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 117.482 0.641 . . . . 0.0 112.019 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.513 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -82.05 7.53 13.08 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.972 178.233 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.786 ' O ' HD12 ' A' ' 15' ' ' LEU . . . -162.3 24.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.718 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 14' ' ' GLY . 7.2 mp -133.62 -83.09 0.46 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.66 0.266 . . . . 0.0 110.673 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.71 7.57 38.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.142 0.496 . . . . 0.0 111.017 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -119.29 -25.17 2.76 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.536 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.89 85.48 2.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.7 0.762 . . . . 0.0 110.008 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -138.65 12.77 2.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.466 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.01 13.96 5.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.856 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.99 -174.29 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.783 0.325 . . . . 0.0 110.776 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.0 t0 62.09 13.84 6.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.997 0.427 . . . . 0.0 110.84 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -148.46 12.49 0.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.23 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -99.11 -52.7 3.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.344 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -120.98 110.46 16.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.399 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.64 -116.9 0.07 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.093 0.473 . . . . 0.0 110.953 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t70 66.14 15.48 10.1 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.329 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -87.95 -19.9 26.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.958 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -93.44 15.15 16.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.431 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -81.86 137.86 35.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.84 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 p -82.27 148.19 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.099 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.96 134.77 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.67 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -109.89 115.22 29.41 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.798 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 31.01 65.36 0.16 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.043 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -68.66 146.2 53.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.749 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.96 -26.72 9.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.314 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.0 m -90.66 142.86 27.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 0.0 111.178 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -93.97 92.75 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.858 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.43 145.26 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.363 0.602 . . . . 0.0 111.99 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.774 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.22 129.48 7.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.008 179.049 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -112.94 129.36 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.213 0.53 . . . . 0.0 111.731 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.947 HD23 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -127.24 140.3 52.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.874 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.682 ' O ' HD13 ' A' ' 48' ' ' ILE . 18.2 mttp -49.27 127.54 15.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -73.14 92.2 1.7 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.73 0.776 . . . . 0.0 110.74 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.444 ' C ' ' N ' ' A' ' 47' ' ' GLU . 6.9 m -126.2 171.12 11.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.207 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -49.95 -16.8 0.31 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.831 ' CB ' HD21 ' A' ' 96' ' ' LEU . 12.5 tt0 -65.46 -74.26 0.11 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.509 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.947 HD11 HD23 ' A' ' 42' ' ' LEU . 2.2 mp -54.7 -31.92 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.2 0.524 . . . . 0.0 109.912 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -47.5 -61.68 1.81 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.51 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.7 ' CB ' HD22 ' A' ' 95' ' ' LEU . 32.9 m -82.09 -44.78 16.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.056 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.783 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -52.52 -48.85 65.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.737 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.705 HG13 HD23 ' A' ' 56' ' ' LEU . 1.6 tp -62.53 -48.52 87.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.061 0.458 . . . . 0.0 109.964 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.697 ' O ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -50.54 -47.47 57.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.402 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.721 ' HA ' HG23 ' A' ' 58' ' ' THR . 28.7 mt-10 -77.77 -71.05 0.44 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.343 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.88 HG13 HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -30.64 -59.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.96 ' HG ' HD22 ' A' ' 57' ' ' LEU . 0.7 OUTLIER -78.91 -50.16 11.65 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.172 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.96 HD22 ' HG ' ' A' ' 56' ' ' LEU . 3.1 mm? -65.03 -48.25 74.56 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 119.312 0.96 . . . . 0.0 111.376 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.721 HG23 ' HA ' ' A' ' 54' ' ' GLU . 46.0 p -53.0 -71.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.018 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.465 ' HB3' HG23 ' A' ' 64' ' ' VAL . 9.1 m-20 -62.35 -18.17 60.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.964 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.694 ' HE1' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -51.24 -78.1 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.694 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -19.7 64.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.086 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 58' ' ' THR . 4.8 ttpp -59.73 -70.38 0.17 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.021 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.91 21.73 0.17 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.522 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 65' ' ' ASN . 43.1 t -98.38 -78.36 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.625 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.782 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.8 m-20 154.51 170.82 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.048 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 80.8 Cg_endo -88.62 -7.39 5.62 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.972 2.448 . . . . 0.0 111.955 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.782 HG22 ' HB3' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -64.62 -85.33 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.878 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -28.97 86.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.635 0.731 . . . . 0.0 111.815 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.2 p30 -115.91 143.28 45.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.563 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.555 HG23 HG23 ' A' ' 79' ' ' ILE . 1.5 p -96.27 151.0 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.321 0.581 . . . . 0.0 111.559 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 16.4 pt-20 -144.92 135.38 24.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.551 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -79.85 114.56 18.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.783 0.325 . . . . 0.0 110.434 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -85.09 -78.47 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.996 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.31 -66.73 0.68 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . -125.0 3.85 8.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.676 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.6 158.1 44.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.808 0.337 . . . . 0.0 110.823 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.652 ' CD1' HG21 ' A' ' 48' ' ' ILE . 78.2 m95 -77.29 142.99 39.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.546 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.583 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.5 m0 -114.8 109.85 18.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.356 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.774 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -100.02 116.17 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.191 0.52 . . . . 0.0 111.382 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -111.72 134.63 53.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.122 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.613 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . . . -144.43 158.76 43.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.898 0.38 . . . . 0.0 111.556 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.489 ' OD1' HG21 ' A' ' 67' ' ' THR . 1.0 OUTLIER -109.18 143.34 38.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.921 179.198 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.93 -69.05 0.62 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.483 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.53 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -177.07 152.31 0.89 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.213 0.53 . . . . 0.0 111.728 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.732 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -125.79 160.47 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.696 ' HB2' HG22 ' A' ' 124' ' ' THR . 17.2 pt-20 -147.24 125.86 12.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.499 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.88 HG13 HG13 ' A' ' 55' ' ' ILE . 38.2 t -95.48 146.9 6.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.673 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 8.9 p30 -101.54 151.82 21.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.639 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.471 ' O ' ' OD1' ' A' ' 121' ' ' ASN . 1.2 t -105.34 99.85 9.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.296 0.57 . . . . 0.0 110.186 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.1 m-20 159.75 -37.58 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.954 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -69.93 -75.82 0.11 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.635 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.637 HD12 ' CD2' ' A' ' 51' ' ' PHE . 1.6 tt -52.88 -56.42 7.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.521 ' H ' HG23 ' A' ' 92' ' ' ILE . 56.0 p -46.14 -43.3 14.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.0 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -51.14 -45.81 61.75 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 109.959 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.7 HD22 ' CB ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -91.2 -18.77 23.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.591 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.831 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.32 19.31 13.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.193 0.521 . . . . 0.0 110.746 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 98' ' ' ARG . . . 99.79 68.56 0.88 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.494 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -30.05 148.07 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.084 0.468 . . . . 0.0 111.895 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 55.3 105.59 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.412 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -175.46 -158.85 0.07 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.632 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.09 132.39 35.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.165 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.473 HG21 ' OG1' ' A' ' 118' ' ' THR . 5.9 p -81.51 -28.59 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.806 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.702 ' CE2' HG22 ' A' ' 118' ' ' THR . 4.0 m-85 -77.44 -2.82 37.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.749 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.788 ' O ' HG12 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -46.02 -35.87 5.17 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-O 120.876 0.369 . . . . 0.0 110.62 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.542 ' CE2' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -80.66 134.35 35.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.152 179.31 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.801 ' O ' HD23 ' A' ' 106' ' ' LEU . 3.9 tt 75.46 7.68 3.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.862 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.788 HG12 ' O ' ' A' ' 104' ' ' ASP . 11.4 p -86.02 -36.84 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.828 0.347 . . . . 0.0 111.255 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -178.43 48.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.616 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.676 HG21 HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -113.41 86.17 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.261 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.97 -65.78 0.21 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.942 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.528 ' C ' HG22 ' A' ' 112' ' ' THR . 5.9 t 165.44 169.81 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.524 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -179.18 133.84 0.12 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.976 0.417 . . . . 0.0 111.513 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 113' ' ' ILE . 5.0 mm -104.85 113.71 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.54 0.686 . . . . 0.0 110.94 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 152.45 146.85 4.45 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.132 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.29 127.25 32.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.64 0.257 . . . . 0.0 110.594 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.711 ' HB2' HD13 ' A' ' 106' ' ' LEU . . . -115.72 124.66 51.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.088 0.47 . . . . 0.0 111.766 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 23.6 p90 -136.92 118.95 15.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.854 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.702 HG22 ' CE2' ' A' ' 103' ' ' TYR . 11.0 t -95.35 152.66 18.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.217 0.532 . . . . 0.0 111.498 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.614 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.7 pp -148.41 116.46 6.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.893 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.06 -104.17 0.37 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.188 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.2 OUTLIER -129.61 83.97 2.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.24 0.543 . . . . 0.0 109.653 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 8.6 mttt 148.73 112.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.998 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.575 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 9.5 p90 -109.18 124.38 50.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.069 0.461 . . . . 0.0 110.817 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.696 HG22 ' HB2' ' A' ' 86' ' ' GLU . 7.3 p -100.49 141.72 32.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.643 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.818 HD11 HG23 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -120.82 117.61 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.87 0.843 . . . . 0.0 111.296 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 115' ' ' ARG . 12.8 t -103.61 155.47 18.52 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.105 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.466 ' CB ' HG13 ' A' ' 38' ' ' VAL . 30.1 t -144.41 18.96 1.71 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.301 0.572 . . . . 0.0 109.855 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -123.97 -27.15 3.94 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.459 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 65.27 107.94 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.189 0.518 . . . . 0.0 110.796 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 67.9 mtm -93.76 16.07 14.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.49 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -106.67 46.59 1.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.539 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 18.6 mt -91.74 55.36 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.936 0.398 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.807 ' HA ' HD12 ' A' ' 136' ' ' LEU . 70.6 m-20 59.92 28.89 18.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.022 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -52.66 57.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.702 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -115.4 31.33 6.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.614 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.807 HD12 ' HA ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -128.21 -161.65 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.83 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 71.63 -55.94 0.65 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.335 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -114.61 111.0 20.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.11 177.36 7.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -132.16 133.71 44.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.087 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.808 0.337 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 t 56.96 -169.16 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 t -133.4 -53.38 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.027 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -98.62 151.47 20.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -58.6 -26.87 64.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.954 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.2 m120 64.94 90.69 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.91 103.11 4.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.102 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -64.18 -134.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.387 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.434 ' O ' ' HE3' ' A' ' 13' ' ' MET . 1.5 m-20 -46.41 -26.42 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.126 0.489 . . . . 0.0 112.318 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.58 -26.5 62.63 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.527 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 8' ' ' TYR . . . -94.28 -26.22 14.52 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.731 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.472 ' CD1' ' H ' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -92.29 -26.33 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.79 0.805 . . . . 0.0 110.664 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.439 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER 28.7 46.07 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.79 -1.55 . . . . 0.0 113.34 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.472 ' H ' ' CD1' ' A' ' 12' ' ' ILE . . . -149.2 -89.41 0.08 OUTLIER Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.184 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.58 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.7 mm? -44.01 -69.61 0.13 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.738 0.304 . . . . 0.0 111.415 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.426 ' H ' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -99.61 -6.42 27.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.192 0.52 . . . . 0.0 111.642 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.16 -13.35 42.75 Favored Glycine 0 C--N 1.313 -0.723 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.704 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.45 81.55 2.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.133 0.492 . . . . 0.0 110.632 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -137.6 12.01 2.96 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.354 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.05 15.16 6.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.71 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.98 -171.69 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.849 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.71 14.22 4.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.06 0.457 . . . . 0.0 110.568 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -141.25 11.29 2.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.978 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.74 -45.05 14.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.515 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -120.4 110.85 17.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.644 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.52 -115.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.937 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 t0 67.04 15.34 10.1 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.377 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -76.5 -26.37 55.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.771 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -144.61 17.1 1.65 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.367 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -97.5 165.91 11.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.93 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.29 150.72 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.052 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 10.9 p -109.95 134.42 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.861 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.406 ' O ' ' C ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -110.42 115.11 29.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.251 0.548 . . . . 0.0 110.867 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 33' ' ' HIS . 0.9 OUTLIER 29.04 71.04 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.198 179.36 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.414 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 3.9 t -76.22 142.65 41.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.933 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -107.28 27.97 8.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.9 m -69.11 143.56 54.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.071 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.582 HG13 ' CB ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -87.64 98.89 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.69 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 113' ' ' ILE . 7.2 t -117.17 152.82 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.314 0.578 . . . . 0.0 111.881 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.777 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -164.53 128.09 2.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.085 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.42 130.7 65.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.251 0.548 . . . . 0.0 111.927 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.032 HD23 HD11 ' A' ' 48' ' ' ILE . 9.0 tp -128.04 140.49 51.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.816 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.665 ' O ' HD13 ' A' ' 48' ' ' ILE . 7.6 ttmm -47.17 124.53 6.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.569 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.476 ' HA ' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -71.68 90.36 1.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.501 0.667 . . . . 0.0 110.655 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.475 ' C ' ' N ' ' A' ' 47' ' ' GLU . 3.7 m -125.72 171.79 10.34 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.198 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -48.11 -17.77 0.15 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.269 0.557 . . . . 0.0 109.526 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.795 ' HA ' HD21 ' A' ' 96' ' ' LEU . 25.7 tt0 -63.23 -77.42 0.05 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.468 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.032 HD11 HD23 ' A' ' 42' ' ' LEU . 2.3 mp -54.62 -31.74 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -47.03 -60.23 2.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.276 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.604 ' CB ' HD22 ' A' ' 95' ' ' LEU . 3.9 m -84.17 -45.59 12.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.054 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.825 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -51.44 -47.64 62.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.513 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.689 HD13 HG23 ' A' ' 48' ' ' ILE . 1.5 tp -63.66 -49.04 83.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.062 0.458 . . . . 0.0 109.818 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -50.78 -45.04 58.9 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.802 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.789 ' HA ' HG23 ' A' ' 58' ' ' THR . 3.2 mt-10 -77.25 -77.19 0.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.695 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.853 HG13 HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -30.98 -55.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.689 ' N ' HG23 ' A' ' 55' ' ' ILE . 7.0 tt -71.28 -60.52 2.19 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 57' ' ' LEU . 2.6 mm? -66.85 -48.23 69.5 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.789 HG23 ' HA ' ' A' ' 54' ' ' GLU . 51.8 p -51.98 -71.82 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.062 0.458 . . . . 0.0 110.279 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.492 ' HB2' HG21 ' A' ' 64' ' ' VAL . 6.3 m-20 -60.59 -23.21 64.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.891 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.709 ' HE1' HG13 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.32 -78.0 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -67.91 -26.17 65.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.297 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.0 ttpp -52.02 -66.54 0.37 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.872 0.367 . . . . 0.0 111.281 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -169.76 30.39 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.255 0.55 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 65' ' ' ASN . 24.1 t -101.68 -78.63 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.348 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.784 ' HB3' HG22 ' A' ' 67' ' ' THR . 5.1 m-20 154.49 165.92 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 O-C-N 123.523 0.514 . . . . 0.0 110.946 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.464 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 94.7 Cg_endo -86.19 -3.54 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.79 2.327 . . . . 0.0 111.922 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.784 HG22 ' HB3' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -68.82 -86.75 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.44 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.709 HG13 ' HE1' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -24.29 89.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.559 0.695 . . . . 0.0 111.895 -179.405 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -116.04 143.1 45.92 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.04 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.538 HG23 HG23 ' A' ' 79' ' ' ILE . 1.5 p -96.73 153.06 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.146 0.498 . . . . 0.0 111.547 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.512 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 27.6 tt0 -143.83 133.09 23.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.991 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.65 114.37 21.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.295 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -94.3 -81.67 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.318 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.42 -69.21 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.835 0.35 . . . . 0.0 111.354 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . -126.55 5.45 7.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.034 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.66 153.91 43.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 110.889 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.641 ' CD1' HG21 ' A' ' 48' ' ' ILE . 82.7 m95 -76.83 143.07 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.62 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.512 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.3 m0 -111.3 105.03 13.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.339 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.777 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.81 110.56 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.028 0.442 . . . . 0.0 110.824 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -112.13 135.71 52.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.066 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.657 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . . . -144.09 156.9 44.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.417 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.423 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 0.5 OUTLIER -109.07 128.93 55.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.449 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.04 -67.67 3.12 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.327 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.61 152.38 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.252 0.548 . . . . 0.0 111.619 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.74 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -127.08 160.21 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.745 ' HB3' HG23 ' A' ' 124' ' ' THR . 2.3 pt-20 -149.39 125.69 10.81 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.547 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.853 HG13 HG13 ' A' ' 55' ' ' ILE . 62.1 t -95.3 146.48 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.476 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 122' ' ' LYS . 6.7 t70 -95.72 151.41 19.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.408 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.491 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 7.6 t -104.01 100.02 9.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.111 0.482 . . . . 0.0 110.082 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.2 m-20 157.7 -36.43 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.337 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 94' ' ' GLU . 0.9 OUTLIER -69.88 -76.41 0.1 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.543 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.573 HD12 ' CD2' ' A' ' 51' ' ' PHE . 2.8 tt -54.05 -56.5 9.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.357 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.512 ' H ' HG23 ' A' ' 92' ' ' ILE . 16.9 p -47.58 -36.05 10.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.876 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.45 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -57.83 -46.21 85.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.109 0.481 . . . . 0.0 110.053 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.604 HD22 ' CB ' ' A' ' 50' ' ' THR . 0.7 OUTLIER -90.5 -18.46 25.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.626 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.795 HD21 ' HA ' ' A' ' 47' ' ' GLU . 1.1 mm? -98.67 14.03 30.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.054 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.6 68.09 0.37 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.063 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -33.07 149.86 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.088 0.47 . . . . 0.0 111.97 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.63 17.99 9.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.324 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -165.36 0.4 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.939 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -96.0 -162.76 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.933 HG23 ' CD1' ' A' ' 123' ' ' PHE . 1.5 p -117.44 -32.07 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.084 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -81.58 5.77 17.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.579 0.228 . . . . 0.0 111.474 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 107' ' ' VAL . 11.6 t70 -60.6 -39.32 87.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.651 0.262 . . . . 0.0 110.811 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.528 ' HE2' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -66.87 -14.03 62.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.13 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -143.01 35.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.786 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 104' ' ' ASP . 10.8 p -87.18 -32.94 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.112 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -176.85 38.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.407 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.605 HG21 HG23 ' A' ' 112' ' ' THR . 25.6 m -69.56 165.81 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.644 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.9 m -54.51 -46.79 73.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.004 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.3 140.85 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.605 HG23 HG21 ' A' ' 109' ' ' VAL . 1.4 p -149.75 75.35 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.504 HD13 ' HA ' ' A' ' 113' ' ' ILE . 4.9 mm -58.99 106.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.48 0.657 . . . . 0.0 111.007 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.56 144.98 4.26 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.878 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 126' ' ' THR . 19.6 mtm180 -76.55 125.8 29.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.801 0.334 . . . . 0.0 110.736 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.68 ' HB2' HD13 ' A' ' 106' ' ' LEU . . . -104.04 125.28 50.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.965 0.412 . . . . 0.0 111.658 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 13.9 p90 -133.91 120.58 20.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.772 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.849 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.5 t -97.11 158.45 15.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.237 0.541 . . . . 0.0 111.929 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 119' ' ' LEU . 3.0 pp -157.42 118.06 3.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.793 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.8 -106.35 0.86 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.817 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -132.55 83.85 2.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.5 OUTLIER 152.37 110.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.191 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.933 ' CD1' HG23 ' A' ' 102' ' ' VAL . 2.1 p90 -101.6 132.33 47.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.236 0.541 . . . . 0.0 111.132 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.745 HG23 ' HB3' ' A' ' 86' ' ' GLU . 30.4 m -106.98 134.43 50.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.747 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.763 ' H ' HD12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -117.32 117.45 55.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.711 0.767 . . . . 0.0 111.011 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.9 t -109.57 155.16 21.76 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.943 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.582 ' CB ' HG13 ' A' ' 38' ' ' VAL . 28.8 t -142.63 21.97 1.99 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.354 0.597 . . . . 0.0 109.705 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.625 ' O ' HD22 ' A' ' 129' ' ' LEU . 2.3 mt-10 -124.0 45.04 2.57 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.106 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.625 HD22 ' O ' ' A' ' 128' ' ' GLU . 1.0 OUTLIER -137.23 16.45 2.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.297 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 55.1 mtm -95.81 15.76 19.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.295 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -157.07 68.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.584 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.53 -53.99 46.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 110.855 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 61.41 42.6 11.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.993 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -56.53 15.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.717 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.85 32.0 5.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.689 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 13.7 mt -109.57 -145.52 0.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.806 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -39.91 -41.7 1.21 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -113.25 103.74 11.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.025 0.44 . . . . 0.0 111.018 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -155.89 -164.42 1.71 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.969 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.08 163.17 2.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.949 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.064 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.799 0.333 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 p -166.58 95.41 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.851 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 p -153.66 129.46 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.77 146.97 34.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p -61.58 -34.47 75.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.933 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -134.66 155.51 50.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -164.44 142.29 6.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.891 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -103.32 20.7 17.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.322 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.555 ' HA ' HG12 ' A' ' 12' ' ' ILE . 28.8 m-20 -54.1 -18.33 3.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.135 0.493 . . . . 0.0 111.666 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.37 -22.52 54.73 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.625 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.441 ' HA3' ' CE1' ' A' ' 8' ' ' TYR . . . -125.29 -7.63 5.78 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.266 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.891 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.2 pp -61.33 -18.64 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 117.567 0.683 . . . . 0.0 111.793 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.423 ' HE2' ' H ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -84.19 9.33 13.07 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.91 178.187 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.99 -46.92 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.319 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -74.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.68 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -101.83 11.42 38.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.095 0.474 . . . . 0.0 111.161 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -112.55 -16.08 9.05 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.081 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.03 80.71 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.026 0.441 . . . . 0.0 110.531 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -142.67 7.61 1.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.669 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.84 18.19 7.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.812 0.339 . . . . 0.0 111.426 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.46 -174.26 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.908 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.2 t0 62.42 12.95 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.101 0.477 . . . . 0.0 110.912 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -143.78 10.64 1.59 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.961 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -98.32 -50.45 4.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.714 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.11 113.47 20.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.238 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.56 -116.58 0.08 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.099 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 t0 66.53 15.58 10.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.484 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -60.22 -29.13 68.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.921 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.15 106.89 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.189 0.518 . . . . 0.0 110.869 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -89.63 154.61 19.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.918 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -100.04 139.96 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.041 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.4 p -109.89 134.75 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.858 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.93 115.23 29.41 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.834 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 33.18 61.2 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.116 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 t -81.29 146.13 30.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.807 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.55 16.24 16.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.22 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.5 m -120.47 144.56 47.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.859 0.362 . . . . 0.0 111.007 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.677 HG11 HG23 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -101.45 106.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.498 179.389 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 113' ' ' ILE . 12.4 t -121.47 150.32 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 121.42 0.629 . . . . 0.0 112.252 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.77 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -164.78 130.96 2.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.865 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 111' ' ' SER . 0.0 OUTLIER -112.65 128.92 69.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.262 0.553 . . . . 0.0 111.863 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.931 ' HG ' HG11 ' A' ' 109' ' ' VAL . 0.5 OUTLIER -128.18 148.4 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.356 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.61 153.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.852 0.358 . . . . 0.0 111.381 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.444 ' HA ' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -90.7 22.35 3.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.599 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.449 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -71.52 171.64 11.0 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.068 -178.544 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -49.39 -14.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.57 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.982 ' HG3' HD21 ' A' ' 96' ' ' LEU . 1.4 tt0 -63.82 -76.82 0.06 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.989 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -55.96 -44.31 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.365 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -39.65 -58.61 1.28 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.907 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.878 ' HB ' HD11 ' A' ' 95' ' ' LEU . 27.5 m -84.16 -56.47 3.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.892 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.916 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -47.15 -50.42 20.47 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.547 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.8 tp -59.43 -48.2 88.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.818 0.342 . . . . 0.0 110.179 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.788 ' O ' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -50.51 -52.38 39.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.339 0.59 . . . . 0.0 109.604 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.751 ' HA ' HG23 ' A' ' 58' ' ' THR . 13.2 mm-40 -69.05 -81.18 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.649 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.916 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -23.27 -58.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.74 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.5 mp -73.25 -66.2 0.71 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.788 HD22 ' O ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -62.94 -33.33 75.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.751 HG23 ' HA ' ' A' ' 54' ' ' GLU . 70.0 p -60.89 -67.7 0.38 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.267 0.556 . . . . 0.0 110.905 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.614 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 0.1 OUTLIER -85.69 -42.81 13.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.805 ' CG ' HG11 ' A' ' 68' ' ' VAL . 52.0 m-85 -69.94 -24.28 63.33 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -92.59 -50.99 5.33 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.722 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.0 ttmt -60.81 -41.37 95.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.422 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.71 ' O ' HG23 ' A' ' 64' ' ' VAL . 8.5 p-10 179.72 104.0 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.888 0.375 . . . . 0.0 111.698 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER 177.85 -53.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.138 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.517 ' N ' HG12 ' A' ' 64' ' ' VAL . 4.3 m-20 -179.53 143.07 0.38 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 111.876 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.04 -4.0 10.4 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.742 2.295 . . . . 0.0 111.858 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.552 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -83.52 -108.17 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.533 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.805 HG11 ' CG ' ' A' ' 60' ' ' TYR . 9.5 p 27.01 49.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.296 0.57 . . . . 0.0 111.657 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -82.25 137.72 34.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.124 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -98.06 154.0 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.228 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 2.4 mm-40 -142.23 120.12 11.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.059 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -78.85 114.0 17.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.418 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 2.2 tpt180 -98.08 -145.28 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.914 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.73 -19.9 44.33 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 120.605 0.24 . . . . 0.0 111.436 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.26 -50.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.593 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.49 156.14 29.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.381 . . . . 0.0 110.738 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.989 ' CD1' HG21 ' A' ' 48' ' ' ILE . 38.3 m95 -81.84 143.69 31.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.391 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.467 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 9.4 m0 -108.84 107.16 17.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.383 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.77 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.2 109.55 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.1 0.476 . . . . 0.0 110.051 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -118.35 141.7 48.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.184 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB3' HG22 ' A' ' 85' ' ' ILE . . . -143.38 157.95 44.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.52 120.85 40.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.953 0.406 . . . . 0.0 111.595 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.07 -65.46 1.93 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.085 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.596 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -178.53 155.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 0.0 110.769 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.783 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -133.3 156.81 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.689 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.823 ' HB2' HG22 ' A' ' 124' ' ' THR . 3.3 pt-20 -144.79 123.69 12.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.212 0.53 . . . . 0.0 111.664 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.758 HG23 HD11 ' A' ' 125' ' ' ILE . 28.8 t -94.3 146.28 6.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.553 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 0.8 OUTLIER -89.93 152.03 21.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.329 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 41.4 t -114.48 101.12 8.83 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 7.7 t0 161.55 -28.69 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.436 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -86.58 -69.11 0.7 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.649 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.819 HD12 ' CD2' ' A' ' 51' ' ' PHE . 0.9 OUTLIER -52.8 -80.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.494 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.607 ' N ' HG12 ' A' ' 92' ' ' ILE . 6.5 p -19.94 -55.68 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 76.5 mm-40 -54.79 -47.15 74.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 0.0 111.799 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.878 HD11 ' HB ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -89.96 -28.81 18.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.895 -178.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.982 HD21 ' HG3' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -56.9 -19.93 20.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.99 -44.98 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.01 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER 171.11 -171.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -58.81 100.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.055 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CB ' ' HB2' ' A' ' 93' ' ' SER . 0.1 OUTLIER -114.77 -165.7 1.04 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.98 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.65 -173.87 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 0.0 111.045 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.8 HG21 ' OG1' ' A' ' 118' ' ' THR . 4.3 p -83.89 173.37 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.944 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.642 ' H ' HG22 ' A' ' 102' ' ' VAL . 0.5 OUTLIER 69.91 9.77 7.23 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.697 -179.044 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.586 ' O ' HG12 ' A' ' 107' ' ' VAL . 8.7 p-10 -80.14 -35.0 37.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.291 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.582 ' CE1' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -63.57 -52.97 58.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.703 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -97.93 31.78 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.986 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 104' ' ' ASP . 14.5 p -72.91 -44.76 57.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.069 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.489 ' N ' HG13 ' A' ' 107' ' ' VAL . 0.4 OUTLIER 173.76 96.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.818 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.931 HG11 ' HG ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -134.38 -171.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.96 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.1 OUTLIER -47.84 -40.28 20.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.909 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.5 ' HB3' HG23 ' A' ' 41' ' ' VAL . 2.2 t 171.83 157.54 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.817 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 63.0 p -156.51 75.95 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.119 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 113' ' ' ILE . 6.2 mm -59.95 108.17 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.386 0.612 . . . . 0.0 111.084 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.43 141.91 3.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.011 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 126' ' ' THR . 34.9 mtm105 -77.05 120.21 21.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.657 0.265 . . . . 0.0 110.409 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.734 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -104.54 126.41 51.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.096 0.475 . . . . 0.0 112.263 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.457 ' HE1' HD23 ' A' ' 119' ' ' LEU . 5.7 p90 -136.14 125.39 24.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.603 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.8 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.5 t -91.21 159.11 16.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.185 0.517 . . . . 0.0 111.961 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.5 pp -161.25 116.82 2.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.916 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.78 -109.13 1.85 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.689 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -129.1 83.1 2.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 11.5 mttt 151.34 120.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.525 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.68 ' CD1' HG23 ' A' ' 102' ' ' VAL . 1.3 p90 -108.45 135.5 49.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.845 0.355 . . . . 0.0 110.528 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.823 HG22 ' HB2' ' A' ' 86' ' ' GLU . 19.3 p -109.81 134.65 51.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.685 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.783 HD13 ' CD1' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -114.95 117.48 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.839 0.828 . . . . 0.0 110.6 178.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 115' ' ' ARG . 10.7 t -99.51 156.74 16.88 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.651 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.442 ' HB2' HG13 ' A' ' 38' ' ' VAL . 2.7 m -142.71 20.88 2.0 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.335 0.588 . . . . 0.0 109.653 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -122.58 143.79 49.52 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.986 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 64.17 107.13 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.232 0.539 . . . . 0.0 110.756 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.8 ttt -125.62 15.19 8.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.248 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -84.6 -68.17 1.4 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.521 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.98 100.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.781 0.324 . . . . 0.0 110.85 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -118.42 36.66 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.076 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -59.72 -51.03 71.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.662 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.736 ' O ' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -117.16 32.02 6.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.569 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.736 HD23 ' O ' ' A' ' 135' ' ' LYS . 3.6 mt -134.49 -159.42 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.765 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 72.33 -55.77 0.66 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.378 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -149.73 153.62 37.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.853 0.359 . . . . 0.0 110.974 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.31 93.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -59.4 125.78 25.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.99 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.075 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 mtm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.755 0.312 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.87 35.83 1.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.1 t -76.32 110.22 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -83.64 147.9 27.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.1 t -153.96 -79.25 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.35 96.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.9 116.07 31.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.233 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.771 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -63.65 -133.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.344 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.461 ' HA ' HG12 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -46.96 -22.09 0.29 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.544 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -73.32 -16.27 61.37 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.404 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.76 -1.56 3.34 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.322 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.0 pp -67.97 -15.94 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-O 121.424 0.631 . . . . 0.0 111.912 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.544 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.49 9.12 14.28 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.916 178.203 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.23 -48.69 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.678 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -79.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 110.902 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -93.06 11.3 28.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.032 0.444 . . . . 0.0 111.242 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.96 -20.94 5.5 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.233 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -129.52 80.63 1.97 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.023 0.44 . . . . 0.0 110.623 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -145.52 9.76 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.738 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.28 17.28 10.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.893 0.377 . . . . 0.0 111.224 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.0 -9.49 58.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.673 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.3 11.3 24.04 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.865 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 1.2 tm0? -142.7 12.48 1.89 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.965 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -102.85 -53.54 2.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.136 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -121.09 110.32 16.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.28 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.63 -115.26 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.043 0.449 . . . . 0.0 111.109 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 t0 69.17 15.64 8.62 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.272 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.75 -26.31 44.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.998 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -175.27 104.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.62 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -139.3 159.37 42.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.787 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 31' ' ' VAL . 10.9 p -117.96 124.43 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.218 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 10.8 p -110.1 134.68 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.667 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 34' ' ' GLU . 9.7 m-70 -110.36 115.08 29.03 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.924 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 33' ' ' HIS . 0.1 OUTLIER 25.35 48.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.41 179.487 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -91.99 129.36 37.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.91 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.58 34.31 0.86 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.402 ' C ' ' HG ' ' A' ' 127' ' ' SER . 15.9 m -85.75 155.8 20.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.115 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.745 HG13 ' HB3' ' A' ' 127' ' ' SER . 0.2 OUTLIER -110.9 107.18 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.59 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.572 HG22 ' HG2' ' A' ' 80' ' ' LYS . 11.6 t -119.48 152.45 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.401 0.62 . . . . 0.0 112.108 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.769 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -165.55 128.69 2.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.968 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.542 HG23 ' OG ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -112.07 132.43 60.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.337 0.589 . . . . 0.0 111.739 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.098 HD23 HD11 ' A' ' 48' ' ' ILE . 1.1 tp -127.96 140.17 52.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.513 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -48.88 128.44 15.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.426 0.155 . . . . 0.0 110.761 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.487 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -78.72 86.94 4.64 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.545 0.688 . . . . 0.0 110.441 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.46 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -126.03 171.41 10.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.403 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.35 -14.35 0.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.201 0.524 . . . . 0.0 109.739 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.679 ' HG3' HD21 ' A' ' 96' ' ' LEU . 2.6 tt0 -72.53 -63.83 1.08 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.088 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.098 HD11 HD23 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -61.66 -44.92 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.169 0.509 . . . . 0.0 110.139 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -42.44 -55.89 3.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.588 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.815 HG21 ' HG ' ' A' ' 95' ' ' LEU . 75.8 m -67.0 -77.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.967 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -39.7 -55.15 1.96 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.102 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.57 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.5 tp -45.81 -45.7 5.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.076 0.465 . . . . 0.0 109.839 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.631 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.4 pt-20 -57.12 -40.54 77.28 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.743 ' HA ' HG23 ' A' ' 58' ' ' THR . 2.9 mp0 -81.75 -91.8 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.547 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.967 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.78 -54.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.879 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -72.71 -42.53 64.09 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.631 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -83.14 -45.93 13.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.279 0.561 . . . . 0.0 110.696 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.743 HG23 ' HA ' ' A' ' 54' ' ' GLU . 69.5 p -53.61 -70.47 0.09 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.993 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.591 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 5.4 m-20 -89.66 -30.43 18.11 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.879 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 32.0 m-85 -80.15 -24.67 40.26 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.524 1.056 . . . . 0.0 111.566 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 2.2 tptt -90.39 -47.66 7.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.052 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.641 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -56.08 -47.46 77.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.752 0.31 . . . . 0.0 111.226 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.703 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -179.52 102.2 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.983 0.42 . . . . 0.0 111.282 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -179.92 -57.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.718 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.574 ' N ' HG12 ' A' ' 64' ' ' VAL . 4.0 m-80 178.65 127.8 0.21 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.608 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -85.21 -17.33 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.658 2.239 . . . . 0.0 111.908 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ASN . 1.8 t -57.41 -49.91 74.69 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.561 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.827 HG11 ' CD1' ' A' ' 60' ' ' TYR . 2.9 p -42.73 87.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.09 0.472 . . . . 0.0 111.194 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.2 p30 -115.25 142.57 46.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.303 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.44 HG23 HG23 ' A' ' 79' ' ' ILE . 0.7 OUTLIER -96.97 153.2 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 121.187 0.518 . . . . 0.0 111.622 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -142.9 123.34 13.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.121 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -79.86 114.35 18.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.295 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -93.73 -71.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.368 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.09 -69.94 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.128 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.24 4.55 9.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.814 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.48 149.78 39.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.834 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.835 ' CD1' HG21 ' A' ' 48' ' ' ILE . 74.9 m95 -77.45 142.72 39.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.571 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.564 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.7 m0 -107.67 106.63 17.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.27 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.769 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.19 110.87 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 0.0 110.142 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.572 ' HG2' HG22 ' A' ' 39' ' ' VAL . 5.0 mtpt -116.51 135.52 53.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.046 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.56 ' HB3' ' CG2' ' A' ' 85' ' ' ILE . . . -144.46 159.26 43.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.793 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -96.8 148.32 23.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.959 0.409 . . . . 0.0 111.352 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.87 -69.73 0.42 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.343 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.729 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -179.58 161.46 1.03 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.913 0.387 . . . . 0.0 110.883 -179.377 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.812 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -141.08 155.77 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.801 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.7 ' HB3' HG23 ' A' ' 124' ' ' THR . 13.2 pt-20 -140.31 124.01 17.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.018 0.437 . . . . 0.0 111.481 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.882 HG13 HG13 ' A' ' 55' ' ' ILE . 24.8 t -93.67 143.86 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.581 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 6.3 t70 -88.25 151.73 22.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.012 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 54.0 t -111.78 100.51 8.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.047 0.451 . . . . 0.0 109.86 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 3.1 t70 162.41 -36.14 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.932 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.24 -68.05 0.56 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.984 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.574 ' HB ' ' CD2' ' A' ' 51' ' ' PHE . 1.6 tt -59.32 -55.67 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.591 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.501 ' H ' HG23 ' A' ' 92' ' ' ILE . 19.9 p -48.81 -32.92 9.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.599 0.238 . . . . 0.0 111.628 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.2 mm-40 -62.55 -47.64 82.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.754 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.861 HD13 ' O ' ' A' ' 95' ' ' LEU . 2.3 tm? -90.05 -17.21 28.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.703 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.679 HD21 ' HG3' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.26 8.35 44.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.832 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 131.23 70.08 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.177 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -31.23 147.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.059 0.457 . . . . 0.0 111.836 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 64.21 18.22 11.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.082 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -71.87 -167.14 0.26 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.086 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -100.79 -164.08 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.664 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.901 HG23 ' CD1' ' A' ' 123' ' ' PHE . 1.5 p -113.15 -33.56 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.041 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.513 ' CZ ' HG22 ' A' ' 118' ' ' THR . 20.3 m-85 -80.1 5.59 13.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.327 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.459 ' O ' HG12 ' A' ' 107' ' ' VAL . 25.1 p-10 -59.4 -41.74 90.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.647 0.26 . . . . 0.0 110.968 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.542 ' HE2' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -60.73 -28.11 68.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.774 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.542 HD13 ' OG1' ' A' ' 112' ' ' THR . 3.1 tp -131.5 40.6 3.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.028 0.442 . . . . 0.0 110.938 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 104' ' ' ASP . 14.9 p -87.19 -36.29 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 178.65 69.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.486 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.604 HG11 ' HG ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -113.26 179.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.062 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.517 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.9 OUTLIER -46.54 -43.84 17.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.067 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.542 ' OG ' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER 170.68 165.25 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.982 0.42 . . . . 0.0 111.301 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 42.4 p -159.08 80.67 0.77 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.85 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 113' ' ' ILE . 5.1 mm -58.95 105.09 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.49 0.662 . . . . 0.0 111.286 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' A' ' 126' ' ' THR . . . 144.34 144.72 4.23 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.965 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.75 120.04 21.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.58 0.229 . . . . 0.0 110.493 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -99.81 125.31 45.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.97 0.414 . . . . 0.0 112.037 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 1.7 p90 -131.45 122.36 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.361 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.81 ' OG1' HG21 ' A' ' 102' ' ' VAL . 15.2 t -103.33 158.9 16.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 111.882 -178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.617 ' O ' HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -167.78 134.32 2.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.356 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.45 -109.89 1.58 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.674 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.43 83.73 2.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.712 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 7.3 mttt 153.39 122.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.503 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.901 ' CD1' HG23 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -107.93 139.55 42.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.933 0.396 . . . . 0.0 110.444 179.214 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.7 HG23 ' HB3' ' A' ' 86' ' ' GLU . 37.6 m -114.24 130.04 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.44 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.812 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -112.31 117.78 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.794 0.806 . . . . 0.0 110.74 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.4 t -98.31 156.34 16.77 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.504 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.745 ' HB3' HG13 ' A' ' 38' ' ' VAL . 71.7 p -150.0 30.96 0.7 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.65 -44.17 7.94 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.899 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.1 mp 62.09 106.57 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.18 0.514 . . . . 0.0 110.905 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 25.8 mtm -94.2 15.21 17.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.326 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.5 96.15 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.542 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.68 -48.84 75.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.918 0.39 . . . . 0.0 110.792 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.33 30.1 4.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.82 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -33.55 51.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.838 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -104.93 11.18 33.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.315 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.655 ' O ' HD23 ' A' ' 136' ' ' LEU . 8.2 tt -116.47 -5.58 11.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.057 0.456 . . . . 0.0 111.621 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -85.62 2.91 43.19 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.659 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 175.39 117.7 0.02 OUTLIER 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -141.08 179.22 6.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -175.3 141.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.963 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.084 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.765 0.317 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 m 62.62 119.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.3 m -63.34 -30.19 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.182 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.01 131.12 36.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.9 m -126.74 153.26 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -132.42 129.74 39.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.988 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.492 ' HB1' ' OD1' ' A' ' 9' ' ' ASP . . . -161.65 175.05 12.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.049 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.905 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -148.12 21.91 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.465 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.492 ' OD1' ' HB1' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -55.91 -15.69 3.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.064 0.459 . . . . 0.0 111.484 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.471 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -79.52 -17.23 54.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.413 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.66 -8.55 3.1 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.169 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.905 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.2 pp -60.52 -20.07 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 117.527 0.663 . . . . 0.0 111.871 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.471 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.76 8.64 16.49 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.742 177.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 18' ' ' LYS . . . -131.91 -34.37 0.39 Allowed Glycine 0 CA--C 1.518 0.268 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.477 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mp -77.15 -80.24 0.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.745 0.307 . . . . 0.0 111.002 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.48 9.94 29.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.967 0.413 . . . . 0.0 111.535 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.95 -27.14 2.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.948 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 1.4 tmtt? -130.14 85.29 2.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.719 0.771 . . . . 0.0 110.242 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -134.83 8.14 3.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.683 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 62.59 18.24 10.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.842 0.354 . . . . 0.0 111.384 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.29 -177.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.4 t0 63.87 12.0 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.79 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -146.41 11.58 1.15 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.943 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -83.37 -44.43 14.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.389 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -121.04 110.47 16.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.625 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.09 -123.71 0.07 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.158 0.504 . . . . 0.0 110.434 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.68 19.12 0.13 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.753 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -69.51 -25.56 64.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.2 16.09 10.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.258 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -120.04 136.15 54.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.923 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.5 p -87.42 140.34 15.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.094 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 p -109.87 134.57 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.411 ' O ' ' C ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -110.46 114.95 28.77 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.673 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 33' ' ' HIS . 0.3 OUTLIER 26.41 59.65 0.08 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.345 179.45 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.7 m -119.51 112.49 19.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -106.59 43.86 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 81' ' ' ALA . 30.4 m -75.23 146.36 41.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.831 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -90.58 102.36 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.103 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.823 ' C ' HD12 ' A' ' 40' ' ' LEU . 2.9 t -107.9 139.42 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.115 0.483 . . . . 0.0 111.543 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.823 HD12 ' C ' ' A' ' 39' ' ' VAL . 8.9 mp -136.42 104.27 5.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.036 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.62 127.03 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.363 0.602 . . . . 0.0 111.961 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.647 HD13 HD11 ' A' ' 48' ' ' ILE . 4.5 mt -127.67 145.41 50.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.746 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.0 119.99 4.9 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.488 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.77 91.08 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.427 0.632 . . . . 0.0 110.888 -178.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.445 ' C ' ' H ' ' A' ' 47' ' ' GLU . 50.0 m -125.93 170.3 11.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.451 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -53.65 -11.79 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.142 0.496 . . . . 0.0 109.793 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.655 ' HB2' HD11 ' A' ' 96' ' ' LEU . 1.9 tt0 -75.11 -65.47 0.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.492 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.695 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.4 OUTLIER -58.27 -44.47 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.3 0.571 . . . . 0.0 109.67 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -43.87 -53.72 5.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.345 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.528 HG21 ' CD1' ' A' ' 95' ' ' LEU . 25.9 m -79.93 -64.96 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.196 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.923 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -45.07 -46.9 11.83 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.372 -178.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.4 tp -61.44 -48.48 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.163 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -50.76 -38.99 51.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.048 0.451 . . . . 0.0 109.822 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.708 ' CA ' HG23 ' A' ' 58' ' ' THR . 2.8 mt-10 -82.89 -87.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.781 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.923 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.9 -56.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 179.472 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.0 ' HG ' HG12 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -72.98 -42.53 63.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.822 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.74 -46.35 13.27 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.623 -179.103 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.708 HG23 ' CA ' ' A' ' 54' ' ' GLU . 51.4 p -49.24 -72.61 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.57 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.442 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 0.9 OUTLIER -94.05 -25.92 16.99 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -177.404 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 1.006 ' CD2' HG11 ' A' ' 68' ' ' VAL . 7.7 m-85 -87.41 -1.37 57.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 119.306 -0.957 . . . . 0.0 112.737 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.584 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 2.5 tptt -118.06 -41.59 2.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.683 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.66 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.9 OUTLIER -58.91 -51.66 69.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.263 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.593 ' O ' HG23 ' A' ' 64' ' ' VAL . 22.3 p-10 -178.93 90.21 0.02 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.39 0.614 . . . . 0.0 112.012 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 63' ' ' ASN . 24.6 t -161.77 -53.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.505 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.491 ' HB3' HG22 ' A' ' 67' ' ' THR . 5.0 m-20 177.62 141.67 0.25 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.396 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.48 -23.34 2.82 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.77 2.314 . . . . 0.0 112.152 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.491 HG22 ' HB3' ' A' ' 65' ' ' ASN . 9.6 t -55.19 -38.44 68.38 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.302 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.006 HG11 ' CD2' ' A' ' 60' ' ' TYR . 82.2 t -61.9 74.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.64 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 67' ' ' THR . 16.0 p30 -116.0 142.29 46.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.973 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.544 HG23 HD12 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.54 149.38 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.389 0.614 . . . . 0.0 111.682 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.663 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.2 OUTLIER -143.75 123.53 13.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.573 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -88.44 114.84 25.47 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.107 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.407 ' NH1' ' CZ3' ' A' ' 78' ' ' TRP . 11.6 tpt180 -99.86 -100.04 0.24 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.618 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.31 -78.66 0.1 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.844 0.354 . . . . 0.0 111.27 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.68 -40.04 0.34 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.3 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.85 158.85 19.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.787 0.327 . . . . 0.0 110.545 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.695 ' CD1' HG21 ' A' ' 48' ' ' ILE . 75.4 m95 -77.43 126.32 30.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.527 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.663 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.7 m0 -96.69 109.97 22.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.289 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.702 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -96.52 136.68 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.086 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -129.11 135.72 49.26 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.021 0.438 . . . . 0.0 112.153 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.831 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . . . -144.5 158.48 43.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.756 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.406 ' N ' ' OG1' ' A' ' 67' ' ' THR . 0.4 OUTLIER -115.06 127.39 55.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.95 0.405 . . . . 0.0 111.251 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 84.25 -68.31 3.54 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.902 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER 178.42 160.71 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.014 0.435 . . . . 0.0 111.347 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.907 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -151.53 160.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.436 179.128 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.726 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.3 OUTLIER -136.09 125.22 24.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.165 0.507 . . . . 0.0 111.693 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.604 HG23 HD11 ' A' ' 125' ' ' ILE . 99.6 t -92.31 144.65 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.524 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.43 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 5.7 m-20 -87.95 152.64 21.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.441 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 51.9 t -112.16 100.55 8.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.157 0.503 . . . . 0.0 109.743 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 10.0 t70 165.21 -36.51 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.773 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 94' ' ' GLU . 7.4 mt-10 -74.96 -69.31 0.48 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.59 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.549 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 0.7 OUTLIER -63.99 -54.51 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.671 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.475 ' H ' HG23 ' A' ' 92' ' ' ILE . 18.3 p -44.12 -30.69 0.8 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.133 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 3.2 mm-40 -68.51 -71.54 0.21 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.125 0.488 . . . . 0.0 110.235 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.528 ' CD1' HG21 ' A' ' 50' ' ' THR . 0.3 OUTLIER -62.31 -19.94 63.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.134 -179.625 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -98.06 -1.76 41.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.58 0.229 . . . . 0.0 111.395 -179.461 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' HA3' ' CD2' ' A' ' 100' ' ' PHE . . . 152.56 66.03 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.87 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -28.02 137.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.782 0.433 . . . . 0.0 112.123 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 64.17 19.66 11.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.541 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.463 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -58.55 -162.9 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.107 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -105.58 -85.74 0.48 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.998 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.848 HG21 ' OG1' ' A' ' 118' ' ' THR . 2.0 p 179.54 -54.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.667 0.27 . . . . 0.0 111.554 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.451 ' H ' HG13 ' A' ' 102' ' ' VAL . 6.8 m-85 -64.98 -13.24 57.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.652 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -47.36 -29.98 2.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.598 0.237 . . . . 0.0 111.469 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.622 ' O ' HG11 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -71.19 -30.09 65.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.034 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.661 HD22 ' HB3' ' A' ' 116' ' ' ALA . 0.9 OUTLIER -134.71 42.28 2.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.969 0.414 . . . . 0.0 110.92 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 108' ' ' ASP . 12.1 p -83.19 -45.67 18.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.119 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.487 ' N ' HG13 ' A' ' 107' ' ' VAL . 6.1 m-20 -160.05 31.0 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.622 HG11 ' O ' ' A' ' 105' ' ' PHE . 34.7 m -59.49 165.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.578 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.55 -46.27 66.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.023 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.741 ' O ' HG23 ' A' ' 112' ' ' THR . 0.5 OUTLIER -174.59 163.37 3.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.741 HG23 ' O ' ' A' ' 111' ' ' SER . 0.5 OUTLIER -177.18 85.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.138 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 113' ' ' ILE . 7.4 mm -60.45 113.45 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.359 0.599 . . . . 0.0 110.779 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.73 140.93 3.79 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.702 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.817 ' HB3' HG22 ' A' ' 126' ' ' THR . 26.3 ttp180 -79.65 119.62 22.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.622 0.249 . . . . 0.0 110.715 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.672 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -101.28 125.29 47.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.015 0.436 . . . . 0.0 111.776 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 30.9 p90 -132.71 116.55 16.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.521 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.848 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.8 t -83.03 163.17 21.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.313 0.577 . . . . 0.0 111.992 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.4 pp -170.16 115.57 0.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.578 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.64 -107.1 1.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.571 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.26 83.66 2.04 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER 152.04 109.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.598 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.706 ' CD1' HG23 ' A' ' 102' ' ' VAL . 1.1 p90 -95.16 139.74 31.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.873 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.726 HG23 ' HB3' ' A' ' 86' ' ' GLU . 45.1 m -111.31 127.18 55.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.359 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.907 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -108.6 118.14 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.857 0.837 . . . . 0.0 110.737 178.898 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.817 HG22 ' HB3' ' A' ' 115' ' ' ARG . 2.6 t -96.82 155.8 16.62 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.728 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.775 ' HB2' HG13 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -149.07 23.74 0.94 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.267 0.556 . . . . 0.0 109.615 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -121.77 -167.53 1.55 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.316 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.5 mp 64.76 107.13 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.224 0.535 . . . . 0.0 110.852 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 mtp -115.91 15.66 16.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.311 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 113.74 107.67 2.79 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.548 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.3 mp -140.19 -59.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.802 0.334 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.408 ' HA ' ' HB2' ' A' ' 136' ' ' LEU . 11.1 m-20 60.2 24.52 13.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.079 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.77 -58.39 5.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.593 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -117.05 32.51 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.482 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 136' ' ' LEU . 6.7 tp -92.18 -147.61 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.846 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -40.88 -32.81 0.25 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.771 0.319 . . . . 0.0 111.626 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -106.8 102.25 11.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.997 0.427 . . . . 0.0 110.909 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.408 ' O ' ' CG ' ' A' ' 140' ' ' HIS . 0.1 OUTLIER -166.8 -176.51 3.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.914 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.408 ' CG ' ' O ' ' A' ' 139' ' ' TYR . 54.8 m80 -160.68 125.76 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.95 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.088 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.842 0.354 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 m -147.13 -64.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.5 t -83.68 77.51 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -100.93 151.09 22.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.4 m -61.22 136.76 58.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 63.12 116.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.071 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -123.37 -168.82 1.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.957 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.916 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -138.34 20.55 2.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.581 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.5 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.3 m-20 -57.31 -13.78 3.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.149 0.5 . . . . 0.0 111.566 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.463 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -79.17 -18.65 52.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.443 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.417 ' HA3' ' CE1' ' A' ' 8' ' ' TYR . . . -130.31 -9.42 2.98 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.232 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.916 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.2 pp -59.06 -20.78 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 117.637 0.719 . . . . 0.0 111.883 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.463 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -85.76 9.33 16.78 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.915 178.118 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.402 ' HA2' ' CB ' ' A' ' 18' ' ' LYS . . . -142.81 -50.52 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.623 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.55 -77.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.752 0.311 . . . . 0.0 111.056 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.22 10.73 28.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.021 0.439 . . . . 0.0 111.397 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.68 -22.47 4.33 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.134 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.402 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -128.85 80.74 1.99 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.12 0.486 . . . . 0.0 110.408 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -138.02 9.06 2.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.61 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 63.3 18.51 11.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.359 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.34 -178.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t70 63.58 13.03 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.12 0.485 . . . . 0.0 110.617 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -152.27 13.84 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.214 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -89.84 -46.6 8.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.358 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -118.5 110.37 17.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.453 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.78 -114.87 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.109 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 t0 74.2 15.26 3.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.407 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.64 -21.67 54.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.07 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 68.02 15.08 9.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.378 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -96.64 136.33 37.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.783 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -118.13 138.96 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.295 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.424 HG21 ' OG ' ' A' ' 35' ' ' SER . 10.6 p -109.92 135.01 50.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.808 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -109.87 115.29 29.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.191 0.52 . . . . 0.0 110.73 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 35.78 61.92 0.68 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.963 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.424 ' OG ' HG21 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -72.39 108.91 5.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.891 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -151.48 31.62 0.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.0 m -115.79 141.76 47.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.759 HG13 ' HB3' ' A' ' 127' ' ' SER . 0.2 OUTLIER -88.88 93.75 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.992 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.727 HG22 ' HG2' ' A' ' 80' ' ' LYS . 3.7 t -105.67 147.54 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.225 0.536 . . . . 0.0 111.854 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.83 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.64 120.59 3.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.884 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.54 130.29 67.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.339 0.59 . . . . 0.0 112.116 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.982 HD22 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -127.05 139.86 52.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.429 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -54.29 132.03 42.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.484 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -61.88 89.22 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.505 0.669 . . . . 0.0 109.975 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 47' ' ' GLU . 14.8 m -125.86 170.62 11.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.905 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -52.77 -11.75 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 109.931 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.835 ' CB ' HD21 ' A' ' 96' ' ' LEU . 3.6 tt0 -69.33 -75.5 0.11 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.245 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.982 HD11 HD22 ' A' ' 42' ' ' LEU . 3.8 mm -53.81 -39.87 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 24.4 m120 -43.48 -57.74 2.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.376 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.75 ' CB ' HD22 ' A' ' 95' ' ' LEU . 53.5 m -85.73 -57.63 2.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.605 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.933 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -47.23 -45.53 23.58 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.766 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.666 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.3 tp -65.56 -49.23 79.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.863 0.363 . . . . 0.0 110.272 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.3 pt-20 -53.41 -40.55 65.2 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.098 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.714 ' O ' HG23 ' A' ' 58' ' ' THR . 23.7 mm-40 -80.37 -70.08 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.942 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.933 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -37.86 -59.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.724 ' N ' HG23 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -72.52 -36.61 68.38 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.69 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -84.0 -46.81 11.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.517 -0.739 . . . . 0.0 110.916 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.715 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 71.6 p -50.0 -70.86 0.08 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.223 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 7.3 m-20 -94.35 -29.3 15.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.953 ' CG ' HG11 ' A' ' 68' ' ' VAL . 2.3 m-85 -83.83 -1.61 54.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.534 -0.867 . . . . 0.0 112.711 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.598 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -118.87 -40.41 2.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.785 178.518 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.715 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -58.23 -50.2 74.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.707 0.289 . . . . 0.0 111.289 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.527 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.4 OUTLIER 179.57 89.29 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.212 0.53 . . . . 0.0 111.276 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.622 HG11 ' CE1' ' A' ' 60' ' ' TYR . 9.7 t -158.94 -58.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.54 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.481 ' HB3' HG22 ' A' ' 67' ' ' THR . 3.8 m-20 174.25 145.92 0.21 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.894 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -89.14 -19.36 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.046 2.497 . . . . 0.0 112.462 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.15 -64.26 0.83 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.321 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.953 HG11 ' CG ' ' A' ' 60' ' ' TYR . 1.7 p -41.73 87.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 121.048 0.451 . . . . 0.0 110.96 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.8 p30 -116.22 142.57 46.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.479 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.507 HG23 HG23 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -97.0 153.23 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.105 0.479 . . . . 0.0 111.531 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.57 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.6 OUTLIER -142.65 118.74 10.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.241 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.27 114.64 24.05 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.445 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.44 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 3.8 mmp_? -101.58 -117.42 0.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.239 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.35 76.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.79 0.329 . . . . 0.0 111.272 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.88 -37.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.641 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -82.79 162.0 21.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.961 0.41 . . . . 0.0 110.618 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.636 ' CD1' HG21 ' A' ' 48' ' ' ILE . 50.0 m95 -86.01 140.56 30.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.742 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.57 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.4 m0 -110.97 108.7 18.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.39 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.83 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.47 116.21 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.629 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.727 ' HG2' HG22 ' A' ' 39' ' ' VAL . 11.4 mtmt -119.46 136.39 54.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.08 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.422 ' HB3' ' CG2' ' A' ' 85' ' ' ILE . . . -143.41 158.71 43.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.69 137.6 44.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 111.358 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.07 -69.83 3.19 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.926 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.406 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 179.86 158.62 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 0.0 111.041 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.747 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.85 160.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.745 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.1 OUTLIER -140.71 125.2 17.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 111.643 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.881 HG13 HG13 ' A' ' 55' ' ' ILE . 18.0 t -94.66 138.55 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.641 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 5.3 m-20 -80.51 152.24 28.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.207 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 46.9 t -113.11 100.85 8.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 109.958 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.5 m-20 161.88 -37.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.27 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 94' ' ' GLU . 6.8 mt-10 -72.5 -68.59 0.46 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.697 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.625 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -58.55 -58.26 7.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.273 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.533 ' H ' HG23 ' A' ' 92' ' ' ILE . 44.7 p -45.28 -34.14 2.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.553 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 0.5 OUTLIER -61.26 -47.34 86.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 110.359 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.75 HD22 ' CB ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -90.11 -17.0 28.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.785 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.835 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -98.01 9.47 42.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.933 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 129.28 69.69 0.12 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.309 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -34.8 149.09 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.059 0.457 . . . . 0.0 111.439 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.88 17.66 10.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.149 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.432 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -69.57 -167.84 0.15 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.679 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -131.2 135.16 47.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.84 0.353 . . . . 0.0 110.966 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.772 HG21 ' OG1' ' A' ' 118' ' ' THR . 8.1 p -51.14 166.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.934 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.51 ' H ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER 79.38 1.87 2.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.895 -179.169 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.799 ' O ' HG12 ' A' ' 107' ' ' VAL . 8.2 t0 -73.77 -31.71 63.44 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.984 0.421 . . . . 0.0 110.232 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.469 ' CE1' ' HB2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -64.82 -26.03 68.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.772 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 0.5 OUTLIER -127.69 30.65 5.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.624 179.571 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.799 HG12 ' O ' ' A' ' 104' ' ' ASP . 9.2 p -83.05 -34.71 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.166 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.569 ' OD1' HG13 ' A' ' 107' ' ' VAL . 49.8 p30 -178.12 39.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.797 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.612 HG11 HD11 ' A' ' 42' ' ' LEU . 12.0 m -70.86 172.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.374 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.52 -44.43 56.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.166 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.2 m 172.95 157.7 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -178.95 122.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.926 0.393 . . . . 0.0 111.639 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 113' ' ' ILE . 9.4 mm -92.56 121.12 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.3 0.571 . . . . 0.0 111.005 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.46 143.07 3.78 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.954 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -77.78 120.23 22.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.783 0.325 . . . . 0.0 110.39 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -101.09 125.22 47.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.065 0.46 . . . . 0.0 111.929 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 117' ' ' TYR . 4.8 p90 -136.08 121.36 19.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.462 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.772 ' OG1' HG21 ' A' ' 102' ' ' VAL . 15.3 t -105.0 142.45 34.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.339 0.59 . . . . 0.0 111.995 -178.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.857 HD22 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -148.24 125.69 11.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.652 179.134 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.99 -110.84 3.68 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.671 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.49 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.09 83.84 2.05 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.1 OUTLIER 153.22 101.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.747 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.641 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 8.4 p90 -88.67 128.88 35.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.102 0.477 . . . . 0.0 110.98 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.745 HG23 ' HB3' ' A' ' 86' ' ' GLU . 29.9 m -103.07 132.48 49.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.117 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.795 HD11 HG23 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -114.88 118.67 59.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.924 0.869 . . . . 0.0 110.979 179.146 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 115' ' ' ARG . 5.4 t -96.3 156.28 16.41 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.456 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.759 ' HB3' HG13 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -138.05 14.84 2.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.383 0.611 . . . . 0.0 109.542 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.04 -22.88 8.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.62 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.9 mp -92.42 16.06 12.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.348 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.99 15.72 23.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.288 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.496 ' O ' HD13 ' A' ' 132' ' ' LEU . . . -104.34 -102.13 2.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.497 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 132' ' ' LEU . 0.9 OUTLIER -121.55 61.31 0.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.781 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -114.53 32.98 5.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.933 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -65.13 -49.92 68.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.828 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.04 -7.95 28.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.382 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.707 HD13 ' CD1' ' A' ' 139' ' ' TYR . 5.3 mt 61.48 118.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.823 0.344 . . . . 0.0 110.95 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -96.93 -43.08 7.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.805 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -150.22 108.72 3.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.818 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.707 ' CD1' HD13 ' A' ' 136' ' ' LEU . 17.4 p90 -138.29 28.14 2.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.036 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.78 156.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.864 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.145 -179.974 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mmm . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.798 0.332 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -102.13 -73.78 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.7 m -112.64 -35.61 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.155 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -127.18 146.04 50.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 t -147.6 168.88 20.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -75.44 -177.02 3.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.91 121.62 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.179 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.888 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -103.29 21.71 15.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.378 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' HA ' HG12 ' A' ' 12' ' ' ILE . 11.0 m-20 -55.1 -16.77 3.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.114 0.483 . . . . 0.0 111.538 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.504 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -78.31 -16.09 58.08 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.485 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.73 -9.02 2.33 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.241 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.888 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.1 pp -60.39 -20.39 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 CA-C-N 117.574 0.687 . . . . 0.0 111.811 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.504 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -82.92 7.55 15.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.877 178.143 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.96 21.07 0.44 Allowed Glycine 0 CA--C 1.519 0.332 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.57 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.6 -83.49 0.63 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.661 0.267 . . . . 0.0 110.608 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.0 9.26 40.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.084 0.468 . . . . 0.0 110.938 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.11 -15.76 8.25 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.985 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.01 81.26 2.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.017 0.437 . . . . 0.0 110.216 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -140.53 10.8 2.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.635 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.67 14.44 7.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.3 -169.86 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.844 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.12 14.97 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.041 0.448 . . . . 0.0 110.541 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -138.09 10.35 2.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.066 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.47 -57.49 2.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.582 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -120.14 110.88 17.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.627 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.51 -117.5 0.07 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.29 16.74 9.71 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.267 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -73.16 -27.92 61.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.012 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.18 14.29 25.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.441 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -141.43 152.32 44.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.953 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -110.83 135.32 50.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.991 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.0 p -109.9 134.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.855 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.408 ' O ' ' C ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -110.28 115.29 29.43 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.809 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 33' ' ' HIS . 1.2 mt-10 28.57 58.12 0.12 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.102 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.9 m -101.13 129.82 47.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.073 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -151.87 36.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.558 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.2 m -72.93 145.38 46.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.206 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.825 HG13 ' OG ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -99.41 99.18 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.606 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.792 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.9 t -112.0 152.44 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.33 0.586 . . . . 0.0 112.389 -178.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.792 HD23 ' O ' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -148.59 107.88 3.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.527 178.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -113.4 125.93 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.031 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.916 HD13 HG13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -128.63 148.66 50.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.133 178.127 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.32 127.53 17.51 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.489 ' HA ' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -66.3 90.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.535 0.684 . . . . 0.0 111.043 -179.023 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.464 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -125.94 171.36 10.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.956 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.89 -17.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.669 ' HG3' HD11 ' A' ' 96' ' ' LEU . 8.2 tt0 -62.02 -72.31 0.13 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.239 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.916 HG13 HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -59.75 -40.66 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -40.83 -59.48 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.409 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.655 HG21 ' HG ' ' A' ' 95' ' ' LEU . 2.4 m -79.47 -61.87 1.87 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.877 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.869 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -43.82 -45.52 7.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.237 -179.184 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -62.63 -47.23 93.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.862 0.363 . . . . 0.0 110.284 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.643 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -54.23 -41.18 68.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.516 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.637 ' O ' HG23 ' A' ' 58' ' ' THR . 7.4 mt-10 -81.07 -68.64 0.67 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.043 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.869 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -37.17 -57.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.705 ' N ' HG23 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -74.85 -38.41 61.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.643 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.49 -46.88 12.86 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.884 -178.472 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.695 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 50.6 p -53.54 -69.81 0.11 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.489 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.452 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 20.5 m-20 -91.72 -29.66 16.7 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.82 ' CD1' HG21 ' A' ' 68' ' ' VAL . 8.4 m-85 -87.15 -2.07 58.36 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.427 -0.909 . . . . 0.0 113.236 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.567 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -117.75 -40.71 2.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 178.348 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.695 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -62.08 -49.98 73.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.611 ' O ' HG23 ' A' ' 64' ' ' VAL . 14.1 p-10 -177.71 90.49 0.03 OUTLIER 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.507 0.67 . . . . 0.0 112.297 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.687 HG11 ' CE1' ' A' ' 60' ' ' TYR . 20.2 t -162.05 -54.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.076 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.555 ' HB3' HG22 ' A' ' 67' ' ' THR . 5.6 m-20 170.49 143.45 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.482 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.479 ' O ' ' ND2' ' A' ' 69' ' ' ASN . 85.0 Cg_endo -85.64 -16.43 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.981 2.454 . . . . 0.0 112.237 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 65' ' ' ASN . 14.7 t -53.16 -39.47 63.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.286 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.82 HG21 ' CD1' ' A' ' 60' ' ' TYR . 63.5 t -61.81 86.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.826 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 66' ' ' PRO . 7.7 m120 -115.43 142.44 46.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.859 0.361 . . . . 0.0 111.056 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.657 HG23 HD12 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -96.84 153.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 121.235 0.541 . . . . 0.0 111.548 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -142.08 117.98 10.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.787 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.3 114.52 18.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.645 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.518 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -95.23 -146.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.083 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.2 -73.57 0.08 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.629 0.252 . . . . 0.0 111.637 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . -126.42 12.48 7.07 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.479 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -142.83 158.66 43.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.086 0.443 . . . . 0.0 111.091 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.658 ' O ' HG12 ' A' ' 41' ' ' VAL . 58.7 m95 -80.73 142.75 33.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.229 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.606 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.0 m0 -115.79 108.5 16.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.635 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.822 ' N ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -96.89 127.21 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 135.83 49.66 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.947 0.403 . . . . 0.0 111.241 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.575 ' CB ' HG21 ' A' ' 85' ' ' ILE . . . -143.86 159.05 43.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.849 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -106.97 148.3 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.076 0.465 . . . . 0.0 111.328 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 68.08 -69.85 0.32 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.331 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER 177.92 160.71 0.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.922 0.391 . . . . 0.0 111.02 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.956 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -149.55 160.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.956 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.548 ' CB ' ' HB ' ' A' ' 124' ' ' THR . 1.0 OUTLIER -138.14 126.1 22.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.128 0.49 . . . . 0.0 111.414 -179.501 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.643 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 23.0 t -94.49 146.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.603 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.433 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 8.8 t70 -90.11 152.15 21.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.103 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.472 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 49.8 t -109.46 100.74 9.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.295 0.569 . . . . 0.0 109.745 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 0.7 OUTLIER 162.45 -35.98 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.979 -179.257 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -74.26 -71.85 0.31 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.748 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.637 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.0 OUTLIER -57.11 -56.35 15.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.803 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.449 ' H ' HG23 ' A' ' 92' ' ' ILE . 15.1 p -46.62 -35.62 6.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.734 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.9 OUTLIER -60.19 -46.21 90.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.098 0.475 . . . . 0.0 110.367 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.814 HD13 ' O ' ' A' ' 95' ' ' LEU . 1.1 tm? -90.17 -17.62 27.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.601 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.669 HD11 ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -99.7 12.33 36.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.974 0.416 . . . . 0.0 110.999 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.418 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 126.29 69.52 0.18 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.279 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -35.11 148.61 0.02 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.08 0.467 . . . . 0.0 111.66 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 64.8 17.48 11.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.342 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -69.65 -177.58 1.26 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.607 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -81.81 -91.87 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.689 HG21 ' OG1' ' A' ' 118' ' ' THR . 2.7 p 179.42 -42.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.688 0.28 . . . . 0.0 111.1 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.684 ' CE2' HG22 ' A' ' 118' ' ' THR . 4.9 m-85 -71.71 -6.69 43.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.367 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.71 -34.24 18.26 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.782 0.325 . . . . 0.0 111.026 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.533 ' CD1' ' CE2' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -60.54 -34.95 74.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.631 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.503 HD13 ' OG1' ' A' ' 112' ' ' THR . 5.6 tp -133.21 41.89 3.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.473 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.9 p -81.59 -39.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.298 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -166.14 31.47 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.002 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.402 HG11 HD23 ' A' ' 42' ' ' LEU . 29.5 m -65.07 174.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.295 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -55.96 -42.47 76.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.9 OUTLIER 171.65 151.72 0.06 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.503 ' OG1' HD13 ' A' ' 106' ' ' LEU . 65.8 p -159.88 98.51 1.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.906 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 113' ' ' ILE . 17.1 mm -65.89 127.31 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 0.0 110.966 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.81 144.48 5.37 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.041 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.521 ' HB2' HG23 ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.84 120.55 22.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.7 0.286 . . . . 0.0 110.414 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.457 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -106.9 124.59 49.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.129 0.49 . . . . 0.0 112.263 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.529 ' CZ ' HG23 ' A' ' 124' ' ' THR . 2.0 p90 -137.04 119.29 15.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.296 178.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.689 ' OG1' HG21 ' A' ' 102' ' ' VAL . 10.9 t -99.81 142.71 30.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.251 0.548 . . . . 0.0 111.969 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.831 ' O ' HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -146.38 133.11 19.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.507 179.23 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 56.9 -112.02 3.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.611 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.503 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.9 84.06 2.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.4 OUTLIER 152.11 100.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.526 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.643 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 14.2 p90 -88.28 133.08 34.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.17 0.509 . . . . 0.0 110.949 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.548 ' HB ' ' CB ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -107.93 130.67 55.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.858 -179.458 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.956 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -112.82 118.58 58.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.891 0.853 . . . . 0.0 111.368 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.521 HG23 ' HB2' ' A' ' 115' ' ' ARG . 9.1 t -97.24 155.59 16.79 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.087 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.825 ' OG ' HG13 ' A' ' 38' ' ' VAL . 2.2 m -146.02 19.28 1.43 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.256 0.551 . . . . 0.0 109.842 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -123.68 -178.45 4.04 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.246 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 63.05 17.66 10.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.26 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.9 ttt -95.56 15.81 18.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.379 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -137.93 -88.86 0.21 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.447 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mp 63.69 -78.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.78 0.324 . . . . 0.0 111.015 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.541 ' HA ' HD13 ' A' ' 136' ' ' LEU . 32.7 p30 -109.76 35.17 3.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.806 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.7 mmm-85 -63.94 -44.51 92.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.445 ' H ' HD12 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -114.64 24.91 11.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.013 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 136' ' ' LEU . 0.3 OUTLIER -136.99 11.87 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 111.434 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -50.0 -28.8 7.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.205 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.03 15.86 3.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.289 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -85.54 103.71 14.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.863 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -98.23 167.22 11.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.158 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.514 ' HA ' HG12 ' A' ' 12' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.224 0.535 . . . . 0.0 111.49 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -75.5 -15.89 60.36 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.848 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.03 -9.25 2.2 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.333 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.514 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.1 pp -60.4 -19.2 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-N 117.538 0.669 . . . . 0.0 112.069 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.49 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -83.91 9.64 11.69 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.041 178.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.04 -43.8 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.732 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.58 -80.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 110.989 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.43 -14.49 26.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.438 0.637 . . . . 0.0 111.512 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.8 -18.03 62.35 Favored Glycine 0 C--N 1.312 -0.805 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.895 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.22 81.11 1.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 110.878 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 9.2 t0 -138.67 8.36 2.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.515 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.46 ' CG ' ' O ' ' A' ' 19' ' ' ASP . 13.3 p90 46.91 73.93 0.17 Allowed 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.8 0.81 . . . . 0.0 111.087 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.56 -8.44 38.19 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.602 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -90.13 11.85 19.64 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.032 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.239 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.88 0.371 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.0 m -74.37 145.23 43.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.884 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.719 HG11 HG23 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -86.26 106.32 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.884 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.75 HG22 ' HG2' ' A' ' 80' ' ' LYS . 13.5 t -118.3 154.09 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.328 0.585 . . . . 0.0 111.832 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.699 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -177.93 125.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.265 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -112.03 135.22 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.668 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.77 HD23 HD11 ' A' ' 48' ' ' ILE . 3.5 tp -125.73 139.52 53.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.639 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -50.76 139.61 16.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.129 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.466 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -87.52 87.65 7.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.396 0.617 . . . . 0.0 110.462 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.43 ' C ' ' N ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -125.78 170.64 11.39 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.543 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.67 -12.13 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.993 0.425 . . . . 0.0 110.34 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.818 ' CD ' HD11 ' A' ' 96' ' ' LEU . 1.4 tt0 -80.82 -58.11 3.24 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.342 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.813 HG21 ' CD1' ' A' ' 77' ' ' TRP . 1.4 mp -63.86 -44.89 98.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.963 0.411 . . . . 0.0 110.241 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -40.49 -59.85 1.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.058 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.74 HG21 ' HG ' ' A' ' 95' ' ' LEU . 58.5 m -69.96 -68.47 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.007 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.882 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -42.66 -47.01 5.23 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.595 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.5 tp -55.87 -47.97 79.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.165 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.485 ' O ' ' CD2' ' A' ' 57' ' ' LEU . 1.6 pt-20 -53.29 -48.78 68.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 109.755 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.798 ' HA ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -70.64 -81.6 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.67 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.882 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -22.02 -57.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.7 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.4 mp -74.22 -66.0 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.576 HD13 ' N ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -63.41 -33.12 74.85 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -177.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.798 HG23 ' HA ' ' A' ' 54' ' ' GLU . 70.0 p -62.93 -66.2 0.58 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.338 0.59 . . . . 0.0 110.757 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.62 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -83.24 -46.35 12.78 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.805 ' CG ' HG11 ' A' ' 68' ' ' VAL . 49.6 m-85 -69.04 -24.71 64.21 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -90.99 -51.48 5.32 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.657 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 58' ' ' THR . 13.6 ttpt -60.68 -43.16 98.05 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.271 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.698 ' O ' HG23 ' A' ' 64' ' ' VAL . 2.0 p30 179.76 103.8 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.103 0.477 . . . . 0.0 111.753 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER 178.51 -52.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.027 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.465 ' N ' HG12 ' A' ' 64' ' ' VAL . 5.1 m-20 178.86 141.56 0.28 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.738 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.55 -10.41 10.87 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.698 2.265 . . . . 0.0 111.956 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.516 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -78.3 -106.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.61 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.805 HG11 ' CG ' ' A' ' 60' ' ' TYR . 9.7 p 26.56 49.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.359 0.599 . . . . 0.0 111.629 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -82.32 136.52 35.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.199 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.75 153.76 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.041 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 7.9 mm-40 -142.44 116.28 9.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.188 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -86.38 114.52 23.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.571 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.445 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 21.4 mmt180 -103.17 -120.67 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.973 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.78 -54.04 50.92 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.862 0.363 . . . . 0.0 111.133 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.83 -39.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.644 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -79.93 162.5 24.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.673 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.813 ' CD1' HG21 ' A' ' 48' ' ' ILE . 22.8 m95 -90.92 142.71 27.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.154 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.511 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.4 m0 -106.52 102.4 11.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.266 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.847 HD13 ' N ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -97.01 107.41 19.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.174 0.511 . . . . 0.0 110.411 -179.184 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.75 ' HG2' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -121.9 143.71 49.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.455 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.564 ' HB3' HG22 ' A' ' 85' ' ' ILE . . . -143.4 158.51 43.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.296 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.41 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.4 OUTLIER -102.94 132.84 48.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.865 0.364 . . . . 0.0 111.438 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.52 -68.21 3.47 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.001 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.493 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -176.46 152.89 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 110.691 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.817 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -133.69 157.92 42.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.795 ' HB2' HG22 ' A' ' 124' ' ' THR . 12.5 pt-20 -147.75 122.27 9.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.467 . . . . 0.0 111.825 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.773 HG13 HG13 ' A' ' 55' ' ' ILE . 29.2 t -94.74 137.16 23.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.59 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 18.0 p30 -84.31 151.93 24.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.893 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.465 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 21.4 t -109.83 100.55 9.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.131 0.491 . . . . 0.0 109.849 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 0.8 OUTLIER 161.5 -35.87 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.079 -179.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.02 -70.35 0.36 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.826 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.62 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.5 tt -57.8 -58.93 4.23 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.191 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.516 ' H ' HG23 ' A' ' 92' ' ' ILE . 4.9 t -44.75 -34.76 2.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.798 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.6 mm-40 -60.9 -48.22 82.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.542 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.843 ' O ' HD13 ' A' ' 95' ' ' LEU . 1.5 tm? -90.23 -16.98 28.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.725 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.818 HD11 ' CD ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.33 10.19 41.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 98' ' ' ARG . . . 125.46 70.72 0.19 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.117 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -30.72 147.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.149 0.5 . . . . 0.0 111.834 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.45 17.91 11.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.038 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -165.19 0.05 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.933 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.21 -167.88 1.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.035 HG23 ' CD1' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -113.14 -43.89 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.719 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -2.57 16.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.36 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.83 -40.79 22.25 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.878 0.37 . . . . 0.0 110.264 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.608 ' HE2' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -83.4 146.36 28.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.788 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.839 HD12 ' HB ' ' A' ' 112' ' ' THR . 3.5 tt 64.51 14.76 9.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 111.179 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 108' ' ' ASP . 14.2 p -74.17 -44.88 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.813 0.34 . . . . 0.0 111.07 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.484 ' N ' HG13 ' A' ' 107' ' ' VAL . 1.6 p30 178.54 54.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.67 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.587 HG21 HD11 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -98.0 -166.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.468 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -43.61 -40.15 3.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.154 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.472 ' HB3' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER 170.52 149.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.846 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.839 ' HB ' HD12 ' A' ' 106' ' ' LEU . 37.1 p -157.75 84.9 0.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 113' ' ' ILE . 10.4 mm -77.16 114.5 17.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.434 0.635 . . . . 0.0 111.395 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 143.89 142.01 3.87 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.029 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 126' ' ' THR . 23.4 ttt180 -77.1 120.1 21.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.614 0.245 . . . . 0.0 110.44 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.807 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -104.76 125.39 50.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.077 0.465 . . . . 0.0 112.202 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.581 ' HE1' HD23 ' A' ' 119' ' ' LEU . 3.5 p90 -131.63 127.42 36.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.101 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.877 ' OG1' HG21 ' A' ' 102' ' ' VAL . 11.7 t -100.26 149.35 23.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.344 0.592 . . . . 0.0 112.097 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.656 ' O ' HD12 ' A' ' 119' ' ' LEU . 3.3 pp -146.62 118.11 7.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.663 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.14 -104.29 0.51 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.981 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -133.06 83.68 2.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.028 0.442 . . . . 0.0 109.932 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.3 OUTLIER 152.95 115.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.471 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 1.035 ' CD1' HG23 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -104.21 138.46 40.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.988 0.423 . . . . 0.0 110.789 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.795 HG22 ' HB2' ' A' ' 86' ' ' GLU . 17.8 p -114.13 133.33 55.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.315 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.817 HD13 ' CD1' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -113.82 117.56 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.819 0.818 . . . . 0.0 110.565 179.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 115' ' ' ARG . 8.8 t -100.54 156.37 17.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.748 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.449 ' CB ' ' HA ' ' A' ' 38' ' ' VAL . 8.9 t -142.36 17.27 2.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.348 0.594 . . . . 0.0 109.555 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 N--CA 1.446 -0.655 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.14 -178.714 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.526 ' HA ' HG12 ' A' ' 12' ' ' ILE . 4.1 m-20 . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.114 0.483 . . . . 0.0 111.408 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.491 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -78.73 -16.74 56.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.389 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.6 -8.91 2.7 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.261 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.526 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.1 pp -61.09 -19.84 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 117.626 0.713 . . . . 0.0 111.852 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.491 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.72 8.5 16.85 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.789 178.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.11 -43.5 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.33 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.19 -80.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.68 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.74 11.19 32.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.064 0.459 . . . . 0.0 111.17 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -112.62 -17.17 8.2 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.145 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -128.54 80.83 1.99 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.027 0.442 . . . . 0.0 110.42 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -142.51 13.71 1.96 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.36 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -86.51 6.23 31.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 0.0 111.095 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.34 -177.15 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.344 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 t0 65.29 13.35 8.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.197 0.522 . . . . 0.0 110.017 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.815 179.939 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 t0 . . . . . 0 CA--C 1.53 0.195 0 CA-C-O 120.613 0.244 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.537 HG21 ' HD2' ' A' ' 80' ' ' LYS . 16.3 m -67.59 153.52 43.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.957 0.408 . . . . 0.0 111.124 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.888 HG21 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -102.23 112.61 36.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.676 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 80' ' ' LYS . 20.7 t -129.11 152.05 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.436 0.636 . . . . 0.0 112.436 -178.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.788 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -159.84 129.96 5.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.778 178.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.84 134.42 54.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.281 0.562 . . . . 0.0 111.998 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.017 HD23 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -126.29 140.32 52.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.434 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -52.53 129.0 27.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.46 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -75.29 90.0 2.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.498 0.666 . . . . 0.0 110.617 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 47' ' ' GLU . 3.3 m -126.01 171.09 11.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.442 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.54 -16.25 0.21 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.048 0.451 . . . . 0.0 110.047 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.889 ' HG2' HD12 ' A' ' 48' ' ' ILE . 6.8 tt0 -72.6 -63.47 1.15 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.175 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.017 HD11 HD23 ' A' ' 42' ' ' LEU . 1.6 mp -61.31 -44.16 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.294 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -40.82 -59.05 1.51 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.807 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.711 HG21 ' HG ' ' A' ' 95' ' ' LEU . 15.4 m -75.56 -62.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.941 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.875 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -44.34 -48.42 9.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.398 -179.075 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -57.62 -47.77 84.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.879 0.371 . . . . 0.0 110.432 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -53.21 -49.47 66.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.253 0.549 . . . . 0.0 109.601 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.761 ' HA ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -69.86 -82.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.54 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.875 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -21.66 -58.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.706 ' N ' HG23 ' A' ' 55' ' ' ILE . 1.4 mp -73.51 -66.3 0.71 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.605 HD13 ' N ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -63.32 -30.54 71.66 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.761 HG23 ' HA ' ' A' ' 54' ' ' GLU . 72.0 p -62.89 -66.8 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.283 0.563 . . . . 0.0 110.611 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.631 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 65.6 m-20 -83.66 -44.86 14.07 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.894 ' CG ' HG11 ' A' ' 68' ' ' VAL . 66.9 m-85 -70.07 -21.63 63.14 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -93.84 -47.97 6.5 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.864 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.58 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.5 OUTLIER -58.01 -48.57 79.63 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.752 0.31 . . . . 0.0 110.814 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.582 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER 179.31 99.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.289 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 59' ' ' ASP . 0.9 OUTLIER -172.23 -50.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.764 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.455 ' N ' HG12 ' A' ' 64' ' ' VAL . 4.1 m-20 177.41 143.97 0.27 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 0.0 111.935 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -85.29 -3.31 9.45 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.824 2.349 . . . . 0.0 111.71 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.547 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 1.1 t -82.84 -109.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.44 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.894 HG11 ' CG ' ' A' ' 60' ' ' TYR . 10.0 p 26.8 49.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 121.379 0.609 . . . . 0.0 111.606 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -82.05 139.0 34.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.133 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 78' ' ' TRP . 0.5 OUTLIER -97.67 153.45 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.031 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -142.38 116.12 9.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.249 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -86.17 114.51 23.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.735 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 5.7 mmt180 -95.64 -111.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.968 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.9 -38.23 64.43 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.867 0.365 . . . . 0.0 111.128 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.46 -37.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.417 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.95 162.55 23.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.752 0.311 . . . . 0.0 110.551 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.844 ' CD1' HG21 ' A' ' 48' ' ' ILE . 10.3 m95 -94.11 142.84 26.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.521 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.488 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 9.0 m0 -107.56 108.73 20.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.133 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.803 HD13 ' N ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -98.04 113.58 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.173 0.511 . . . . 0.0 110.338 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.537 ' HD2' HG21 ' A' ' 37' ' ' THR . 3.6 tttt -122.39 140.23 52.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.84 ' HB3' HG22 ' A' ' 85' ' ' ILE . . . -142.86 138.65 30.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.765 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.453 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.3 OUTLIER -77.55 108.2 10.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.046 0.45 . . . . 0.0 111.455 -179.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 104.03 -62.31 0.4 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.082 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.888 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 178.04 162.13 0.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.066 0.46 . . . . 0.0 111.353 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.84 HG22 ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -136.67 159.61 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.13 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.744 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.1 OUTLIER -142.75 118.2 10.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.146 0.498 . . . . 0.0 111.468 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.836 HG13 HG13 ' A' ' 55' ' ' ILE . 17.4 t -94.4 128.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.826 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 2.6 m-20 -77.3 151.97 34.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.153 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 22.5 t -106.26 100.62 10.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.136 0.493 . . . . 0.0 109.906 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 9.3 t0 160.3 -35.69 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.823 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -70.83 -72.87 0.19 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.943 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.658 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.3 tt -56.56 -57.85 7.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.503 ' H ' HG23 ' A' ' 92' ' ' ILE . 35.0 p -45.43 -36.61 4.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.755 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -58.34 -46.79 85.56 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.122 0.486 . . . . 0.0 110.239 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.842 ' O ' HD13 ' A' ' 95' ' ' LEU . 2.0 tm? -90.26 -17.2 27.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.474 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.752 HD11 ' CG ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -99.77 13.17 34.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.81 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 100' ' ' PHE . . . 118.99 67.94 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.18 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -33.56 150.41 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.208 0.528 . . . . 0.0 111.99 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.52 19.02 10.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.373 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.407 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -77.24 -166.52 0.74 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.049 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -93.5 -169.47 2.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.882 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.895 HG23 ' CD1' ' A' ' 123' ' ' PHE . 1.4 p -111.64 -34.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.118 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -79.91 3.91 18.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.477 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.774 ' O ' HG12 ' A' ' 107' ' ' VAL . 3.5 m-20 -59.6 -38.22 80.66 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.705 0.288 . . . . 0.0 110.947 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.473 ' CE1' ' HB2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -64.05 -43.04 96.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.765 0.316 . . . . 0.0 110.76 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.841 HD22 ' HB3' ' A' ' 116' ' ' ALA . 1.3 tp -106.73 26.03 10.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.218 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.774 HG12 ' O ' ' A' ' 104' ' ' ASP . 15.0 p -73.69 -24.39 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.9 0.381 . . . . 0.0 110.947 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -171.57 -86.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.458 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 110' ' ' SER . 43.0 t 55.9 160.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.056 0.455 . . . . 0.0 111.601 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.508 ' N ' HG12 ' A' ' 109' ' ' VAL . 30.3 t -55.14 -47.89 74.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.053 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.56 150.93 9.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.733 HG22 ' HB2' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -156.73 74.31 0.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.049 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.444 ' HA ' HD13 ' A' ' 113' ' ' ILE . 5.1 mm -62.34 106.2 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.349 0.595 . . . . 0.0 111.23 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 148.39 140.28 3.3 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.046 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 126' ' ' THR . 61.3 ttp85 -76.7 126.01 30.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.614 0.245 . . . . 0.0 110.643 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.841 ' HB3' HD22 ' A' ' 106' ' ' LEU . . . -104.43 125.36 50.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.031 0.443 . . . . 0.0 112.007 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.48 ' O ' ' CD1' ' A' ' 117' ' ' TYR . 1.7 p90 -128.32 120.79 27.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.814 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.8 t -98.37 161.25 13.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.343 0.592 . . . . 0.0 112.008 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -169.94 133.6 1.21 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.32 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.92 -110.78 1.21 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.681 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -134.33 84.02 2.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 88' ' ' ASP . 7.6 mttt 153.73 117.39 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.489 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.895 ' CD1' HG23 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -104.72 137.75 42.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.063 0.458 . . . . 0.0 110.84 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.744 HG23 ' HB3' ' A' ' 86' ' ' GLU . 55.2 m -112.72 126.05 54.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.028 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.748 HD11 HG23 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -110.94 117.42 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.859 0.838 . . . . 0.0 111.131 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 115' ' ' ARG . 5.2 t -115.23 154.27 29.36 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.995 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.754 ' CB ' HG13 ' A' ' 38' ' ' VAL . 6.5 t -147.55 25.85 1.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.343 0.592 . . . . 0.0 109.679 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.653 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.044 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.556 ' HA ' HG12 ' A' ' 12' ' ' ILE . 0.6 OUTLIER . . . . . 0 CA--C 1.52 -0.207 0 CA-C-O 121.256 0.55 . . . . 0.0 111.461 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.86 -21.72 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.529 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.51 -10.72 4.85 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.233 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.556 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.0 pp -61.16 -21.35 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-N 117.595 0.697 . . . . 0.0 111.842 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.465 ' HE3' ' HB2' ' A' ' 13' ' ' MET . 0.0 OUTLIER -87.57 8.99 22.62 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.775 178.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.414 ' HA2' ' CB ' ' A' ' 18' ' ' LYS . . . -136.09 -49.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.502 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mp -61.67 -81.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 110.866 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 10.04 26.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.007 0.432 . . . . 0.0 111.431 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.93 -26.45 3.83 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.961 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HG3' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -128.9 81.49 2.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.142 0.496 . . . . 0.0 110.332 179.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -116.97 -27.27 6.6 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.367 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -92.76 15.47 14.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.363 . . . . 0.0 111.402 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HB2' ' HG3' ' A' ' 18' ' ' LYS . . . -80.63 -6.37 58.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.221 0.534 . . . . 0.0 111.768 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -88.97 12.06 16.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.444 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.204 179.69 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.876 0.37 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.8 m -70.07 139.92 52.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.614 HG11 HG23 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -86.27 99.32 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.879 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.791 ' C ' HD12 ' A' ' 40' ' ' LEU . 3.9 t -107.52 146.07 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.255 0.55 . . . . 0.0 112.321 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.791 HD12 ' C ' ' A' ' 39' ' ' VAL . 6.3 mp -150.34 109.8 4.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.058 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.412 HG23 ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -108.51 128.09 64.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.327 0.584 . . . . 0.0 112.193 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.72 HD13 HD11 ' A' ' 48' ' ' ILE . 24.8 mt -127.07 140.26 52.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.6 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.29 125.72 14.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.744 0.307 . . . . 0.0 111.765 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HD2' ' CE2' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -57.36 87.71 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.267 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.609 ' C ' ' H ' ' A' ' 47' ' ' GLU . 33.2 m -125.02 170.16 11.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.381 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.37 11.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.834 ' CB ' HD21 ' A' ' 96' ' ' LEU . 1.9 tt0 -98.84 -57.68 2.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.976 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.768 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.8 OUTLIER -61.23 -44.49 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.302 0.573 . . . . 0.0 109.613 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -39.43 -62.0 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.126 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.845 HG21 ' HG ' ' A' ' 95' ' ' LEU . 56.7 m -65.41 -74.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.952 ' CD2' HG21 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -40.97 -58.78 1.62 Allowed 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.602 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.6 tp -41.72 -46.67 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.02 0.438 . . . . 0.0 109.963 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.536 ' O ' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -57.36 -53.49 57.49 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.683 ' HA ' HG23 ' A' ' 58' ' ' THR . 35.5 mt-10 -66.55 -94.61 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.949 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.952 HG21 ' CD2' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -18.55 -58.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.753 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -62.96 -77.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.671 HD13 ' N ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -63.68 -16.08 60.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.683 HG23 ' HA ' ' A' ' 54' ' ' GLU . 6.3 p -65.01 -74.38 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.297 0.57 . . . . 0.0 110.137 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.582 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 8.7 m-20 -82.56 -32.71 28.39 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.858 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 1.027 ' CG ' HG11 ' A' ' 68' ' ' VAL . 78.1 m-85 -71.81 -32.04 67.18 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -84.78 -46.08 11.74 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.026 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 58' ' ' THR . 10.1 ttpt -57.85 -48.85 78.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.84 0.352 . . . . 0.0 110.821 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.69 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER 179.55 101.63 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -177.55 -52.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.063 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.498 ' N ' HG12 ' A' ' 64' ' ' VAL . 5.7 m-20 -177.1 138.99 0.43 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.772 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.48 3.07 8.09 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.673 2.249 . . . . 0.0 112.275 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.498 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 1.3 t -91.81 -114.1 0.09 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.108 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.027 HG11 ' CG ' ' A' ' 60' ' ' TYR . 8.4 p 28.46 43.47 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.115 0.484 . . . . 0.0 112.246 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.42 138.86 31.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.054 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.22 151.04 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-O 121.243 0.544 . . . . 0.0 111.659 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.771 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -143.42 116.89 9.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.02 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -80.19 124.29 28.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.461 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.464 ' HG3' ' CD2' ' A' ' 78' ' ' TRP . 5.2 mmt-85 -111.45 -117.4 0.3 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.64 -82.98 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -133.12 17.53 4.56 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.187 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.7 155.99 44.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.786 0.326 . . . . 0.0 110.688 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.768 ' CD1' HG21 ' A' ' 48' ' ' ILE . 73.7 m95 -76.4 125.89 30.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.29 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.771 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.1 m0 -96.62 106.59 18.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.663 ' CD1' ' N ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.58 122.12 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.194 -178.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -128.58 136.22 50.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.692 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 67' ' ' THR . . . -142.75 153.48 43.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.835 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.465 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.4 OUTLIER -105.0 129.52 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.644 -179.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.96 -67.62 2.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.256 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.499 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 179.31 157.14 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.636 -179.272 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.816 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.97 154.76 15.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.633 ' HB2' HG22 ' A' ' 124' ' ' THR . 11.7 pt-20 -141.03 124.57 16.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.05 0.452 . . . . 0.0 111.304 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.951 HG13 HG13 ' A' ' 55' ' ' ILE . 39.1 t -94.35 129.37 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.922 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 6.8 m-20 -76.41 151.78 36.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.911 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.452 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 27.8 t -108.9 100.79 9.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.138 0.495 . . . . 0.0 109.908 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.5 m-20 160.17 -36.13 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.17 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -71.28 -69.19 0.39 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.0 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.642 ' HB ' ' CD2' ' A' ' 51' ' ' PHE . 1.1 tt -59.21 -51.49 71.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.713 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.448 ' N ' HG23 ' A' ' 92' ' ' ILE . 44.9 p -52.74 -33.59 48.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.454 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -62.22 -46.58 88.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.973 0.416 . . . . 0.0 111.078 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.868 ' O ' HD13 ' A' ' 95' ' ' LEU . 2.5 tm? -90.18 -20.07 23.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.056 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.834 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -98.19 10.03 41.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.961 0.41 . . . . 0.0 111.018 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.42 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 129.67 69.11 0.11 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.231 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.5 158.82 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.072 0.463 . . . . 0.0 111.24 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 63.32 17.62 10.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.902 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER -75.66 -168.57 0.87 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.706 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -130.39 150.9 51.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.999 0.428 . . . . 0.0 111.236 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.82 HG21 ' OG1' ' A' ' 118' ' ' THR . 7.7 p -64.66 166.79 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.779 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.661 ' CE2' HG22 ' A' ' 118' ' ' THR . 1.2 m-85 71.62 7.16 5.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.049 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -79.7 -30.06 40.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 110.329 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.51 ' CE1' ' CD2' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -80.85 -0.58 39.58 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.278 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.71 29.5 1.12 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.832 0.349 . . . . 0.0 110.792 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 103' ' ' TYR . 7.3 p -87.2 -32.88 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.246 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -174.73 36.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.736 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.616 HG11 HD21 ' A' ' 42' ' ' LEU . 18.9 m -69.5 167.91 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.563 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.1 m -47.52 -47.25 27.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.22 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.412 ' CB ' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -177.34 166.27 2.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 1.2 t 177.31 103.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.295 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 113' ' ' ILE . 10.5 mm -81.93 117.49 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.389 0.614 . . . . 0.0 111.155 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.31 141.82 3.95 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.994 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.94 119.76 21.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.68 0.276 . . . . 0.0 110.492 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.794 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -107.28 125.39 51.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.978 0.418 . . . . 0.0 111.86 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.499 ' HE1' HD23 ' A' ' 119' ' ' LEU . 20.2 p90 -132.28 125.68 31.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.712 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.82 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.0 t -91.17 150.26 21.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.306 0.574 . . . . 0.0 111.985 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.554 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.4 pp -155.31 115.7 3.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.568 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.34 -106.75 1.11 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.535 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.47 83.52 2.02 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.1 OUTLIER 153.94 99.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.034 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.77 ' CD1' HG23 ' A' ' 102' ' ' VAL . 3.2 p90 -90.96 133.5 35.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.082 0.468 . . . . 0.0 110.721 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.633 HG22 ' HB2' ' A' ' 86' ' ' GLU . 2.4 p -108.0 141.02 40.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.436 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.872 HD11 HG23 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -118.38 117.4 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.913 0.863 . . . . 0.0 110.825 178.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 115' ' ' ARG . 4.5 t -97.95 155.99 16.83 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.52 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.439 ' CB ' ' HA ' ' A' ' 38' ' ' VAL . 13.2 t -147.28 20.52 1.21 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.257 0.551 . . . . 0.0 109.857 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.651 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.117 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.731 ' HA ' HD11 ' A' ' 12' ' ' ILE . 1.1 m-20 . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 121.638 0.733 . . . . 0.0 112.566 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.572 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -59.64 -7.97 1.78 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.598 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.37 -19.63 6.58 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.792 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.731 HD11 ' HA ' ' A' ' 9' ' ' ASP . 2.0 pp -108.18 66.88 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.572 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -139.47 14.96 2.56 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.884 178.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.436 ' HA2' ' CB ' ' A' ' 18' ' ' LYS . . . -127.7 -41.8 0.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.24 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.405 HD12 ' H ' ' A' ' 15' ' ' LEU . 5.4 mp -60.85 -75.41 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.782 0.325 . . . . 0.0 110.749 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 9.39 43.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.84 -24.48 5.51 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.859 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.436 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -128.0 81.3 2.01 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.106 0.479 . . . . 0.0 110.074 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -121.12 -36.87 3.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.374 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.47 14.93 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.541 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.28 -173.68 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.901 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.56 13.9 5.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.03 0.443 . . . . 0.0 110.657 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.035 179.766 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.696 0.284 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.7 m -72.24 145.42 47.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.024 0.44 . . . . 0.0 111.125 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.614 HG22 ' HB3' ' A' ' 127' ' ' SER . 0.2 OUTLIER -89.32 102.31 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.154 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.605 HG22 ' HG2' ' A' ' 80' ' ' LYS . 9.6 t -116.23 153.33 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.331 0.586 . . . . 0.0 111.669 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.881 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -173.1 128.26 0.46 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.285 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.464 ' CG1' ' CD1' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -112.44 134.71 54.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.177 0.513 . . . . 0.0 111.662 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.994 HD23 HD11 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -126.52 139.96 52.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.465 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.45 129.17 21.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.492 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -75.72 90.17 2.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.796 0.808 . . . . 0.0 110.433 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.445 ' C ' ' N ' ' A' ' 47' ' ' GLU . 1.1 t -126.27 171.01 11.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.449 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.11 -14.47 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.886 ' HG2' HD12 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -71.79 -61.56 1.74 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.221 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.994 HD11 HD23 ' A' ' 42' ' ' LEU . 1.5 mp -64.64 -43.22 96.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.092 0.472 . . . . 0.0 109.844 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -40.05 -58.18 1.49 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.727 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.435 HG21 ' HG ' ' A' ' 95' ' ' LEU . 1.2 m -78.11 -61.98 1.82 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.106 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.827 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -45.01 -44.44 9.96 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.517 -178.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.588 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.6 tp -62.2 -47.45 93.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.041 0.448 . . . . 0.0 109.868 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -53.91 -37.31 63.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.102 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.756 ' HA ' HG23 ' A' ' 58' ' ' THR . 0.9 OUTLIER -83.8 -75.57 0.33 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.53 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.827 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -31.22 -54.07 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.673 ' N ' HG23 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -76.92 -41.21 44.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -177.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.44 -47.18 12.56 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.498 -178.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.756 HG23 ' HA ' ' A' ' 54' ' ' GLU . 51.4 p -52.72 -68.91 0.13 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.485 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.445 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 0.5 OUTLIER -91.87 -33.8 14.78 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.852 ' CD1' HG21 ' A' ' 68' ' ' VAL . 7.5 m-85 -82.99 -3.12 56.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.455 -0.898 . . . . 0.0 113.091 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 2.3 tptt -115.99 -42.52 3.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.104 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.695 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -58.87 -51.27 70.76 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.573 0.225 . . . . 0.0 111.311 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.545 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -179.42 89.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.235 0.54 . . . . 0.0 111.862 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.626 HG11 ' CE1' ' A' ' 60' ' ' TYR . 24.4 t -160.12 -52.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.19 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 4.8 m-20 171.54 132.22 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.267 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 65' ' ' ASN . 4.7 Cg_exo -78.57 -18.36 12.14 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.658 2.239 . . . . 0.0 111.929 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -51.94 -50.84 60.38 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.4 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.852 HG21 ' CD1' ' A' ' 60' ' ' TYR . 78.2 t -43.83 87.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.651 0.262 . . . . 0.0 111.43 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 67' ' ' THR . 18.1 p30 -116.56 138.9 51.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.803 0.335 . . . . 0.0 111.613 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 78' ' ' TRP . 1.3 p -102.71 153.69 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.102 0.477 . . . . 0.0 111.662 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -142.82 129.72 20.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.432 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.51 114.89 20.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.935 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.477 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -89.92 -146.76 0.18 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.734 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.15 -22.42 60.88 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 111.398 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.14 -35.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.627 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -89.5 159.7 17.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 110.795 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.788 ' CD1' HG21 ' A' ' 48' ' ' ILE . 45.8 m95 -83.46 142.67 30.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.447 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.555 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 7.6 m0 -112.58 110.34 20.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.483 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.881 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -100.41 118.48 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.209 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.605 ' HG2' HG22 ' A' ' 39' ' ' VAL . 6.8 mtpt -126.6 136.76 52.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.487 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -143.63 158.85 43.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.827 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.42 135.96 49.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.229 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.69 -69.43 2.92 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.143 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.434 ' CD ' ' N ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER 178.76 160.9 0.66 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.965 0.412 . . . . 0.0 111.245 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.9 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -152.04 157.04 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.582 179.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.768 ' HB2' HG22 ' A' ' 124' ' ' THR . 7.3 pt-20 -141.38 125.6 17.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.039 0.447 . . . . 0.0 111.708 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.786 HG13 HG13 ' A' ' 55' ' ' ILE . 6.2 t -94.76 127.21 46.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.546 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.425 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 5.3 m-20 -76.44 152.42 36.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.102 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.543 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -107.47 100.06 9.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.392 0.615 . . . . 0.0 109.671 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.439 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER 164.6 -36.3 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.115 -179.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -73.09 -72.25 0.26 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.666 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.651 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -55.86 -59.66 2.49 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.908 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.535 ' H ' HG23 ' A' ' 92' ' ' ILE . 16.3 p -44.03 -37.08 2.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -57.47 -48.68 78.55 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.141 0.496 . . . . 0.0 110.401 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.761 ' O ' HD13 ' A' ' 95' ' ' LEU . 2.7 tm? -90.75 -19.13 23.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.555 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.793 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -91.07 9.65 30.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . 110.47 74.24 0.76 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.593 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -38.63 162.94 0.0 OUTLIER 'General case' 0 CA--C 1.526 0.037 0 CA-C-O 121.14 0.495 . . . . 0.0 111.377 -179.348 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.45 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 19.1 pt20 47.84 98.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.66 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' A' ' 93' ' ' SER . 0.0 OUTLIER -160.04 -152.69 0.3 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.603 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -124.2 124.36 42.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.887 0.375 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.714 HG21 ' OG1' ' A' ' 118' ' ' THR . 12.5 p -53.79 166.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.242 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.532 ' N ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER 80.48 -2.21 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.812 ' O ' HG12 ' A' ' 107' ' ' VAL . 7.5 t70 -60.47 -30.45 69.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.746 ' CE1' HD23 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -76.94 -30.02 55.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.34 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.746 HD23 ' CE1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -108.97 21.44 17.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.207 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.812 HG12 ' O ' ' A' ' 104' ' ' ASP . 13.2 p -87.32 -37.08 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 0.0 111.277 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.532 ' OD2' HG22 ' A' ' 107' ' ' VAL . 0.9 OUTLIER 168.82 88.48 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.802 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.55 83.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.11 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.8 t 66.74 -63.99 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.195 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.529 ' O ' HG23 ' A' ' 112' ' ' THR . 0.1 OUTLIER 175.68 163.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.995 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 111' ' ' SER . 20.5 p -160.16 83.39 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 113' ' ' ILE . 8.4 mm -66.58 110.27 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.56 0.695 . . . . 0.0 111.192 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 146.61 148.09 4.7 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.597 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.461 ' HB2' HG23 ' A' ' 126' ' ' THR . 1.8 mmm180 -76.6 120.05 21.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.56 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -108.14 125.22 51.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.063 0.459 . . . . 0.0 112.144 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.505 ' HE1' HD23 ' A' ' 119' ' ' LEU . 11.4 p90 -136.33 118.52 15.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.412 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.714 ' OG1' HG21 ' A' ' 102' ' ' VAL . 13.7 t -91.21 134.92 34.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.189 0.519 . . . . 0.0 111.731 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.583 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.6 pp -134.01 115.92 14.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.797 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.05 -106.16 0.84 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.992 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 89' ' ' CYS . 0.5 OUTLIER -133.16 83.97 2.1 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.499 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.2 OUTLIER 152.25 95.14 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.455 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.541 ' CD1' HG23 ' A' ' 102' ' ' VAL . 24.0 p90 -88.12 126.62 35.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.015 0.436 . . . . 0.0 111.151 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.768 HG22 ' HB2' ' A' ' 86' ' ' GLU . 12.2 p -102.87 136.14 43.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.149 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -116.09 118.4 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.778 0.799 . . . . 0.0 111.232 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 115' ' ' ARG . 11.3 t -98.2 156.1 16.85 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.16 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.614 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -140.13 13.61 2.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.448 0.642 . . . . 0.0 109.54 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.445 -0.701 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.104 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.471 ' HA ' HG12 ' A' ' 12' ' ' ILE . 3.6 m-20 . . . . . 0 N--CA 1.461 0.109 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.426 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -84.14 -16.93 41.78 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.638 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.18 -13.11 2.44 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.959 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 9' ' ' ASP . 1.9 pp -56.73 -23.61 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 117.732 0.766 . . . . 0.0 111.854 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.426 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.73 8.21 17.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.866 178.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 18' ' ' LYS . . . -135.55 -38.07 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.469 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.66 -74.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.672 0.272 . . . . 0.0 111.127 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.5 9.13 41.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.582 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.88 -24.85 4.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.135 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.499 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 4.5 tmtt? -130.93 85.63 2.29 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.698 0.761 . . . . 0.0 110.321 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -128.04 2.51 5.89 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.471 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.2 18.0 7.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.877 0.37 . . . . 0.0 111.536 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.88 -178.16 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.042 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.96 11.08 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.904 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.041 179.763 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.85 0.357 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 m -67.69 140.85 56.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.661 HG11 HG22 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -97.18 131.22 44.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.987 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 113' ' ' ILE . 8.9 t -129.88 140.06 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 5.6 tp -128.5 104.33 7.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.481 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.417 ' CG2' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -111.74 126.85 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.24 0.543 . . . . 0.0 111.259 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.549 HD22 HD11 ' A' ' 48' ' ' ILE . 1.5 mt -126.69 140.9 52.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.684 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.7 OUTLIER -51.81 119.07 3.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.666 0.27 . . . . 0.0 111.054 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HD2' ' NE1' ' A' ' 77' ' ' TRP . 0.1 OUTLIER -46.79 91.97 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 47' ' ' GLU . 13.6 m -125.38 169.36 12.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.914 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -67.03 3.69 1.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.764 ' CB ' HD21 ' A' ' 96' ' ' LEU . 1.4 tt0 -90.02 -59.32 2.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.801 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.756 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.5 OUTLIER -55.33 -43.72 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 121.171 0.51 . . . . 0.0 109.878 179.287 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -42.45 -61.59 1.17 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.342 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.811 HG21 ' HG ' ' A' ' 95' ' ' LEU . 83.8 m -68.43 -75.43 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.957 ' CD1' HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -39.12 -62.02 0.69 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 119.687 -0.197 . . . . 0.0 111.5 -178.317 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.585 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -42.16 -46.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.983 0.421 . . . . 0.0 110.049 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' O ' HD22 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -56.66 -53.64 55.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.657 ' HA ' HG23 ' A' ' 58' ' ' THR . 8.3 mt-10 -66.91 -94.42 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.016 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.957 HG21 ' CD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -18.74 -61.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.775 ' N ' HD13 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -61.46 -76.22 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -64.12 -15.49 59.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.657 HG23 ' HA ' ' A' ' 54' ' ' GLU . 3.3 p -63.37 -75.39 0.08 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.204 0.525 . . . . 0.0 110.013 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.591 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 2.1 p30 -85.77 -31.47 22.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.768 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.992 ' CG ' HG11 ' A' ' 68' ' ' VAL . 86.1 m-85 -73.64 -29.46 62.35 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.23 -0.588 . . . . 0.0 112.048 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.632 ' CE ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -86.43 -45.05 11.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.641 179.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.5 ttmt -55.58 -51.65 66.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.432 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.685 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER 179.62 100.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.939 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -177.52 -55.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.348 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.556 ' N ' HG12 ' A' ' 64' ' ' VAL . 4.4 m-20 178.69 129.92 0.22 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.846 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -86.63 -16.9 3.56 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.86 2.373 . . . . 0.0 112.111 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.856 HG21 ' ND2' ' A' ' 82' ' ' ASN . 1.8 t -55.26 -39.49 69.86 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.551 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.992 HG11 ' CG ' ' A' ' 60' ' ' TYR . 11.6 p -66.02 65.81 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.406 0.622 . . . . 0.0 110.893 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -101.04 143.32 31.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.887 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.438 HG23 ' CD1' ' A' ' 79' ' ' ILE . 0.5 OUTLIER -95.65 149.67 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.483 0.658 . . . . 0.0 111.693 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 1.6 tp10 -143.66 125.97 15.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.529 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -84.66 115.45 22.67 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.225 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HB2' ' CG ' ' A' ' 78' ' ' TRP . 0.1 OUTLIER -96.38 -114.39 0.13 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.417 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.77 -80.54 0.05 OUTLIER 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.783 0.325 . . . . 0.0 111.581 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.82 -24.84 2.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.037 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -102.52 162.6 12.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.752 0.31 . . . . 0.0 110.842 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.756 ' CD1' HG21 ' A' ' 48' ' ' ILE . 83.4 m95 -76.05 122.72 24.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.269 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.573 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.6 m0 -96.56 107.63 20.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.683 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.676 ' CD1' ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -96.94 137.48 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.435 -178.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -128.81 136.0 49.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.316 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -143.31 157.89 44.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.712 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.856 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -104.82 135.41 46.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.4 . . . . 0.0 110.701 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.63 -67.08 0.28 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.786 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 126' ' ' THR . 0.0 OUTLIER 178.14 173.57 0.62 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.116 0.484 . . . . 0.0 111.311 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.987 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -152.36 162.37 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.419 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.733 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.4 OUTLIER -129.23 121.94 28.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.183 0.516 . . . . 0.0 111.551 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.949 HG23 HD11 ' A' ' 125' ' ' ILE . 55.0 t -94.36 125.29 47.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.564 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -76.81 151.82 35.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.028 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.465 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 17.1 t -108.5 100.68 9.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 3.1 m-20 161.01 -32.95 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.09 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -74.34 -70.81 0.37 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.009 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.575 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -58.46 -51.61 69.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.589 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.426 ' N ' HG23 ' A' ' 92' ' ' ILE . 24.2 p -52.68 -35.29 55.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.523 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -60.15 -44.65 94.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.928 0.394 . . . . 0.0 110.806 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.821 ' O ' HD13 ' A' ' 95' ' ' LEU . 3.4 tm? -90.27 -21.6 22.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.761 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.764 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.46 12.26 35.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.901 0.382 . . . . 0.0 111.218 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.16 66.44 0.13 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.591 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.34 152.56 0.02 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 65.48 18.12 11.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.46 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -166.15 0.25 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.994 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -121.88 140.7 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.717 HG21 ' OG1' ' A' ' 118' ' ' THR . 11.9 p -56.82 163.59 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.004 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.552 ' CE2' HG22 ' A' ' 118' ' ' THR . 0.9 OUTLIER 70.07 9.67 7.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.278 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.43 -32.48 24.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.365 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.531 ' HD1' HD23 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -66.66 -33.03 74.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.511 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.531 HD23 ' HD1' ' A' ' 105' ' ' PHE . 0.6 OUTLIER -124.62 33.3 5.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.707 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 108' ' ' ASP . 14.9 p -63.24 -40.55 89.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.414 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.41 ' N ' HG13 ' A' ' 107' ' ' VAL . 23.0 t0 -174.65 81.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.856 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.515 HG11 HD23 ' A' ' 42' ' ' LEU . 3.4 t -127.73 165.67 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.036 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.476 ' N ' HG12 ' A' ' 109' ' ' VAL . 15.1 t -43.3 -46.16 6.22 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.477 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.417 ' CB ' ' CG2' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -172.49 151.08 2.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.825 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.84 ' C ' HD12 ' A' ' 113' ' ' ILE . 35.5 p -156.27 99.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.242 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.84 HD12 ' C ' ' A' ' 112' ' ' THR . 1.1 mp 59.75 -77.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.542 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 112' ' ' THR . . . 170.98 -100.07 0.15 Allowed Glycine 0 C--N 1.309 -0.925 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.173 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.535 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -93.25 129.76 39.2 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.815 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -122.47 136.37 54.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.453 ' O ' ' CD1' ' A' ' 117' ' ' TYR . 36.5 p90 -136.44 116.74 13.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.253 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.717 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.1 t -86.38 151.19 23.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.818 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.4 pp -159.96 116.21 2.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.822 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.63 -110.47 2.8 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.713 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -132.85 83.85 2.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 1.9 mtpp 152.52 95.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.795 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.62 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 6.5 p90 -88.31 124.07 33.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.177 0.513 . . . . 0.0 110.785 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.733 HG23 ' HB3' ' A' ' 86' ' ' GLU . 17.2 m -98.37 125.85 43.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.463 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.987 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -102.05 117.23 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.009 0.909 . . . . 0.0 111.02 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.451 ' HA ' ' HB2' ' A' ' 84' ' ' LYS . 9.7 t -97.43 155.38 16.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.967 -1.469 . . . . 0.0 110.513 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.583 ' CB ' HG13 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -136.83 14.85 3.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 109.668 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.446 -0.675 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.298 -178.352 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.526 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.5 p30 . . . . . 0 CA--C 1.519 -0.212 0 CA-C-O 121.169 0.509 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.507 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -75.24 -16.91 60.43 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.779 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.12 -9.92 2.33 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.377 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.526 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.1 pp -60.48 -19.73 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 117.466 0.633 . . . . 0.0 112.087 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.507 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.14 8.81 14.39 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.015 178.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -136.68 -52.77 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.401 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.51 -80.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.308 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 10.76 30.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 111.18 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.33 -21.18 5.95 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.05 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -128.05 80.69 1.98 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 110.373 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.468 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 17.7 t0 -128.04 -25.42 3.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.346 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 19' ' ' ASP . 9.2 p90 47.93 74.82 0.15 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.722 0.772 . . . . 0.0 111.11 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.29 -9.65 59.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.505 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.82 11.49 22.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.81 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.117 179.791 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.814 0.34 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.8 m -88.61 148.4 24.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.789 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.747 HG13 ' HB3' ' A' ' 127' ' ' SER . 0.2 OUTLIER -93.0 103.13 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.402 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.719 ' C ' HD12 ' A' ' 40' ' ' LEU . 4.3 t -111.72 149.78 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.092 0.472 . . . . 0.0 111.423 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.719 HD12 ' C ' ' A' ' 39' ' ' VAL . 5.7 mp -155.06 105.19 2.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.397 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -113.22 127.56 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.141 0.496 . . . . 0.0 112.269 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.769 HD13 HG13 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -128.53 147.19 50.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.181 178.137 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -48.86 132.28 18.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.13 89.95 0.46 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.499 0.666 . . . . 0.0 110.683 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.441 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -126.15 170.86 11.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.515 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -51.65 -14.24 0.32 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.759 ' CG ' HD11 ' A' ' 96' ' ' LEU . 11.6 tt0 -66.72 -70.98 0.21 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.252 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.825 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.8 OUTLIER -59.15 -43.65 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 121.183 0.516 . . . . 0.0 109.727 178.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -39.6 -59.06 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.407 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.649 HG21 ' HG ' ' A' ' 95' ' ' LEU . 8.6 m -78.85 -62.02 1.83 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.064 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.891 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -43.96 -47.26 8.5 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.324 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.622 ' HA ' ' CG2' ' A' ' 55' ' ' ILE . 1.7 tp -61.55 -47.11 94.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.025 0.44 . . . . 0.0 110.34 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 pt-20 -53.85 -41.72 67.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.567 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' ' 58' ' ' THR . 1.0 OUTLIER -81.32 -66.86 0.83 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.0 0.429 . . . . 0.0 111.0 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.891 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -37.25 -58.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.829 HD12 HD12 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -75.13 -35.9 61.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -177.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -81.87 -46.82 13.58 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.65 -178.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.72 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 68.7 p -52.17 -70.17 0.09 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.381 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.445 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 2.5 m-20 -92.79 -32.52 14.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.933 ' CG ' HG11 ' A' ' 68' ' ' VAL . 2.4 m-85 -80.53 -6.01 57.58 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.839 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -113.96 -41.24 3.58 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.933 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.72 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.2 ttmt -57.61 -51.17 70.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.66 0.267 . . . . 0.0 111.43 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.453 ' N ' ' ND2' ' A' ' 63' ' ' ASN . 0.1 OUTLIER 179.4 88.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 111.395 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.624 HG11 ' CE1' ' A' ' 60' ' ' TYR . 20.9 t -156.44 -54.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.399 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.472 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.6 m-20 169.86 149.36 0.14 Allowed Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.912 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -89.76 -20.72 1.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.192 2.595 . . . . 0.0 112.88 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.57 HG23 ' H ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -46.89 -65.52 0.55 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.211 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.933 HG11 ' CG ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -42.1 87.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.117 179.324 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.1 p30 -116.07 142.28 47.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.474 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.808 HG23 HD12 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.74 149.72 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.083 0.468 . . . . 0.0 111.029 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.711 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 17.1 mt-10 -143.35 116.05 8.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.35 114.34 26.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.905 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -101.06 -80.88 0.49 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.67 -73.36 0.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.87 0.366 . . . . 0.0 111.422 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.08 -42.15 0.19 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.518 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -83.27 164.26 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.394 . . . . 0.0 110.737 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.825 ' CD1' HG21 ' A' ' 48' ' ' ILE . 30.5 m95 -88.38 136.31 33.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.325 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.711 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 12.5 m0 -103.94 107.1 17.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.485 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.808 HD12 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -96.47 121.7 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -126.73 136.29 52.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.027 0.442 . . . . 0.0 111.654 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . . . -143.53 158.67 43.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.783 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.55 139.17 47.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.866 0.365 . . . . 0.0 111.243 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.79 -69.56 3.03 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.025 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -179.05 158.4 0.91 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.948 0.404 . . . . 0.0 111.128 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.827 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -146.03 152.23 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.714 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.7 OUTLIER -135.41 123.01 22.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 111.428 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.822 HG23 HD11 ' A' ' 125' ' ' ILE . 24.3 t -94.61 136.68 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.826 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 8.6 t70 -76.72 152.03 35.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.957 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 10.6 t -109.59 101.08 10.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.155 0.502 . . . . 0.0 109.888 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.3 m-20 160.21 -36.38 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.3 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -71.76 -71.96 0.25 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.198 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.643 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.1 tt -57.71 -56.65 14.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.475 ' H ' HG23 ' A' ' 92' ' ' ILE . 5.1 t -45.6 -35.94 4.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.655 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.436 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.2 mm-40 -60.93 -46.82 89.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.095 0.474 . . . . 0.0 110.508 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.778 ' O ' HD13 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -89.88 -14.66 33.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.528 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.759 HD11 ' CG ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -103.32 10.55 37.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.439 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 140.13 67.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.673 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -32.48 135.0 0.09 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.019 0.438 . . . . 0.0 111.618 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.23 17.3 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.602 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.5 OUTLIER -70.13 -171.62 0.47 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.591 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -132.99 151.68 52.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.061 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.877 HG23 ' CD1' ' A' ' 123' ' ' PHE . 11.5 p -57.82 160.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.016 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.511 ' N ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER 79.7 9.7 1.48 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.138 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.444 ' O ' HG12 ' A' ' 107' ' ' VAL . 1.7 t70 -92.94 -23.33 18.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.958 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.504 ' CE1' ' CE2' ' A' ' 123' ' ' PHE . 1.0 OUTLIER -79.62 -37.89 35.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.134 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -105.79 29.67 6.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 108' ' ' ASP . 13.9 p -81.63 -44.49 20.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.995 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.477 ' N ' HG13 ' A' ' 107' ' ' VAL . 2.2 m-20 -179.98 88.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.481 HG21 HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -141.77 81.41 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.065 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 t 68.95 -63.59 0.36 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.978 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.652 ' O ' HG23 ' A' ' 112' ' ' THR . 1.3 m 174.05 160.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 111' ' ' SER . 2.0 p -163.91 94.8 0.77 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.421 ' HA ' HD13 ' A' ' 113' ' ' ILE . 13.0 mm -71.35 120.03 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.231 0.538 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.94 137.2 3.45 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.032 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.1 OUTLIER -77.42 119.59 21.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.644 0.259 . . . . 0.0 110.321 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.79 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -102.56 125.46 49.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 0.0 112.014 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.447 ' O ' ' CD1' ' A' ' 117' ' ' TYR . 13.1 p90 -128.91 121.18 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.364 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.747 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.4 t -95.96 153.56 17.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.363 0.602 . . . . 0.0 112.128 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.873 ' O ' HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -163.59 123.7 2.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.436 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.04 -109.88 2.85 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.121 -1.037 . . . . 0.0 111.487 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -138.37 83.95 2.0 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 2.0 mtpm? 154.29 100.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.674 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.877 ' CD1' HG23 ' A' ' 102' ' ' VAL . 1.7 p90 -88.76 137.29 32.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.972 0.415 . . . . 0.0 111.006 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.714 HG23 ' HB3' ' A' ' 86' ' ' GLU . 23.9 m -110.6 129.38 55.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.246 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.827 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -110.22 117.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.859 0.838 . . . . 0.0 110.814 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.9 t -96.52 156.46 16.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.552 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.747 ' HB3' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.46 16.92 2.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.495 0.664 . . . . 0.0 109.555 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 N--CA 1.445 -0.692 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.296 -178.827 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.573 ' HA ' HD12 ' A' ' 12' ' ' ILE . 1.6 p-10 . . . . . 0 CA--C 1.513 -0.48 0 CA-C-O 121.209 0.528 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.55 -32.21 42.13 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.833 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.44 -40.52 47.71 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.286 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.593 ' O ' ' N ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -108.27 9.85 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 120.234 -0.587 . . . . 0.0 111.764 178.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.529 ' HA ' ' CE ' ' A' ' 13' ' ' MET . 0.0 OUTLIER 59.2 -62.99 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.647 0.737 . . . . 0.0 112.344 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -166.78 25.04 0.14 Allowed Glycine 0 C--N 1.3 -1.451 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.934 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.2 mt -82.64 -81.89 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.665 0.269 . . . . 0.0 110.958 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.03 8.57 37.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.033 0.444 . . . . 0.0 111.159 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.83 -20.89 5.56 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.049 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -128.49 81.01 2.0 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.339 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.01 8.95 3.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.534 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.506 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -84.08 2.15 40.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.163 0.506 . . . . 0.0 111.04 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.65 -170.76 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.063 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 t70 62.32 14.28 6.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.163 0.506 . . . . 0.0 110.339 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.955 179.748 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.985 0.421 . . . . 0.0 110.472 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 81' ' ' ALA . 88.4 m -93.46 148.24 22.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.266 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -85.69 97.9 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.477 179.379 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.7 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.4 t -111.31 150.85 13.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.337 0.589 . . . . 0.0 112.163 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.809 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.12 119.79 3.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.764 178.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.678 ' C ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -113.46 126.51 70.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.173 0.511 . . . . 0.0 111.85 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.722 HD23 HD11 ' A' ' 48' ' ' ILE . 7.6 mp -126.76 140.43 52.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.606 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -48.45 133.06 16.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.497 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -78.32 87.62 4.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.502 0.668 . . . . 0.0 110.99 -179.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.481 ' C ' ' N ' ' A' ' 47' ' ' GLU . 21.8 m -126.4 170.99 11.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.887 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -14.12 0.17 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.289 0.566 . . . . 0.0 109.583 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.802 ' HG3' HD11 ' A' ' 96' ' ' LEU . 12.2 tt0 -70.12 -71.6 0.23 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.327 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.726 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.6 OUTLIER -59.18 -45.0 93.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.136 0.493 . . . . 0.0 110.073 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -38.78 -53.4 1.68 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.059 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.766 HG21 HD13 ' A' ' 95' ' ' LEU . 73.8 m -72.48 -74.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.941 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -41.23 -44.47 2.63 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.615 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -56.04 -48.08 79.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.223 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 3.0 pt-20 -52.14 -50.31 61.99 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.692 ' HA ' HG23 ' A' ' 58' ' ' THR . 6.9 mt-10 -68.76 -87.89 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.536 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.941 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.13 -62.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.882 ' HG ' HG12 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -65.6 -70.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.582 HD13 ' N ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -64.4 -23.85 67.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.692 HG23 ' HA ' ' A' ' 54' ' ' GLU . 15.5 p -60.42 -70.95 0.15 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.337 0.589 . . . . 0.0 110.784 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -86.88 -36.72 18.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.345 -178.054 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.961 ' CE1' HG21 ' A' ' 68' ' ' VAL . 97.7 m-85 -76.66 -13.57 60.04 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.496 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -103.94 -41.02 6.0 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.198 178.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.585 ' HB2' ' O ' ' A' ' 58' ' ' THR . 3.8 ttpt -68.32 -50.07 56.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.071 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.592 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -177.4 87.0 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 121.379 0.609 . . . . 0.0 112.524 179.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.757 ' HB ' ' HA ' ' A' ' 60' ' ' TYR . 25.4 t -161.92 -54.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.495 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.564 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.6 m-20 169.48 144.38 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.4 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -86.26 -20.87 2.62 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.897 2.398 . . . . 0.0 112.485 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 65' ' ' ASN . 4.6 t -51.77 -48.74 63.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.234 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.961 HG21 ' CE1' ' A' ' 60' ' ' TYR . 54.3 t -53.56 82.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.872 0.367 . . . . 0.0 110.635 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 67' ' ' THR . 19.5 p30 -116.06 142.73 46.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.495 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.554 HG23 HG23 ' A' ' 79' ' ' ILE . 0.8 OUTLIER -96.82 153.89 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.267 0.556 . . . . 0.0 111.575 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -142.05 124.48 15.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.501 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.24 114.22 18.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.959 0.409 . . . . 0.0 110.771 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.464 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -90.49 -150.83 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.644 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.94 -49.74 76.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.673 0.273 . . . . 0.0 111.065 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.08 15.82 1.02 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.203 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.57 161.17 38.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.953 0.376 . . . . 0.0 111.081 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.726 ' CD1' HG21 ' A' ' 48' ' ' ILE . 63.4 m95 -85.44 143.37 28.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.496 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.3 m0 -116.72 105.7 12.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.634 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.809 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.52 112.22 30.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 0.0 110.155 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -112.34 135.41 53.06 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.218 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.651 ' O ' HG23 ' A' ' 37' ' ' THR . . . -144.65 158.65 43.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.015 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.546 HD22 HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -104.6 148.64 26.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.98 0.419 . . . . 0.0 111.298 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.94 -70.11 0.3 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.171 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.542 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 178.97 159.68 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.371 . . . . 0.0 110.935 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.837 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.6 160.3 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.799 ' HB2' HG22 ' A' ' 124' ' ' THR . 9.1 pt-20 -138.91 127.63 23.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.166 0.507 . . . . 0.0 111.636 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.695 HG13 HG13 ' A' ' 55' ' ' ILE . 27.5 t -94.52 146.2 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.533 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -88.98 152.04 21.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.043 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.603 ' HB2' HG23 ' A' ' 102' ' ' VAL . 42.7 t -109.49 101.03 10.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.234 0.54 . . . . 0.0 109.908 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 0.9 OUTLIER 161.11 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.226 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 94' ' ' GLU . 2.6 mm-40 -77.34 -69.52 0.53 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.958 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.602 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.3 tt -62.2 -56.02 20.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.314 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.488 ' H ' HG23 ' A' ' 92' ' ' ILE . 7.0 t -45.24 -32.43 1.93 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.389 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -63.5 -61.28 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.002 0.43 . . . . 0.0 110.493 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 50' ' ' THR . 0.2 OUTLIER -75.31 -17.24 60.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.909 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.802 HD11 ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -101.89 8.32 41.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.293 -179.237 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.45 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 143.04 65.93 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.562 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -33.57 133.61 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.968 0.413 . . . . 0.0 111.736 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 70.14 17.34 7.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.638 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.45 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -66.33 -175.5 0.36 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.61 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -85.5 -95.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.769 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.603 HG23 ' HB2' ' A' ' 89' ' ' CYS . 10.1 p 179.4 -35.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.682 0.277 . . . . 0.0 111.284 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.727 ' CE2' HG22 ' A' ' 118' ' ' THR . 5.0 m-85 -72.81 -2.67 21.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.079 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.534 ' O ' HG12 ' A' ' 107' ' ' VAL . 1.8 p30 -46.18 -39.44 9.69 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.874 0.369 . . . . 0.0 110.584 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.465 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -75.47 143.51 42.55 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.915 179.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 116' ' ' ALA . 3.7 tt 62.06 18.57 10.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.187 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 104' ' ' ASP . 7.6 p -82.8 -42.27 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.794 0.33 . . . . 0.0 111.038 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.433 ' N ' HG13 ' A' ' 107' ' ' VAL . 2.0 t70 -179.95 51.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.703 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -113.08 85.87 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.487 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.8 -65.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.151 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 109' ' ' VAL . 6.6 t 168.65 172.37 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.765 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER 179.27 120.87 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.882 0.372 . . . . 0.0 111.505 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.1 mm -87.52 122.83 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.331 0.586 . . . . 0.0 111.059 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.87 141.6 3.88 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.984 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 126' ' ' THR . 41.7 mtt-85 -77.24 120.11 21.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.667 ' HB3' HD22 ' A' ' 106' ' ' LEU . . . -105.36 123.84 48.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.162 0.506 . . . . 0.0 112.156 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.568 ' HE1' HD23 ' A' ' 119' ' ' LEU . 13.5 p90 -137.73 119.49 15.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.369 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.727 HG22 ' CE2' ' A' ' 103' ' ' TYR . 14.7 t -93.99 136.24 34.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.118 0.485 . . . . 0.0 111.85 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.595 ' O ' HD12 ' A' ' 119' ' ' LEU . 3.1 pp -135.07 118.75 17.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.76 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.73 -106.63 1.02 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.88 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.37 83.4 2.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.881 0.372 . . . . 0.0 110.118 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 3.7 mttt 152.3 97.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.592 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.641 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 15.1 p90 -88.26 126.31 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.423 . . . . 0.0 111.124 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.799 HG22 ' HB2' ' A' ' 86' ' ' GLU . 19.6 p -102.13 137.38 40.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.867 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.837 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -119.36 118.24 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.78 0.8 . . . . 0.0 111.268 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 115' ' ' ARG . 10.3 t -98.04 156.06 16.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.472 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.432 ' CB ' ' HA ' ' A' ' 38' ' ' VAL . 13.2 t -143.4 19.83 1.88 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.41 0.624 . . . . 0.0 109.489 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 N--CA 1.446 -0.644 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.019 -178.633 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.469 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.9 p30 . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 121.259 0.552 . . . . 0.0 111.511 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.513 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -74.42 -16.16 60.89 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.763 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.99 -10.98 1.89 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.308 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.507 HD12 ' C ' ' A' ' 12' ' ' ILE . 2.0 pp -58.66 -20.84 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 117.482 0.641 . . . . 0.0 112.019 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.513 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -82.05 7.53 13.08 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.972 178.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.786 ' O ' HD12 ' A' ' 15' ' ' LEU . . . -162.3 24.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.718 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 14' ' ' GLY . 7.2 mp -133.62 -83.09 0.46 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.66 0.266 . . . . 0.0 110.673 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.71 7.57 38.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.142 0.496 . . . . 0.0 111.017 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -119.29 -25.17 2.76 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.536 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.89 85.48 2.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.7 0.762 . . . . 0.0 110.008 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -138.65 12.77 2.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.466 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.01 13.96 5.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.856 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.99 -174.29 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.783 0.325 . . . . 0.0 110.776 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.0 t0 62.09 13.84 6.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.997 0.427 . . . . 0.0 110.84 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.23 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.705 0.288 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.0 m -90.66 142.86 27.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 0.0 111.178 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -93.97 92.75 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.858 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.43 145.26 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.363 0.602 . . . . 0.0 111.99 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.774 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.22 129.48 7.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.008 179.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -112.94 129.36 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.213 0.53 . . . . 0.0 111.731 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.947 HD23 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -127.24 140.3 52.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.874 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.682 ' O ' HD13 ' A' ' 48' ' ' ILE . 18.2 mttp -49.27 127.54 15.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -73.14 92.2 1.7 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.73 0.776 . . . . 0.0 110.74 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.444 ' C ' ' N ' ' A' ' 47' ' ' GLU . 6.9 m -126.2 171.12 11.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.207 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -49.95 -16.8 0.31 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.831 ' CB ' HD21 ' A' ' 96' ' ' LEU . 12.5 tt0 -65.46 -74.26 0.11 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.509 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.947 HD11 HD23 ' A' ' 42' ' ' LEU . 2.2 mp -54.7 -31.92 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.2 0.524 . . . . 0.0 109.912 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -47.5 -61.68 1.81 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.51 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.7 ' CB ' HD22 ' A' ' 95' ' ' LEU . 32.9 m -82.09 -44.78 16.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.056 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.783 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -52.52 -48.85 65.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.737 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.705 HG13 HD23 ' A' ' 56' ' ' LEU . 1.6 tp -62.53 -48.52 87.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.061 0.458 . . . . 0.0 109.964 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.697 ' O ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -50.54 -47.47 57.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.402 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.721 ' HA ' HG23 ' A' ' 58' ' ' THR . 28.7 mt-10 -77.77 -71.05 0.44 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.343 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.88 HG13 HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -30.64 -59.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.96 ' HG ' HD22 ' A' ' 57' ' ' LEU . 0.7 OUTLIER -78.91 -50.16 11.65 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.96 HD22 ' HG ' ' A' ' 56' ' ' LEU . 3.1 mm? -65.03 -48.25 74.56 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 119.312 0.96 . . . . 0.0 111.376 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.721 HG23 ' HA ' ' A' ' 54' ' ' GLU . 46.0 p -53.0 -71.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.018 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.465 ' HB3' HG23 ' A' ' 64' ' ' VAL . 9.1 m-20 -62.35 -18.17 60.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.964 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.694 ' HE1' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -51.24 -78.1 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.694 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -19.7 64.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.086 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 58' ' ' THR . 4.8 ttpp -59.73 -70.38 0.17 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.021 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.91 21.73 0.17 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.522 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 65' ' ' ASN . 43.1 t -98.38 -78.36 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.625 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.782 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.8 m-20 154.51 170.82 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.048 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 80.8 Cg_endo -88.62 -7.39 5.62 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.972 2.448 . . . . 0.0 111.955 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.782 HG22 ' HB3' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -64.62 -85.33 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.878 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.706 ' O ' HG22 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -28.97 86.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.635 0.731 . . . . 0.0 111.815 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.2 p30 -115.91 143.28 45.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.563 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.555 HG23 HG23 ' A' ' 79' ' ' ILE . 1.5 p -96.27 151.0 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.321 0.581 . . . . 0.0 111.559 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 16.4 pt-20 -144.92 135.38 24.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.551 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -79.85 114.56 18.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.783 0.325 . . . . 0.0 110.434 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -85.09 -78.47 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.996 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.31 -66.73 0.68 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . -125.0 3.85 8.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.676 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.6 158.1 44.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.808 0.337 . . . . 0.0 110.823 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.652 ' CD1' HG21 ' A' ' 48' ' ' ILE . 78.2 m95 -77.29 142.99 39.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.546 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.583 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.5 m0 -114.8 109.85 18.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.356 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.774 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -100.02 116.17 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.191 0.52 . . . . 0.0 111.382 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -111.72 134.63 53.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.122 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.613 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . . . -144.43 158.76 43.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.898 0.38 . . . . 0.0 111.556 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.626 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -109.18 143.34 38.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.921 179.198 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.93 -69.05 0.62 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.483 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.53 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -177.07 152.31 0.89 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.213 0.53 . . . . 0.0 111.728 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.732 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -125.79 160.47 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.696 ' HB2' HG22 ' A' ' 124' ' ' THR . 17.2 pt-20 -147.24 125.86 12.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.499 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.88 HG13 HG13 ' A' ' 55' ' ' ILE . 38.2 t -95.48 146.9 6.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.673 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 8.9 p30 -101.54 151.82 21.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.639 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.628 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 1.2 t -105.34 99.85 9.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.296 0.57 . . . . 0.0 110.186 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.1 m-20 159.75 -37.58 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.954 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -69.93 -75.82 0.11 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.635 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.637 HD12 ' CD2' ' A' ' 51' ' ' PHE . 1.6 tt -52.88 -56.42 7.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.521 ' H ' HG23 ' A' ' 92' ' ' ILE . 56.0 p -46.14 -43.3 14.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.0 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -51.14 -45.81 61.75 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 109.959 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.7 HD22 ' CB ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -91.2 -18.77 23.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.591 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.831 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.32 19.31 13.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.193 0.521 . . . . 0.0 110.746 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 98' ' ' ARG . . . 99.79 68.56 0.88 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.494 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -30.05 148.07 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.084 0.468 . . . . 0.0 111.895 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 55.3 105.59 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.412 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -175.46 -158.85 0.07 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.632 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.09 132.39 35.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.165 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.473 HG21 ' OG1' ' A' ' 118' ' ' THR . 5.9 p -81.51 -28.59 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.806 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.702 ' CE2' HG22 ' A' ' 118' ' ' THR . 4.0 m-85 -77.44 -2.82 37.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.749 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.788 ' O ' HG12 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -46.02 -35.87 5.17 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-O 120.876 0.369 . . . . 0.0 110.62 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.542 ' CE2' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -80.66 134.35 35.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.152 179.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.801 HD23 ' O ' ' A' ' 106' ' ' LEU . 3.9 tt 75.46 7.68 3.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.862 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.788 HG12 ' O ' ' A' ' 104' ' ' ASP . 11.4 p -86.02 -36.84 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.828 0.347 . . . . 0.0 111.255 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -178.43 48.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.616 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.676 HG21 HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -113.41 86.17 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.261 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.97 -65.78 0.21 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.942 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.528 ' C ' HG22 ' A' ' 112' ' ' THR . 5.9 t 165.44 169.81 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.524 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.528 HG22 ' C ' ' A' ' 111' ' ' SER . 0.2 OUTLIER -179.18 133.84 0.12 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.976 0.417 . . . . 0.0 111.513 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 113' ' ' ILE . 5.0 mm -104.85 113.71 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.54 0.686 . . . . 0.0 110.94 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 152.45 146.85 4.45 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.132 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.29 127.25 32.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.64 0.257 . . . . 0.0 110.594 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.711 ' HB2' HD13 ' A' ' 106' ' ' LEU . . . -115.72 124.66 51.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.088 0.47 . . . . 0.0 111.766 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.453 ' O ' ' CD1' ' A' ' 117' ' ' TYR . 23.6 p90 -136.92 118.95 15.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.854 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.702 HG22 ' CE2' ' A' ' 103' ' ' TYR . 11.0 t -95.35 152.66 18.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.217 0.532 . . . . 0.0 111.498 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.614 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.7 pp -148.41 116.46 6.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.893 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.06 -104.17 0.37 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.188 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.628 ' ND2' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -129.61 83.97 2.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.24 0.543 . . . . 0.0 109.653 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 8.6 mttt 148.73 112.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.998 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.575 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 9.5 p90 -109.18 124.38 50.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.069 0.461 . . . . 0.0 110.817 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.696 HG22 ' HB2' ' A' ' 86' ' ' GLU . 7.3 p -100.49 141.72 32.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.643 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.818 HD11 HG23 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -120.82 117.61 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.87 0.843 . . . . 0.0 111.296 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 115' ' ' ARG . 12.8 t -103.61 155.47 18.52 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.105 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.466 ' CB ' HG13 ' A' ' 38' ' ' VAL . 30.1 t -144.41 18.96 1.71 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.301 0.572 . . . . 0.0 109.855 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 N--CA 1.447 -0.606 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.459 -178.647 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.434 ' O ' ' HE3' ' A' ' 13' ' ' MET . 1.5 m-20 . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 121.126 0.489 . . . . 0.0 112.318 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.58 -26.5 62.63 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.527 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.28 -26.22 14.52 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.731 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.472 ' CD1' ' H ' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -92.29 -26.33 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.79 0.805 . . . . 0.0 110.664 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.439 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER 28.7 46.07 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.79 -1.55 . . . . 0.0 113.34 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.472 ' H ' ' CD1' ' A' ' 12' ' ' ILE . . . -149.2 -89.41 0.08 OUTLIER Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.184 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.58 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.7 mm? -44.01 -69.61 0.13 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.738 0.304 . . . . 0.0 111.415 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.426 ' H ' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -99.61 -6.42 27.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.192 0.52 . . . . 0.0 111.642 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.16 -13.35 42.75 Favored Glycine 0 C--N 1.313 -0.723 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.704 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.45 81.55 2.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.133 0.492 . . . . 0.0 110.632 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -137.6 12.01 2.96 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.354 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.05 15.16 6.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.71 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.98 -171.69 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.849 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.71 14.22 4.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.06 0.457 . . . . 0.0 110.568 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.978 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.837 0.351 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.9 m -69.11 143.56 54.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.071 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.582 HG13 ' CB ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -87.64 98.89 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.69 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 113' ' ' ILE . 7.2 t -117.17 152.82 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.314 0.578 . . . . 0.0 111.881 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.777 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -164.53 128.09 2.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.085 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.42 130.7 65.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.251 0.548 . . . . 0.0 111.927 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.032 HD23 HD11 ' A' ' 48' ' ' ILE . 9.0 tp -128.04 140.49 51.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.816 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.665 ' O ' HD13 ' A' ' 48' ' ' ILE . 7.6 ttmm -47.17 124.53 6.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.569 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.476 ' HA ' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -71.68 90.36 1.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.501 0.667 . . . . 0.0 110.655 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.475 ' C ' ' N ' ' A' ' 47' ' ' GLU . 3.7 m -125.72 171.79 10.34 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.198 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -48.11 -17.77 0.15 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.269 0.557 . . . . 0.0 109.526 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.795 ' HA ' HD21 ' A' ' 96' ' ' LEU . 25.7 tt0 -63.23 -77.42 0.05 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.468 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.032 HD11 HD23 ' A' ' 42' ' ' LEU . 2.3 mp -54.62 -31.74 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -47.03 -60.23 2.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.276 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.604 ' CB ' HD22 ' A' ' 95' ' ' LEU . 3.9 m -84.17 -45.59 12.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.054 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.825 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -51.44 -47.64 62.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.513 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.689 HD13 HG23 ' A' ' 48' ' ' ILE . 1.5 tp -63.66 -49.04 83.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.062 0.458 . . . . 0.0 109.818 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -50.78 -45.04 58.9 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.802 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.789 ' HA ' HG23 ' A' ' 58' ' ' THR . 3.2 mt-10 -77.25 -77.19 0.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.695 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.853 HG13 HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -30.98 -55.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.689 ' N ' HG23 ' A' ' 55' ' ' ILE . 7.0 tt -71.28 -60.52 2.19 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 57' ' ' LEU . 2.6 mm? -66.85 -48.23 69.5 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.789 HG23 ' HA ' ' A' ' 54' ' ' GLU . 51.8 p -51.98 -71.82 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.062 0.458 . . . . 0.0 110.279 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.492 ' HB2' HG21 ' A' ' 64' ' ' VAL . 6.3 m-20 -60.59 -23.21 64.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.891 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.709 ' HE1' HG13 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.32 -78.0 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -67.91 -26.17 65.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.297 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.0 ttpp -52.02 -66.54 0.37 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.872 0.367 . . . . 0.0 111.281 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -169.76 30.39 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.255 0.55 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 65' ' ' ASN . 24.1 t -101.68 -78.63 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.348 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.784 ' HB3' HG22 ' A' ' 67' ' ' THR . 5.1 m-20 154.49 165.92 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 O-C-N 123.523 0.514 . . . . 0.0 110.946 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.464 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 94.7 Cg_endo -86.19 -3.54 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.79 2.327 . . . . 0.0 111.922 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.784 HG22 ' HB3' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -68.82 -86.75 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.44 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.709 HG13 ' HE1' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -24.29 89.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.559 0.695 . . . . 0.0 111.895 -179.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -116.04 143.1 45.92 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.04 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.538 HG23 HG23 ' A' ' 79' ' ' ILE . 1.5 p -96.73 153.06 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.146 0.498 . . . . 0.0 111.547 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.512 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 27.6 tt0 -143.83 133.09 23.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.991 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.65 114.37 21.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.295 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -94.3 -81.67 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.318 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.42 -69.21 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.835 0.35 . . . . 0.0 111.354 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . -126.55 5.45 7.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.034 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.66 153.91 43.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 110.889 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.641 ' CD1' HG21 ' A' ' 48' ' ' ILE . 82.7 m95 -76.83 143.07 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.62 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.512 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.3 m0 -111.3 105.03 13.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.339 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.777 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.81 110.56 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.028 0.442 . . . . 0.0 110.824 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -112.13 135.71 52.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.066 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.657 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . . . -144.09 156.9 44.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.417 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.423 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 0.5 OUTLIER -109.07 128.93 55.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.449 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.04 -67.67 3.12 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.327 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.61 152.38 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.252 0.548 . . . . 0.0 111.619 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.74 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -127.08 160.21 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.745 ' HB3' HG23 ' A' ' 124' ' ' THR . 2.3 pt-20 -149.39 125.69 10.81 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.547 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.853 HG13 HG13 ' A' ' 55' ' ' ILE . 62.1 t -95.3 146.48 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.476 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 122' ' ' LYS . 6.7 t70 -95.72 151.41 19.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.408 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.491 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 7.6 t -104.01 100.02 9.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.111 0.482 . . . . 0.0 110.082 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.2 m-20 157.7 -36.43 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.337 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 94' ' ' GLU . 0.9 OUTLIER -69.88 -76.41 0.1 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.543 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.573 HD12 ' CD2' ' A' ' 51' ' ' PHE . 2.8 tt -54.05 -56.5 9.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.357 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.512 ' H ' HG23 ' A' ' 92' ' ' ILE . 16.9 p -47.58 -36.05 10.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.876 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.45 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -57.83 -46.21 85.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.109 0.481 . . . . 0.0 110.053 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.604 HD22 ' CB ' ' A' ' 50' ' ' THR . 0.7 OUTLIER -90.5 -18.46 25.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.626 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.795 HD21 ' HA ' ' A' ' 47' ' ' GLU . 1.1 mm? -98.67 14.03 30.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.054 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.6 68.09 0.37 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.063 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -33.07 149.86 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.088 0.47 . . . . 0.0 111.97 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.63 17.99 9.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.324 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -165.36 0.4 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.939 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -96.0 -162.76 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.933 HG23 ' CD1' ' A' ' 123' ' ' PHE . 1.5 p -117.44 -32.07 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.084 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -81.58 5.77 17.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.579 0.228 . . . . 0.0 111.474 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 107' ' ' VAL . 11.6 t70 -60.6 -39.32 87.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.651 0.262 . . . . 0.0 110.811 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.528 ' HE2' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -66.87 -14.03 62.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.13 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -143.01 35.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.786 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 104' ' ' ASP . 10.8 p -87.18 -32.94 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.112 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -176.85 38.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.407 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.605 HG21 HG23 ' A' ' 112' ' ' THR . 25.6 m -69.56 165.81 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.644 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.9 m -54.51 -46.79 73.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.004 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.3 140.85 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.605 HG23 HG21 ' A' ' 109' ' ' VAL . 1.4 p -149.75 75.35 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.504 ' HA ' HD13 ' A' ' 113' ' ' ILE . 4.9 mm -58.99 106.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.48 0.657 . . . . 0.0 111.007 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.56 144.98 4.26 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.878 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 126' ' ' THR . 19.6 mtm180 -76.55 125.8 29.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.801 0.334 . . . . 0.0 110.736 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.68 ' HB2' HD13 ' A' ' 106' ' ' LEU . . . -104.04 125.28 50.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.965 0.412 . . . . 0.0 111.658 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.453 ' O ' ' CD1' ' A' ' 117' ' ' TYR . 13.9 p90 -133.91 120.58 20.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.772 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.849 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.5 t -97.11 158.45 15.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.237 0.541 . . . . 0.0 111.929 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 119' ' ' LEU . 3.0 pp -157.42 118.06 3.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.793 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.8 -106.35 0.86 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.817 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -132.55 83.85 2.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.5 OUTLIER 152.37 110.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.191 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.933 ' CD1' HG23 ' A' ' 102' ' ' VAL . 2.1 p90 -101.6 132.33 47.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.236 0.541 . . . . 0.0 111.132 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.745 HG23 ' HB3' ' A' ' 86' ' ' GLU . 30.4 m -106.98 134.43 50.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.747 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.763 HD12 ' H ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -117.32 117.45 55.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.711 0.767 . . . . 0.0 111.011 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.9 t -109.57 155.16 21.76 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.943 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.582 ' CB ' HG13 ' A' ' 38' ' ' VAL . 28.8 t -142.63 21.97 1.99 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.354 0.597 . . . . 0.0 109.705 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.446 -0.674 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.106 -178.806 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.555 ' HA ' HG12 ' A' ' 12' ' ' ILE . 28.8 m-20 . . . . . 0 CA--C 1.519 -0.222 0 CA-C-O 121.135 0.493 . . . . 0.0 111.666 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.37 -22.52 54.73 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.625 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.29 -7.63 5.78 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.266 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.555 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.2 pp -61.33 -18.64 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 117.567 0.683 . . . . 0.0 111.793 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.423 ' H ' ' HE2' ' A' ' 13' ' ' MET . 0.0 OUTLIER -84.19 9.33 13.07 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.91 178.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.99 -46.92 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.319 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -74.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.68 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -101.83 11.42 38.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.095 0.474 . . . . 0.0 111.161 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -112.55 -16.08 9.05 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.081 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.03 80.71 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.026 0.441 . . . . 0.0 110.531 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -142.67 7.61 1.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.669 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.84 18.19 7.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.812 0.339 . . . . 0.0 111.426 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.46 -174.26 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.908 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.2 t0 62.42 12.95 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.101 0.477 . . . . 0.0 110.912 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.961 179.728 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.664 0.268 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.5 m -120.47 144.56 47.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.859 0.362 . . . . 0.0 111.007 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.677 HG11 HG23 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -101.45 106.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.498 179.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 113' ' ' ILE . 12.4 t -121.47 150.32 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 121.42 0.629 . . . . 0.0 112.252 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.77 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -164.78 130.96 2.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.865 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 111' ' ' SER . 0.0 OUTLIER -112.65 128.92 69.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.262 0.553 . . . . 0.0 111.863 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.931 ' HG ' HG11 ' A' ' 109' ' ' VAL . 0.5 OUTLIER -128.18 148.4 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.356 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.61 153.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.852 0.358 . . . . 0.0 111.381 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.444 ' HA ' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -90.7 22.35 3.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.599 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.449 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -71.52 171.64 11.0 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.068 -178.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -49.39 -14.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.57 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.982 ' HG3' HD21 ' A' ' 96' ' ' LEU . 1.4 tt0 -63.82 -76.82 0.06 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.989 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -55.96 -44.31 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.365 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -39.65 -58.61 1.28 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.907 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.878 ' HB ' HD11 ' A' ' 95' ' ' LEU . 27.5 m -84.16 -56.47 3.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.892 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.916 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -47.15 -50.42 20.47 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.547 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.8 tp -59.43 -48.2 88.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.818 0.342 . . . . 0.0 110.179 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.788 ' O ' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -50.51 -52.38 39.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.339 0.59 . . . . 0.0 109.604 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.751 ' HA ' HG23 ' A' ' 58' ' ' THR . 13.2 mm-40 -69.05 -81.18 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.649 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.916 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -23.27 -58.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.74 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.5 mp -73.25 -66.2 0.71 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.788 HD22 ' O ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -62.94 -33.33 75.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.751 HG23 ' HA ' ' A' ' 54' ' ' GLU . 70.0 p -60.89 -67.7 0.38 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.267 0.556 . . . . 0.0 110.905 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.614 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 0.1 OUTLIER -85.69 -42.81 13.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.805 ' CG ' HG11 ' A' ' 68' ' ' VAL . 52.0 m-85 -69.94 -24.28 63.33 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -92.59 -50.99 5.33 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.722 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.0 ttmt -60.81 -41.37 95.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.422 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.71 ' O ' HG23 ' A' ' 64' ' ' VAL . 3.4 p30 179.72 104.0 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.888 0.375 . . . . 0.0 111.698 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER 177.85 -53.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.138 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.517 ' N ' HG12 ' A' ' 64' ' ' VAL . 4.3 m-20 -179.53 143.07 0.38 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 111.876 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.04 -4.0 10.4 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.742 2.295 . . . . 0.0 111.858 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.552 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -83.52 -108.17 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.533 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.805 HG11 ' CG ' ' A' ' 60' ' ' TYR . 9.5 p 27.01 49.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.296 0.57 . . . . 0.0 111.657 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -82.25 137.72 34.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.124 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -98.06 154.0 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.228 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 2.4 mm-40 -142.23 120.12 11.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.059 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -78.85 114.0 17.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.418 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.447 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 2.2 tpt180 -98.08 -145.28 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.914 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.73 -19.9 44.33 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 120.605 0.24 . . . . 0.0 111.436 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.26 -50.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.593 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.49 156.14 29.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.381 . . . . 0.0 110.738 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.989 ' CD1' HG21 ' A' ' 48' ' ' ILE . 38.3 m95 -81.84 143.69 31.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.391 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.467 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 9.4 m0 -108.84 107.16 17.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.383 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.77 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.2 109.55 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.1 0.476 . . . . 0.0 110.051 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -118.35 141.7 48.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.184 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB3' HG22 ' A' ' 85' ' ' ILE . . . -143.38 157.95 44.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.52 120.85 40.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.953 0.406 . . . . 0.0 111.595 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.07 -65.46 1.93 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.085 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.596 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -178.53 155.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 0.0 110.769 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.783 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -133.3 156.81 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.823 ' HB2' HG22 ' A' ' 124' ' ' THR . 3.3 pt-20 -144.79 123.69 12.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.212 0.53 . . . . 0.0 111.664 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.758 HG23 HD11 ' A' ' 125' ' ' ILE . 28.8 t -94.3 146.28 6.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.553 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 0.8 OUTLIER -89.93 152.03 21.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.329 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 41.4 t -114.48 101.12 8.83 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 7.7 t0 161.55 -28.69 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.436 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -86.58 -69.11 0.7 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.649 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.819 HD12 ' CD2' ' A' ' 51' ' ' PHE . 0.9 OUTLIER -52.8 -80.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.494 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.607 ' N ' HG12 ' A' ' 92' ' ' ILE . 6.5 p -19.94 -55.68 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 76.5 mm-40 -54.79 -47.15 74.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 0.0 111.799 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.878 HD11 ' HB ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -89.96 -28.81 18.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.895 -178.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.982 HD21 ' HG3' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -56.9 -19.93 20.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.99 -44.98 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.01 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER 171.11 -171.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -58.81 100.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.055 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CB ' ' HB2' ' A' ' 93' ' ' SER . 0.1 OUTLIER -114.77 -165.7 1.04 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.98 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.65 -173.87 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 0.0 111.045 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.8 HG21 ' OG1' ' A' ' 118' ' ' THR . 4.3 p -83.89 173.37 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.944 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.642 ' H ' HG22 ' A' ' 102' ' ' VAL . 0.5 OUTLIER 69.91 9.77 7.23 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.697 -179.044 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.586 ' O ' HG12 ' A' ' 107' ' ' VAL . 8.7 p-10 -80.14 -35.0 37.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.291 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.582 ' CE1' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -63.57 -52.97 58.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.703 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -97.93 31.78 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.986 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 104' ' ' ASP . 14.5 p -72.91 -44.76 57.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.069 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.489 ' N ' HG13 ' A' ' 107' ' ' VAL . 0.4 OUTLIER 173.76 96.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.818 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.931 HG11 ' HG ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -134.38 -171.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.96 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.1 OUTLIER -47.84 -40.28 20.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.909 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.5 ' HB3' HG23 ' A' ' 41' ' ' VAL . 2.2 t 171.83 157.54 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.817 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 63.0 p -156.51 75.95 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.119 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.439 ' HA ' HD13 ' A' ' 113' ' ' ILE . 6.2 mm -59.95 108.17 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.386 0.612 . . . . 0.0 111.084 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.43 141.91 3.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.011 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 126' ' ' THR . 34.9 mtm105 -77.05 120.21 21.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.657 0.265 . . . . 0.0 110.409 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.734 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -104.54 126.41 51.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.096 0.475 . . . . 0.0 112.263 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.457 ' HE1' HD23 ' A' ' 119' ' ' LEU . 5.7 p90 -136.14 125.39 24.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.603 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.8 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.5 t -91.21 159.11 16.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.185 0.517 . . . . 0.0 111.961 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.5 pp -161.25 116.82 2.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.916 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.78 -109.13 1.85 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.689 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -129.1 83.1 2.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 11.5 mttt 151.34 120.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.525 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.68 ' CD1' HG23 ' A' ' 102' ' ' VAL . 1.3 p90 -108.45 135.5 49.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.845 0.355 . . . . 0.0 110.528 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.823 HG22 ' HB2' ' A' ' 86' ' ' GLU . 19.3 p -109.81 134.65 51.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.685 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.783 HD13 ' CD1' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -114.95 117.48 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.839 0.828 . . . . 0.0 110.6 178.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 115' ' ' ARG . 10.7 t -99.51 156.74 16.88 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.651 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.442 ' HB2' HG13 ' A' ' 38' ' ' VAL . 2.7 m -142.71 20.88 2.0 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.335 0.588 . . . . 0.0 109.653 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 N--CA 1.446 -0.666 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.986 -178.573 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.461 ' HA ' HG12 ' A' ' 12' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.544 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -73.32 -16.27 61.37 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.404 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.76 -1.56 3.34 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.322 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.521 HD12 ' C ' ' A' ' 12' ' ' ILE . 2.0 pp -67.97 -15.94 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-O 121.424 0.631 . . . . 0.0 111.912 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.544 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.49 9.12 14.28 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.916 178.203 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.23 -48.69 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.678 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -79.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 110.902 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -93.06 11.3 28.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.032 0.444 . . . . 0.0 111.242 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.96 -20.94 5.5 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.233 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -129.52 80.63 1.97 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.023 0.44 . . . . 0.0 110.623 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -145.52 9.76 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.738 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.28 17.28 10.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.893 0.377 . . . . 0.0 111.224 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.0 -9.49 58.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.673 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.3 11.3 24.04 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.865 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.965 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.832 0.349 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.402 ' C ' ' HG ' ' A' ' 127' ' ' SER . 15.9 m -85.75 155.8 20.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.115 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.745 HG13 ' HB3' ' A' ' 127' ' ' SER . 0.2 OUTLIER -110.9 107.18 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.59 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.572 HG22 ' HG2' ' A' ' 80' ' ' LYS . 11.6 t -119.48 152.45 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.401 0.62 . . . . 0.0 112.108 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.769 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -165.55 128.69 2.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.968 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.542 HG23 ' OG ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -112.07 132.43 60.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.337 0.589 . . . . 0.0 111.739 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.098 HD23 HD11 ' A' ' 48' ' ' ILE . 1.1 tp -127.96 140.17 52.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.513 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -48.88 128.44 15.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.426 0.155 . . . . 0.0 110.761 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.487 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -78.72 86.94 4.64 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.545 0.688 . . . . 0.0 110.441 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.46 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -126.03 171.41 10.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.403 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.35 -14.35 0.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.201 0.524 . . . . 0.0 109.739 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.679 ' HG3' HD21 ' A' ' 96' ' ' LEU . 2.6 tt0 -72.53 -63.83 1.08 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.088 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.098 HD11 HD23 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -61.66 -44.92 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.169 0.509 . . . . 0.0 110.139 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -42.44 -55.89 3.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.588 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.815 HG21 ' HG ' ' A' ' 95' ' ' LEU . 75.8 m -67.0 -77.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.967 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -39.7 -55.15 1.96 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.102 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.57 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.5 tp -45.81 -45.7 5.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.076 0.465 . . . . 0.0 109.839 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.631 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.4 pt-20 -57.12 -40.54 77.28 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.743 ' HA ' HG23 ' A' ' 58' ' ' THR . 2.9 mp0 -81.75 -91.8 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.547 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.967 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.78 -54.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.879 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -72.71 -42.53 64.09 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.631 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -83.14 -45.93 13.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.279 0.561 . . . . 0.0 110.696 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.743 HG23 ' HA ' ' A' ' 54' ' ' GLU . 69.5 p -53.61 -70.47 0.09 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.993 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.591 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 5.4 m-20 -89.66 -30.43 18.11 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.879 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 32.0 m-85 -80.15 -24.67 40.26 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.524 1.056 . . . . 0.0 111.566 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 2.2 tptt -90.39 -47.66 7.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.052 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.641 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -56.08 -47.46 77.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.752 0.31 . . . . 0.0 111.226 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.703 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -179.52 102.2 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.983 0.42 . . . . 0.0 111.282 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -179.92 -57.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.718 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.574 ' N ' HG12 ' A' ' 64' ' ' VAL . 1.1 m120 178.65 127.8 0.21 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.608 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -85.21 -17.33 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.658 2.239 . . . . 0.0 111.908 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.684 HG21 HD22 ' A' ' 82' ' ' ASN . 1.8 t -57.41 -49.91 74.69 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.561 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.827 HG11 ' CD1' ' A' ' 60' ' ' TYR . 2.9 p -42.73 87.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.09 0.472 . . . . 0.0 111.194 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.2 p30 -115.25 142.57 46.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.303 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.44 HG23 HG23 ' A' ' 79' ' ' ILE . 0.7 OUTLIER -96.97 153.2 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 121.187 0.518 . . . . 0.0 111.622 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -142.9 123.34 13.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.121 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -79.86 114.35 18.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.295 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -93.73 -71.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.368 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.09 -69.94 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.128 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.24 4.55 9.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.814 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.48 149.78 39.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.834 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.835 ' CD1' HG21 ' A' ' 48' ' ' ILE . 74.9 m95 -77.45 142.72 39.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.571 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.564 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.7 m0 -107.67 106.63 17.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.27 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.769 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.19 110.87 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 0.0 110.142 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.572 ' HG2' HG22 ' A' ' 39' ' ' VAL . 5.0 mtpt -116.51 135.52 53.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.046 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.56 ' HB3' ' CG2' ' A' ' 85' ' ' ILE . . . -144.46 159.26 43.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.793 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.684 HD22 HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -96.8 148.32 23.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.959 0.409 . . . . 0.0 111.352 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.87 -69.73 0.42 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.343 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.729 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -179.58 161.46 1.03 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.913 0.387 . . . . 0.0 110.883 -179.377 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.812 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -141.08 155.77 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.801 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.7 ' HB3' HG23 ' A' ' 124' ' ' THR . 13.2 pt-20 -140.31 124.01 17.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.018 0.437 . . . . 0.0 111.481 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.882 HG13 HG13 ' A' ' 55' ' ' ILE . 24.8 t -93.67 143.86 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.581 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 6.3 t70 -88.25 151.73 22.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.012 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 54.0 t -111.78 100.51 8.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.047 0.451 . . . . 0.0 109.86 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 3.1 t70 162.41 -36.14 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.932 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.24 -68.05 0.56 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.984 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.574 ' HB ' ' CD2' ' A' ' 51' ' ' PHE . 1.6 tt -59.32 -55.67 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.591 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.501 ' H ' HG23 ' A' ' 92' ' ' ILE . 19.9 p -48.81 -32.92 9.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.599 0.238 . . . . 0.0 111.628 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.2 mm-40 -62.55 -47.64 82.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.754 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.861 ' O ' HD13 ' A' ' 95' ' ' LEU . 2.3 tm? -90.05 -17.21 28.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.703 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.679 HD21 ' HG3' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.26 8.35 44.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.832 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 131.23 70.08 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.177 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -31.23 147.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.059 0.457 . . . . 0.0 111.836 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 64.21 18.22 11.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.082 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -71.87 -167.14 0.26 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.086 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -100.79 -164.08 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.664 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.901 HG23 ' CD1' ' A' ' 123' ' ' PHE . 1.5 p -113.15 -33.56 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.041 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.513 ' CZ ' HG22 ' A' ' 118' ' ' THR . 20.3 m-85 -80.1 5.59 13.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.327 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.459 ' O ' HG12 ' A' ' 107' ' ' VAL . 25.1 p-10 -59.4 -41.74 90.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.647 0.26 . . . . 0.0 110.968 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.542 ' HE2' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -60.73 -28.11 68.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.774 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.542 HD13 ' OG1' ' A' ' 112' ' ' THR . 3.1 tp -131.5 40.6 3.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.028 0.442 . . . . 0.0 110.938 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 104' ' ' ASP . 14.9 p -87.19 -36.29 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 178.65 69.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.486 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.604 HG11 ' HG ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -113.26 179.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.062 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.517 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.9 OUTLIER -46.54 -43.84 17.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.067 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.542 ' OG ' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER 170.68 165.25 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.982 0.42 . . . . 0.0 111.301 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 42.4 p -159.08 80.67 0.77 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.85 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.441 ' HA ' HD13 ' A' ' 113' ' ' ILE . 5.1 mm -58.95 105.09 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.49 0.662 . . . . 0.0 111.286 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' A' ' 126' ' ' THR . . . 144.34 144.72 4.23 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.965 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.75 120.04 21.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.58 0.229 . . . . 0.0 110.493 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -99.81 125.31 45.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.97 0.414 . . . . 0.0 112.037 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.471 ' O ' ' CD1' ' A' ' 117' ' ' TYR . 1.7 p90 -131.45 122.36 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.361 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.81 ' OG1' HG21 ' A' ' 102' ' ' VAL . 15.2 t -103.33 158.9 16.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 111.882 -178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -167.78 134.32 2.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.356 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.45 -109.89 1.58 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.674 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.43 83.73 2.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 7.3 mttt 153.39 122.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.503 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.901 ' CD1' HG23 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -107.93 139.55 42.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.933 0.396 . . . . 0.0 110.444 179.214 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.7 HG23 ' HB3' ' A' ' 86' ' ' GLU . 37.6 m -114.24 130.04 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.44 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.812 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -112.31 117.78 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.794 0.806 . . . . 0.0 110.74 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.4 t -98.31 156.34 16.77 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.504 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.745 ' HB3' HG13 ' A' ' 38' ' ' VAL . 71.7 p -150.0 30.96 0.7 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.562 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.899 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.483 ' HA ' HG12 ' A' ' 12' ' ' ILE . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.125 0 CA-C-O 121.064 0.459 . . . . 0.0 111.484 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.471 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -79.52 -17.23 54.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.413 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.66 -8.55 3.1 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.169 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.483 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.2 pp -60.52 -20.07 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 117.527 0.663 . . . . 0.0 111.871 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.471 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.76 8.64 16.49 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.742 177.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 18' ' ' LYS . . . -131.91 -34.37 0.39 Allowed Glycine 0 CA--C 1.518 0.268 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.477 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mp -77.15 -80.24 0.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.745 0.307 . . . . 0.0 111.002 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.48 9.94 29.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.967 0.413 . . . . 0.0 111.535 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.95 -27.14 2.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.948 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 1.4 tmtt? -130.14 85.29 2.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.719 0.771 . . . . 0.0 110.242 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -134.83 8.14 3.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.683 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 62.59 18.24 10.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.842 0.354 . . . . 0.0 111.384 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.29 -177.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.4 t0 63.87 12.0 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.79 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.943 179.845 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.882 0.373 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 81' ' ' ALA . 30.4 m -75.23 146.36 41.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.831 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -90.58 102.36 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.103 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.823 ' C ' HD12 ' A' ' 40' ' ' LEU . 2.9 t -107.9 139.42 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.115 0.483 . . . . 0.0 111.543 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.823 HD12 ' C ' ' A' ' 39' ' ' VAL . 8.9 mp -136.42 104.27 5.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.036 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.62 127.03 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.363 0.602 . . . . 0.0 111.961 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.647 HD13 HD11 ' A' ' 48' ' ' ILE . 4.5 mt -127.67 145.41 50.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.746 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.0 119.99 4.9 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.488 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.77 91.08 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.427 0.632 . . . . 0.0 110.888 -178.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.445 ' C ' ' H ' ' A' ' 47' ' ' GLU . 50.0 m -125.93 170.3 11.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.451 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -53.65 -11.79 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.142 0.496 . . . . 0.0 109.793 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.655 ' HB2' HD11 ' A' ' 96' ' ' LEU . 1.9 tt0 -75.11 -65.47 0.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.492 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.695 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.4 OUTLIER -58.27 -44.47 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.3 0.571 . . . . 0.0 109.67 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -43.87 -53.72 5.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.345 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.528 HG21 ' CD1' ' A' ' 95' ' ' LEU . 25.9 m -79.93 -64.96 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.196 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.923 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -45.07 -46.9 11.83 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.372 -178.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.4 tp -61.44 -48.48 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.163 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -50.76 -38.99 51.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.048 0.451 . . . . 0.0 109.822 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.708 ' CA ' HG23 ' A' ' 58' ' ' THR . 2.8 mt-10 -82.89 -87.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.781 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.923 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.9 -56.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 179.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.0 ' HG ' HG12 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -72.98 -42.53 63.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.74 -46.35 13.27 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.623 -179.103 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.708 HG23 ' CA ' ' A' ' 54' ' ' GLU . 51.4 p -49.24 -72.61 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.57 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.442 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 0.9 OUTLIER -94.05 -25.92 16.99 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -177.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 1.006 ' CD2' HG11 ' A' ' 68' ' ' VAL . 7.7 m-85 -87.41 -1.37 57.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 119.306 -0.957 . . . . 0.0 112.737 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.584 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 2.5 tptt -118.06 -41.59 2.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.683 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.66 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.9 OUTLIER -58.91 -51.66 69.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.263 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.593 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -178.93 90.21 0.02 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.39 0.614 . . . . 0.0 112.012 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 63' ' ' ASN . 24.6 t -161.77 -53.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.505 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.491 ' HB3' HG22 ' A' ' 67' ' ' THR . 5.0 m-20 177.62 141.67 0.25 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.396 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.48 -23.34 2.82 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.77 2.314 . . . . 0.0 112.152 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.491 HG22 ' HB3' ' A' ' 65' ' ' ASN . 9.6 t -55.19 -38.44 68.38 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.302 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.006 HG11 ' CD2' ' A' ' 60' ' ' TYR . 82.2 t -61.9 74.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.64 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 67' ' ' THR . 16.0 p30 -116.0 142.29 46.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.973 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.544 HG23 HD12 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.54 149.38 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.389 0.614 . . . . 0.0 111.682 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.663 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.2 OUTLIER -143.75 123.53 13.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.573 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -88.44 114.84 25.47 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.107 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.407 ' NH1' ' CZ3' ' A' ' 78' ' ' TRP . 11.6 tpt180 -99.86 -100.04 0.24 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.618 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.31 -78.66 0.1 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.844 0.354 . . . . 0.0 111.27 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.68 -40.04 0.34 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.3 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.85 158.85 19.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.787 0.327 . . . . 0.0 110.545 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.695 ' CD1' HG21 ' A' ' 48' ' ' ILE . 75.4 m95 -77.43 126.32 30.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.527 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.663 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.7 m0 -96.69 109.97 22.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.289 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.702 ' CD1' ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -96.52 136.68 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -129.11 135.72 49.26 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.021 0.438 . . . . 0.0 112.153 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.831 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . . . -144.5 158.48 43.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.756 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.406 ' N ' ' OG1' ' A' ' 67' ' ' THR . 0.4 OUTLIER -115.06 127.39 55.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.95 0.405 . . . . 0.0 111.251 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 84.25 -68.31 3.54 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.902 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER 178.42 160.71 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.014 0.435 . . . . 0.0 111.347 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.907 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -151.53 160.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.436 179.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.726 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.3 OUTLIER -136.09 125.22 24.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.165 0.507 . . . . 0.0 111.693 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.604 HG23 HD11 ' A' ' 125' ' ' ILE . 99.6 t -92.31 144.65 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.524 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.43 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 5.7 m-20 -87.95 152.64 21.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.441 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 51.9 t -112.16 100.55 8.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.157 0.503 . . . . 0.0 109.743 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 10.0 t70 165.21 -36.51 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.773 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 94' ' ' GLU . 7.4 mt-10 -74.96 -69.31 0.48 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.59 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.549 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 0.7 OUTLIER -63.99 -54.51 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.475 ' H ' HG23 ' A' ' 92' ' ' ILE . 18.3 p -44.12 -30.69 0.8 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.133 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 3.2 mm-40 -68.51 -71.54 0.21 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.125 0.488 . . . . 0.0 110.235 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.528 ' CD1' HG21 ' A' ' 50' ' ' THR . 0.3 OUTLIER -62.31 -19.94 63.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.134 -179.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -98.06 -1.76 41.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.58 0.229 . . . . 0.0 111.395 -179.461 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.463 ' HA3' ' CD2' ' A' ' 100' ' ' PHE . . . 152.56 66.03 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.87 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -28.02 137.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.782 0.433 . . . . 0.0 112.123 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 64.17 19.66 11.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.541 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.463 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -58.55 -162.9 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.107 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -105.58 -85.74 0.48 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.998 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.848 HG21 ' OG1' ' A' ' 118' ' ' THR . 2.0 p 179.54 -54.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.667 0.27 . . . . 0.0 111.554 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.451 ' H ' HG13 ' A' ' 102' ' ' VAL . 6.8 m-85 -64.98 -13.24 57.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.652 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -47.36 -29.98 2.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.598 0.237 . . . . 0.0 111.469 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.622 ' O ' HG11 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -71.19 -30.09 65.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.034 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.661 HD22 ' HB3' ' A' ' 116' ' ' ALA . 0.9 OUTLIER -134.71 42.28 2.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.969 0.414 . . . . 0.0 110.92 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 108' ' ' ASP . 12.1 p -83.19 -45.67 18.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.119 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.487 ' N ' HG13 ' A' ' 107' ' ' VAL . 6.1 m-20 -160.05 31.0 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.622 HG11 ' O ' ' A' ' 105' ' ' PHE . 34.7 m -59.49 165.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.578 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.55 -46.27 66.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.023 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.741 ' O ' HG23 ' A' ' 112' ' ' THR . 0.5 OUTLIER -174.59 163.37 3.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.741 HG23 ' O ' ' A' ' 111' ' ' SER . 0.5 OUTLIER -177.18 85.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.138 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 113' ' ' ILE . 7.4 mm -60.45 113.45 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.359 0.599 . . . . 0.0 110.779 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.73 140.93 3.79 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.702 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.817 ' HB3' HG22 ' A' ' 126' ' ' THR . 26.3 ttp180 -79.65 119.62 22.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.622 0.249 . . . . 0.0 110.715 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.672 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -101.28 125.29 47.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.015 0.436 . . . . 0.0 111.776 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.465 ' O ' ' CD1' ' A' ' 117' ' ' TYR . 30.9 p90 -132.71 116.55 16.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.521 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.848 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.8 t -83.03 163.17 21.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.313 0.577 . . . . 0.0 111.992 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.4 pp -170.16 115.57 0.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.578 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.64 -107.1 1.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.571 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.26 83.66 2.04 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER 152.04 109.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.598 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.706 ' CD1' HG23 ' A' ' 102' ' ' VAL . 1.1 p90 -95.16 139.74 31.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.873 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.726 HG23 ' HB3' ' A' ' 86' ' ' GLU . 45.1 m -111.31 127.18 55.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.359 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.907 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -108.6 118.14 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.857 0.837 . . . . 0.0 110.737 178.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.817 HG22 ' HB3' ' A' ' 115' ' ' ARG . 2.6 t -96.82 155.8 16.62 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.728 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.775 ' HB2' HG13 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -149.07 23.74 0.94 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.267 0.556 . . . . 0.0 109.615 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.447 -0.578 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.316 -178.374 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.5 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.3 m-20 . . . . . 0 CA--C 1.52 -0.188 0 CA-C-O 121.149 0.5 . . . . 0.0 111.566 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.463 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -79.17 -18.65 52.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.443 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.31 -9.42 2.98 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.232 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.5 HG12 ' HA ' ' A' ' 9' ' ' ASP . 2.2 pp -59.06 -20.78 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 117.637 0.719 . . . . 0.0 111.883 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.463 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -85.76 9.33 16.78 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.915 178.118 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.402 ' HA2' ' CB ' ' A' ' 18' ' ' LYS . . . -142.81 -50.52 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.623 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.55 -77.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.752 0.311 . . . . 0.0 111.056 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.22 10.73 28.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.021 0.439 . . . . 0.0 111.397 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.68 -22.47 4.33 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.134 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.402 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -128.85 80.74 1.99 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.12 0.486 . . . . 0.0 110.408 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -138.02 9.06 2.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.61 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 63.3 18.51 11.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.359 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.34 -178.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t70 63.58 13.03 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.12 0.485 . . . . 0.0 110.617 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.214 179.992 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.885 0.374 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.0 m -115.79 141.76 47.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.759 HG13 ' HB3' ' A' ' 127' ' ' SER . 0.2 OUTLIER -88.88 93.75 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.992 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.727 HG22 ' HG2' ' A' ' 80' ' ' LYS . 3.7 t -105.67 147.54 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.225 0.536 . . . . 0.0 111.854 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.83 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.64 120.59 3.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.884 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.54 130.29 67.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.339 0.59 . . . . 0.0 112.116 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.982 HD22 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -127.05 139.86 52.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.429 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -54.29 132.03 42.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.484 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -61.88 89.22 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.505 0.669 . . . . 0.0 109.975 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 47' ' ' GLU . 14.8 m -125.86 170.62 11.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.905 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -52.77 -11.75 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 109.931 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.835 ' CB ' HD21 ' A' ' 96' ' ' LEU . 3.6 tt0 -69.33 -75.5 0.11 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.245 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.982 HD11 HD22 ' A' ' 42' ' ' LEU . 3.8 mm -53.81 -39.87 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 24.4 m120 -43.48 -57.74 2.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.376 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.75 ' CB ' HD22 ' A' ' 95' ' ' LEU . 53.5 m -85.73 -57.63 2.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.605 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.933 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -47.23 -45.53 23.58 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.766 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.666 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.3 tp -65.56 -49.23 79.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.863 0.363 . . . . 0.0 110.272 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.3 pt-20 -53.41 -40.55 65.2 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.098 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.714 ' O ' HG23 ' A' ' 58' ' ' THR . 23.7 mm-40 -80.37 -70.08 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.942 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.933 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -37.86 -59.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.724 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -72.52 -36.61 68.38 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.69 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -84.0 -46.81 11.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.517 -0.739 . . . . 0.0 110.916 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.715 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 71.6 p -50.0 -70.86 0.08 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.223 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 7.3 m-20 -94.35 -29.3 15.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.953 ' CG ' HG11 ' A' ' 68' ' ' VAL . 2.3 m-85 -83.83 -1.61 54.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.534 -0.867 . . . . 0.0 112.711 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.598 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -118.87 -40.41 2.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.785 178.518 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.715 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -58.23 -50.2 74.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.707 0.289 . . . . 0.0 111.289 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.527 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER 179.57 89.29 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.212 0.53 . . . . 0.0 111.276 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.622 HG11 ' CE1' ' A' ' 60' ' ' TYR . 9.7 t -158.94 -58.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.54 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.481 ' HB3' HG22 ' A' ' 67' ' ' THR . 3.8 m-20 174.25 145.92 0.21 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.894 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -89.14 -19.36 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.046 2.497 . . . . 0.0 112.462 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.15 -64.26 0.83 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.321 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.953 HG11 ' CG ' ' A' ' 60' ' ' TYR . 1.7 p -41.73 87.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 121.048 0.451 . . . . 0.0 110.96 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.8 p30 -116.22 142.57 46.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.479 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.507 HG23 HG23 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -97.0 153.23 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.105 0.479 . . . . 0.0 111.531 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.57 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.6 OUTLIER -142.65 118.74 10.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.241 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.27 114.64 24.05 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.445 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.44 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 3.8 mmp_? -101.58 -117.42 0.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.239 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.35 76.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.79 0.329 . . . . 0.0 111.272 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.88 -37.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.641 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -82.79 162.0 21.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.961 0.41 . . . . 0.0 110.618 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.636 ' CD1' HG21 ' A' ' 48' ' ' ILE . 50.0 m95 -86.01 140.56 30.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.742 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.57 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.4 m0 -110.97 108.7 18.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.39 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.83 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.47 116.21 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.629 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.727 ' HG2' HG22 ' A' ' 39' ' ' VAL . 11.4 mtmt -119.46 136.39 54.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.08 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.422 ' HB3' ' CG2' ' A' ' 85' ' ' ILE . . . -143.41 158.71 43.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.69 137.6 44.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 111.358 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.07 -69.83 3.19 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.926 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.406 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 179.86 158.62 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 0.0 111.041 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.747 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.85 160.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.745 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.1 OUTLIER -140.71 125.2 17.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 111.643 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.881 HG13 HG13 ' A' ' 55' ' ' ILE . 18.0 t -94.66 138.55 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.641 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 5.3 m-20 -80.51 152.24 28.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.207 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 46.9 t -113.11 100.85 8.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 109.958 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.5 m-20 161.88 -37.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.27 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 94' ' ' GLU . 6.8 mt-10 -72.5 -68.59 0.46 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.697 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.625 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -58.55 -58.26 7.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.273 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.533 ' H ' HG23 ' A' ' 92' ' ' ILE . 44.7 p -45.28 -34.14 2.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.553 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 0.5 OUTLIER -61.26 -47.34 86.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 110.359 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.75 HD22 ' CB ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -90.11 -17.0 28.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.785 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.835 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -98.01 9.47 42.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.933 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 129.28 69.69 0.12 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.309 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -34.8 149.09 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.059 0.457 . . . . 0.0 111.439 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.88 17.66 10.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.149 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.432 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -69.57 -167.84 0.15 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.679 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -131.2 135.16 47.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.84 0.353 . . . . 0.0 110.966 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.772 HG21 ' OG1' ' A' ' 118' ' ' THR . 8.1 p -51.14 166.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.934 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.51 ' H ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER 79.38 1.87 2.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.895 -179.169 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.799 ' O ' HG12 ' A' ' 107' ' ' VAL . 8.2 t0 -73.77 -31.71 63.44 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.984 0.421 . . . . 0.0 110.232 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.469 ' CE1' ' HB2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -64.82 -26.03 68.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.772 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 0.5 OUTLIER -127.69 30.65 5.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.624 179.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.799 HG12 ' O ' ' A' ' 104' ' ' ASP . 9.2 p -83.05 -34.71 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.166 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.569 ' OD1' HG13 ' A' ' 107' ' ' VAL . 49.8 p30 -178.12 39.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.797 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.612 HG11 HD11 ' A' ' 42' ' ' LEU . 12.0 m -70.86 172.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.374 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.52 -44.43 56.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.166 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.2 m 172.95 157.7 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -178.95 122.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.926 0.393 . . . . 0.0 111.639 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 113' ' ' ILE . 9.4 mm -92.56 121.12 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.3 0.571 . . . . 0.0 111.005 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.46 143.07 3.78 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.954 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -77.78 120.23 22.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.783 0.325 . . . . 0.0 110.39 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -101.09 125.22 47.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.065 0.46 . . . . 0.0 111.929 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.472 ' O ' ' CD1' ' A' ' 117' ' ' TYR . 4.8 p90 -136.08 121.36 19.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.462 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.772 ' OG1' HG21 ' A' ' 102' ' ' VAL . 15.3 t -105.0 142.45 34.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.339 0.59 . . . . 0.0 111.995 -178.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.857 ' O ' HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -148.24 125.69 11.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.652 179.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.99 -110.84 3.68 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.671 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.49 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.09 83.84 2.05 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.1 OUTLIER 153.22 101.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.747 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.641 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 8.4 p90 -88.67 128.88 35.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.102 0.477 . . . . 0.0 110.98 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.745 HG23 ' HB3' ' A' ' 86' ' ' GLU . 29.9 m -103.07 132.48 49.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.117 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.795 HD11 HG23 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -114.88 118.67 59.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.924 0.869 . . . . 0.0 110.979 179.146 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 115' ' ' ARG . 5.4 t -96.3 156.28 16.41 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.456 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.759 ' HB3' HG13 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -138.05 14.84 2.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.383 0.611 . . . . 0.0 109.542 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.642 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.62 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.468 ' HA ' HG12 ' A' ' 12' ' ' ILE . 11.0 m-20 . . . . . 0 CA--C 1.521 -0.166 0 CA-C-O 121.114 0.483 . . . . 0.0 111.538 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.504 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -78.31 -16.09 58.08 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.485 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.73 -9.02 2.33 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.241 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.49 HD12 ' C ' ' A' ' 12' ' ' ILE . 2.1 pp -60.39 -20.39 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 CA-C-N 117.574 0.687 . . . . 0.0 111.811 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.504 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -82.92 7.55 15.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.877 178.143 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.96 21.07 0.44 Allowed Glycine 0 CA--C 1.519 0.332 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.57 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.6 -83.49 0.63 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.661 0.267 . . . . 0.0 110.608 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.0 9.26 40.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.084 0.468 . . . . 0.0 110.938 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.11 -15.76 8.25 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.985 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.01 81.26 2.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.017 0.437 . . . . 0.0 110.216 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -140.53 10.8 2.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.635 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.67 14.44 7.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.3 -169.86 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.844 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.12 14.97 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.041 0.448 . . . . 0.0 110.541 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.066 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.937 0.399 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.2 m -72.93 145.38 46.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.206 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.825 HG13 ' OG ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -99.41 99.18 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.606 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.792 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.9 t -112.0 152.44 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.33 0.586 . . . . 0.0 112.389 -178.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.792 HD23 ' O ' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -148.59 107.88 3.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.527 178.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -113.4 125.93 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.031 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.916 HD13 HG13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -128.63 148.66 50.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.133 178.127 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.32 127.53 17.51 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.489 ' HA ' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -66.3 90.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.535 0.684 . . . . 0.0 111.043 -179.023 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.464 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -125.94 171.36 10.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.956 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.89 -17.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.669 ' HG3' HD11 ' A' ' 96' ' ' LEU . 8.2 tt0 -62.02 -72.31 0.13 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.239 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.916 HG13 HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -59.75 -40.66 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -40.83 -59.48 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.409 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.655 HG21 ' HG ' ' A' ' 95' ' ' LEU . 2.4 m -79.47 -61.87 1.87 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.877 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.869 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -43.82 -45.52 7.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.237 -179.184 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -62.63 -47.23 93.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.862 0.363 . . . . 0.0 110.284 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.643 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -54.23 -41.18 68.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.516 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.637 ' O ' HG23 ' A' ' 58' ' ' THR . 7.4 mt-10 -81.07 -68.64 0.67 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.043 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.869 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -37.17 -57.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.705 ' N ' HG23 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -74.85 -38.41 61.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.643 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.49 -46.88 12.86 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.884 -178.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.695 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 50.6 p -53.54 -69.81 0.11 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.489 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.452 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 20.5 m-20 -91.72 -29.66 16.7 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.82 ' CD1' HG21 ' A' ' 68' ' ' VAL . 8.4 m-85 -87.15 -2.07 58.36 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.427 -0.909 . . . . 0.0 113.236 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.567 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -117.75 -40.71 2.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 178.348 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.695 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -62.08 -49.98 73.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.611 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -177.71 90.49 0.03 OUTLIER 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.507 0.67 . . . . 0.0 112.297 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.687 HG11 ' CE1' ' A' ' 60' ' ' TYR . 20.2 t -162.05 -54.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.076 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.555 ' HB3' HG22 ' A' ' 67' ' ' THR . 5.6 m-20 170.49 143.45 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.482 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.64 -16.43 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.981 2.454 . . . . 0.0 112.237 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 65' ' ' ASN . 14.7 t -53.16 -39.47 63.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.286 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.82 HG21 ' CD1' ' A' ' 60' ' ' TYR . 63.5 t -61.81 86.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.826 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 67' ' ' THR . 8.9 m-80 -115.43 142.44 46.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.859 0.361 . . . . 0.0 111.056 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.657 HG23 HD12 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -96.84 153.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 121.235 0.541 . . . . 0.0 111.548 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -142.08 117.98 10.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.787 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.3 114.52 18.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.645 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.518 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -95.23 -146.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.083 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.2 -73.57 0.08 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.629 0.252 . . . . 0.0 111.637 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . -126.42 12.48 7.07 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.479 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -142.83 158.66 43.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.086 0.443 . . . . 0.0 111.091 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.658 ' O ' HG12 ' A' ' 41' ' ' VAL . 58.7 m95 -80.73 142.75 33.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.229 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.606 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.0 m0 -115.79 108.5 16.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.635 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.822 HD13 ' N ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -96.89 127.21 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 135.83 49.66 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.947 0.403 . . . . 0.0 111.241 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.575 ' CB ' HG21 ' A' ' 85' ' ' ILE . . . -143.86 159.05 43.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.849 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -106.97 148.3 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.076 0.465 . . . . 0.0 111.328 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 68.08 -69.85 0.32 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.331 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.422 ' CD ' ' N ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER 177.92 160.71 0.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.922 0.391 . . . . 0.0 111.02 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.956 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -149.55 160.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.956 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.548 ' CB ' ' HB ' ' A' ' 124' ' ' THR . 1.0 OUTLIER -138.14 126.1 22.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.128 0.49 . . . . 0.0 111.414 -179.501 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.643 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 23.0 t -94.49 146.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.603 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.433 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 8.8 t70 -90.11 152.15 21.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.103 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.472 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 49.8 t -109.46 100.74 9.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.295 0.569 . . . . 0.0 109.745 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 0.7 OUTLIER 162.45 -35.98 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.979 -179.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -74.26 -71.85 0.31 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.748 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.637 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.0 OUTLIER -57.11 -56.35 15.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.449 ' H ' HG23 ' A' ' 92' ' ' ILE . 15.1 p -46.62 -35.62 6.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.734 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.9 OUTLIER -60.19 -46.21 90.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.098 0.475 . . . . 0.0 110.367 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.814 ' O ' HD13 ' A' ' 95' ' ' LEU . 1.1 tm? -90.17 -17.62 27.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.601 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.669 HD11 ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -99.7 12.33 36.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.974 0.416 . . . . 0.0 110.999 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.418 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 126.29 69.52 0.18 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.279 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -35.11 148.61 0.02 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.08 0.467 . . . . 0.0 111.66 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 64.8 17.48 11.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.342 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -69.65 -177.58 1.26 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.607 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -81.81 -91.87 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.689 HG21 ' OG1' ' A' ' 118' ' ' THR . 2.7 p 179.42 -42.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.688 0.28 . . . . 0.0 111.1 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.684 ' CE2' HG22 ' A' ' 118' ' ' THR . 4.9 m-85 -71.71 -6.69 43.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.367 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.71 -34.24 18.26 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.782 0.325 . . . . 0.0 111.026 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.533 ' CD1' ' CE2' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -60.54 -34.95 74.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.631 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.503 HD13 ' OG1' ' A' ' 112' ' ' THR . 5.6 tp -133.21 41.89 3.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.473 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.9 p -81.59 -39.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.298 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -166.14 31.47 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.002 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.402 HG11 HD23 ' A' ' 42' ' ' LEU . 29.5 m -65.07 174.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.295 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -55.96 -42.47 76.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.9 OUTLIER 171.65 151.72 0.06 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.503 ' OG1' HD13 ' A' ' 106' ' ' LEU . 65.8 p -159.88 98.51 1.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.906 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 113' ' ' ILE . 17.1 mm -65.89 127.31 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 0.0 110.966 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.81 144.48 5.37 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.041 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.521 ' HB2' HG23 ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.84 120.55 22.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.7 0.286 . . . . 0.0 110.414 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.457 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -106.9 124.59 49.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.129 0.49 . . . . 0.0 112.263 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.529 ' CZ ' HG23 ' A' ' 124' ' ' THR . 2.0 p90 -137.04 119.29 15.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.296 178.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.689 ' OG1' HG21 ' A' ' 102' ' ' VAL . 10.9 t -99.81 142.71 30.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.251 0.548 . . . . 0.0 111.969 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -146.38 133.11 19.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.507 179.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 56.9 -112.02 3.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.611 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.503 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.9 84.06 2.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.4 OUTLIER 152.11 100.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.526 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.643 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 14.2 p90 -88.28 133.08 34.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.17 0.509 . . . . 0.0 110.949 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.548 ' HB ' ' CB ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -107.93 130.67 55.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.858 -179.458 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.956 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -112.82 118.58 58.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.891 0.853 . . . . 0.0 111.368 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.521 HG23 ' HB2' ' A' ' 115' ' ' ARG . 9.1 t -97.24 155.59 16.79 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.087 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.825 ' OG ' HG13 ' A' ' 38' ' ' VAL . 2.2 m -146.02 19.28 1.43 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.256 0.551 . . . . 0.0 109.842 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 N--CA 1.445 -0.698 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.246 -178.755 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mtp . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.841 0.353 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.0 t -92.54 79.56 4.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.49 97.9 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -78.27 145.44 35.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.3 t -144.29 123.21 12.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.026 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -130.98 95.14 3.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 62.43 -174.73 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.998 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.879 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -146.07 21.49 1.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.447 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.514 ' HA ' HG12 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -53.4 -20.78 4.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.224 0.535 . . . . 0.0 111.49 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -75.5 -15.89 60.36 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.848 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.03 -9.25 2.2 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.333 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.1 pp -60.4 -19.2 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-N 117.538 0.669 . . . . 0.0 112.069 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.49 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -83.91 9.64 11.69 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.041 178.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.04 -43.8 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.732 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.58 -80.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 110.989 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.43 -14.49 26.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.438 0.637 . . . . 0.0 111.512 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.8 -18.03 62.35 Favored Glycine 0 C--N 1.312 -0.805 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.895 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.22 81.11 1.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 110.878 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 9.2 t0 -138.67 8.36 2.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.515 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.46 ' CG ' ' O ' ' A' ' 19' ' ' ASP . 13.3 p90 46.91 73.93 0.17 Allowed 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.8 0.81 . . . . 0.0 111.087 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.56 -8.44 38.19 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.602 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -90.13 11.85 19.64 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.032 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -138.32 12.79 2.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.239 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -95.53 -54.38 3.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.525 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -120.98 111.13 17.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.519 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.36 -115.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.112 0.482 . . . . 0.0 111.028 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 t70 71.25 15.57 6.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.377 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -56.4 -26.74 54.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.918 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -177.49 105.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.106 0.479 . . . . 0.0 110.435 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -99.29 162.15 13.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.004 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -93.38 141.65 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.003 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 11.2 p -110.04 134.69 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.817 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -110.18 115.3 29.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.859 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 33.35 85.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.147 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.403 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -121.33 144.06 48.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.892 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -103.44 28.23 6.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.027 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.0 m -74.37 145.23 43.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.884 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.719 HG11 HG23 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -86.26 106.32 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.884 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.75 HG22 ' HG2' ' A' ' 80' ' ' LYS . 13.5 t -118.3 154.09 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.328 0.585 . . . . 0.0 111.832 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.699 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -177.93 125.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.265 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -112.03 135.22 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.668 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.77 HD23 HD11 ' A' ' 48' ' ' ILE . 3.5 tp -125.73 139.52 53.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.639 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -50.76 139.61 16.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.129 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.466 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -87.52 87.65 7.46 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.396 0.617 . . . . 0.0 110.462 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.43 ' C ' ' N ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -125.78 170.64 11.39 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.543 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.67 -12.13 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.993 0.425 . . . . 0.0 110.34 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.818 ' CD ' HD11 ' A' ' 96' ' ' LEU . 1.4 tt0 -80.82 -58.11 3.24 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.342 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.813 HG21 ' CD1' ' A' ' 77' ' ' TRP . 1.4 mp -63.86 -44.89 98.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.963 0.411 . . . . 0.0 110.241 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -40.49 -59.85 1.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.058 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.74 HG21 ' HG ' ' A' ' 95' ' ' LEU . 58.5 m -69.96 -68.47 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.007 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.882 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -42.66 -47.01 5.23 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.595 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.5 tp -55.87 -47.97 79.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.165 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.485 ' O ' ' CD2' ' A' ' 57' ' ' LEU . 1.6 pt-20 -53.29 -48.78 68.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 109.755 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.798 ' HA ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -70.64 -81.6 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.67 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.882 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -22.02 -57.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.7 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.4 mp -74.22 -66.0 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.576 HD13 ' N ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -63.41 -33.12 74.85 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -177.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.798 HG23 ' HA ' ' A' ' 54' ' ' GLU . 70.0 p -62.93 -66.2 0.58 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.338 0.59 . . . . 0.0 110.757 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.62 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -83.24 -46.35 12.78 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.805 ' CG ' HG11 ' A' ' 68' ' ' VAL . 49.6 m-85 -69.04 -24.71 64.21 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -90.99 -51.48 5.32 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.657 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 58' ' ' THR . 13.6 ttpt -60.68 -43.16 98.05 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.271 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.698 ' O ' HG23 ' A' ' 64' ' ' VAL . 2.0 p30 179.76 103.8 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.103 0.477 . . . . 0.0 111.753 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER 178.51 -52.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.027 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.465 ' N ' HG12 ' A' ' 64' ' ' VAL . 5.1 m-20 178.86 141.56 0.28 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.738 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.55 -10.41 10.87 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.698 2.265 . . . . 0.0 111.956 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.516 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -78.3 -106.25 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.61 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.805 HG11 ' CG ' ' A' ' 60' ' ' TYR . 9.7 p 26.56 49.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.359 0.599 . . . . 0.0 111.629 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -82.32 136.52 35.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.199 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.75 153.76 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.041 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 7.9 mm-40 -142.44 116.28 9.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.188 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -86.38 114.52 23.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.571 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.445 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 21.4 mmt180 -103.17 -120.67 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.973 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.78 -54.04 50.92 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.862 0.363 . . . . 0.0 111.133 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.83 -39.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.644 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -79.93 162.5 24.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.673 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.813 ' CD1' HG21 ' A' ' 48' ' ' ILE . 22.8 m95 -90.92 142.71 27.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.154 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.511 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.4 m0 -106.52 102.4 11.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.266 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.847 HD13 ' N ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -97.01 107.41 19.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.174 0.511 . . . . 0.0 110.411 -179.184 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.75 ' HG2' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -121.9 143.71 49.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.455 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.564 ' HB3' HG22 ' A' ' 85' ' ' ILE . . . -143.4 158.51 43.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.296 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.41 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.4 OUTLIER -102.94 132.84 48.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.865 0.364 . . . . 0.0 111.438 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.52 -68.21 3.47 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.001 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.493 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -176.46 152.89 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 110.691 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.817 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -133.69 157.92 42.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.795 ' HB2' HG22 ' A' ' 124' ' ' THR . 12.5 pt-20 -147.75 122.27 9.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.467 . . . . 0.0 111.825 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.773 HG13 HG13 ' A' ' 55' ' ' ILE . 29.2 t -94.74 137.16 23.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.59 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 18.0 p30 -84.31 151.93 24.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.893 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.465 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 21.4 t -109.83 100.55 9.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.131 0.491 . . . . 0.0 109.849 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 0.8 OUTLIER 161.5 -35.87 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.079 -179.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.02 -70.35 0.36 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.826 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.62 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.5 tt -57.8 -58.93 4.23 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.191 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.516 ' H ' HG23 ' A' ' 92' ' ' ILE . 4.9 t -44.75 -34.76 2.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.798 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.6 mm-40 -60.9 -48.22 82.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 110.542 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.843 ' O ' HD13 ' A' ' 95' ' ' LEU . 1.5 tm? -90.23 -16.98 28.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.725 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.818 HD11 ' CD ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.33 10.19 41.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 98' ' ' ARG . . . 125.46 70.72 0.19 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.117 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -30.72 147.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.149 0.5 . . . . 0.0 111.834 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.45 17.91 11.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.038 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -165.19 0.05 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.933 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.21 -167.88 1.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.035 HG23 ' CD1' ' A' ' 123' ' ' PHE . 0.2 OUTLIER -113.14 -43.89 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.719 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -2.57 16.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.36 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.83 -40.79 22.25 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.878 0.37 . . . . 0.0 110.264 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.608 ' HE2' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -83.4 146.36 28.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.788 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.839 HD12 ' HB ' ' A' ' 112' ' ' THR . 3.5 tt 64.51 14.76 9.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 111.179 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 108' ' ' ASP . 14.2 p -74.17 -44.88 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.813 0.34 . . . . 0.0 111.07 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.484 ' N ' HG13 ' A' ' 107' ' ' VAL . 1.6 p30 178.54 54.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.67 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.587 HG21 HD11 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -98.0 -166.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.468 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -43.61 -40.15 3.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.154 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.472 ' HB3' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER 170.52 149.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.846 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.839 ' HB ' HD12 ' A' ' 106' ' ' LEU . 37.1 p -157.75 84.9 0.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 113' ' ' ILE . 10.4 mm -77.16 114.5 17.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.434 0.635 . . . . 0.0 111.395 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 143.89 142.01 3.87 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.029 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 126' ' ' THR . 23.4 ttt180 -77.1 120.1 21.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.614 0.245 . . . . 0.0 110.44 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.807 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -104.76 125.39 50.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.077 0.465 . . . . 0.0 112.202 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.581 ' HE1' HD23 ' A' ' 119' ' ' LEU . 3.5 p90 -131.63 127.42 36.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.101 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.877 ' OG1' HG21 ' A' ' 102' ' ' VAL . 11.7 t -100.26 149.35 23.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.344 0.592 . . . . 0.0 112.097 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.656 ' O ' HD12 ' A' ' 119' ' ' LEU . 3.3 pp -146.62 118.11 7.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.663 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.14 -104.29 0.51 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.981 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -133.06 83.68 2.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.028 0.442 . . . . 0.0 109.932 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.3 OUTLIER 152.95 115.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.471 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 1.035 ' CD1' HG23 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -104.21 138.46 40.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.988 0.423 . . . . 0.0 110.789 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.795 HG22 ' HB2' ' A' ' 86' ' ' GLU . 17.8 p -114.13 133.33 55.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.315 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.817 HD13 ' CD1' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -113.82 117.56 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.819 0.818 . . . . 0.0 110.565 179.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 115' ' ' ARG . 8.8 t -100.54 156.37 17.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.748 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.449 ' CB ' ' HA ' ' A' ' 38' ' ' VAL . 8.9 t -142.36 17.27 2.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.348 0.594 . . . . 0.0 109.555 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -124.75 -49.4 1.75 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.14 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.8 tp 63.86 18.08 10.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.301 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 12.4 ttp 69.34 15.7 8.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.246 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 78.3 102.82 0.2 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.493 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -29.97 65.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 110.93 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -113.64 69.72 0.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -33.51 23.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.809 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -109.64 -17.55 13.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.138 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.673 ' N ' HD22 ' A' ' 136' ' ' LEU . 0.2 OUTLIER -105.58 15.12 27.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.968 0.413 . . . . 0.0 111.177 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.35 -31.88 1.81 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.294 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -139.91 133.01 29.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -160.77 109.18 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.966 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -139.8 177.39 7.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.077 179.965 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.813 0.339 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 t -174.71 91.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 t -74.84 151.22 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.946 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.4 p30 -106.43 146.77 30.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.031 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.4 p -131.83 172.88 11.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.63 102.43 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.0 143.35 48.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.09 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.896 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -106.02 22.18 16.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.414 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.526 ' HA ' HG12 ' A' ' 12' ' ' ILE . 4.1 m-20 -55.59 -16.19 3.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.114 0.483 . . . . 0.0 111.408 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.491 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -78.73 -16.74 56.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.389 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.6 -8.91 2.7 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.261 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.896 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.1 pp -61.09 -19.84 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 117.626 0.713 . . . . 0.0 111.852 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.491 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.72 8.5 16.85 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.789 178.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.11 -43.5 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.33 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.19 -80.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.68 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.74 11.19 32.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.064 0.459 . . . . 0.0 111.17 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -112.62 -17.17 8.2 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.145 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -128.54 80.83 1.99 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.027 0.442 . . . . 0.0 110.42 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -142.51 13.71 1.96 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.36 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -86.51 6.23 31.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 0.0 111.095 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.34 -177.15 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.344 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 t0 65.29 13.35 8.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.197 0.522 . . . . 0.0 110.017 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -138.35 9.74 2.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.815 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -90.14 -55.92 3.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.621 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -120.63 110.89 16.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.815 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.23 -127.33 0.09 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.132 0.492 . . . . 0.0 110.311 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 171.44 27.32 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.894 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -75.31 -29.91 60.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -118.17 14.77 14.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.335 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.71 143.42 28.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.933 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -87.91 144.9 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.074 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.408 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 10.3 p -109.91 134.61 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.828 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -110.21 115.27 29.42 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.929 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 33.64 75.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.017 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.408 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 39.1 t -88.47 148.99 23.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.857 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -113.37 7.95 17.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.354 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.537 HG21 ' HD2' ' A' ' 80' ' ' LYS . 16.3 m -67.59 153.52 43.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.957 0.408 . . . . 0.0 111.124 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.888 HG21 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -102.23 112.61 36.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.676 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 80' ' ' LYS . 20.7 t -129.11 152.05 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.436 0.636 . . . . 0.0 112.436 -178.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.788 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -159.84 129.96 5.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.778 178.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.84 134.42 54.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.281 0.562 . . . . 0.0 111.998 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.017 HD23 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -126.29 140.32 52.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.434 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -52.53 129.0 27.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.46 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -75.29 90.0 2.6 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.498 0.666 . . . . 0.0 110.617 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 47' ' ' GLU . 3.3 m -126.01 171.09 11.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.442 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.54 -16.25 0.21 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.048 0.451 . . . . 0.0 110.047 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.889 ' HG2' HD12 ' A' ' 48' ' ' ILE . 6.8 tt0 -72.6 -63.47 1.15 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.175 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.017 HD11 HD23 ' A' ' 42' ' ' LEU . 1.6 mp -61.31 -44.16 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.294 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -40.82 -59.05 1.51 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.807 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.711 HG21 ' HG ' ' A' ' 95' ' ' LEU . 15.4 m -75.56 -62.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.941 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.875 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -44.34 -48.42 9.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.398 -179.075 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -57.62 -47.77 84.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.879 0.371 . . . . 0.0 110.432 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -53.21 -49.47 66.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.253 0.549 . . . . 0.0 109.601 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.761 ' HA ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -69.86 -82.05 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.54 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.875 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -21.66 -58.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.706 ' N ' HG23 ' A' ' 55' ' ' ILE . 1.4 mp -73.51 -66.3 0.71 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.605 HD13 ' N ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -63.32 -30.54 71.66 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.761 HG23 ' HA ' ' A' ' 54' ' ' GLU . 72.0 p -62.89 -66.8 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.283 0.563 . . . . 0.0 110.611 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.631 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 65.6 m-20 -83.66 -44.86 14.07 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.894 ' CG ' HG11 ' A' ' 68' ' ' VAL . 66.9 m-85 -70.07 -21.63 63.14 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -93.84 -47.97 6.5 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.864 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.58 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.5 OUTLIER -58.01 -48.57 79.63 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.752 0.31 . . . . 0.0 110.814 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.582 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER 179.31 99.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.289 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 59' ' ' ASP . 0.9 OUTLIER -172.23 -50.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.764 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.455 ' N ' HG12 ' A' ' 64' ' ' VAL . 4.1 m-20 177.41 143.97 0.27 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 0.0 111.935 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -85.29 -3.31 9.45 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.824 2.349 . . . . 0.0 111.71 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.547 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 1.1 t -82.84 -109.31 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.44 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.894 HG11 ' CG ' ' A' ' 60' ' ' TYR . 10.0 p 26.8 49.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 121.379 0.609 . . . . 0.0 111.606 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -82.05 139.0 34.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.133 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 78' ' ' TRP . 0.5 OUTLIER -97.67 153.45 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.031 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -142.38 116.12 9.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.249 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -86.17 114.51 23.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.735 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 5.7 mmt180 -95.64 -111.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.968 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.9 -38.23 64.43 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.867 0.365 . . . . 0.0 111.128 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.46 -37.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.417 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.95 162.55 23.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.752 0.311 . . . . 0.0 110.551 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.844 ' CD1' HG21 ' A' ' 48' ' ' ILE . 10.3 m95 -94.11 142.84 26.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.521 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.488 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 9.0 m0 -107.56 108.73 20.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.133 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.803 HD13 ' N ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -98.04 113.58 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.173 0.511 . . . . 0.0 110.338 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.537 ' HD2' HG21 ' A' ' 37' ' ' THR . 3.6 tttt -122.39 140.23 52.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.447 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.84 ' HB3' HG22 ' A' ' 85' ' ' ILE . . . -142.86 138.65 30.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.765 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.453 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.3 OUTLIER -77.55 108.2 10.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.046 0.45 . . . . 0.0 111.455 -179.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 104.03 -62.31 0.4 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.082 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.888 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 178.04 162.13 0.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.066 0.46 . . . . 0.0 111.353 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.84 HG22 ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -136.67 159.61 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.13 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.744 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.1 OUTLIER -142.75 118.2 10.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.146 0.498 . . . . 0.0 111.468 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.836 HG13 HG13 ' A' ' 55' ' ' ILE . 17.4 t -94.4 128.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.826 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 2.6 m-20 -77.3 151.97 34.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.153 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 22.5 t -106.26 100.62 10.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.136 0.493 . . . . 0.0 109.906 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 9.3 t0 160.3 -35.69 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.823 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -70.83 -72.87 0.19 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.943 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.658 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.3 tt -56.56 -57.85 7.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.503 ' H ' HG23 ' A' ' 92' ' ' ILE . 35.0 p -45.43 -36.61 4.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.755 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -58.34 -46.79 85.56 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.122 0.486 . . . . 0.0 110.239 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.842 ' O ' HD13 ' A' ' 95' ' ' LEU . 2.0 tm? -90.26 -17.2 27.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.474 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.752 HD11 ' CG ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -99.77 13.17 34.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.81 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 100' ' ' PHE . . . 118.99 67.94 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.18 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -33.56 150.41 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.208 0.528 . . . . 0.0 111.99 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.52 19.02 10.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.373 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.407 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -77.24 -166.52 0.74 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.049 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -93.5 -169.47 2.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.882 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.895 HG23 ' CD1' ' A' ' 123' ' ' PHE . 1.4 p -111.64 -34.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.118 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -79.91 3.91 18.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.477 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.774 ' O ' HG12 ' A' ' 107' ' ' VAL . 3.5 m-20 -59.6 -38.22 80.66 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.705 0.288 . . . . 0.0 110.947 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.473 ' CE1' ' HB2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -64.05 -43.04 96.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.765 0.316 . . . . 0.0 110.76 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.841 HD22 ' HB3' ' A' ' 116' ' ' ALA . 1.3 tp -106.73 26.03 10.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.218 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.774 HG12 ' O ' ' A' ' 104' ' ' ASP . 15.0 p -73.69 -24.39 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.9 0.381 . . . . 0.0 110.947 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -171.57 -86.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.458 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 110' ' ' SER . 43.0 t 55.9 160.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.056 0.455 . . . . 0.0 111.601 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.508 ' N ' HG12 ' A' ' 109' ' ' VAL . 30.3 t -55.14 -47.89 74.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.053 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.56 150.93 9.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.733 HG22 ' HB2' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -156.73 74.31 0.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.049 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.444 ' HA ' HD13 ' A' ' 113' ' ' ILE . 5.1 mm -62.34 106.2 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.349 0.595 . . . . 0.0 111.23 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 148.39 140.28 3.3 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.046 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 126' ' ' THR . 61.3 ttp85 -76.7 126.01 30.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.614 0.245 . . . . 0.0 110.643 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.841 ' HB3' HD22 ' A' ' 106' ' ' LEU . . . -104.43 125.36 50.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.031 0.443 . . . . 0.0 112.007 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.48 ' O ' ' CD1' ' A' ' 117' ' ' TYR . 1.7 p90 -128.32 120.79 27.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.814 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.8 t -98.37 161.25 13.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.343 0.592 . . . . 0.0 112.008 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -169.94 133.6 1.21 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.32 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.92 -110.78 1.21 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.681 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -134.33 84.02 2.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 88' ' ' ASP . 7.6 mttt 153.73 117.39 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.489 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.895 ' CD1' HG23 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -104.72 137.75 42.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.063 0.458 . . . . 0.0 110.84 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.744 HG23 ' HB3' ' A' ' 86' ' ' GLU . 55.2 m -112.72 126.05 54.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.028 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.748 HD11 HG23 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -110.94 117.42 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.859 0.838 . . . . 0.0 111.131 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 115' ' ' ARG . 5.2 t -115.23 154.27 29.36 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.995 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.754 ' CB ' HG13 ' A' ' 38' ' ' VAL . 6.5 t -147.55 25.85 1.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.343 0.592 . . . . 0.0 109.679 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -121.22 48.52 1.64 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.044 -178.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.2 mp -124.79 17.17 8.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.202 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 17.6 ttp 65.63 16.43 10.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.303 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -100.04 62.71 0.66 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.458 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.64 45.47 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.354 . . . . 0.0 110.9 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.579 ' HA ' HD12 ' A' ' 136' ' ' LEU . 15.9 m-20 59.35 28.42 17.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.0 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.46 -51.78 7.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.688 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.56 -17.11 22.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 133' ' ' ASP . 9.2 mt -73.75 -154.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.591 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 72.87 -56.7 0.65 Allowed 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.819 0.343 . . . . 0.0 111.03 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.54 -166.28 1.3 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.46 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.6 t80 61.52 114.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.704 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -101.14 154.57 18.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.128 179.986 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 mtm . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.755 0.312 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.11 112.54 1.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.8 m -58.55 177.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.165 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -112.36 133.53 54.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.1 p -78.63 -171.88 2.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 60.42 38.45 19.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.34 -174.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.121 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.902 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -126.13 21.04 7.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.465 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.556 ' HA ' HG12 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -54.02 -19.48 4.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.256 0.55 . . . . 0.0 111.461 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.86 -21.72 59.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.529 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.51 -10.72 4.85 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.233 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.902 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.0 pp -61.16 -21.35 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-N 117.595 0.697 . . . . 0.0 111.842 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.465 ' HE3' ' HB2' ' A' ' 13' ' ' MET . 0.0 OUTLIER -87.57 8.99 22.62 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.775 178.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.414 ' HA2' ' CB ' ' A' ' 18' ' ' LYS . . . -136.09 -49.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.502 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.408 HD22 ' CE2' ' A' ' 8' ' ' TYR . 2.2 mp -61.67 -81.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 10.04 26.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.007 0.432 . . . . 0.0 111.431 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.93 -26.45 3.83 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.961 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HG3' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -128.9 81.49 2.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.142 0.496 . . . . 0.0 110.332 179.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -116.97 -27.27 6.6 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.367 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -92.76 15.47 14.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.363 . . . . 0.0 111.402 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HB2' ' HG3' ' A' ' 18' ' ' LYS . . . -80.63 -6.37 58.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.221 0.534 . . . . 0.0 111.768 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -88.97 12.06 16.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.444 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -138.85 13.13 2.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.204 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -88.47 -54.26 4.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.164 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -120.95 110.37 16.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.397 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.38 -11.55 40.2 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.121 0.486 . . . . 0.0 111.967 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -79.15 8.47 5.79 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.026 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -88.62 -18.61 27.63 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.439 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -94.33 15.29 17.9 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.344 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -106.19 141.85 36.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.879 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.99 133.31 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.019 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.09 134.56 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.895 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -110.36 115.15 29.17 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.753 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 33.39 62.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.066 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.8 m -117.74 110.23 17.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.031 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.0 36.76 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.815 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.8 m -70.07 139.92 52.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.614 HG11 HG23 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -86.27 99.32 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.879 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.791 ' C ' HD12 ' A' ' 40' ' ' LEU . 3.9 t -107.52 146.07 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.255 0.55 . . . . 0.0 112.321 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.791 HD12 ' C ' ' A' ' 39' ' ' VAL . 6.3 mp -150.34 109.8 4.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.058 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.412 HG23 ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -108.51 128.09 64.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.327 0.584 . . . . 0.0 112.193 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.72 HD13 HD11 ' A' ' 48' ' ' ILE . 24.8 mt -127.07 140.26 52.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.6 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.29 125.72 14.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.744 0.307 . . . . 0.0 111.765 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HD2' ' CE2' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -57.36 87.71 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.267 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.609 ' C ' ' H ' ' A' ' 47' ' ' GLU . 33.2 m -125.02 170.16 11.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.381 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.37 11.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.834 ' CB ' HD21 ' A' ' 96' ' ' LEU . 1.9 tt0 -98.84 -57.68 2.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.976 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.768 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.8 OUTLIER -61.23 -44.49 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.302 0.573 . . . . 0.0 109.613 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -39.43 -62.0 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.126 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.845 HG21 ' HG ' ' A' ' 95' ' ' LEU . 56.7 m -65.41 -74.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.952 ' CD2' HG21 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -40.97 -58.78 1.62 Allowed 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.602 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.6 tp -41.72 -46.67 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.02 0.438 . . . . 0.0 109.963 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.536 ' O ' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -57.36 -53.49 57.49 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.683 ' HA ' HG23 ' A' ' 58' ' ' THR . 35.5 mt-10 -66.55 -94.61 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.949 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.952 HG21 ' CD2' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -18.55 -58.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.753 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -62.96 -77.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.671 HD13 ' N ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -63.68 -16.08 60.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.683 HG23 ' HA ' ' A' ' 54' ' ' GLU . 6.3 p -65.01 -74.38 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.297 0.57 . . . . 0.0 110.137 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.582 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 8.7 m-20 -82.56 -32.71 28.39 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.858 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 1.027 ' CG ' HG11 ' A' ' 68' ' ' VAL . 78.1 m-85 -71.81 -32.04 67.18 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -84.78 -46.08 11.74 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.026 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 58' ' ' THR . 10.1 ttpt -57.85 -48.85 78.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.84 0.352 . . . . 0.0 110.821 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.69 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER 179.55 101.63 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -177.55 -52.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.063 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.498 ' N ' HG12 ' A' ' 64' ' ' VAL . 5.7 m-20 -177.1 138.99 0.43 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.772 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -82.48 3.07 8.09 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.673 2.249 . . . . 0.0 112.275 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.498 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 1.3 t -91.81 -114.1 0.09 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.108 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.027 HG11 ' CG ' ' A' ' 60' ' ' TYR . 8.4 p 28.46 43.47 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.115 0.484 . . . . 0.0 112.246 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.42 138.86 31.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.054 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.22 151.04 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-O 121.243 0.544 . . . . 0.0 111.659 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.771 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -143.42 116.89 9.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.02 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -80.19 124.29 28.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.461 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.464 ' HG3' ' CD2' ' A' ' 78' ' ' TRP . 5.2 mmt-85 -111.45 -117.4 0.3 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.64 -82.98 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -133.12 17.53 4.56 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.187 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.7 155.99 44.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.786 0.326 . . . . 0.0 110.688 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.768 ' CD1' HG21 ' A' ' 48' ' ' ILE . 73.7 m95 -76.4 125.89 30.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.29 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.771 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.1 m0 -96.62 106.59 18.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.663 ' CD1' ' N ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.58 122.12 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.194 -178.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -128.58 136.22 50.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.692 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 67' ' ' THR . . . -142.75 153.48 43.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.835 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.465 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.4 OUTLIER -105.0 129.52 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.644 -179.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.96 -67.62 2.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.256 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.499 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 179.31 157.14 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.636 -179.272 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.816 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.97 154.76 15.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.633 ' HB2' HG22 ' A' ' 124' ' ' THR . 11.7 pt-20 -141.03 124.57 16.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.05 0.452 . . . . 0.0 111.304 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.951 HG13 HG13 ' A' ' 55' ' ' ILE . 39.1 t -94.35 129.37 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.922 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 6.8 m-20 -76.41 151.78 36.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.911 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.452 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 27.8 t -108.9 100.79 9.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.138 0.495 . . . . 0.0 109.908 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.5 m-20 160.17 -36.13 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.17 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -71.28 -69.19 0.39 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.0 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.642 ' HB ' ' CD2' ' A' ' 51' ' ' PHE . 1.1 tt -59.21 -51.49 71.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.713 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.448 ' N ' HG23 ' A' ' 92' ' ' ILE . 44.9 p -52.74 -33.59 48.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.454 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -62.22 -46.58 88.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.973 0.416 . . . . 0.0 111.078 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.868 ' O ' HD13 ' A' ' 95' ' ' LEU . 2.5 tm? -90.18 -20.07 23.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.056 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.834 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -98.19 10.03 41.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.961 0.41 . . . . 0.0 111.018 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.42 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 129.67 69.11 0.11 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.231 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.5 158.82 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.072 0.463 . . . . 0.0 111.24 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 63.32 17.62 10.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.902 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER -75.66 -168.57 0.87 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.706 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -130.39 150.9 51.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.999 0.428 . . . . 0.0 111.236 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.82 HG21 ' OG1' ' A' ' 118' ' ' THR . 7.7 p -64.66 166.79 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.779 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.661 ' CE2' HG22 ' A' ' 118' ' ' THR . 1.2 m-85 71.62 7.16 5.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.049 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -79.7 -30.06 40.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 110.329 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.51 ' CE1' ' CD2' ' A' ' 123' ' ' PHE . 0.1 OUTLIER -80.85 -0.58 39.58 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.278 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.71 29.5 1.12 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.832 0.349 . . . . 0.0 110.792 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 103' ' ' TYR . 7.3 p -87.2 -32.88 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.246 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -174.73 36.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.736 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.616 HG11 HD21 ' A' ' 42' ' ' LEU . 18.9 m -69.5 167.91 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.563 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.1 m -47.52 -47.25 27.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.22 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.412 ' CB ' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -177.34 166.27 2.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 1.2 t 177.31 103.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.295 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 113' ' ' ILE . 10.5 mm -81.93 117.49 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.389 0.614 . . . . 0.0 111.155 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.31 141.82 3.95 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.994 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.94 119.76 21.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.68 0.276 . . . . 0.0 110.492 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.794 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -107.28 125.39 51.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.978 0.418 . . . . 0.0 111.86 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.499 ' HE1' HD23 ' A' ' 119' ' ' LEU . 20.2 p90 -132.28 125.68 31.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.712 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.82 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.0 t -91.17 150.26 21.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.306 0.574 . . . . 0.0 111.985 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.554 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.4 pp -155.31 115.7 3.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.568 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.34 -106.75 1.11 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.535 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.47 83.52 2.02 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.1 OUTLIER 153.94 99.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.034 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.77 ' CD1' HG23 ' A' ' 102' ' ' VAL . 3.2 p90 -90.96 133.5 35.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.082 0.468 . . . . 0.0 110.721 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.633 HG22 ' HB2' ' A' ' 86' ' ' GLU . 2.4 p -108.0 141.02 40.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.436 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.872 HD11 HG23 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -118.38 117.4 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.913 0.863 . . . . 0.0 110.825 178.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 115' ' ' ARG . 4.5 t -97.95 155.99 16.83 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.52 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.439 ' CB ' ' HA ' ' A' ' 38' ' ' VAL . 13.2 t -147.28 20.52 1.21 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.257 0.551 . . . . 0.0 109.857 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.537 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -122.48 107.66 12.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.117 -178.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 128' ' ' GLU . 0.5 OUTLIER -169.53 101.49 0.33 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.604 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 9.9 ttt -139.6 15.68 2.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.306 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.76 -51.1 3.33 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.535 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 tp 61.85 117.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.857 0.36 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.535 ' HA ' HD12 ' A' ' 136' ' ' LEU . 32.5 m-20 -137.14 35.35 2.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.985 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.1 tpt85 -53.88 -46.75 71.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 110.658 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.0 30.86 7.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.316 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 133' ' ' ASP . 1.7 mt -138.86 -159.09 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.766 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 71.77 -56.93 0.63 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.873 0.368 . . . . 0.0 111.244 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -129.15 140.93 51.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -155.04 65.38 0.65 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -129.04 148.64 51.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.101 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.867 0.365 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 t -144.28 -167.7 2.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.827 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.4 m -57.9 175.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.18 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -73.07 130.04 39.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.66 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -95.93 98.91 10.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -134.59 106.62 7.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.724 ' HB3' ' HA3' ' A' ' 11' ' ' GLY . . . -142.15 -179.94 6.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 0.0 111.318 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -66.34 131.67 46.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.948 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.731 ' HA ' HD11 ' A' ' 12' ' ' ILE . 1.1 m-20 41.54 -75.06 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.638 0.733 . . . . 0.0 112.566 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.692 ' N ' ' O ' ' A' ' 8' ' ' TYR . . . -59.64 -7.97 1.78 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.598 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.724 ' HA3' ' HB3' ' A' ' 7' ' ' ALA . . . -113.37 -19.63 6.58 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.792 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.731 HD11 ' HA ' ' A' ' 9' ' ' ASP . 2.0 pp -108.18 66.88 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.572 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -139.47 14.96 2.56 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.884 178.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.436 ' HA2' ' CB ' ' A' ' 18' ' ' LYS . . . -127.7 -41.8 0.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.24 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.66 HD11 ' O ' ' A' ' 5' ' ' SER . 5.4 mp -60.85 -75.41 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.782 0.325 . . . . 0.0 110.749 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 9.39 43.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.84 -24.48 5.51 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.859 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -128.0 81.3 2.01 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.106 0.479 . . . . 0.0 110.074 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -121.12 -36.87 3.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.374 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.47 14.93 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.541 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.28 -173.68 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.901 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.56 13.9 5.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.03 0.443 . . . . 0.0 110.657 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -143.11 10.78 1.74 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.035 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.27 -52.9 4.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.191 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -121.05 110.22 15.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.445 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.69 -10.97 41.14 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.139 0.495 . . . . 0.0 111.93 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.85 8.2 4.9 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.888 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -84.89 -20.28 30.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.496 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -160.12 98.36 1.3 Allowed 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.104 0.478 . . . . 0.0 110.61 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -107.5 156.82 18.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.847 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.9 p -104.14 142.67 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 12.6 p -109.97 134.47 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.808 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.412 ' O ' ' C ' ' A' ' 34' ' ' GLU . 22.6 m170 -110.43 115.08 29.01 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.915 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 33' ' ' HIS . 1.0 OUTLIER 25.96 62.19 0.07 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.307 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.403 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 16.1 m -120.52 112.01 18.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.952 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -93.47 -19.1 21.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.7 m -72.24 145.42 47.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.024 0.44 . . . . 0.0 111.125 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.614 HG22 ' HB3' ' A' ' 127' ' ' SER . 0.2 OUTLIER -89.32 102.31 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.154 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.605 HG22 ' HG2' ' A' ' 80' ' ' LYS . 9.6 t -116.23 153.33 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.331 0.586 . . . . 0.0 111.669 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.881 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -173.1 128.26 0.46 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.285 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.464 ' CG1' ' CD1' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -112.44 134.71 54.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.177 0.513 . . . . 0.0 111.662 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.994 HD23 HD11 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -126.52 139.96 52.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.465 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.45 129.17 21.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.492 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -75.72 90.17 2.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.796 0.808 . . . . 0.0 110.433 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.445 ' C ' ' N ' ' A' ' 47' ' ' GLU . 1.1 t -126.27 171.01 11.29 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.449 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.11 -14.47 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.886 ' HG2' HD12 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -71.79 -61.56 1.74 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.221 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.994 HD11 HD23 ' A' ' 42' ' ' LEU . 1.5 mp -64.64 -43.22 96.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.092 0.472 . . . . 0.0 109.844 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -40.05 -58.18 1.49 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.727 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.435 HG21 ' HG ' ' A' ' 95' ' ' LEU . 1.2 m -78.11 -61.98 1.82 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.106 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.827 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -45.01 -44.44 9.96 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.517 -178.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.588 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.6 tp -62.2 -47.45 93.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.041 0.448 . . . . 0.0 109.868 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -53.91 -37.31 63.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.102 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.756 ' HA ' HG23 ' A' ' 58' ' ' THR . 0.9 OUTLIER -83.8 -75.57 0.33 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.53 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.827 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -31.22 -54.07 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.673 ' N ' HG23 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -76.92 -41.21 44.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -177.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.44 -47.18 12.56 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.498 -178.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.756 HG23 ' HA ' ' A' ' 54' ' ' GLU . 51.4 p -52.72 -68.91 0.13 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.485 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.445 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 0.5 OUTLIER -91.87 -33.8 14.78 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.852 ' CD1' HG21 ' A' ' 68' ' ' VAL . 7.5 m-85 -82.99 -3.12 56.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.455 -0.898 . . . . 0.0 113.091 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 2.3 tptt -115.99 -42.52 3.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.104 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.695 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -58.87 -51.27 70.76 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.573 0.225 . . . . 0.0 111.311 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.545 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -179.42 89.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.235 0.54 . . . . 0.0 111.862 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.626 HG11 ' CE1' ' A' ' 60' ' ' TYR . 24.4 t -160.12 -52.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.19 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 4.8 m-20 171.54 132.22 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.267 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 65' ' ' ASN . 4.7 Cg_exo -78.57 -18.36 12.14 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.658 2.239 . . . . 0.0 111.929 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -51.94 -50.84 60.38 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.4 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.852 HG21 ' CD1' ' A' ' 60' ' ' TYR . 78.2 t -43.83 87.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.651 0.262 . . . . 0.0 111.43 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 67' ' ' THR . 18.1 p30 -116.56 138.9 51.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.803 0.335 . . . . 0.0 111.613 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 78' ' ' TRP . 1.3 p -102.71 153.69 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.102 0.477 . . . . 0.0 111.662 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -142.82 129.72 20.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.432 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.51 114.89 20.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.935 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.477 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -89.92 -146.76 0.18 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.734 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.15 -22.42 60.88 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 111.398 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.14 -35.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.627 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -89.5 159.7 17.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 110.795 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.788 ' CD1' HG21 ' A' ' 48' ' ' ILE . 45.8 m95 -83.46 142.67 30.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.447 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.555 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 7.6 m0 -112.58 110.34 20.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.483 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.881 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -100.41 118.48 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 110.209 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.605 ' HG2' HG22 ' A' ' 39' ' ' VAL . 6.8 mtpt -126.6 136.76 52.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.487 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -143.63 158.85 43.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.827 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.42 135.96 49.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.229 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.69 -69.43 2.92 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.143 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.434 ' CD ' ' N ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER 178.76 160.9 0.66 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.965 0.412 . . . . 0.0 111.245 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.9 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -152.04 157.04 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.582 179.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.768 ' HB2' HG22 ' A' ' 124' ' ' THR . 7.3 pt-20 -141.38 125.6 17.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.039 0.447 . . . . 0.0 111.708 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.786 HG13 HG13 ' A' ' 55' ' ' ILE . 6.2 t -94.76 127.21 46.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.546 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.425 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 5.3 m-20 -76.44 152.42 36.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.102 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.543 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -107.47 100.06 9.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.392 0.615 . . . . 0.0 109.671 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.439 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER 164.6 -36.3 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.115 -179.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -73.09 -72.25 0.26 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.666 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.651 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -55.86 -59.66 2.49 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.439 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.908 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.535 ' H ' HG23 ' A' ' 92' ' ' ILE . 16.3 p -44.03 -37.08 2.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.7 OUTLIER -57.47 -48.68 78.55 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.141 0.496 . . . . 0.0 110.401 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.761 ' O ' HD13 ' A' ' 95' ' ' LEU . 2.7 tm? -90.75 -19.13 23.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.555 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.793 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -91.07 9.65 30.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . 110.47 74.24 0.76 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.593 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -38.63 162.94 0.0 OUTLIER 'General case' 0 CA--C 1.526 0.037 0 CA-C-O 121.14 0.495 . . . . 0.0 111.377 -179.348 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.45 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 19.1 pt20 47.84 98.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.66 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' A' ' 93' ' ' SER . 0.0 OUTLIER -160.04 -152.69 0.3 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.603 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -124.2 124.36 42.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.887 0.375 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.714 HG21 ' OG1' ' A' ' 118' ' ' THR . 12.5 p -53.79 166.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.242 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.532 ' N ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER 80.48 -2.21 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.812 ' O ' HG12 ' A' ' 107' ' ' VAL . 7.5 t70 -60.47 -30.45 69.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.746 ' CE1' HD23 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -76.94 -30.02 55.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.34 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.746 HD23 ' CE1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -108.97 21.44 17.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.207 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.812 HG12 ' O ' ' A' ' 104' ' ' ASP . 13.2 p -87.32 -37.08 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 0.0 111.277 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.532 ' OD2' HG22 ' A' ' 107' ' ' VAL . 0.9 OUTLIER 168.82 88.48 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.802 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.55 83.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.11 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.8 t 66.74 -63.99 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.195 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.529 ' O ' HG23 ' A' ' 112' ' ' THR . 0.1 OUTLIER 175.68 163.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.995 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 111' ' ' SER . 20.5 p -160.16 83.39 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 113' ' ' ILE . 8.4 mm -66.58 110.27 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.56 0.695 . . . . 0.0 111.192 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 146.61 148.09 4.7 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.597 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.461 ' HB2' HG23 ' A' ' 126' ' ' THR . 1.8 mmm180 -76.6 120.05 21.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.56 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -108.14 125.22 51.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.063 0.459 . . . . 0.0 112.144 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.505 ' HE1' HD23 ' A' ' 119' ' ' LEU . 11.4 p90 -136.33 118.52 15.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.412 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.714 ' OG1' HG21 ' A' ' 102' ' ' VAL . 13.7 t -91.21 134.92 34.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.189 0.519 . . . . 0.0 111.731 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.583 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.6 pp -134.01 115.92 14.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.797 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.05 -106.16 0.84 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.992 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 89' ' ' CYS . 0.5 OUTLIER -133.16 83.97 2.1 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.499 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.2 OUTLIER 152.25 95.14 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.455 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.541 ' CD1' HG23 ' A' ' 102' ' ' VAL . 24.0 p90 -88.12 126.62 35.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.015 0.436 . . . . 0.0 111.151 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.768 HG22 ' HB2' ' A' ' 86' ' ' GLU . 12.2 p -102.87 136.14 43.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.149 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.9 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -116.09 118.4 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.778 0.799 . . . . 0.0 111.232 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 115' ' ' ARG . 11.3 t -98.2 156.1 16.85 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.16 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.614 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -140.13 13.61 2.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.448 0.642 . . . . 0.0 109.54 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.17 -72.82 0.67 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.104 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.428 HD13 HG21 ' A' ' 126' ' ' THR . 3.9 tp 63.83 17.03 10.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.453 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.5 ttt -93.57 15.75 15.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.237 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -118.48 41.0 2.13 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.479 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mp -66.31 176.78 1.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -112.8 26.75 10.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.945 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -54.21 49.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.928 0.394 . . . . 0.0 110.686 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.34 -28.58 12.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.691 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -163.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.83 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 70.87 -56.17 0.63 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.884 0.373 . . . . 0.0 111.262 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.59 119.76 18.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.2 93.39 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -126.39 171.06 11.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.119 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.758 0.314 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.7 t -61.77 174.7 0.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.68 -54.17 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.168 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -102.26 133.49 47.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.23 -56.16 7.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 59.97 93.35 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.003 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.536 ' O ' HG22 ' A' ' 12' ' ' ILE . . . -73.54 163.44 28.02 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.517 0.675 . . . . 0.0 111.573 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 12' ' ' ILE . 64.9 t80 -73.82 166.58 23.07 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.924 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.471 ' HA ' HG12 ' A' ' 12' ' ' ILE . 3.6 m-20 -51.01 -10.53 0.07 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.429 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.426 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -84.14 -16.93 41.78 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.638 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.18 -13.11 2.44 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.959 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 8' ' ' TYR . 1.9 pp -56.73 -23.61 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 117.732 0.766 . . . . 0.0 111.854 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.426 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.73 8.21 17.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.866 178.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 18' ' ' LYS . . . -135.55 -38.07 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.469 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.66 -74.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.672 0.272 . . . . 0.0 111.127 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.5 9.13 41.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.582 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.88 -24.85 4.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.135 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.499 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 4.5 tmtt? -130.93 85.63 2.29 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.698 0.761 . . . . 0.0 110.321 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -128.04 2.51 5.89 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.471 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.2 18.0 7.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.877 0.37 . . . . 0.0 111.536 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.88 -178.16 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.042 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.96 11.08 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.904 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -145.12 10.99 1.33 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.041 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -98.83 -55.35 2.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.338 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -121.05 110.26 16.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.524 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.67 -109.51 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.514 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -55.9 -21.69 21.76 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.368 0.604 . . . . 0.0 111.577 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.12 -19.91 66.21 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.672 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -178.87 106.45 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.55 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.61 165.65 14.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.4 p -87.28 145.52 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.487 HG21 ' OG ' ' A' ' 35' ' ' SER . 10.6 p -109.89 134.7 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.91 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 34' ' ' GLU . 56.1 p-80 -110.14 115.07 29.07 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.715 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 33' ' ' HIS . 1.3 mt-10 29.4 54.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.104 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.487 ' OG ' HG21 ' A' ' 32' ' ' VAL . 12.8 p -71.69 129.14 37.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.939 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.05 -26.31 11.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.888 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 m -67.69 140.85 56.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.661 HG11 HG22 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -97.18 131.22 44.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.987 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 113' ' ' ILE . 8.9 t -129.88 140.06 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 5.6 tp -128.5 104.33 7.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.481 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.417 ' CG2' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -111.74 126.85 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.24 0.543 . . . . 0.0 111.259 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.549 HD22 HD11 ' A' ' 48' ' ' ILE . 1.5 mt -126.69 140.9 52.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.684 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 45' ' ' SER . 0.7 OUTLIER -51.81 119.07 3.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.666 0.27 . . . . 0.0 111.054 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HD2' ' NE1' ' A' ' 77' ' ' TRP . 0.1 OUTLIER -46.79 91.97 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 47' ' ' GLU . 13.6 m -125.38 169.36 12.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.914 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -67.03 3.69 1.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.764 ' CB ' HD21 ' A' ' 96' ' ' LEU . 1.4 tt0 -90.02 -59.32 2.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.801 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.756 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.5 OUTLIER -55.33 -43.72 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 121.171 0.51 . . . . 0.0 109.878 179.287 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -42.45 -61.59 1.17 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.342 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.811 HG21 ' HG ' ' A' ' 95' ' ' LEU . 83.8 m -68.43 -75.43 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.957 ' CD1' HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -39.12 -62.02 0.69 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 119.687 -0.197 . . . . 0.0 111.5 -178.317 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.585 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -42.16 -46.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.983 0.421 . . . . 0.0 110.049 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' O ' HD22 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -56.66 -53.64 55.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.657 ' HA ' HG23 ' A' ' 58' ' ' THR . 8.3 mt-10 -66.91 -94.42 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.016 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.957 HG21 ' CD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -18.74 -61.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.775 ' N ' HD13 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -61.46 -76.22 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -64.12 -15.49 59.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.657 HG23 ' HA ' ' A' ' 54' ' ' GLU . 3.3 p -63.37 -75.39 0.08 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.204 0.525 . . . . 0.0 110.013 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.591 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 2.1 p30 -85.77 -31.47 22.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.768 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.992 ' CG ' HG11 ' A' ' 68' ' ' VAL . 86.1 m-85 -73.64 -29.46 62.35 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.23 -0.588 . . . . 0.0 112.048 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.632 ' CE ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -86.43 -45.05 11.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.641 179.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.5 ttmt -55.58 -51.65 66.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.432 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.685 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER 179.62 100.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.939 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -177.52 -55.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.348 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.556 ' N ' HG12 ' A' ' 64' ' ' VAL . 4.4 m-20 178.69 129.92 0.22 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.846 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -86.63 -16.9 3.56 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.86 2.373 . . . . 0.0 112.111 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.856 HG21 ' ND2' ' A' ' 82' ' ' ASN . 1.8 t -55.26 -39.49 69.86 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.551 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.992 HG11 ' CG ' ' A' ' 60' ' ' TYR . 11.6 p -66.02 65.81 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.406 0.622 . . . . 0.0 110.893 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -101.04 143.32 31.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.887 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.438 HG23 ' CD1' ' A' ' 79' ' ' ILE . 0.5 OUTLIER -95.65 149.67 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.483 0.658 . . . . 0.0 111.693 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 1.6 tp10 -143.66 125.97 15.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.529 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -84.66 115.45 22.67 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.225 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HB2' ' CG ' ' A' ' 78' ' ' TRP . 0.1 OUTLIER -96.38 -114.39 0.13 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.417 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.77 -80.54 0.05 OUTLIER 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.783 0.325 . . . . 0.0 111.581 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.82 -24.84 2.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.037 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -102.52 162.6 12.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.752 0.31 . . . . 0.0 110.842 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.756 ' CD1' HG21 ' A' ' 48' ' ' ILE . 83.4 m95 -76.05 122.72 24.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.269 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.573 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.6 m0 -96.56 107.63 20.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.683 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.676 ' CD1' ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -96.94 137.48 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.435 -178.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -128.81 136.0 49.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.316 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -143.31 157.89 44.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.712 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.856 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -104.82 135.41 46.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.4 . . . . 0.0 110.701 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.63 -67.08 0.28 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.786 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 126' ' ' THR . 0.0 OUTLIER 178.14 173.57 0.62 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.116 0.484 . . . . 0.0 111.311 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.987 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -152.36 162.37 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.419 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.733 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.4 OUTLIER -129.23 121.94 28.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.183 0.516 . . . . 0.0 111.551 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.949 HG23 HD11 ' A' ' 125' ' ' ILE . 55.0 t -94.36 125.29 47.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.564 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -76.81 151.82 35.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.028 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.465 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 17.1 t -108.5 100.68 9.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 3.1 m-20 161.01 -32.95 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.09 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -74.34 -70.81 0.37 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.009 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.575 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -58.46 -51.61 69.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.589 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.426 ' N ' HG23 ' A' ' 92' ' ' ILE . 24.2 p -52.68 -35.29 55.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.523 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -60.15 -44.65 94.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.928 0.394 . . . . 0.0 110.806 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.821 ' O ' HD13 ' A' ' 95' ' ' LEU . 3.4 tm? -90.27 -21.6 22.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.761 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.764 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.46 12.26 35.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.901 0.382 . . . . 0.0 111.218 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.16 66.44 0.13 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.591 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.34 152.56 0.02 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 65.48 18.12 11.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.46 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -166.15 0.25 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.994 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -121.88 140.7 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.717 HG21 ' OG1' ' A' ' 118' ' ' THR . 11.9 p -56.82 163.59 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.004 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.552 ' CE2' HG22 ' A' ' 118' ' ' THR . 0.9 OUTLIER 70.07 9.67 7.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.278 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.43 -32.48 24.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.365 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.531 ' HD1' HD23 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -66.66 -33.03 74.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.511 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.531 HD23 ' HD1' ' A' ' 105' ' ' PHE . 0.6 OUTLIER -124.62 33.3 5.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.707 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 108' ' ' ASP . 14.9 p -63.24 -40.55 89.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.414 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.41 ' N ' HG13 ' A' ' 107' ' ' VAL . 23.0 t0 -174.65 81.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.856 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.515 HG11 HD23 ' A' ' 42' ' ' LEU . 3.4 t -127.73 165.67 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.036 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.476 ' N ' HG12 ' A' ' 109' ' ' VAL . 15.1 t -43.3 -46.16 6.22 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.477 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.417 ' CB ' ' CG2' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -172.49 151.08 2.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.825 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.84 ' C ' HD12 ' A' ' 113' ' ' ILE . 35.5 p -156.27 99.69 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.242 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.84 HD12 ' C ' ' A' ' 112' ' ' THR . 1.1 mp 59.75 -77.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.542 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 112' ' ' THR . . . 170.98 -100.07 0.15 Allowed Glycine 0 C--N 1.309 -0.925 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.173 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.535 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -93.25 129.76 39.2 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.815 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -122.47 136.37 54.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.453 ' O ' ' CD1' ' A' ' 117' ' ' TYR . 36.5 p90 -136.44 116.74 13.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.253 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.717 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.1 t -86.38 151.19 23.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.818 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.4 pp -159.96 116.21 2.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.822 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.63 -110.47 2.8 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.713 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -132.85 83.85 2.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 1.9 mtpp 152.52 95.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.795 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.62 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 6.5 p90 -88.31 124.07 33.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.177 0.513 . . . . 0.0 110.785 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.733 HG23 ' HB3' ' A' ' 86' ' ' GLU . 17.2 m -98.37 125.85 43.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.463 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.987 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -102.05 117.23 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.009 0.909 . . . . 0.0 111.02 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.451 ' HA ' ' HB2' ' A' ' 84' ' ' LYS . 9.7 t -97.43 155.38 16.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.967 -1.469 . . . . 0.0 110.513 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.583 ' CB ' HG13 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -136.83 14.85 3.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 109.668 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -121.85 -64.91 1.17 Allowed 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.298 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.8 tp 63.93 17.71 10.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.273 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 ttm -91.28 15.12 12.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.322 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -97.69 -19.37 25.0 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.548 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.3 mp -76.75 119.62 20.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.381 . . . . 0.0 110.933 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -125.61 32.82 5.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -50.03 34.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -111.77 -15.55 13.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.197 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 136' ' ' LEU . 3.9 tt -86.3 4.5 38.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.1 0.476 . . . . 0.0 111.531 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.08 -23.63 0.52 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.306 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -150.35 19.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.645 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.405 ' HB2' ' HA ' ' A' ' 136' ' ' LEU . 0.1 OUTLIER -49.67 127.86 16.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.195 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -76.26 162.15 28.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.071 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.856 0.36 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.53 142.36 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.5 t -74.49 -40.04 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -102.31 130.22 48.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 t -103.42 62.79 0.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -109.0 149.95 28.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.78 155.69 48.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.161 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.897 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -101.71 22.63 12.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.367 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.526 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.5 p30 -53.36 -20.14 4.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.524 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.507 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -75.24 -16.91 60.43 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.779 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.12 -9.92 2.33 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.377 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.897 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.1 pp -60.48 -19.73 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 117.466 0.633 . . . . 0.0 112.087 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.507 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.14 8.81 14.39 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.015 178.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -136.68 -52.77 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.401 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.51 -80.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.308 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 10.76 30.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 111.18 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.33 -21.18 5.95 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.05 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -128.05 80.69 1.98 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 110.373 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.468 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 17.7 t0 -128.04 -25.42 3.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.346 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 19' ' ' ASP . 9.2 p90 47.93 74.82 0.15 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.722 0.772 . . . . 0.0 111.11 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.29 -9.65 59.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.505 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -90.82 11.49 22.32 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.81 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -138.53 12.72 2.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.117 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.23 -53.61 3.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.498 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -120.34 110.5 16.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.604 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.78 -116.2 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.062 0.458 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.54 14.86 9.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.484 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -70.4 -29.84 66.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.643 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -159.35 97.61 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.494 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -110.83 166.34 11.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.053 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -102.76 151.81 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.114 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.82 134.94 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.88 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.41 ' O ' ' C ' ' A' ' 34' ' ' GLU . 29.0 m-70 -110.14 115.08 29.1 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.801 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 33' ' ' HIS . 0.7 OUTLIER 28.02 72.57 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.207 179.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.91 129.0 35.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.692 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.32 27.85 0.25 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.993 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.8 m -88.61 148.4 24.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.789 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.747 HG13 ' HB3' ' A' ' 127' ' ' SER . 0.2 OUTLIER -93.0 103.13 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.402 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.719 ' C ' HD12 ' A' ' 40' ' ' LEU . 4.3 t -111.72 149.78 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.092 0.472 . . . . 0.0 111.423 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.719 HD12 ' C ' ' A' ' 39' ' ' VAL . 5.7 mp -155.06 105.19 2.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.397 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -113.22 127.56 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.141 0.496 . . . . 0.0 112.269 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.769 HD13 HG13 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -128.53 147.19 50.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.181 178.137 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -48.86 132.28 18.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.13 89.95 0.46 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.499 0.666 . . . . 0.0 110.683 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.441 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -126.15 170.86 11.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.515 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -51.65 -14.24 0.32 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.759 ' CG ' HD11 ' A' ' 96' ' ' LEU . 11.6 tt0 -66.72 -70.98 0.21 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.252 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.825 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.8 OUTLIER -59.15 -43.65 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 121.183 0.516 . . . . 0.0 109.727 178.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -39.6 -59.06 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.407 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.649 HG21 ' HG ' ' A' ' 95' ' ' LEU . 8.6 m -78.85 -62.02 1.83 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.064 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.891 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -43.96 -47.26 8.5 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.839 -0.164 . . . . 0.0 111.324 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.622 ' HA ' ' CG2' ' A' ' 55' ' ' ILE . 1.7 tp -61.55 -47.11 94.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.025 0.44 . . . . 0.0 110.34 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 pt-20 -53.85 -41.72 67.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.567 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' ' 58' ' ' THR . 1.0 OUTLIER -81.32 -66.86 0.83 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.0 0.429 . . . . 0.0 111.0 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.891 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -37.25 -58.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.829 HD12 HD12 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -75.13 -35.9 61.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -177.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -81.87 -46.82 13.58 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.65 -178.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.72 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 68.7 p -52.17 -70.17 0.09 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.381 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.445 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 2.5 m-20 -92.79 -32.52 14.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.933 ' CG ' HG11 ' A' ' 68' ' ' VAL . 2.4 m-85 -80.53 -6.01 57.58 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.839 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -113.96 -41.24 3.58 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.933 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.72 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.2 ttmt -57.61 -51.17 70.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.66 0.267 . . . . 0.0 111.43 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.453 ' N ' ' ND2' ' A' ' 63' ' ' ASN . 0.1 OUTLIER 179.4 88.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 111.395 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.624 HG11 ' CE1' ' A' ' 60' ' ' TYR . 20.9 t -156.44 -54.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.399 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.472 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.6 m-20 169.86 149.36 0.14 Allowed Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.912 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -89.76 -20.72 1.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.192 2.595 . . . . 0.0 112.88 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.57 HG23 ' H ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -46.89 -65.52 0.55 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.211 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.933 HG11 ' CG ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -42.1 87.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.117 179.324 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.1 p30 -116.07 142.28 47.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.474 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.808 HG23 HD12 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.74 149.72 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.083 0.468 . . . . 0.0 111.029 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.711 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 17.1 mt-10 -143.35 116.05 8.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -91.35 114.34 26.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.905 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -101.06 -80.88 0.49 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.67 -73.36 0.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.87 0.366 . . . . 0.0 111.422 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.08 -42.15 0.19 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.518 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -83.27 164.26 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.394 . . . . 0.0 110.737 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.825 ' CD1' HG21 ' A' ' 48' ' ' ILE . 30.5 m95 -88.38 136.31 33.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.325 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.711 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 12.5 m0 -103.94 107.1 17.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.485 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.808 HD12 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -96.47 121.7 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -126.73 136.29 52.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.027 0.442 . . . . 0.0 111.654 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . . . -143.53 158.67 43.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.783 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.55 139.17 47.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.866 0.365 . . . . 0.0 111.243 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.79 -69.56 3.03 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.025 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -179.05 158.4 0.91 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.948 0.404 . . . . 0.0 111.128 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.827 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -146.03 152.23 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.714 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.7 OUTLIER -135.41 123.01 22.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 111.428 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.822 HG23 HD11 ' A' ' 125' ' ' ILE . 24.3 t -94.61 136.68 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.826 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 8.6 t70 -76.72 152.03 35.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.957 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 10.6 t -109.59 101.08 10.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.155 0.502 . . . . 0.0 109.888 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.3 m-20 160.21 -36.38 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.3 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -71.76 -71.96 0.25 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.198 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.643 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.1 tt -57.71 -56.65 14.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.475 ' H ' HG23 ' A' ' 92' ' ' ILE . 5.1 t -45.6 -35.94 4.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.655 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.436 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.2 mm-40 -60.93 -46.82 89.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.095 0.474 . . . . 0.0 110.508 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.778 ' O ' HD13 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -89.88 -14.66 33.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.528 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.759 HD11 ' CG ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -103.32 10.55 37.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.439 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 140.13 67.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.673 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -32.48 135.0 0.09 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.019 0.438 . . . . 0.0 111.618 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.23 17.3 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.602 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.5 OUTLIER -70.13 -171.62 0.47 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.591 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -132.99 151.68 52.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.061 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.877 HG23 ' CD1' ' A' ' 123' ' ' PHE . 11.5 p -57.82 160.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.016 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.511 ' N ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER 79.7 9.7 1.48 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.138 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.444 ' O ' HG12 ' A' ' 107' ' ' VAL . 1.7 t70 -92.94 -23.33 18.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.958 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.504 ' CE1' ' CE2' ' A' ' 123' ' ' PHE . 1.0 OUTLIER -79.62 -37.89 35.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.134 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -105.79 29.67 6.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 108' ' ' ASP . 13.9 p -81.63 -44.49 20.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.995 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.477 ' N ' HG13 ' A' ' 107' ' ' VAL . 2.2 m-20 -179.98 88.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.481 HG21 HD23 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -141.77 81.41 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.065 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 t 68.95 -63.59 0.36 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.978 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.652 ' O ' HG23 ' A' ' 112' ' ' THR . 1.3 m 174.05 160.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 111' ' ' SER . 2.0 p -163.91 94.8 0.77 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.421 ' HA ' HD13 ' A' ' 113' ' ' ILE . 13.0 mm -71.35 120.03 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.231 0.538 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.94 137.2 3.45 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.032 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.1 OUTLIER -77.42 119.59 21.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.644 0.259 . . . . 0.0 110.321 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.79 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -102.56 125.46 49.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 0.0 112.014 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.447 ' O ' ' CD1' ' A' ' 117' ' ' TYR . 13.1 p90 -128.91 121.18 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.364 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.747 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.4 t -95.96 153.56 17.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.363 0.602 . . . . 0.0 112.128 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.873 ' O ' HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -163.59 123.7 2.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.436 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.04 -109.88 2.85 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.121 -1.037 . . . . 0.0 111.487 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -138.37 83.95 2.0 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 2.0 mtpm? 154.29 100.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.674 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.877 ' CD1' HG23 ' A' ' 102' ' ' VAL . 1.7 p90 -88.76 137.29 32.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.972 0.415 . . . . 0.0 111.006 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.714 HG23 ' HB3' ' A' ' 86' ' ' GLU . 23.9 m -110.6 129.38 55.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.246 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.827 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -110.22 117.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.859 0.838 . . . . 0.0 110.814 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.9 t -96.52 156.46 16.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.552 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.747 ' HB3' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -139.46 16.92 2.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.495 0.664 . . . . 0.0 109.555 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -120.46 167.91 11.87 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.296 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.3 mp 62.61 107.05 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.2 0.524 . . . . 0.0 110.938 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.67 15.28 20.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.402 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.46 33.8 3.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.618 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.8 mp -64.7 116.41 6.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.77 0.319 . . . . 0.0 110.858 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -150.82 93.79 1.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.937 0.398 . . . . 0.0 111.061 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.61 -55.5 3.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.697 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.432 ' C ' HD12 ' A' ' 136' ' ' LEU . 4.1 mttm -106.87 17.46 23.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.715 ' N ' HD12 ' A' ' 136' ' ' LEU . 0.3 OUTLIER -135.85 11.4 3.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.942 0.401 . . . . 0.0 111.36 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -48.4 -31.08 5.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.257 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -123.03 109.29 13.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -166.68 162.24 16.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.97 178.32 6.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.067 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.1 mtt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.758 0.314 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.7 p -78.95 -26.1 43.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.037 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.4 t 66.82 135.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.147 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -126.29 145.75 50.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t -156.23 97.98 1.82 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -69.27 97.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.836 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.03 174.73 10.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.468 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -127.15 29.39 5.6 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 120.977 0.418 . . . . 0.0 111.365 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.573 ' HA ' HD12 ' A' ' 12' ' ' ILE . 1.6 p-10 -55.36 -23.01 21.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.98 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.55 -32.21 42.13 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.833 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.468 ' HA3' ' CD1' ' A' ' 8' ' ' TYR . . . -73.44 -40.52 47.71 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.286 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.593 ' O ' ' N ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -108.27 9.85 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 120.234 -0.587 . . . . 0.0 111.764 178.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.529 ' HA ' ' CE ' ' A' ' 13' ' ' MET . 0.0 OUTLIER 59.2 -62.99 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.647 0.737 . . . . 0.0 112.344 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -166.78 25.04 0.14 Allowed Glycine 0 C--N 1.3 -1.451 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.934 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.2 mt -82.64 -81.89 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.665 0.269 . . . . 0.0 110.958 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.03 8.57 37.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.033 0.444 . . . . 0.0 111.159 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.83 -20.89 5.56 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.049 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -128.49 81.01 2.0 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.339 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.01 8.95 3.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.534 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.506 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -84.08 2.15 40.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.163 0.506 . . . . 0.0 111.04 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.65 -170.76 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.063 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 t70 62.32 14.28 6.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.163 0.506 . . . . 0.0 110.339 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -133.42 9.52 4.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.955 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.75 -53.69 4.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.57 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -120.99 111.89 18.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.771 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.48 -117.93 0.07 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.027 0.442 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 62.47 17.04 9.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.382 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.26 -20.89 29.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -93.35 14.57 18.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.853 0.358 . . . . 0.0 111.363 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -121.32 151.3 40.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.831 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 p -116.63 137.25 51.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.335 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 p -109.93 135.2 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.808 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.414 ' O ' ' C ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -109.82 115.29 29.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.192 0.52 . . . . 0.0 110.756 -179.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 33' ' ' HIS . 1.2 mt-10 27.74 61.23 0.11 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.28 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.4 t -81.95 148.67 28.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.966 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.35 58.54 4.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.472 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 81' ' ' ALA . 88.4 m -93.46 148.24 22.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.266 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -85.69 97.9 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.477 179.379 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.7 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.4 t -111.31 150.85 13.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.337 0.589 . . . . 0.0 112.163 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.809 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.12 119.79 3.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.764 178.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.678 ' C ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -113.46 126.51 70.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.173 0.511 . . . . 0.0 111.85 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.722 HD23 HD11 ' A' ' 48' ' ' ILE . 7.6 mp -126.76 140.43 52.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.606 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -48.45 133.06 16.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.497 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -78.32 87.62 4.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.502 0.668 . . . . 0.0 110.99 -179.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.481 ' C ' ' N ' ' A' ' 47' ' ' GLU . 21.8 m -126.4 170.99 11.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.887 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -14.12 0.17 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.289 0.566 . . . . 0.0 109.583 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.802 ' HG3' HD11 ' A' ' 96' ' ' LEU . 12.2 tt0 -70.12 -71.6 0.23 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.327 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.726 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.6 OUTLIER -59.18 -45.0 93.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.136 0.493 . . . . 0.0 110.073 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -38.78 -53.4 1.68 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.059 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.766 HG21 HD13 ' A' ' 95' ' ' LEU . 73.8 m -72.48 -74.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.941 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -41.23 -44.47 2.63 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.615 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -56.04 -48.08 79.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.223 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 3.0 pt-20 -52.14 -50.31 61.99 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.692 ' HA ' HG23 ' A' ' 58' ' ' THR . 6.9 mt-10 -68.76 -87.89 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.536 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.941 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.13 -62.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.882 ' HG ' HG12 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -65.6 -70.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.582 HD13 ' N ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -64.4 -23.85 67.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.692 HG23 ' HA ' ' A' ' 54' ' ' GLU . 15.5 p -60.42 -70.95 0.15 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.337 0.589 . . . . 0.0 110.784 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -86.88 -36.72 18.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.345 -178.054 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.961 ' CE1' HG21 ' A' ' 68' ' ' VAL . 97.7 m-85 -76.66 -13.57 60.04 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.496 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -103.94 -41.02 6.0 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.198 178.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.585 ' HB2' ' O ' ' A' ' 58' ' ' THR . 3.8 ttpt -68.32 -50.07 56.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.071 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.592 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -177.4 87.0 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 121.379 0.609 . . . . 0.0 112.524 179.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.757 ' HB ' ' HA ' ' A' ' 60' ' ' TYR . 25.4 t -161.92 -54.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.495 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.564 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.6 m-20 169.48 144.38 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.4 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -86.26 -20.87 2.62 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.897 2.398 . . . . 0.0 112.485 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 65' ' ' ASN . 4.6 t -51.77 -48.74 63.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.234 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.961 HG21 ' CE1' ' A' ' 60' ' ' TYR . 54.3 t -53.56 82.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.872 0.367 . . . . 0.0 110.635 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 67' ' ' THR . 19.5 p30 -116.06 142.73 46.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.495 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.554 HG23 HG23 ' A' ' 79' ' ' ILE . 0.8 OUTLIER -96.82 153.89 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.267 0.556 . . . . 0.0 111.575 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -142.05 124.48 15.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.501 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.24 114.22 18.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.959 0.409 . . . . 0.0 110.771 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.464 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -90.49 -150.83 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.644 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.94 -49.74 76.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.673 0.273 . . . . 0.0 111.065 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.08 15.82 1.02 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.203 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.57 161.17 38.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.953 0.376 . . . . 0.0 111.081 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.726 ' CD1' HG21 ' A' ' 48' ' ' ILE . 63.4 m95 -85.44 143.37 28.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.496 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.3 m0 -116.72 105.7 12.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.634 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.809 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.52 112.22 30.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 0.0 110.155 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -112.34 135.41 53.06 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.218 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.651 ' O ' HG23 ' A' ' 37' ' ' THR . . . -144.65 158.65 43.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.015 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.546 HD22 HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -104.6 148.64 26.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.98 0.419 . . . . 0.0 111.298 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.94 -70.11 0.3 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.171 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.542 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 178.97 159.68 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.371 . . . . 0.0 110.935 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.837 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.6 160.3 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.799 ' HB2' HG22 ' A' ' 124' ' ' THR . 9.1 pt-20 -138.91 127.63 23.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.166 0.507 . . . . 0.0 111.636 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.695 HG13 HG13 ' A' ' 55' ' ' ILE . 27.5 t -94.52 146.2 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.533 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -88.98 152.04 21.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.043 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.603 ' HB2' HG23 ' A' ' 102' ' ' VAL . 42.7 t -109.49 101.03 10.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.234 0.54 . . . . 0.0 109.908 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 0.9 OUTLIER 161.11 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.226 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 94' ' ' GLU . 2.6 mm-40 -77.34 -69.52 0.53 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.958 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.602 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.3 tt -62.2 -56.02 20.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.314 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.488 ' H ' HG23 ' A' ' 92' ' ' ILE . 7.0 t -45.24 -32.43 1.93 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.389 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -63.5 -61.28 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.002 0.43 . . . . 0.0 110.493 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 50' ' ' THR . 0.2 OUTLIER -75.31 -17.24 60.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.909 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.802 HD11 ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -101.89 8.32 41.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.293 -179.237 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.45 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 143.04 65.93 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.562 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -33.57 133.61 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.968 0.413 . . . . 0.0 111.736 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 70.14 17.34 7.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.638 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.45 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -66.33 -175.5 0.36 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.61 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -85.5 -95.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.769 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.603 HG23 ' HB2' ' A' ' 89' ' ' CYS . 10.1 p 179.4 -35.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.682 0.277 . . . . 0.0 111.284 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.727 ' CE2' HG22 ' A' ' 118' ' ' THR . 5.0 m-85 -72.81 -2.67 21.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.079 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.534 ' O ' HG12 ' A' ' 107' ' ' VAL . 1.8 p30 -46.18 -39.44 9.69 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.874 0.369 . . . . 0.0 110.584 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.465 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -75.47 143.51 42.55 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.915 179.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 116' ' ' ALA . 3.7 tt 62.06 18.57 10.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.187 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 104' ' ' ASP . 7.6 p -82.8 -42.27 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.794 0.33 . . . . 0.0 111.038 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.433 ' N ' HG13 ' A' ' 107' ' ' VAL . 2.0 t70 -179.95 51.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.703 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -113.08 85.87 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.487 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.8 -65.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.151 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 109' ' ' VAL . 6.6 t 168.65 172.37 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.765 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER 179.27 120.87 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.882 0.372 . . . . 0.0 111.505 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.1 mm -87.52 122.83 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.331 0.586 . . . . 0.0 111.059 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.87 141.6 3.88 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.984 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 126' ' ' THR . 41.7 mtt-85 -77.24 120.11 21.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.667 ' HB3' HD22 ' A' ' 106' ' ' LEU . . . -105.36 123.84 48.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.162 0.506 . . . . 0.0 112.156 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.568 ' HE1' HD23 ' A' ' 119' ' ' LEU . 13.5 p90 -137.73 119.49 15.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.369 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.727 HG22 ' CE2' ' A' ' 103' ' ' TYR . 14.7 t -93.99 136.24 34.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.118 0.485 . . . . 0.0 111.85 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.595 ' O ' HD12 ' A' ' 119' ' ' LEU . 3.1 pp -135.07 118.75 17.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.76 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.73 -106.63 1.02 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.88 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.37 83.4 2.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.881 0.372 . . . . 0.0 110.118 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 3.7 mttt 152.3 97.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.592 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.641 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 15.1 p90 -88.26 126.31 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.423 . . . . 0.0 111.124 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.799 HG22 ' HB2' ' A' ' 86' ' ' GLU . 19.6 p -102.13 137.38 40.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.867 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.837 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -119.36 118.24 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.78 0.8 . . . . 0.0 111.268 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 115' ' ' ARG . 10.3 t -98.04 156.06 16.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.472 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.432 ' CB ' ' HA ' ' A' ' 38' ' ' VAL . 13.2 t -143.4 19.83 1.88 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.41 0.624 . . . . 0.0 109.489 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -122.87 -166.33 1.43 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.019 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 69.21 109.87 0.05 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.201 0.524 . . . . 0.0 110.952 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 6.9 ttp -107.88 16.21 23.72 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.207 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -58.0 -65.25 3.66 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.566 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.95 114.23 6.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.363 . . . . 0.0 110.8 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.4 p30 -88.86 58.35 4.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.964 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -48.5 78.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.778 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.406 ' H ' HD22 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -124.05 17.35 9.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.251 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.601 ' N ' HD22 ' A' ' 136' ' ' LEU . 0.9 OUTLIER -116.89 12.42 14.72 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.026 0.441 . . . . 0.0 110.899 179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -54.58 -28.94 49.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.234 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -132.25 123.9 27.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.991 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -153.35 -173.28 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -139.37 164.44 29.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.144 -179.929 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 mtm . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.826 0.345 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.75 -39.77 4.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.6 t 68.37 -68.45 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.162 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -74.8 150.9 39.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.954 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 60.94 39.82 16.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -162.86 41.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 59.76 -174.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.038 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.886 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -113.19 22.78 13.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.253 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.469 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.9 p30 -52.6 -20.93 3.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.259 0.552 . . . . 0.0 111.511 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.513 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -74.42 -16.16 60.89 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.763 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.99 -10.98 1.89 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.308 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.886 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.0 pp -58.66 -20.84 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 117.482 0.641 . . . . 0.0 112.019 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.513 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -82.05 7.53 13.08 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.972 178.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.786 ' O ' HD12 ' A' ' 15' ' ' LEU . . . -162.3 24.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.718 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 14' ' ' GLY . 7.2 mp -133.62 -83.09 0.46 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.66 0.266 . . . . 0.0 110.673 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.71 7.57 38.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.142 0.496 . . . . 0.0 111.017 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -119.29 -25.17 2.76 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.536 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.89 85.48 2.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.7 0.762 . . . . 0.0 110.008 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -138.65 12.77 2.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.466 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.01 13.96 5.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.856 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.99 -174.29 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.783 0.325 . . . . 0.0 110.776 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.0 t0 62.09 13.84 6.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.997 0.427 . . . . 0.0 110.84 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -148.46 12.49 0.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.23 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -99.11 -52.7 3.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.344 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -120.98 110.46 16.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.399 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.64 -116.9 0.07 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.093 0.473 . . . . 0.0 110.953 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t70 66.14 15.48 10.1 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.329 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -87.95 -19.9 26.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.958 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -93.44 15.15 16.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.431 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -81.86 137.86 35.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.84 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 p -82.27 148.19 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.099 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.96 134.77 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.67 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -109.89 115.22 29.41 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.798 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 31.01 65.36 0.16 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.043 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -68.66 146.2 53.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.749 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.96 -26.72 9.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.314 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.0 m -90.66 142.86 27.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 0.0 111.178 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -93.97 92.75 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.858 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.43 145.26 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.363 0.602 . . . . 0.0 111.99 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.774 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.22 129.48 7.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.008 179.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -112.94 129.36 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.213 0.53 . . . . 0.0 111.731 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.947 HD23 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -127.24 140.3 52.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.874 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.682 ' O ' HD13 ' A' ' 48' ' ' ILE . 18.2 mttp -49.27 127.54 15.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -73.14 92.2 1.7 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.73 0.776 . . . . 0.0 110.74 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.444 ' C ' ' N ' ' A' ' 47' ' ' GLU . 6.9 m -126.2 171.12 11.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.207 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -49.95 -16.8 0.31 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.831 ' CB ' HD21 ' A' ' 96' ' ' LEU . 12.5 tt0 -65.46 -74.26 0.11 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.509 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.947 HD11 HD23 ' A' ' 42' ' ' LEU . 2.2 mp -54.7 -31.92 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.2 0.524 . . . . 0.0 109.912 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -47.5 -61.68 1.81 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.51 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.7 ' CB ' HD22 ' A' ' 95' ' ' LEU . 32.9 m -82.09 -44.78 16.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.056 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.783 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -52.52 -48.85 65.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.737 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.705 HG13 HD23 ' A' ' 56' ' ' LEU . 1.6 tp -62.53 -48.52 87.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.061 0.458 . . . . 0.0 109.964 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.697 ' O ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -50.54 -47.47 57.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.402 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.721 ' HA ' HG23 ' A' ' 58' ' ' THR . 28.7 mt-10 -77.77 -71.05 0.44 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.343 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.88 HG13 HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -30.64 -59.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.96 ' HG ' HD22 ' A' ' 57' ' ' LEU . 0.7 OUTLIER -78.91 -50.16 11.65 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.96 HD22 ' HG ' ' A' ' 56' ' ' LEU . 3.1 mm? -65.03 -48.25 74.56 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 119.312 0.96 . . . . 0.0 111.376 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.721 HG23 ' HA ' ' A' ' 54' ' ' GLU . 46.0 p -53.0 -71.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.018 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.465 ' HB3' HG23 ' A' ' 64' ' ' VAL . 9.1 m-20 -62.35 -18.17 60.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.964 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.694 ' HE1' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -51.24 -78.1 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.694 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -19.7 64.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.086 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 58' ' ' THR . 4.8 ttpp -59.73 -70.38 0.17 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.021 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.91 21.73 0.17 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.522 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 65' ' ' ASN . 43.1 t -98.38 -78.36 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.625 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.782 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.8 m-20 154.51 170.82 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.048 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 80.8 Cg_endo -88.62 -7.39 5.62 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.972 2.448 . . . . 0.0 111.955 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.782 HG22 ' HB3' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -64.62 -85.33 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.878 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.706 ' O ' HG22 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -28.97 86.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.635 0.731 . . . . 0.0 111.815 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.2 p30 -115.91 143.28 45.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.563 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.555 HG23 HG23 ' A' ' 79' ' ' ILE . 1.5 p -96.27 151.0 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.321 0.581 . . . . 0.0 111.559 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 16.4 pt-20 -144.92 135.38 24.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.551 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -79.85 114.56 18.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.783 0.325 . . . . 0.0 110.434 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -85.09 -78.47 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.996 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -132.31 -66.73 0.68 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . -125.0 3.85 8.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.676 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.6 158.1 44.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.808 0.337 . . . . 0.0 110.823 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.652 ' CD1' HG21 ' A' ' 48' ' ' ILE . 78.2 m95 -77.29 142.99 39.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.546 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.583 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 6.5 m0 -114.8 109.85 18.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.356 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.774 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -100.02 116.17 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.191 0.52 . . . . 0.0 111.382 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -111.72 134.63 53.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.122 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.613 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . . . -144.43 158.76 43.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.898 0.38 . . . . 0.0 111.556 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.626 ' ND2' HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -109.18 143.34 38.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.921 179.198 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.93 -69.05 0.62 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.483 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.53 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -177.07 152.31 0.89 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.213 0.53 . . . . 0.0 111.728 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.732 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -125.79 160.47 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.696 ' HB2' HG22 ' A' ' 124' ' ' THR . 17.2 pt-20 -147.24 125.86 12.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.499 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.88 HG13 HG13 ' A' ' 55' ' ' ILE . 38.2 t -95.48 146.9 6.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.673 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 8.9 p30 -101.54 151.82 21.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.639 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.628 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 1.2 t -105.34 99.85 9.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.296 0.57 . . . . 0.0 110.186 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.1 m-20 159.75 -37.58 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.954 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -69.93 -75.82 0.11 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.635 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.637 HD12 ' CD2' ' A' ' 51' ' ' PHE . 1.6 tt -52.88 -56.42 7.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.521 ' H ' HG23 ' A' ' 92' ' ' ILE . 56.0 p -46.14 -43.3 14.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.0 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -51.14 -45.81 61.75 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 109.959 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.7 HD22 ' CB ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -91.2 -18.77 23.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.591 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.831 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.32 19.31 13.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.193 0.521 . . . . 0.0 110.746 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 98' ' ' ARG . . . 99.79 68.56 0.88 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.494 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -30.05 148.07 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.084 0.468 . . . . 0.0 111.895 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 55.3 105.59 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.412 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -175.46 -158.85 0.07 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.632 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.09 132.39 35.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 111.165 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.473 HG21 ' OG1' ' A' ' 118' ' ' THR . 5.9 p -81.51 -28.59 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.806 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.702 ' CE2' HG22 ' A' ' 118' ' ' THR . 4.0 m-85 -77.44 -2.82 37.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.749 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.788 ' O ' HG12 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -46.02 -35.87 5.17 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-O 120.876 0.369 . . . . 0.0 110.62 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.542 ' CE2' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -80.66 134.35 35.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.152 179.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.801 HD23 ' O ' ' A' ' 106' ' ' LEU . 3.9 tt 75.46 7.68 3.93 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.862 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.788 HG12 ' O ' ' A' ' 104' ' ' ASP . 11.4 p -86.02 -36.84 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.828 0.347 . . . . 0.0 111.255 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -178.43 48.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.616 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.676 HG21 HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -113.41 86.17 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.261 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.97 -65.78 0.21 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.942 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.528 ' C ' HG22 ' A' ' 112' ' ' THR . 5.9 t 165.44 169.81 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.524 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.528 HG22 ' C ' ' A' ' 111' ' ' SER . 0.2 OUTLIER -179.18 133.84 0.12 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.976 0.417 . . . . 0.0 111.513 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 113' ' ' ILE . 5.0 mm -104.85 113.71 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.54 0.686 . . . . 0.0 110.94 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 152.45 146.85 4.45 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.132 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.29 127.25 32.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.64 0.257 . . . . 0.0 110.594 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.711 ' HB2' HD13 ' A' ' 106' ' ' LEU . . . -115.72 124.66 51.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.088 0.47 . . . . 0.0 111.766 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.453 ' O ' ' CD1' ' A' ' 117' ' ' TYR . 23.6 p90 -136.92 118.95 15.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.854 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.702 HG22 ' CE2' ' A' ' 103' ' ' TYR . 11.0 t -95.35 152.66 18.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.217 0.532 . . . . 0.0 111.498 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.614 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.7 pp -148.41 116.46 6.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.893 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.06 -104.17 0.37 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.188 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.628 ' ND2' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -129.61 83.97 2.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.24 0.543 . . . . 0.0 109.653 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 8.6 mttt 148.73 112.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.998 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.575 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 9.5 p90 -109.18 124.38 50.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.069 0.461 . . . . 0.0 110.817 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.696 HG22 ' HB2' ' A' ' 86' ' ' GLU . 7.3 p -100.49 141.72 32.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.643 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.818 HD11 HG23 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -120.82 117.61 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.87 0.843 . . . . 0.0 111.296 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 115' ' ' ARG . 12.8 t -103.61 155.47 18.52 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.105 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.466 ' CB ' HG13 ' A' ' 38' ' ' VAL . 30.1 t -144.41 18.96 1.71 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.301 0.572 . . . . 0.0 109.855 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -123.97 -27.15 3.94 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.459 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 65.27 107.94 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.189 0.518 . . . . 0.0 110.796 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 67.9 mtm -93.76 16.07 14.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.49 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -106.67 46.59 1.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.539 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 18.6 mt -91.74 55.36 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.936 0.398 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.807 ' HA ' HD12 ' A' ' 136' ' ' LEU . 70.6 m-20 59.92 28.89 18.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.022 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -52.66 57.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.702 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -115.4 31.33 6.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.614 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.807 HD12 ' HA ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -128.21 -161.65 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.83 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 71.63 -55.94 0.65 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.335 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -114.61 111.0 20.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.11 177.36 7.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -132.16 133.71 44.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.087 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.808 0.337 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 t 56.96 -169.16 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 t -133.4 -53.38 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.027 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -98.62 151.47 20.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -58.6 -26.87 64.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.954 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.2 m120 64.94 90.69 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.91 103.11 4.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.102 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.452 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -64.18 -134.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.387 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.434 ' O ' ' HE3' ' A' ' 13' ' ' MET . 1.5 m-20 -46.41 -26.42 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.126 0.489 . . . . 0.0 112.318 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.58 -26.5 62.63 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.527 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 8' ' ' TYR . . . -94.28 -26.22 14.52 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.731 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.472 ' CD1' ' H ' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -92.29 -26.33 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 121.79 0.805 . . . . 0.0 110.664 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.439 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER 28.7 46.07 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.79 -1.55 . . . . 0.0 113.34 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.472 ' H ' ' CD1' ' A' ' 12' ' ' ILE . . . -149.2 -89.41 0.08 OUTLIER Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.184 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.58 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.7 mm? -44.01 -69.61 0.13 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.738 0.304 . . . . 0.0 111.415 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.426 ' H ' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -99.61 -6.42 27.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.192 0.52 . . . . 0.0 111.642 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.16 -13.35 42.75 Favored Glycine 0 C--N 1.313 -0.723 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.704 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.45 81.55 2.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.133 0.492 . . . . 0.0 110.632 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -137.6 12.01 2.96 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.354 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.05 15.16 6.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.71 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.98 -171.69 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.849 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.71 14.22 4.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.06 0.457 . . . . 0.0 110.568 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -141.25 11.29 2.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.978 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.74 -45.05 14.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.515 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -120.4 110.85 17.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.644 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.52 -115.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.937 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 t0 67.04 15.34 10.1 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.377 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -76.5 -26.37 55.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.771 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -144.61 17.1 1.65 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.367 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -97.5 165.91 11.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.93 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.29 150.72 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.052 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 10.9 p -109.95 134.42 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.861 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.406 ' O ' ' C ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -110.42 115.11 29.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.251 0.548 . . . . 0.0 110.867 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 33' ' ' HIS . 0.9 OUTLIER 29.04 71.04 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.198 179.36 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.414 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 3.9 t -76.22 142.65 41.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.933 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -107.28 27.97 8.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.9 m -69.11 143.56 54.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.071 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.582 HG13 ' CB ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -87.64 98.89 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.69 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 113' ' ' ILE . 7.2 t -117.17 152.82 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.314 0.578 . . . . 0.0 111.881 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.777 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -164.53 128.09 2.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.085 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.42 130.7 65.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 121.251 0.548 . . . . 0.0 111.927 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.032 HD23 HD11 ' A' ' 48' ' ' ILE . 9.0 tp -128.04 140.49 51.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.816 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.665 ' O ' HD13 ' A' ' 48' ' ' ILE . 7.6 ttmm -47.17 124.53 6.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.569 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.476 ' HA ' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -71.68 90.36 1.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.501 0.667 . . . . 0.0 110.655 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.475 ' C ' ' N ' ' A' ' 47' ' ' GLU . 3.7 m -125.72 171.79 10.34 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.198 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -48.11 -17.77 0.15 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.269 0.557 . . . . 0.0 109.526 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.795 ' HA ' HD21 ' A' ' 96' ' ' LEU . 25.7 tt0 -63.23 -77.42 0.05 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.468 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.032 HD11 HD23 ' A' ' 42' ' ' LEU . 2.3 mp -54.62 -31.74 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -47.03 -60.23 2.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.276 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.604 ' CB ' HD22 ' A' ' 95' ' ' LEU . 3.9 m -84.17 -45.59 12.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.054 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.825 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -51.44 -47.64 62.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.513 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.689 HD13 HG23 ' A' ' 48' ' ' ILE . 1.5 tp -63.66 -49.04 83.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.062 0.458 . . . . 0.0 109.818 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -50.78 -45.04 58.9 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.802 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.789 ' HA ' HG23 ' A' ' 58' ' ' THR . 3.2 mt-10 -77.25 -77.19 0.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.695 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.853 HG13 HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -30.98 -55.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.689 ' N ' HG23 ' A' ' 55' ' ' ILE . 7.0 tt -71.28 -60.52 2.19 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 57' ' ' LEU . 2.6 mm? -66.85 -48.23 69.5 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.789 HG23 ' HA ' ' A' ' 54' ' ' GLU . 51.8 p -51.98 -71.82 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.062 0.458 . . . . 0.0 110.279 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.492 ' HB2' HG21 ' A' ' 64' ' ' VAL . 6.3 m-20 -60.59 -23.21 64.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.891 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.709 ' HE1' HG13 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.32 -78.0 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -67.91 -26.17 65.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.297 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.0 ttpp -52.02 -66.54 0.37 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.872 0.367 . . . . 0.0 111.281 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -169.76 30.39 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.255 0.55 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 65' ' ' ASN . 24.1 t -101.68 -78.63 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.348 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.784 ' HB3' HG22 ' A' ' 67' ' ' THR . 5.1 m-20 154.49 165.92 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 O-C-N 123.523 0.514 . . . . 0.0 110.946 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.464 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 94.7 Cg_endo -86.19 -3.54 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.79 2.327 . . . . 0.0 111.922 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.784 HG22 ' HB3' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -68.82 -86.75 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.44 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.709 HG13 ' HE1' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -24.29 89.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 121.559 0.695 . . . . 0.0 111.895 -179.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -116.04 143.1 45.92 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.04 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.538 HG23 HG23 ' A' ' 79' ' ' ILE . 1.5 p -96.73 153.06 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.146 0.498 . . . . 0.0 111.547 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.512 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 27.6 tt0 -143.83 133.09 23.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.991 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.65 114.37 21.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.295 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -94.3 -81.67 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.318 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.42 -69.21 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.835 0.35 . . . . 0.0 111.354 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . -126.55 5.45 7.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.034 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.66 153.91 43.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.768 0.318 . . . . 0.0 110.889 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.641 ' CD1' HG21 ' A' ' 48' ' ' ILE . 82.7 m95 -76.83 143.07 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.62 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.512 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.3 m0 -111.3 105.03 13.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.339 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.777 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.81 110.56 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.028 0.442 . . . . 0.0 110.824 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -112.13 135.71 52.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.066 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.657 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . . . -144.09 156.9 44.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.417 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.423 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 0.5 OUTLIER -109.07 128.93 55.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.449 179.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.04 -67.67 3.12 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.327 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.61 152.38 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.252 0.548 . . . . 0.0 111.619 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.74 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -127.08 160.21 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.745 ' HB3' HG23 ' A' ' 124' ' ' THR . 2.3 pt-20 -149.39 125.69 10.81 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.547 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.853 HG13 HG13 ' A' ' 55' ' ' ILE . 62.1 t -95.3 146.48 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.476 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 122' ' ' LYS . 6.7 t70 -95.72 151.41 19.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.408 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.491 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 7.6 t -104.01 100.02 9.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.111 0.482 . . . . 0.0 110.082 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.2 m-20 157.7 -36.43 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.337 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 94' ' ' GLU . 0.9 OUTLIER -69.88 -76.41 0.1 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.543 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.573 HD12 ' CD2' ' A' ' 51' ' ' PHE . 2.8 tt -54.05 -56.5 9.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.357 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.512 ' H ' HG23 ' A' ' 92' ' ' ILE . 16.9 p -47.58 -36.05 10.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.876 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.45 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -57.83 -46.21 85.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.109 0.481 . . . . 0.0 110.053 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.604 HD22 ' CB ' ' A' ' 50' ' ' THR . 0.7 OUTLIER -90.5 -18.46 25.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.626 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.795 HD21 ' HA ' ' A' ' 47' ' ' GLU . 1.1 mm? -98.67 14.03 30.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.054 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.6 68.09 0.37 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.063 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -33.07 149.86 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.088 0.47 . . . . 0.0 111.97 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.63 17.99 9.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.324 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -165.36 0.4 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.939 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -96.0 -162.76 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.933 HG23 ' CD1' ' A' ' 123' ' ' PHE . 1.5 p -117.44 -32.07 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.084 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -81.58 5.77 17.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.579 0.228 . . . . 0.0 111.474 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 107' ' ' VAL . 11.6 t70 -60.6 -39.32 87.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.651 0.262 . . . . 0.0 110.811 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.528 ' HE2' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -66.87 -14.03 62.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.13 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -143.01 35.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.786 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 104' ' ' ASP . 10.8 p -87.18 -32.94 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.112 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -176.85 38.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.407 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.605 HG21 HG23 ' A' ' 112' ' ' THR . 25.6 m -69.56 165.81 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.644 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.9 m -54.51 -46.79 73.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.004 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.3 140.85 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.605 HG23 HG21 ' A' ' 109' ' ' VAL . 1.4 p -149.75 75.35 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.504 ' HA ' HD13 ' A' ' 113' ' ' ILE . 4.9 mm -58.99 106.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.48 0.657 . . . . 0.0 111.007 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.56 144.98 4.26 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.878 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 126' ' ' THR . 19.6 mtm180 -76.55 125.8 29.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.801 0.334 . . . . 0.0 110.736 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.68 ' HB2' HD13 ' A' ' 106' ' ' LEU . . . -104.04 125.28 50.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.965 0.412 . . . . 0.0 111.658 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.453 ' O ' ' CD1' ' A' ' 117' ' ' TYR . 13.9 p90 -133.91 120.58 20.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.772 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.849 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.5 t -97.11 158.45 15.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.237 0.541 . . . . 0.0 111.929 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 119' ' ' LEU . 3.0 pp -157.42 118.06 3.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.793 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.8 -106.35 0.86 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.817 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -132.55 83.85 2.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.5 OUTLIER 152.37 110.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.191 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.933 ' CD1' HG23 ' A' ' 102' ' ' VAL . 2.1 p90 -101.6 132.33 47.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.236 0.541 . . . . 0.0 111.132 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.745 HG23 ' HB3' ' A' ' 86' ' ' GLU . 30.4 m -106.98 134.43 50.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.747 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.763 HD12 ' H ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -117.32 117.45 55.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.711 0.767 . . . . 0.0 111.011 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.9 t -109.57 155.16 21.76 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.943 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.582 ' CB ' HG13 ' A' ' 38' ' ' VAL . 28.8 t -142.63 21.97 1.99 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.354 0.597 . . . . 0.0 109.705 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.625 ' O ' HD22 ' A' ' 129' ' ' LEU . 2.3 mt-10 -124.0 45.04 2.57 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.106 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.625 HD22 ' O ' ' A' ' 128' ' ' GLU . 1.0 OUTLIER -137.23 16.45 2.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.297 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 55.1 mtm -95.81 15.76 19.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.295 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -157.07 68.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.584 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.53 -53.99 46.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 110.855 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 61.41 42.6 11.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.993 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -56.53 15.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.717 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.85 32.0 5.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.689 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 13.7 mt -109.57 -145.52 0.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.806 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -39.91 -41.7 1.21 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -113.25 103.74 11.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.025 0.44 . . . . 0.0 111.018 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -155.89 -164.42 1.71 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.969 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.08 163.17 2.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.949 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.064 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.799 0.333 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 p -166.58 95.41 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.851 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 p -153.66 129.46 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.77 146.97 34.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p -61.58 -34.47 75.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.933 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -134.66 155.51 50.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -164.44 142.29 6.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.891 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -103.32 20.7 17.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.322 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.555 ' HA ' HG12 ' A' ' 12' ' ' ILE . 28.8 m-20 -54.1 -18.33 3.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.135 0.493 . . . . 0.0 111.666 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.37 -22.52 54.73 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.625 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.441 ' HA3' ' CE1' ' A' ' 8' ' ' TYR . . . -125.29 -7.63 5.78 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.266 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.891 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.2 pp -61.33 -18.64 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 117.567 0.683 . . . . 0.0 111.793 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.423 ' H ' ' HE2' ' A' ' 13' ' ' MET . 0.0 OUTLIER -84.19 9.33 13.07 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.91 178.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.99 -46.92 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.319 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -74.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.68 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -101.83 11.42 38.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.095 0.474 . . . . 0.0 111.161 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -112.55 -16.08 9.05 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.081 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.03 80.71 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.026 0.441 . . . . 0.0 110.531 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -142.67 7.61 1.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.669 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.84 18.19 7.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.812 0.339 . . . . 0.0 111.426 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.46 -174.26 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.908 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.2 t0 62.42 12.95 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.101 0.477 . . . . 0.0 110.912 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -143.78 10.64 1.59 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.961 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -98.32 -50.45 4.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.714 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.11 113.47 20.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.238 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.56 -116.58 0.08 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.099 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 t0 66.53 15.58 10.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.484 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -60.22 -29.13 68.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.921 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.15 106.89 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.189 0.518 . . . . 0.0 110.869 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -89.63 154.61 19.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.918 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -100.04 139.96 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.041 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.4 p -109.89 134.75 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.858 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.93 115.23 29.41 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.834 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 33.18 61.2 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.116 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 t -81.29 146.13 30.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.807 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.55 16.24 16.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.22 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.5 m -120.47 144.56 47.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.859 0.362 . . . . 0.0 111.007 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.677 HG11 HG23 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -101.45 106.05 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.498 179.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 113' ' ' ILE . 12.4 t -121.47 150.32 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 121.42 0.629 . . . . 0.0 112.252 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.77 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -164.78 130.96 2.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.865 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.5 HG23 ' HB3' ' A' ' 111' ' ' SER . 0.0 OUTLIER -112.65 128.92 69.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.262 0.553 . . . . 0.0 111.863 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.931 ' HG ' HG11 ' A' ' 109' ' ' VAL . 0.5 OUTLIER -128.18 148.4 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.356 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.61 153.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.852 0.358 . . . . 0.0 111.381 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.444 ' HA ' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -90.7 22.35 3.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.599 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.449 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -71.52 171.64 11.0 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.068 -178.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -49.39 -14.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.57 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.982 ' HG3' HD21 ' A' ' 96' ' ' LEU . 1.4 tt0 -63.82 -76.82 0.06 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.989 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -55.96 -44.31 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.365 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -39.65 -58.61 1.28 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.907 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.878 ' HB ' HD11 ' A' ' 95' ' ' LEU . 27.5 m -84.16 -56.47 3.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.892 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.916 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -47.15 -50.42 20.47 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.547 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.8 tp -59.43 -48.2 88.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.818 0.342 . . . . 0.0 110.179 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.788 ' O ' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -50.51 -52.38 39.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.339 0.59 . . . . 0.0 109.604 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.751 ' HA ' HG23 ' A' ' 58' ' ' THR . 13.2 mm-40 -69.05 -81.18 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.649 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.916 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -23.27 -58.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.74 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 1.5 mp -73.25 -66.2 0.71 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.788 HD22 ' O ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -62.94 -33.33 75.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.751 HG23 ' HA ' ' A' ' 54' ' ' GLU . 70.0 p -60.89 -67.7 0.38 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.267 0.556 . . . . 0.0 110.905 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.614 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 0.1 OUTLIER -85.69 -42.81 13.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.805 ' CG ' HG11 ' A' ' 68' ' ' VAL . 52.0 m-85 -69.94 -24.28 63.33 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -92.59 -50.99 5.33 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.722 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.0 ttmt -60.81 -41.37 95.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.422 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.71 ' O ' HG23 ' A' ' 64' ' ' VAL . 3.4 p30 179.72 104.0 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.888 0.375 . . . . 0.0 111.698 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER 177.85 -53.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.138 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.517 ' N ' HG12 ' A' ' 64' ' ' VAL . 4.3 m-20 -179.53 143.07 0.38 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 111.876 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.04 -4.0 10.4 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.742 2.295 . . . . 0.0 111.858 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.552 ' OG1' ' HA ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -83.52 -108.17 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.533 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.805 HG11 ' CG ' ' A' ' 60' ' ' TYR . 9.5 p 27.01 49.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.296 0.57 . . . . 0.0 111.657 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -82.25 137.72 34.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.124 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -98.06 154.0 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.228 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 2.4 mm-40 -142.23 120.12 11.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.059 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -78.85 114.0 17.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.418 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 2.2 tpt180 -98.08 -145.28 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.914 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.73 -19.9 44.33 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 120.605 0.24 . . . . 0.0 111.436 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.26 -50.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.593 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.49 156.14 29.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.381 . . . . 0.0 110.738 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.989 ' CD1' HG21 ' A' ' 48' ' ' ILE . 38.3 m95 -81.84 143.69 31.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.391 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.467 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 9.4 m0 -108.84 107.16 17.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.383 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.77 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.2 109.55 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.1 0.476 . . . . 0.0 110.051 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -118.35 141.7 48.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.184 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB3' HG22 ' A' ' 85' ' ' ILE . . . -143.38 157.95 44.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.52 120.85 40.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.953 0.406 . . . . 0.0 111.595 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.07 -65.46 1.93 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.085 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.596 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -178.53 155.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 0.0 110.769 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.783 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -133.3 156.81 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.823 ' HB2' HG22 ' A' ' 124' ' ' THR . 3.3 pt-20 -144.79 123.69 12.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.212 0.53 . . . . 0.0 111.664 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.758 HG23 HD11 ' A' ' 125' ' ' ILE . 28.8 t -94.3 146.28 6.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.553 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 0.8 OUTLIER -89.93 152.03 21.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.329 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 41.4 t -114.48 101.12 8.83 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 7.7 t0 161.55 -28.69 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.436 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -86.58 -69.11 0.7 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.649 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.819 HD12 ' CD2' ' A' ' 51' ' ' PHE . 0.9 OUTLIER -52.8 -80.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.494 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.607 ' N ' HG12 ' A' ' 92' ' ' ILE . 6.5 p -19.94 -55.68 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 76.5 mm-40 -54.79 -47.15 74.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 0.0 111.799 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.878 HD11 ' HB ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -89.96 -28.81 18.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.895 -178.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.982 HD21 ' HG3' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -56.9 -19.93 20.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.99 -44.98 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.01 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER 171.11 -171.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -58.81 100.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.055 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CB ' ' HB2' ' A' ' 93' ' ' SER . 0.1 OUTLIER -114.77 -165.7 1.04 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.98 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.65 -173.87 2.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 0.0 111.045 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.8 HG21 ' OG1' ' A' ' 118' ' ' THR . 4.3 p -83.89 173.37 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.944 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.642 ' H ' HG22 ' A' ' 102' ' ' VAL . 0.5 OUTLIER 69.91 9.77 7.23 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.697 -179.044 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.586 ' O ' HG12 ' A' ' 107' ' ' VAL . 8.7 p-10 -80.14 -35.0 37.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.291 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.582 ' CE1' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -63.57 -52.97 58.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.703 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -97.93 31.78 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.986 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 104' ' ' ASP . 14.5 p -72.91 -44.76 57.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.069 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.489 ' N ' HG13 ' A' ' 107' ' ' VAL . 0.4 OUTLIER 173.76 96.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.818 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.931 HG11 ' HG ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -134.38 -171.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.96 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.1 OUTLIER -47.84 -40.28 20.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.909 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.5 ' HB3' HG23 ' A' ' 41' ' ' VAL . 2.2 t 171.83 157.54 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.817 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 63.0 p -156.51 75.95 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.119 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.439 ' HA ' HD13 ' A' ' 113' ' ' ILE . 6.2 mm -59.95 108.17 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.386 0.612 . . . . 0.0 111.084 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.43 141.91 3.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.011 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 126' ' ' THR . 34.9 mtm105 -77.05 120.21 21.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.657 0.265 . . . . 0.0 110.409 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.734 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -104.54 126.41 51.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.096 0.475 . . . . 0.0 112.263 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.457 ' HE1' HD23 ' A' ' 119' ' ' LEU . 5.7 p90 -136.14 125.39 24.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.603 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.8 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.5 t -91.21 159.11 16.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.185 0.517 . . . . 0.0 111.961 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.5 pp -161.25 116.82 2.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.916 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.78 -109.13 1.85 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.689 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -129.1 83.1 2.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 11.5 mttt 151.34 120.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.525 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.68 ' CD1' HG23 ' A' ' 102' ' ' VAL . 1.3 p90 -108.45 135.5 49.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.845 0.355 . . . . 0.0 110.528 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.823 HG22 ' HB2' ' A' ' 86' ' ' GLU . 19.3 p -109.81 134.65 51.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.685 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.783 HD13 ' CD1' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -114.95 117.48 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.839 0.828 . . . . 0.0 110.6 178.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 115' ' ' ARG . 10.7 t -99.51 156.74 16.88 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.651 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.442 ' HB2' HG13 ' A' ' 38' ' ' VAL . 2.7 m -142.71 20.88 2.0 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.335 0.588 . . . . 0.0 109.653 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -122.58 143.79 49.52 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.986 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 64.17 107.13 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.232 0.539 . . . . 0.0 110.756 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.8 ttt -125.62 15.19 8.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.248 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -84.6 -68.17 1.4 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.521 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.98 100.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.781 0.324 . . . . 0.0 110.85 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -118.42 36.66 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.076 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -59.72 -51.03 71.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.662 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.736 ' O ' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -117.16 32.02 6.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.569 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.736 HD23 ' O ' ' A' ' 135' ' ' LYS . 3.6 mt -134.49 -159.42 0.96 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.765 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 72.33 -55.77 0.66 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.378 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -149.73 153.62 37.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.853 0.359 . . . . 0.0 110.974 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.31 93.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -59.4 125.78 25.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.99 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.075 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 mtm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.755 0.312 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.87 35.83 1.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.1 t -76.32 110.22 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -83.64 147.9 27.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.1 t -153.96 -79.25 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.35 96.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.9 116.07 31.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.233 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.771 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -63.65 -133.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.344 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.461 ' HA ' HG12 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -46.96 -22.09 0.29 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.544 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -73.32 -16.27 61.37 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.404 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.76 -1.56 3.34 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.322 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.0 pp -67.97 -15.94 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-O 121.424 0.631 . . . . 0.0 111.912 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.544 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.49 9.12 14.28 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.916 178.203 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.23 -48.69 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.678 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -79.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 110.902 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -93.06 11.3 28.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.032 0.444 . . . . 0.0 111.242 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.96 -20.94 5.5 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.233 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -129.52 80.63 1.97 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.023 0.44 . . . . 0.0 110.623 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -145.52 9.76 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.738 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.28 17.28 10.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.893 0.377 . . . . 0.0 111.224 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.0 -9.49 58.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.673 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.3 11.3 24.04 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.865 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -142.7 12.48 1.89 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.965 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -102.85 -53.54 2.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.136 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -121.09 110.32 16.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.28 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.63 -115.26 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.043 0.449 . . . . 0.0 111.109 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 t0 69.17 15.64 8.62 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.272 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.75 -26.31 44.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.998 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -175.27 104.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.62 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -139.3 159.37 42.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.787 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 31' ' ' VAL . 10.9 p -117.96 124.43 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.218 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 10.8 p -110.1 134.68 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.667 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 34' ' ' GLU . 9.7 m-70 -110.36 115.08 29.03 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.924 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 33' ' ' HIS . 0.1 OUTLIER 25.35 48.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.41 179.487 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -91.99 129.36 37.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.91 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.58 34.31 0.86 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.402 ' C ' ' HG ' ' A' ' 127' ' ' SER . 15.9 m -85.75 155.8 20.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.115 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.745 HG13 ' HB3' ' A' ' 127' ' ' SER . 0.2 OUTLIER -110.9 107.18 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.59 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.572 HG22 ' HG2' ' A' ' 80' ' ' LYS . 11.6 t -119.48 152.45 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.401 0.62 . . . . 0.0 112.108 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.769 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -165.55 128.69 2.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.968 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.542 HG23 ' OG ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -112.07 132.43 60.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.337 0.589 . . . . 0.0 111.739 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.098 HD23 HD11 ' A' ' 48' ' ' ILE . 1.1 tp -127.96 140.17 52.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.513 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -48.88 128.44 15.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.426 0.155 . . . . 0.0 110.761 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.487 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -78.72 86.94 4.64 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.545 0.688 . . . . 0.0 110.441 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.46 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -126.03 171.41 10.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.403 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.35 -14.35 0.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.201 0.524 . . . . 0.0 109.739 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.679 ' HG3' HD21 ' A' ' 96' ' ' LEU . 2.6 tt0 -72.53 -63.83 1.08 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.088 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.098 HD11 HD23 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -61.66 -44.92 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.169 0.509 . . . . 0.0 110.139 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -42.44 -55.89 3.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.588 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.815 HG21 ' HG ' ' A' ' 95' ' ' LEU . 75.8 m -67.0 -77.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.967 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -39.7 -55.15 1.96 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.102 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.57 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.5 tp -45.81 -45.7 5.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.076 0.465 . . . . 0.0 109.839 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.631 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.4 pt-20 -57.12 -40.54 77.28 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.743 ' HA ' HG23 ' A' ' 58' ' ' THR . 2.9 mp0 -81.75 -91.8 0.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.547 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.967 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.78 -54.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.879 ' O ' ' HB2' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -72.71 -42.53 64.09 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.631 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -83.14 -45.93 13.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.279 0.561 . . . . 0.0 110.696 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.743 HG23 ' HA ' ' A' ' 54' ' ' GLU . 69.5 p -53.61 -70.47 0.09 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.993 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.591 ' O ' ' HB ' ' A' ' 64' ' ' VAL . 5.4 m-20 -89.66 -30.43 18.11 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.879 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 32.0 m-85 -80.15 -24.67 40.26 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.524 1.056 . . . . 0.0 111.566 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 2.2 tptt -90.39 -47.66 7.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.052 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.641 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER -56.08 -47.46 77.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.752 0.31 . . . . 0.0 111.226 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.703 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -179.52 102.2 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.983 0.42 . . . . 0.0 111.282 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -179.92 -57.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.718 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.574 ' N ' HG12 ' A' ' 64' ' ' VAL . 1.1 m120 178.65 127.8 0.21 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.608 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -85.21 -17.33 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.658 2.239 . . . . 0.0 111.908 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.684 HG21 HD22 ' A' ' 82' ' ' ASN . 1.8 t -57.41 -49.91 74.69 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.561 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.827 HG11 ' CD1' ' A' ' 60' ' ' TYR . 2.9 p -42.73 87.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.09 0.472 . . . . 0.0 111.194 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.2 p30 -115.25 142.57 46.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.303 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.44 HG23 HG23 ' A' ' 79' ' ' ILE . 0.7 OUTLIER -96.97 153.2 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 121.187 0.518 . . . . 0.0 111.622 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -142.9 123.34 13.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.121 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -79.86 114.35 18.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.295 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -93.73 -71.28 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.368 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.09 -69.94 0.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.128 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.24 4.55 9.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.814 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.48 149.78 39.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.834 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.835 ' CD1' HG21 ' A' ' 48' ' ' ILE . 74.9 m95 -77.45 142.72 39.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.571 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.564 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.7 m0 -107.67 106.63 17.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.27 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.769 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.19 110.87 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.082 0.468 . . . . 0.0 110.142 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.572 ' HG2' HG22 ' A' ' 39' ' ' VAL . 5.0 mtpt -116.51 135.52 53.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.046 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.56 ' HB3' ' CG2' ' A' ' 85' ' ' ILE . . . -144.46 159.26 43.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.793 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.684 HD22 HG21 ' A' ' 67' ' ' THR . 0.0 OUTLIER -96.8 148.32 23.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.959 0.409 . . . . 0.0 111.352 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.87 -69.73 0.42 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.343 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.729 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -179.58 161.46 1.03 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.913 0.387 . . . . 0.0 110.883 -179.377 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.812 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -141.08 155.77 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.801 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.7 ' HB3' HG23 ' A' ' 124' ' ' THR . 13.2 pt-20 -140.31 124.01 17.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.018 0.437 . . . . 0.0 111.481 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.882 HG13 HG13 ' A' ' 55' ' ' ILE . 24.8 t -93.67 143.86 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.581 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 6.3 t70 -88.25 151.73 22.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.012 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 54.0 t -111.78 100.51 8.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.047 0.451 . . . . 0.0 109.86 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 3.1 t70 162.41 -36.14 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.932 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.24 -68.05 0.56 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.984 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.574 ' HB ' ' CD2' ' A' ' 51' ' ' PHE . 1.6 tt -59.32 -55.67 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.591 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.501 ' H ' HG23 ' A' ' 92' ' ' ILE . 19.9 p -48.81 -32.92 9.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.599 0.238 . . . . 0.0 111.628 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 1.2 mm-40 -62.55 -47.64 82.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.754 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.861 ' O ' HD13 ' A' ' 95' ' ' LEU . 2.3 tm? -90.05 -17.21 28.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.703 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.679 HD21 ' HG3' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -98.26 8.35 44.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.832 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 131.23 70.08 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.177 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -31.23 147.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.059 0.457 . . . . 0.0 111.836 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 64.21 18.22 11.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.082 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -71.87 -167.14 0.26 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.086 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -100.79 -164.08 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.664 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.901 HG23 ' CD1' ' A' ' 123' ' ' PHE . 1.5 p -113.15 -33.56 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.041 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.513 ' CZ ' HG22 ' A' ' 118' ' ' THR . 20.3 m-85 -80.1 5.59 13.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.327 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.459 ' O ' HG12 ' A' ' 107' ' ' VAL . 25.1 p-10 -59.4 -41.74 90.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.647 0.26 . . . . 0.0 110.968 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.542 ' HE2' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -60.73 -28.11 68.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.774 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.542 HD13 ' OG1' ' A' ' 112' ' ' THR . 3.1 tp -131.5 40.6 3.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.028 0.442 . . . . 0.0 110.938 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 104' ' ' ASP . 14.9 p -87.19 -36.29 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 178.65 69.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.486 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.604 HG11 ' HG ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -113.26 179.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.062 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.517 ' H ' HG12 ' A' ' 109' ' ' VAL . 0.9 OUTLIER -46.54 -43.84 17.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.067 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.542 ' OG ' HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER 170.68 165.25 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.982 0.42 . . . . 0.0 111.301 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 42.4 p -159.08 80.67 0.77 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.85 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.441 ' HA ' HD13 ' A' ' 113' ' ' ILE . 5.1 mm -58.95 105.09 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.49 0.662 . . . . 0.0 111.286 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' A' ' 126' ' ' THR . . . 144.34 144.72 4.23 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.965 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.75 120.04 21.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.58 0.229 . . . . 0.0 110.493 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -99.81 125.31 45.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.97 0.414 . . . . 0.0 112.037 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.471 ' O ' ' CD1' ' A' ' 117' ' ' TYR . 1.7 p90 -131.45 122.36 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.361 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.81 ' OG1' HG21 ' A' ' 102' ' ' VAL . 15.2 t -103.33 158.9 16.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 111.882 -178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -167.78 134.32 2.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.356 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 55.45 -109.89 1.58 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.674 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.43 83.73 2.06 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 7.3 mttt 153.39 122.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.503 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.901 ' CD1' HG23 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -107.93 139.55 42.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.933 0.396 . . . . 0.0 110.444 179.214 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.7 HG23 ' HB3' ' A' ' 86' ' ' GLU . 37.6 m -114.24 130.04 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.44 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.812 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -112.31 117.78 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.794 0.806 . . . . 0.0 110.74 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 115' ' ' ARG . 1.4 t -98.31 156.34 16.77 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.504 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.745 ' HB3' HG13 ' A' ' 38' ' ' VAL . 71.7 p -150.0 30.96 0.7 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.65 -44.17 7.94 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.899 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.1 mp 62.09 106.57 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.18 0.514 . . . . 0.0 110.905 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 25.8 mtm -94.2 15.21 17.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.326 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.5 96.15 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.542 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.68 -48.84 75.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.918 0.39 . . . . 0.0 110.792 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.33 30.1 4.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.82 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -33.55 51.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.838 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -104.93 11.18 33.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.315 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 136' ' ' LEU . 8.2 tt -116.47 -5.58 11.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.057 0.456 . . . . 0.0 111.621 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -85.62 2.91 43.19 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.659 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 175.39 117.7 0.02 OUTLIER 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -141.08 179.22 6.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -175.3 141.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.963 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.084 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.765 0.317 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 m 62.62 119.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.3 m -63.34 -30.19 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.182 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.01 131.12 36.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.9 m -126.74 153.26 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -132.42 129.74 39.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.988 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.492 ' HB1' ' OD1' ' A' ' 9' ' ' ASP . . . -161.65 175.05 12.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.049 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.905 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -148.12 21.91 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.465 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.492 ' OD1' ' HB1' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -55.91 -15.69 3.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.064 0.459 . . . . 0.0 111.484 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.471 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -79.52 -17.23 54.52 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.413 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.66 -8.55 3.1 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.169 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.905 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.2 pp -60.52 -20.07 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 117.527 0.663 . . . . 0.0 111.871 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.471 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -84.76 8.64 16.49 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.742 177.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 18' ' ' LYS . . . -131.91 -34.37 0.39 Allowed Glycine 0 CA--C 1.518 0.268 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.477 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mp -77.15 -80.24 0.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.745 0.307 . . . . 0.0 111.002 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.48 9.94 29.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.967 0.413 . . . . 0.0 111.535 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.95 -27.14 2.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.948 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 1.4 tmtt? -130.14 85.29 2.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.719 0.771 . . . . 0.0 110.242 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -134.83 8.14 3.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.683 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 62.59 18.24 10.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.842 0.354 . . . . 0.0 111.384 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.29 -177.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.177 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.4 t0 63.87 12.0 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.79 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -146.41 11.58 1.15 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.943 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -83.37 -44.43 14.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.389 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -121.04 110.47 16.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.625 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.09 -123.71 0.07 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.158 0.504 . . . . 0.0 110.434 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.68 19.12 0.13 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.753 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -69.51 -25.56 64.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 66.2 16.09 10.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.258 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -120.04 136.15 54.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.923 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.5 p -87.42 140.34 15.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.094 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 p -109.87 134.57 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.411 ' O ' ' C ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -110.46 114.95 28.77 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.673 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 33' ' ' HIS . 0.3 OUTLIER 26.41 59.65 0.08 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.345 179.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.7 m -119.51 112.49 19.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -106.59 43.86 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 81' ' ' ALA . 30.4 m -75.23 146.36 41.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.831 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -90.58 102.36 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.103 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.823 ' C ' HD12 ' A' ' 40' ' ' LEU . 2.9 t -107.9 139.42 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.115 0.483 . . . . 0.0 111.543 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.823 HD12 ' C ' ' A' ' 39' ' ' VAL . 8.9 mp -136.42 104.27 5.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.036 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.62 127.03 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.363 0.602 . . . . 0.0 111.961 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.647 HD13 HD11 ' A' ' 48' ' ' ILE . 4.5 mt -127.67 145.41 50.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.746 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.0 119.99 4.9 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.488 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.77 91.08 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.427 0.632 . . . . 0.0 110.888 -178.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.445 ' C ' ' H ' ' A' ' 47' ' ' GLU . 50.0 m -125.93 170.3 11.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.451 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -53.65 -11.79 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.142 0.496 . . . . 0.0 109.793 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.655 ' HB2' HD11 ' A' ' 96' ' ' LEU . 1.9 tt0 -75.11 -65.47 0.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.492 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.695 HG21 ' CD1' ' A' ' 77' ' ' TRP . 0.4 OUTLIER -58.27 -44.47 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.3 0.571 . . . . 0.0 109.67 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -43.87 -53.72 5.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.345 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.528 HG21 ' CD1' ' A' ' 95' ' ' LEU . 25.9 m -79.93 -64.96 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.196 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.923 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -45.07 -46.9 11.83 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.372 -178.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.4 tp -61.44 -48.48 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.163 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -50.76 -38.99 51.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.048 0.451 . . . . 0.0 109.822 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.708 ' CA ' HG23 ' A' ' 58' ' ' THR . 2.8 mt-10 -82.89 -87.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.781 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.923 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -19.9 -56.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 179.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.0 ' HG ' HG12 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -72.98 -42.53 63.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.74 -46.35 13.27 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.623 -179.103 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.708 HG23 ' CA ' ' A' ' 54' ' ' GLU . 51.4 p -49.24 -72.61 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.57 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.442 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 0.9 OUTLIER -94.05 -25.92 16.99 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -177.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 1.006 ' CD2' HG11 ' A' ' 68' ' ' VAL . 7.7 m-85 -87.41 -1.37 57.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 119.306 -0.957 . . . . 0.0 112.737 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.584 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 2.5 tptt -118.06 -41.59 2.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.683 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.66 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.9 OUTLIER -58.91 -51.66 69.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.263 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.593 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -178.93 90.21 0.02 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.39 0.614 . . . . 0.0 112.012 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 63' ' ' ASN . 24.6 t -161.77 -53.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.505 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.491 ' HB3' HG22 ' A' ' 67' ' ' THR . 5.0 m-20 177.62 141.67 0.25 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.396 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.48 -23.34 2.82 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.77 2.314 . . . . 0.0 112.152 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.491 HG22 ' HB3' ' A' ' 65' ' ' ASN . 9.6 t -55.19 -38.44 68.38 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.302 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.006 HG11 ' CD2' ' A' ' 60' ' ' TYR . 82.2 t -61.9 74.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.64 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 67' ' ' THR . 16.0 p30 -116.0 142.29 46.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.973 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.544 HG23 HD12 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -96.54 149.38 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.389 0.614 . . . . 0.0 111.682 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.663 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.2 OUTLIER -143.75 123.53 13.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.573 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -88.44 114.84 25.47 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.107 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.407 ' NH1' ' CZ3' ' A' ' 78' ' ' TRP . 11.6 tpt180 -99.86 -100.04 0.24 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.618 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.31 -78.66 0.1 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.844 0.354 . . . . 0.0 111.27 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.68 -40.04 0.34 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.3 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.85 158.85 19.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.787 0.327 . . . . 0.0 110.545 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.695 ' CD1' HG21 ' A' ' 48' ' ' ILE . 75.4 m95 -77.43 126.32 30.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.527 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.663 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 10.7 m0 -96.69 109.97 22.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.289 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.702 ' CD1' ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -96.52 136.68 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -129.11 135.72 49.26 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.021 0.438 . . . . 0.0 112.153 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.831 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . . . -144.5 158.48 43.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.756 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.406 ' N ' ' OG1' ' A' ' 67' ' ' THR . 0.4 OUTLIER -115.06 127.39 55.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.95 0.405 . . . . 0.0 111.251 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 84.25 -68.31 3.54 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.902 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER 178.42 160.71 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.014 0.435 . . . . 0.0 111.347 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.907 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -151.53 160.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.436 179.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.726 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.3 OUTLIER -136.09 125.22 24.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.165 0.507 . . . . 0.0 111.693 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.604 HG23 HD11 ' A' ' 125' ' ' ILE . 99.6 t -92.31 144.65 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.524 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.43 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 5.7 m-20 -87.95 152.64 21.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.441 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 51.9 t -112.16 100.55 8.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.157 0.503 . . . . 0.0 109.743 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 10.0 t70 165.21 -36.51 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.773 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 94' ' ' GLU . 7.4 mt-10 -74.96 -69.31 0.48 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.59 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.549 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 0.7 OUTLIER -63.99 -54.51 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.475 ' H ' HG23 ' A' ' 92' ' ' ILE . 18.3 p -44.12 -30.69 0.8 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.133 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 3.2 mm-40 -68.51 -71.54 0.21 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.125 0.488 . . . . 0.0 110.235 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.528 ' CD1' HG21 ' A' ' 50' ' ' THR . 0.3 OUTLIER -62.31 -19.94 63.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.134 -179.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -98.06 -1.76 41.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.58 0.229 . . . . 0.0 111.395 -179.461 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' HA3' ' CD2' ' A' ' 100' ' ' PHE . . . 152.56 66.03 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.87 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -28.02 137.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.782 0.433 . . . . 0.0 112.123 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 64.17 19.66 11.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.541 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.463 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -58.55 -162.9 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.107 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -105.58 -85.74 0.48 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.998 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.848 HG21 ' OG1' ' A' ' 118' ' ' THR . 2.0 p 179.54 -54.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.667 0.27 . . . . 0.0 111.554 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.451 ' H ' HG13 ' A' ' 102' ' ' VAL . 6.8 m-85 -64.98 -13.24 57.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.652 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -47.36 -29.98 2.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.598 0.237 . . . . 0.0 111.469 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.622 ' O ' HG11 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -71.19 -30.09 65.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.034 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.661 HD22 ' HB3' ' A' ' 116' ' ' ALA . 0.9 OUTLIER -134.71 42.28 2.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.969 0.414 . . . . 0.0 110.92 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 108' ' ' ASP . 12.1 p -83.19 -45.67 18.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.119 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.487 ' N ' HG13 ' A' ' 107' ' ' VAL . 6.1 m-20 -160.05 31.0 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.622 HG11 ' O ' ' A' ' 105' ' ' PHE . 34.7 m -59.49 165.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.578 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.55 -46.27 66.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.023 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.741 ' O ' HG23 ' A' ' 112' ' ' THR . 0.5 OUTLIER -174.59 163.37 3.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.741 HG23 ' O ' ' A' ' 111' ' ' SER . 0.5 OUTLIER -177.18 85.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.138 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 113' ' ' ILE . 7.4 mm -60.45 113.45 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.359 0.599 . . . . 0.0 110.779 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 142.73 140.93 3.79 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.702 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.817 ' HB3' HG22 ' A' ' 126' ' ' THR . 26.3 ttp180 -79.65 119.62 22.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.622 0.249 . . . . 0.0 110.715 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.672 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -101.28 125.29 47.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.015 0.436 . . . . 0.0 111.776 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.465 ' O ' ' CD1' ' A' ' 117' ' ' TYR . 30.9 p90 -132.71 116.55 16.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.521 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.848 ' OG1' HG21 ' A' ' 102' ' ' VAL . 14.8 t -83.03 163.17 21.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.313 0.577 . . . . 0.0 111.992 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.4 pp -170.16 115.57 0.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.578 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.64 -107.1 1.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.571 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.26 83.66 2.04 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.8 OUTLIER 152.04 109.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.598 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.706 ' CD1' HG23 ' A' ' 102' ' ' VAL . 1.1 p90 -95.16 139.74 31.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.873 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.726 HG23 ' HB3' ' A' ' 86' ' ' GLU . 45.1 m -111.31 127.18 55.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.359 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.907 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -108.6 118.14 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.857 0.837 . . . . 0.0 110.737 178.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.817 HG22 ' HB3' ' A' ' 115' ' ' ARG . 2.6 t -96.82 155.8 16.62 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.728 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.775 ' HB2' HG13 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -149.07 23.74 0.94 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.267 0.556 . . . . 0.0 109.615 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -121.77 -167.53 1.55 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.316 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.5 mp 64.76 107.13 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.224 0.535 . . . . 0.0 110.852 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 mtp -115.91 15.66 16.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.311 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 113.74 107.67 2.79 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.548 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.3 mp -140.19 -59.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.802 0.334 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.408 ' HA ' ' HB2' ' A' ' 136' ' ' LEU . 11.1 m-20 60.2 24.52 13.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.079 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.77 -58.39 5.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.593 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -117.05 32.51 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.482 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 136' ' ' LEU . 6.7 tp -92.18 -147.61 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.846 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -40.88 -32.81 0.25 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.771 0.319 . . . . 0.0 111.626 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -106.8 102.25 11.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.997 0.427 . . . . 0.0 110.909 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.408 ' O ' ' CG ' ' A' ' 140' ' ' HIS . 0.1 OUTLIER -166.8 -176.51 3.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.914 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.408 ' CG ' ' O ' ' A' ' 139' ' ' TYR . 54.8 m80 -160.68 125.76 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.95 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.088 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.842 0.354 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 m -147.13 -64.01 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.5 t -83.68 77.51 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -100.93 151.09 22.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.4 m -61.22 136.76 58.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 63.12 116.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.071 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -123.37 -168.82 1.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.957 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.916 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -138.34 20.55 2.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.581 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.5 ' HA ' HG12 ' A' ' 12' ' ' ILE . 2.3 m-20 -57.31 -13.78 3.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.149 0.5 . . . . 0.0 111.566 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.463 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -79.17 -18.65 52.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.443 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.417 ' HA3' ' CE1' ' A' ' 8' ' ' TYR . . . -130.31 -9.42 2.98 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.232 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.916 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.2 pp -59.06 -20.78 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 117.637 0.719 . . . . 0.0 111.883 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.463 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -85.76 9.33 16.78 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.915 178.118 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.402 ' HA2' ' CB ' ' A' ' 18' ' ' LYS . . . -142.81 -50.52 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.623 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.55 -77.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.752 0.311 . . . . 0.0 111.056 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.22 10.73 28.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.021 0.439 . . . . 0.0 111.397 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.68 -22.47 4.33 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.134 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.402 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -128.85 80.74 1.99 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.12 0.486 . . . . 0.0 110.408 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -138.02 9.06 2.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.61 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 63.3 18.51 11.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.359 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.34 -178.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t70 63.58 13.03 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.12 0.485 . . . . 0.0 110.617 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -152.27 13.84 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.214 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -89.84 -46.6 8.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.358 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -118.5 110.37 17.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.453 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.78 -114.87 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.109 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 t0 74.2 15.26 3.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.407 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.64 -21.67 54.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.07 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 68.02 15.08 9.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.378 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -96.64 136.33 37.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.783 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -118.13 138.96 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.295 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.424 HG21 ' OG ' ' A' ' 35' ' ' SER . 10.6 p -109.92 135.01 50.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.808 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -109.87 115.29 29.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.191 0.52 . . . . 0.0 110.73 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 35.78 61.92 0.68 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.963 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.424 ' OG ' HG21 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -72.39 108.91 5.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.891 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -151.48 31.62 0.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.0 m -115.79 141.76 47.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.759 HG13 ' HB3' ' A' ' 127' ' ' SER . 0.2 OUTLIER -88.88 93.75 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.992 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.727 HG22 ' HG2' ' A' ' 80' ' ' LYS . 3.7 t -105.67 147.54 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.225 0.536 . . . . 0.0 111.854 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.83 ' O ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -157.64 120.59 3.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.884 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.54 130.29 67.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.339 0.59 . . . . 0.0 112.116 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.982 HD22 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -127.05 139.86 52.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.429 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -54.29 132.03 42.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.484 ' CD ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -61.88 89.22 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.505 0.669 . . . . 0.0 109.975 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 47' ' ' GLU . 14.8 m -125.86 170.62 11.45 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.905 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -52.77 -11.75 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 109.931 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.835 ' CB ' HD21 ' A' ' 96' ' ' LEU . 3.6 tt0 -69.33 -75.5 0.11 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.245 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.982 HD11 HD22 ' A' ' 42' ' ' LEU . 3.8 mm -53.81 -39.87 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 24.4 m120 -43.48 -57.74 2.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.376 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.75 ' CB ' HD22 ' A' ' 95' ' ' LEU . 53.5 m -85.73 -57.63 2.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.605 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.933 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -47.23 -45.53 23.58 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.766 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.666 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.3 tp -65.56 -49.23 79.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.863 0.363 . . . . 0.0 110.272 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.3 pt-20 -53.41 -40.55 65.2 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.098 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.714 ' O ' HG23 ' A' ' 58' ' ' THR . 23.7 mm-40 -80.37 -70.08 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.942 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.933 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -37.86 -59.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.724 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -72.52 -36.61 68.38 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.69 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -84.0 -46.81 11.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.517 -0.739 . . . . 0.0 110.916 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.715 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 71.6 p -50.0 -70.86 0.08 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.223 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 7.3 m-20 -94.35 -29.3 15.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.953 ' CG ' HG11 ' A' ' 68' ' ' VAL . 2.3 m-85 -83.83 -1.61 54.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.534 -0.867 . . . . 0.0 112.711 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.598 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -118.87 -40.41 2.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.785 178.518 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.715 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -58.23 -50.2 74.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.707 0.289 . . . . 0.0 111.289 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.527 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER 179.57 89.29 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.212 0.53 . . . . 0.0 111.276 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.622 HG11 ' CE1' ' A' ' 60' ' ' TYR . 9.7 t -158.94 -58.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.54 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.481 ' HB3' HG22 ' A' ' 67' ' ' THR . 3.8 m-20 174.25 145.92 0.21 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.894 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -89.14 -19.36 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.046 2.497 . . . . 0.0 112.462 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -47.15 -64.26 0.83 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.321 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.953 HG11 ' CG ' ' A' ' 60' ' ' TYR . 1.7 p -41.73 87.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 121.048 0.451 . . . . 0.0 110.96 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.8 p30 -116.22 142.57 46.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.479 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.507 HG23 HG23 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -97.0 153.23 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.105 0.479 . . . . 0.0 111.531 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.57 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.6 OUTLIER -142.65 118.74 10.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.241 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.27 114.64 24.05 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.445 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.44 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 3.8 mmp_? -101.58 -117.42 0.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.239 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.97 -36.35 76.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.79 0.329 . . . . 0.0 111.272 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.88 -37.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.641 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -82.79 162.0 21.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.961 0.41 . . . . 0.0 110.618 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.636 ' CD1' HG21 ' A' ' 48' ' ' ILE . 50.0 m95 -86.01 140.56 30.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.742 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.57 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.4 m0 -110.97 108.7 18.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.39 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.83 HG12 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -98.47 116.21 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.629 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.727 ' HG2' HG22 ' A' ' 39' ' ' VAL . 11.4 mtmt -119.46 136.39 54.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.08 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.422 ' HB3' ' CG2' ' A' ' 85' ' ' ILE . . . -143.41 158.71 43.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.015 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.69 137.6 44.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 111.358 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.07 -69.83 3.19 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.926 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.406 ' HA ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER 179.86 158.62 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 0.0 111.041 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.747 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -143.85 160.53 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.745 ' HB3' HG23 ' A' ' 124' ' ' THR . 0.1 OUTLIER -140.71 125.2 17.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 111.643 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.881 HG13 HG13 ' A' ' 55' ' ' ILE . 18.0 t -94.66 138.55 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.641 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 122' ' ' LYS . 5.3 m-20 -80.51 152.24 28.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.207 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 46.9 t -113.11 100.85 8.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 109.958 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 1.5 m-20 161.88 -37.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.27 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 94' ' ' GLU . 6.8 mt-10 -72.5 -68.59 0.46 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.697 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.625 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.4 tt -58.55 -58.26 7.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.273 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.533 ' H ' HG23 ' A' ' 92' ' ' ILE . 44.7 p -45.28 -34.14 2.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.553 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 0.5 OUTLIER -61.26 -47.34 86.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 110.359 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.75 HD22 ' CB ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -90.11 -17.0 28.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.785 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.835 HD21 ' CB ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -98.01 9.47 42.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.933 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 129.28 69.69 0.12 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.309 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -34.8 149.09 0.02 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.059 0.457 . . . . 0.0 111.439 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.88 17.66 10.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.149 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.432 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -69.57 -167.84 0.15 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.679 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -131.2 135.16 47.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.84 0.353 . . . . 0.0 110.966 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.772 HG21 ' OG1' ' A' ' 118' ' ' THR . 8.1 p -51.14 166.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.934 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.51 ' H ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER 79.38 1.87 2.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.895 -179.169 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.799 ' O ' HG12 ' A' ' 107' ' ' VAL . 8.2 t0 -73.77 -31.71 63.44 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.984 0.421 . . . . 0.0 110.232 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.469 ' CE1' ' HB2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -64.82 -26.03 68.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.772 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 0.5 OUTLIER -127.69 30.65 5.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.624 179.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.799 HG12 ' O ' ' A' ' 104' ' ' ASP . 9.2 p -83.05 -34.71 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.166 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.569 ' OD1' HG13 ' A' ' 107' ' ' VAL . 49.8 p30 -178.12 39.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.797 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.612 HG11 HD11 ' A' ' 42' ' ' LEU . 12.0 m -70.86 172.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.374 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.52 -44.43 56.26 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.166 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.2 m 172.95 157.7 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -178.95 122.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.926 0.393 . . . . 0.0 111.639 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 113' ' ' ILE . 9.4 mm -92.56 121.12 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.3 0.571 . . . . 0.0 111.005 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.46 143.07 3.78 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.954 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -77.78 120.23 22.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.783 0.325 . . . . 0.0 110.39 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -101.09 125.22 47.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.065 0.46 . . . . 0.0 111.929 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.472 ' O ' ' CD1' ' A' ' 117' ' ' TYR . 4.8 p90 -136.08 121.36 19.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.462 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.772 ' OG1' HG21 ' A' ' 102' ' ' VAL . 15.3 t -105.0 142.45 34.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.339 0.59 . . . . 0.0 111.995 -178.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.857 ' O ' HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -148.24 125.69 11.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.652 179.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.99 -110.84 3.68 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.671 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.49 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -135.09 83.84 2.05 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.1 OUTLIER 153.22 101.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.747 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.641 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 8.4 p90 -88.67 128.88 35.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.102 0.477 . . . . 0.0 110.98 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.745 HG23 ' HB3' ' A' ' 86' ' ' GLU . 29.9 m -103.07 132.48 49.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.117 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.795 HD11 HG23 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -114.88 118.67 59.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.924 0.869 . . . . 0.0 110.979 179.146 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 115' ' ' ARG . 5.4 t -96.3 156.28 16.41 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.456 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.759 ' HB3' HG13 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -138.05 14.84 2.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.383 0.611 . . . . 0.0 109.542 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.04 -22.88 8.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.62 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.9 mp -92.42 16.06 12.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.348 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.99 15.72 23.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.288 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.496 ' O ' HD13 ' A' ' 132' ' ' LEU . . . -104.34 -102.13 2.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.497 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.648 ' N ' HD22 ' A' ' 132' ' ' LEU . 0.9 OUTLIER -121.55 61.31 0.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.781 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -114.53 32.98 5.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.933 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -65.13 -49.92 68.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.828 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.04 -7.95 28.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.382 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.707 HD13 ' CD1' ' A' ' 139' ' ' TYR . 5.3 mt 61.48 118.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.823 0.344 . . . . 0.0 110.95 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -96.93 -43.08 7.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.805 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -150.22 108.72 3.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.818 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.707 ' CD1' HD13 ' A' ' 136' ' ' LEU . 17.4 p90 -138.29 28.14 2.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.036 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.78 156.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.864 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.145 -179.974 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mmm . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.798 0.332 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -102.13 -73.78 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.7 m -112.64 -35.61 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.155 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -127.18 146.04 50.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.823 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.6 t -147.6 168.88 20.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -75.44 -177.02 3.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.91 121.62 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.179 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.888 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -103.29 21.71 15.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.378 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' HA ' HG12 ' A' ' 12' ' ' ILE . 11.0 m-20 -55.1 -16.77 3.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.114 0.483 . . . . 0.0 111.538 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.504 ' O ' ' HE1' ' A' ' 13' ' ' MET . . . -78.31 -16.09 58.08 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.485 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.73 -9.02 2.33 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.241 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.888 HG23 ' O ' ' A' ' 8' ' ' TYR . 2.1 pp -60.39 -20.39 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 CA-C-N 117.574 0.687 . . . . 0.0 111.811 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.504 ' HE1' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -82.92 7.55 15.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.877 178.143 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.96 21.07 0.44 Allowed Glycine 0 CA--C 1.519 0.332 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.57 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.6 -83.49 0.63 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.661 0.267 . . . . 0.0 110.608 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.0 9.26 40.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.084 0.468 . . . . 0.0 110.938 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.11 -15.76 8.25 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.985 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.01 81.26 2.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.017 0.437 . . . . 0.0 110.216 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -140.53 10.8 2.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.635 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.67 14.44 7.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.3 -169.86 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.844 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.12 14.97 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.041 0.448 . . . . 0.0 110.541 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -138.09 10.35 2.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.066 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.47 -57.49 2.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.582 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -120.14 110.88 17.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.627 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.51 -117.5 0.07 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.29 16.74 9.71 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.267 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -73.16 -27.92 61.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.012 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -108.18 14.29 25.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.441 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -141.43 152.32 44.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.953 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -110.83 135.32 50.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.991 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.0 p -109.9 134.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.855 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.408 ' O ' ' C ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -110.28 115.29 29.43 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.809 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 33' ' ' HIS . 1.2 mt-10 28.57 58.12 0.12 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.102 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.9 m -101.13 129.82 47.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.073 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -151.87 36.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.558 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.2 m -72.93 145.38 46.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.206 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.825 HG13 ' OG ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -99.41 99.18 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.606 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.792 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.9 t -112.0 152.44 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.33 0.586 . . . . 0.0 112.389 -178.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.792 HD23 ' O ' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -148.59 107.88 3.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.527 178.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -113.4 125.93 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.031 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.916 HD13 HG13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -128.63 148.66 50.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.133 178.127 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.32 127.53 17.51 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.489 ' HA ' ' CD1' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -66.3 90.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.535 0.684 . . . . 0.0 111.043 -179.023 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.464 ' C ' ' N ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -125.94 171.36 10.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.956 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.89 -17.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.669 ' HG3' HD11 ' A' ' 96' ' ' LEU . 8.2 tt0 -62.02 -72.31 0.13 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.239 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.916 HG13 HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -59.75 -40.66 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -40.83 -59.48 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.409 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.655 HG21 ' HG ' ' A' ' 95' ' ' LEU . 2.4 m -79.47 -61.87 1.87 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.877 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.869 ' O ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -43.82 -45.52 7.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.237 -179.184 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 48' ' ' ILE . 1.7 tp -62.63 -47.23 93.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.862 0.363 . . . . 0.0 110.284 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.643 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -54.23 -41.18 68.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.516 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.637 ' O ' HG23 ' A' ' 58' ' ' THR . 7.4 mt-10 -81.07 -68.64 0.67 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.043 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.869 HG22 ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -37.17 -57.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.705 ' N ' HG23 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -74.85 -38.41 61.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.643 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -82.49 -46.88 12.86 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.884 -178.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.695 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 50.6 p -53.54 -69.81 0.11 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.489 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.452 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 20.5 m-20 -91.72 -29.66 16.7 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.82 ' CD1' HG21 ' A' ' 68' ' ' VAL . 8.4 m-85 -87.15 -2.07 58.36 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.427 -0.909 . . . . 0.0 113.236 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.567 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -117.75 -40.71 2.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.852 178.348 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.695 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -62.08 -49.98 73.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.611 ' O ' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -177.71 90.49 0.03 OUTLIER 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.507 0.67 . . . . 0.0 112.297 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.687 HG11 ' CE1' ' A' ' 60' ' ' TYR . 20.2 t -162.05 -54.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.076 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.555 ' HB3' HG22 ' A' ' 67' ' ' THR . 5.6 m-20 170.49 143.45 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.482 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.64 -16.43 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.981 2.454 . . . . 0.0 112.237 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 65' ' ' ASN . 14.7 t -53.16 -39.47 63.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.286 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.82 HG21 ' CD1' ' A' ' 60' ' ' TYR . 63.5 t -61.81 86.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.826 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 67' ' ' THR . 8.9 m-80 -115.43 142.44 46.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.859 0.361 . . . . 0.0 111.056 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.657 HG23 HD12 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -96.84 153.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 121.235 0.541 . . . . 0.0 111.548 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -142.08 117.98 10.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.787 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.3 114.52 18.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.645 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.518 ' HB2' ' CD1' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -95.23 -146.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.083 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.2 -73.57 0.08 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.629 0.252 . . . . 0.0 111.637 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . -126.42 12.48 7.07 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.479 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -142.83 158.66 43.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.086 0.443 . . . . 0.0 111.091 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.658 ' O ' HG12 ' A' ' 41' ' ' VAL . 58.7 m95 -80.73 142.75 33.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.229 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.606 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 8.0 m0 -115.79 108.5 16.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.635 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.822 HD13 ' N ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -96.89 127.21 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 135.83 49.66 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.947 0.403 . . . . 0.0 111.241 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.575 ' CB ' HG21 ' A' ' 85' ' ' ILE . . . -143.86 159.05 43.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.849 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -106.97 148.3 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.076 0.465 . . . . 0.0 111.328 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . 68.08 -69.85 0.32 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.331 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.422 ' CD ' ' N ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER 177.92 160.71 0.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.922 0.391 . . . . 0.0 111.02 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.956 ' O ' HD12 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -149.55 160.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.956 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.548 ' CB ' ' HB ' ' A' ' 124' ' ' THR . 1.0 OUTLIER -138.14 126.1 22.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.128 0.49 . . . . 0.0 111.414 -179.501 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.643 ' HB ' ' CE2' ' A' ' 123' ' ' PHE . 23.0 t -94.49 146.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.603 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.433 ' HA ' ' CG ' ' A' ' 122' ' ' LYS . 8.8 t70 -90.11 152.15 21.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.103 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.472 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 49.8 t -109.46 100.74 9.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.295 0.569 . . . . 0.0 109.745 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 89' ' ' CYS . 0.7 OUTLIER 162.45 -35.98 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.979 -179.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -74.26 -71.85 0.31 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.748 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.637 ' HB ' ' CD1' ' A' ' 51' ' ' PHE . 1.0 OUTLIER -57.11 -56.35 15.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.449 ' H ' HG23 ' A' ' 92' ' ' ILE . 15.1 p -46.62 -35.62 6.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.734 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.9 OUTLIER -60.19 -46.21 90.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.098 0.475 . . . . 0.0 110.367 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.814 ' O ' HD13 ' A' ' 95' ' ' LEU . 1.1 tm? -90.17 -17.62 27.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.601 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.669 HD11 ' HG3' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -99.7 12.33 36.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.974 0.416 . . . . 0.0 110.999 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.418 ' O ' ' CD1' ' A' ' 100' ' ' PHE . . . 126.29 69.52 0.18 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.279 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -35.11 148.61 0.02 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.08 0.467 . . . . 0.0 111.66 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 64.8 17.48 11.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.342 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -69.65 -177.58 1.26 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.607 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -81.81 -91.87 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.98 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.689 HG21 ' OG1' ' A' ' 118' ' ' THR . 2.7 p 179.42 -42.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.688 0.28 . . . . 0.0 111.1 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.684 ' CE2' HG22 ' A' ' 118' ' ' THR . 4.9 m-85 -71.71 -6.69 43.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.367 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.71 -34.24 18.26 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.782 0.325 . . . . 0.0 111.026 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.533 ' CD1' ' CE2' ' A' ' 123' ' ' PHE . 0.0 OUTLIER -60.54 -34.95 74.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.631 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.503 HD13 ' OG1' ' A' ' 112' ' ' THR . 5.6 tp -133.21 41.89 3.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.473 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.9 p -81.59 -39.83 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.298 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -166.14 31.47 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.002 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.402 HG11 HD23 ' A' ' 42' ' ' LEU . 29.5 m -65.07 174.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.295 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -55.96 -42.47 76.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.9 OUTLIER 171.65 151.72 0.06 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.213 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.503 ' OG1' HD13 ' A' ' 106' ' ' LEU . 65.8 p -159.88 98.51 1.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.906 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 113' ' ' ILE . 17.1 mm -65.89 127.31 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 0.0 110.966 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.81 144.48 5.37 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.041 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.521 ' HB2' HG23 ' A' ' 126' ' ' THR . 0.0 OUTLIER -76.84 120.55 22.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.7 0.286 . . . . 0.0 110.414 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.457 ' HB2' HG23 ' A' ' 125' ' ' ILE . . . -106.9 124.59 49.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.129 0.49 . . . . 0.0 112.263 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.529 ' CZ ' HG23 ' A' ' 124' ' ' THR . 2.0 p90 -137.04 119.29 15.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.296 178.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.689 ' OG1' HG21 ' A' ' 102' ' ' VAL . 10.9 t -99.81 142.71 30.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.251 0.548 . . . . 0.0 111.969 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -146.38 133.11 19.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.507 179.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 56.9 -112.02 3.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.611 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.503 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -134.9 84.06 2.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 121' ' ' ASN . 0.4 OUTLIER 152.11 100.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.526 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.643 ' CE2' ' HB ' ' A' ' 87' ' ' VAL . 14.2 p90 -88.28 133.08 34.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.17 0.509 . . . . 0.0 110.949 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.548 ' HB ' ' CB ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -107.93 130.67 55.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.858 -179.458 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.956 HD12 ' O ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -112.82 118.58 58.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.891 0.853 . . . . 0.0 111.368 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.521 HG23 ' HB2' ' A' ' 115' ' ' ARG . 9.1 t -97.24 155.59 16.79 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.087 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.825 ' OG ' HG13 ' A' ' 38' ' ' VAL . 2.2 m -146.02 19.28 1.43 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.256 0.551 . . . . 0.0 109.842 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -123.68 -178.45 4.04 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.246 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 63.05 17.66 10.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.26 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.9 ttt -95.56 15.81 18.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.379 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -137.93 -88.86 0.21 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.447 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mp 63.69 -78.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.78 0.324 . . . . 0.0 111.015 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.541 ' HA ' HD13 ' A' ' 136' ' ' LEU . 32.7 p30 -109.76 35.17 3.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.806 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.7 mmm-85 -63.94 -44.51 92.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.445 ' H ' HD12 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -114.64 24.91 11.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.013 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 136' ' ' LEU . 0.3 OUTLIER -136.99 11.87 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 111.434 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -50.0 -28.8 7.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.205 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.03 15.86 3.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.289 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -85.54 103.71 14.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.863 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -98.23 167.22 11.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.158 179.982 . . . . . . . . 0 0 . 1 stop_ save_